1 00:00:06,289 --> 00:00:07,157 GOOD MORNING, 2 00:00:07,157 --> 00:00:10,860 EVERYONE. WELCOME TO THE 64TH 3 00:00:10,860 --> 00:00:15,732 MEETING OF THE NATIONAL ADVISORY 4 00:00:15,732 --> 00:00:20,370 COUNCIL FOR BIO MEDICAL 5 00:00:20,370 --> 00:00:22,105 ENGINEERING. I'M DAVID GEORGE, 6 00:00:22,105 --> 00:00:25,375 THE ASSOCIATE DIRECTOR AND 7 00:00:25,375 --> 00:00:25,909 EXECUTIVE MEMBER OF THIS 8 00:00:25,909 --> 00:00:29,012 COMMITTE. THIS IS OPEN TO THE 9 00:00:29,012 --> 00:00:31,748 PUBLIC EXCEPT FOR PENDING GRANTS 10 00:00:31,748 --> 00:00:33,650 THIS AFTERNOON. THE OPENING 11 00:00:33,650 --> 00:00:38,721 SESSION IS BEING LIVE-BROADCAST 12 00:00:38,721 --> 00:00:40,990 ON THE NIH VIDEOCAST AND 13 00:00:40,990 --> 00:00:42,892 RECORDED FOR ARCHIVES. THE 14 00:00:42,892 --> 00:00:45,962 COMMUNITY AND PRESENT ERS ARE 15 00:00:45,962 --> 00:00:48,798 PRESENTING THE CONFERENCE. WE 16 00:00:48,798 --> 00:00:50,233 WELCOME ALL. THANK YOU TO ALL 17 00:00:50,233 --> 00:00:53,636 WHO ARE WATCHING ON THE 18 00:00:53,636 --> 00:00:55,939 VIDEOCAST. MEMBERS OF THE PUBLIC 19 00:00:55,939 --> 00:00:58,208 WHO RUSH TO EXPRESS VIEWS 20 00:00:58,208 --> 00:00:59,776 REGARDING ANY ITEMS DISCUSSED 21 00:00:59,776 --> 00:01:02,445 DURING THIS MEETING MAY DO SO IN 22 00:01:02,445 --> 00:01:05,548 WRITING WITHIN THE NEXT TEN DAYS 23 00:01:05,548 --> 00:01:15,992 BY EMAILING ME AT INFO 24 00:01:20,663 --> 00:01:26,603 INFO @ NIBIB.NIH.GOV. PLEASE PUT 25 00:01:26,603 --> 00:01:28,972 NIBIB COUNSEL IN THE SUBJECT 26 00:01:28,972 --> 00:01:31,074 LINE OF THE EMAIL. ALTHOUGH 27 00:01:31,074 --> 00:01:33,109 EVERYONE IS NOW WELL-VERSE ED IN 28 00:01:33,109 --> 00:01:34,811 VIDEO CONFERENCING IN RECENT 29 00:01:34,811 --> 00:01:38,081 YEARS I WILL REMIND EVERYONE TO 30 00:01:38,081 --> 00:01:39,349 PLEASE MUTE YOURSELF WHEN NOT 31 00:01:39,349 --> 00:01:41,851 SPEAKING. FOR COLLEAGUES AND 32 00:01:41,851 --> 00:01:43,253 GUESTS WHO ARE PRESENTING 33 00:01:43,253 --> 00:01:44,754 REMEMBER TO PRESENT FROM THE 34 00:01:44,754 --> 00:01:47,390 FILE ON YOUR COMPUTER'S HARD 35 00:01:47,390 --> 00:01:50,627 DRIVE RATHER THAN NETWORK DRIVE. 36 00:01:50,627 --> 00:01:56,499 BE LAUGHING LOGGED OFF VPN WHEN 37 00:01:56,499 --> 00:01:58,668 PRESENTING AND SHUT DOWN 38 00:01:58,668 --> 00:02:00,203 UNNECESSARY SOFTWARE. THE CHAT 39 00:02:00,203 --> 00:02:02,539 BOX IN ZOOM IS ENABLED TO CHAS 40 00:02:02,539 --> 00:02:05,842 WITH OUR HOST, MR. RYAN DAVA. HE 41 00:02:05,842 --> 00:02:08,044 IS MANAGING OUR VIDEO CONFERENCE 42 00:02:08,044 --> 00:02:10,413 TODAY. FOR TECHNICAL PROBLEMS 43 00:02:10,413 --> 00:02:12,382 DURING THE MEETING REACH OUT TO 44 00:02:12,382 --> 00:02:15,685 RYAN DIRECTLY IN THAT EMAIL. 45 00:02:15,685 --> 00:02:18,254 SO RYAN, IT IS -- YES, THANK 46 00:02:18,254 --> 00:02:19,923 YOU, RYAN. I DIDN'T HAVE THE 47 00:02:19,923 --> 00:02:23,626 CHAT TURNED ON. THANK YOU, RYAN. 48 00:02:23,626 --> 00:02:25,128 I'D LIKE TO NOTE WE HAVE A 49 00:02:25,128 --> 00:02:26,629 QUORUM FOR TODAY'S MEETING. WE 50 00:02:26,629 --> 00:02:28,798 ARE ANTICIPATING DR. JOYCE WONG 51 00:02:28,798 --> 00:02:33,403 TO JOIN US A LITTLE LATER. DR. 52 00:02:33,403 --> 00:02:36,339 GILDA BERABINO WILL BE UNABLE TO 53 00:02:36,339 --> 00:02:38,942 JOIN US TODAY. I WOULD LIKE TO 54 00:02:38,942 --> 00:02:40,944 THANK THE NIBIB COMMITTEE 55 00:02:40,944 --> 00:02:43,746 MANAGEMENT OFFICER PAM 56 00:02:43,746 --> 00:02:45,682 GLIBBINGMAN AND SPECIALIST 57 00:02:45,682 --> 00:02:48,051 ALICIA HOPKINS FOR ORGANIZING 58 00:02:48,051 --> 00:02:49,886 HELP. I WOULD LIKE TO RECOGNIZE 59 00:02:49,886 --> 00:02:53,356 RYAN DAVA, OUR NIBIB COLLEAGUE 60 00:02:53,356 --> 00:02:55,892 AND VIDEOCAST COLLEAGUE FOR 61 00:02:55,892 --> 00:02:58,194 WORKING IN ALL THE VIDEO 62 00:02:58,194 --> 00:02:59,762 ARRANGEMENTS. I WOULD ALSO LIKE 63 00:02:59,762 --> 00:03:04,334 TO THANK DR. CATHY SALAIDA, THE 64 00:03:04,334 --> 00:03:06,269 ASSOCIATE DIRECTOR FOR RESEARCH 65 00:03:06,269 --> 00:03:07,704 ADMINISTRATION FOR NIBIB FOR ALL 66 00:03:07,704 --> 00:03:10,640 HER HELP. HER DETAIL WITH NIBIB 67 00:03:10,640 --> 00:03:13,643 HAS CONCLUDED. WE REALLY 68 00:03:13,643 --> 00:03:21,451 PROSECUTE HER WILL-- APPRECIATE 69 00:03:21,451 --> 00:03:22,719 ANECDOTAL TO HELP OUT. THE WORK 70 00:03:22,719 --> 00:03:24,887 FOR THE ASSOCIATE DIRECTOR IS 71 00:03:24,887 --> 00:03:26,589 ONGOING. I WE HOPE TO MAKE AN 72 00:03:26,589 --> 00:03:28,258 ANNOUNCEMENT BY THE NEXT COUNCIL 73 00:03:28,258 --> 00:03:30,226 MEETING. I ALSO NEED TO POINT 74 00:03:30,226 --> 00:03:32,161 OUT THESE PROCEEDINGS ARE 75 00:03:32,161 --> 00:03:33,830 GOVERNED BY THE FEDERAL -- 76 00:03:33,830 --> 00:03:37,567 EXCUSE ME, FEDERAL ADVISORY 77 00:03:37,567 --> 00:03:40,637 COMMITTEE ACT, FACA, THE 78 00:03:40,637 --> 00:03:41,738 GOVERNMENT AND SUNSHINE ACT. 79 00:03:41,738 --> 00:03:43,439 THAT MEANS THIS MEETING IS A N 80 00:03:43,439 --> 00:03:47,277 ANNOUNCED TO THE PUBLIC IN THE 81 00:03:47,277 --> 00:03:47,577 F 82 00:03:47,577 --> 00:03:50,313 FEDERAL REGISTER AND HAS AN OPEN 83 00:03:50,313 --> 00:03:51,914 PORTION, WE ARE IN NOW AND 84 00:03:51,914 --> 00:03:52,949 CLOSED PORTION THIS AFTERNOON 85 00:03:52,949 --> 00:03:54,517 FOR DISCUSSION OF INDIVIDUAL 86 00:03:54,517 --> 00:03:55,785 APPLICATIONS. WE ANTICIPATE 87 00:03:55,785 --> 00:03:58,888 ADJOURNING THE OPEN SESSION AT 88 00:03:58,888 --> 00:04:02,458 ABOUT 2:00 P.M. TODAY. IN TERMS 89 00:04:02,458 --> 00:04:03,660 OF FUTURE COUNCIL DATE, I WOULD 90 00:04:03,660 --> 00:04:05,662 LIKE TO TAKE A MOMENT TO DRAW 91 00:04:05,662 --> 00:04:07,330 YOUR ATTENTION THAT THE FUTURE 92 00:04:07,330 --> 00:04:09,999 COUNCIL MEETING DATES ARE LISTED 93 00:04:09,999 --> 00:04:12,602 AT THE BOTTOM OF THE AGENDA. 94 00:04:12,602 --> 00:04:14,837 COUNCILMEMBERS, THEY WERE ALSO 95 00:04:14,837 --> 00:04:17,774 FOUND IN THE NIBIB COUNCIL TAB 96 00:04:17,774 --> 00:04:19,776 OF THE ELECTRONIC COUNCIL BOOK. 97 00:04:19,776 --> 00:04:21,210 REVIEW THE DATES, WHEN YOU HAVE 98 00:04:21,210 --> 00:04:24,580 A CHANCE. LET US KNOW WHEN YOU 99 00:04:24,580 --> 00:04:26,416 SEE A CONFLICT FOR ANY OF THESE 100 00:04:26,416 --> 00:04:29,819 DATES. OUR NEXT MEETING WILL BE 101 00:04:29,819 --> 00:04:32,288 MAY 15TH, 2024. THIS WILL BE AN 102 00:04:32,288 --> 00:04:34,924 IN-PERSON MEETING ON THE NIH 103 00:04:34,924 --> 00:04:37,327 CAMPUS. IT WILL BE IN THE PORTER 104 00:04:37,327 --> 00:04:38,494 BUILDING. OR BUILDING 35, FOR 105 00:04:38,494 --> 00:04:41,798 THOSE OF YOU IN THE KNOW. SO WE 106 00:04:41,798 --> 00:04:43,333 ARE LOOKING FORWARD TO 107 00:04:43,333 --> 00:04:45,902 EXPERIENCING COUNCIL ON CAMPUS. 108 00:04:45,902 --> 00:04:48,638 LOOKING INTO -- AHEAD INTO NEXT 109 00:04:48,638 --> 00:04:51,207 YEAR WE NOTE THAT THE CURRENT 110 00:04:51,207 --> 00:05:00,483 DATE FOR THE MAY 2025 MEETING 111 00:05:00,483 --> 00:05:00,817 OV 112 00:05:00,817 --> 00:05:03,586 OVERLAPS WITH THE ARM MEETING SO 113 00:05:03,586 --> 00:05:05,288 LOOKING AT MAY 2025 SO 114 00:05:05,288 --> 00:05:06,322 COUNCILMEMBERS, PLEASE STAND BY. 115 00:05:06,322 --> 00:05:07,724 WE WILL BE IN COMMUNICATION AND 116 00:05:07,724 --> 00:05:09,425 LET YOU KNOW WHEN WE HAVE FOUND 117 00:05:09,425 --> 00:05:11,694 AN IN-PERSON LOCATION FOR THAT 118 00:05:11,694 --> 00:05:14,664 MEETING AND UPDATE YOU 119 00:05:14,664 --> 00:05:15,798 ACCORDINGLY, THANK YOU. FINALLY 120 00:05:15,798 --> 00:05:16,899 I WOULD LIKE TO MOVE INTO 121 00:05:16,899 --> 00:05:21,637 CONSIDERATION OF THE MINUTES AND 122 00:05:21,637 --> 00:05:22,405 COUNCIL OPERATING PROCEDURES. IN 123 00:05:22,405 --> 00:05:24,040 PREPARATION FOR VOTING I ASK THE 124 00:05:24,040 --> 00:05:25,575 COUNCILMEMBER S IF YOU WOULD 125 00:05:25,575 --> 00:05:27,377 PLEASE UNMUTE YOURSELF SO YOU 126 00:05:27,377 --> 00:05:30,680 CAN CAST A VOICE VOTE. THE DRAFT 127 00:05:30,680 --> 00:05:32,849 MINUTES WERE MADE AVAILABLE TO 128 00:05:32,849 --> 00:05:36,652 YOU ABOUT TWO WEEKS AGO IN THE 129 00:05:36,652 --> 00:05:38,488 ECB. ARE THERE ANY COMMENTS OR 130 00:05:38,488 --> 00:05:41,791 MODIFICATIONS YOU WOULD LIKE TO 131 00:05:41,791 --> 00:05:45,795 MAKE TO THE MINUTE S? HEARING 132 00:05:45,795 --> 00:05:47,730 NONE,LY ENTERTAIN A MOTION TO 133 00:05:47,730 --> 00:05:47,997 APPROVE. 134 00:05:47,997 --> 00:05:51,300 >> MOTION TO APPROVE. 135 00:05:51,300 --> 00:05:54,437 >> A SECOND? 136 00:05:54,437 --> 00:05:56,606 >> SECOND IT. 137 00:05:56,606 --> 00:06:00,877 >> ALL IN FAVOR SAY AYE. ALL 138 00:06:00,877 --> 00:06:03,446 OPPOSED NAY. THE MOTION PASSES, 139 00:06:03,446 --> 00:06:05,348 THANK YOU. SIMILARLY FOR THE 140 00:06:05,348 --> 00:06:09,218 COUNCIL OPERATING PROCEDURES, 141 00:06:09,218 --> 00:06:11,154 EVERY JANUARY WE REAFFIRM 142 00:06:11,154 --> 00:06:12,855 COUNCIL PROCEDURES. THE DRAFT 143 00:06:12,855 --> 00:06:14,490 OPERATING PROCEDURES WERE MADE 144 00:06:14,490 --> 00:06:16,793 AVAILABLE TWO WEEKS AGO IN THE 145 00:06:16,793 --> 00:06:19,295 ECB. WE PROPOSED NOTE CHANGES TO 146 00:06:19,295 --> 00:06:21,030 THE OPERATING PROCEDURES THIS 147 00:06:21,030 --> 00:06:23,232 YEAR. ARE THERE ANY COMMENTS OR 148 00:06:23,232 --> 00:06:24,000 MODIFICATIONS YOU WOULD LIKE TO 149 00:06:24,000 --> 00:06:32,241 MAKE TO THE OPERATING 150 00:06:32,241 --> 00:06:36,012 PROCEDURES? MOTION TO APPROVE? 151 00:06:36,012 --> 00:06:37,847 AND IS THERE A SECOND? 152 00:06:37,847 --> 00:06:40,216 >> SECOND. 153 00:06:40,216 --> 00:06:45,955 >> ALL IN FAVOR AYE. ALL 154 00:06:45,955 --> 00:06:48,691 OPPOSED NAY. ALL RIGHT, THANK 155 00:06:48,691 --> 00:06:52,328 YOU. WITH THOSE INTRODUCTIONS IN 156 00:06:52,328 --> 00:06:54,030 ADMINISTRATIVE REMARKS WE WILL 157 00:06:54,030 --> 00:06:57,533 TURN THE PROCEEDINGS OVER TO 158 00:06:57,533 --> 00:06:59,936 NIBIB DIRECTOR DR. BRUCE 159 00:06:59,936 --> 00:07:01,637 TROMBERG, THANK YOU. 160 00:07:01,637 --> 00:07:02,705 >> BRUCE TROMBERG: THANK YOU, 161 00:07:02,705 --> 00:07:04,207 DAVE. MAYBE WE CAN TAKE THE 162 00:07:04,207 --> 00:07:07,243 SLIDE DOWN AND GO INTO OUR 163 00:07:07,243 --> 00:07:08,611 PRETEND LIKE WE ARE ALL IN THE 164 00:07:08,611 --> 00:07:10,947 SAME ROOM. I GUESS WE KNOW NOW 165 00:07:10,947 --> 00:07:12,782 THAT IT IS NOT JUST OUR 166 00:07:12,782 --> 00:07:13,883 IMAGINATIONS. WE HAVE 167 00:07:13,883 --> 00:07:15,852 EXPERIENCED THIS NOW A FEW 168 00:07:15,852 --> 00:07:17,753 TIMES. SO IT IS REALLY SHOULD BE 169 00:07:17,753 --> 00:07:20,756 A LITTLE EASIER PERHAPS OR MAYBE 170 00:07:20,756 --> 00:07:23,459 HARDER GOING BACK TO ZOOM AFTER 171 00:07:23,459 --> 00:07:25,261 WE HAVE DONE THAT. I HAVE TO 172 00:07:25,261 --> 00:07:26,829 ACKNOWLEDGE IT WAS A WISE 173 00:07:26,829 --> 00:07:28,664 DECISION, THANK YOU TO PAM AND 174 00:07:28,664 --> 00:07:31,801 ALICIA AND DAVE FOR ADVOCATING. 175 00:07:31,801 --> 00:07:34,770 SOMEHOW THEY FORESAW THE AMAZING 176 00:07:34,770 --> 00:07:37,406 STORM SYSTEM THAT HIT ALL OF US. 177 00:07:37,406 --> 00:07:40,009 WE STILL HAVE SEVERAL INCHES OF 178 00:07:40,009 --> 00:07:42,211 SNOW ON THE GROUND HERE. 179 00:07:42,211 --> 00:07:43,813 ALTHOUGH ALLEGEDLY IT IS 180 00:07:43,813 --> 00:07:44,981 DISAPPEARING MAYBE TODAY, 181 00:07:44,981 --> 00:07:46,182 PERHAPS TOMORROW. WE ARE 182 00:07:46,182 --> 00:07:48,084 HOPEFUL. SO I THINK IT WAS A 183 00:07:48,084 --> 00:07:51,587 GOOD MOVE. MAYBE A NEW 184 00:07:51,587 --> 00:07:54,156 TRADITION. AT LEAST FOR THE 185 00:07:54,156 --> 00:07:55,892 SHORT-TERM. THANK YOU, DAVE, FOR 186 00:07:55,892 --> 00:07:58,661 TAKING OVER THE REIGNS. BEFORE I 187 00:07:58,661 --> 00:08:01,464 START ANY COMMENTS OR ANYTHING 188 00:08:01,464 --> 00:08:03,466 FROM COUNCIL? I'M TRYING TO MAKE 189 00:08:03,466 --> 00:08:05,601 THIS AS CLOSE TO IN-PERSON AS 190 00:08:05,601 --> 00:08:06,769 POSSIBLE. I APPRECIATE ALL OF 191 00:08:06,769 --> 00:08:08,504 YOU FOR JOINING. PROBABLY DEEP 192 00:08:08,504 --> 00:08:10,406 DOWN INSIDE MANY OF YOU FEEL 193 00:08:10,406 --> 00:08:13,309 LIKE THIS IS ACTUALLY NOT TOO 194 00:08:13,309 --> 00:08:17,346 BAD, ROLLING INTO THE ZOOM 195 00:08:17,346 --> 00:08:19,348 MEETING, AS WELL LOWER BARRIER 196 00:08:19,348 --> 00:08:24,153 TO GETTING ON PLANES, HOTELS AND 197 00:08:24,153 --> 00:08:27,323 THINGS LIKE THAT. ALL RIGHT. 198 00:08:27,323 --> 00:08:28,858 NOTHING IN THE CHAT. THIS IS 199 00:08:28,858 --> 00:08:31,494 ALLOWING ME TO WASTE A LITTLE 200 00:08:31,494 --> 00:08:34,230 BIT OF TIME WHILE I FIND MY 201 00:08:34,230 --> 00:08:37,066 PRESENTATION. SO I WILL JUMP 202 00:08:37,066 --> 00:08:42,538 RIGHT INTO IT. I THINK -- LET ME 203 00:08:42,538 --> 00:08:45,908 GO INTO PRESENTATION MODE. 204 00:08:45,908 --> 00:08:48,945 HOPEFULLY EVERYBODY CAN SEE 205 00:08:48,945 --> 00:08:56,018 THAT. THIS ACTUALLY MARKS-YEAH, 206 00:08:56,018 --> 00:09:01,257 THANK YOU, DAVE. MY P FIRST 207 00:09:01,257 --> 00:09:02,325 PRESENTATION AS DIRECTOR WAS 208 00:09:02,325 --> 00:09:05,127 THREE YEARS AGO IN 2019, SO KIND 209 00:09:05,127 --> 00:09:08,331 OF MARKS A FIVE -- FIVE YEARS IS 210 00:09:08,331 --> 00:09:10,633 SORT OF THE MINIMUM PERIOD OF 211 00:09:10,633 --> 00:09:14,170 TIME THAT MOST DIRECTORS SERVE. 212 00:09:14,170 --> 00:09:15,838 IT IS THE MANDATORY 213 00:09:15,838 --> 00:09:17,273 CONGRESSIONAL REQUIREMENT FOR 214 00:09:17,273 --> 00:09:19,775 REVIEW OF DIRECTORS. SO I'VE 215 00:09:19,775 --> 00:09:22,244 JUST GONE THROUGH THAT. IT'S 216 00:09:22,244 --> 00:09:27,316 BEEN A GREAT PROCESS. LET ME GET 217 00:09:27,316 --> 00:09:30,686 STARTED AGAIN BY THANKING ONCE 218 00:09:30,686 --> 00:09:32,355 AGAIN BUILDING ON DAVE'S 219 00:09:32,355 --> 00:09:34,457 COMMENTS, PAM AND ALICIA FOR 220 00:09:34,457 --> 00:09:39,862 THEIR WONDERFUL JOB WITH COUNCIL 221 00:09:39,862 --> 00:09:41,831 ORGANIZATION. OUR SLIDE TIME, 222 00:09:41,831 --> 00:09:44,133 ASHA, KHALIL AND ALICE, THANK 223 00:09:44,133 --> 00:09:46,335 YOU FOR GIVING ME THE SUBSTRATE 224 00:09:46,335 --> 00:09:47,570 FOR PUTTING THIS TOGETHER AND 225 00:09:47,570 --> 00:09:49,472 WORKING WITH ALL OF OUR PROGRAM 226 00:09:49,472 --> 00:09:50,473 DIRECTORS AND OUR TEAM TO 227 00:09:50,473 --> 00:09:53,843 GENERATE THE IDEAS AND CONCEPTS 228 00:09:53,843 --> 00:09:55,311 FOR OUR INITIAL ROUND OF SLIDES. 229 00:09:55,311 --> 00:10:00,116 OUR SENIOR LEADERSHIP, JILL, 230 00:10:00,116 --> 00:10:02,885 DAVE AND RICHARD, MONU, CHRIS 231 00:10:02,885 --> 00:10:05,921 AND KATHY, WHOM DAVE MENTIONED. 232 00:10:05,921 --> 00:10:08,624 KATHY HAS FINISHED HER DETAIL. 233 00:10:08,624 --> 00:10:11,193 WE CURRENTLY HAVE A SEARCH GOING 234 00:10:11,193 --> 00:10:13,295 ON. AS DAVE MENTIONED WE HOPE TO 235 00:10:13,295 --> 00:10:15,564 BE ABLE TO ANNOUNCE A PERMANENT 236 00:10:15,564 --> 00:10:18,367 HIRING VERY SOON. KATHY HAS BEEN 237 00:10:18,367 --> 00:10:20,136 INSTRMENTAL IN PUTTING THIS 238 00:10:20,136 --> 00:10:23,205 COUNCIL TOGETHER, AS WELL AS 239 00:10:23,205 --> 00:10:26,676 PREVIOUS ONCE. WE ARE VERY 240 00:10:26,676 --> 00:10:29,645 GRATEFUL FOR OF HER EFFORTS. I 241 00:10:29,645 --> 00:10:31,247 WOULD LIKE TO START WITH THE 242 00:10:31,247 --> 00:10:32,882 LEAD STORY, WHICH PROBABLY ALL 243 00:10:32,882 --> 00:10:35,151 OF YOU PROBABLY ARE OF COURSE 244 00:10:35,151 --> 00:10:37,119 AWARE OF NOW, QUITE ACUTELY. I 245 00:10:37,119 --> 00:10:39,155 JUST WANT TO EMPHASIZE A FEW 246 00:10:39,155 --> 00:10:43,726 POINTS. MONICA WAS APPOINTED IN 247 00:10:43,726 --> 00:10:46,929 NOVEMBER, FINALLY, AFTER SENATE 248 00:10:46,929 --> 00:10:49,699 APPROVAL. SENATE SUBCOMMITTEE 249 00:10:49,699 --> 00:10:50,332 INTERROGATION OR QUESTIONING 250 00:10:50,332 --> 00:10:51,600 THAT WENT ON WITH THE FIRST 251 00:10:51,600 --> 00:10:53,602 QUESTION THAT CAME OUT OF THE 252 00:10:53,602 --> 00:10:56,772 HELP COMMITTEE, WHICH IS THE 253 00:10:56,772 --> 00:10:59,308 SUBCOMMITTEE THAT PUTS HER 254 00:10:59,308 --> 00:11:02,778 THROUGH THAT PROCESS OF ASKING 255 00:11:02,778 --> 00:11:05,981 DETAILED QUESTIONS. WAS HOW TO 256 00:11:05,981 --> 00:11:07,416 RESTORE THE TRUST IN SCIENCE AND 257 00:11:07,416 --> 00:11:09,018 WITH THE NIH. I WAS ACTUALLY 258 00:11:09,018 --> 00:11:10,486 QUITE SHOCKED AT. IF YOU HAVE 259 00:11:10,486 --> 00:11:12,021 TIME YOU SHOULD TAKE A LOOK AT 260 00:11:12,021 --> 00:11:15,624 THAT VIDEO ON C-SPAN. MONICA IS 261 00:11:15,624 --> 00:11:18,527 THE 17TH NIH DIRECTOR, THE FIRST 262 00:11:18,527 --> 00:11:19,495 SURGEON AND SECOND WOMAN TO HOLD 263 00:11:19,495 --> 00:11:29,939 THE POSITION. SHE HAS ABOUT 30, 264 00:11:29,939 --> 00:11:30,906 35-YEAR CAREER AS SURGEON. SHE 265 00:11:30,906 --> 00:11:35,177 WAS MEMBER OF THE BRIGHAM AND 266 00:11:35,177 --> 00:11:37,646 DANA FARBER. PRIOR, I THINK MOST 267 00:11:37,646 --> 00:11:41,150 OF YOU KNOW, SHE WAS THE NCI 268 00:11:41,150 --> 00:11:43,018 DIRECTOR. MONICA SPECIALIZED IN 269 00:11:43,018 --> 00:11:45,387 GI CANCERS AND HAD A VERY 270 00:11:45,387 --> 00:11:46,655 VIBRANT RESEARCH PROGRAM IN THAT 271 00:11:46,655 --> 00:11:49,225 AREA. WHAT MANY OF YOU MAY NOT 272 00:11:49,225 --> 00:11:51,560 KNOW IS THAT MONICA AS AN 273 00:11:51,560 --> 00:11:53,295 UNDERGRADUATE MAJORED IN 274 00:11:53,295 --> 00:11:56,132 CHEMICAL ENGINEERING AT 275 00:11:56,132 --> 00:11:59,568 PRINCETON. SHE ACTUALLY DID HER 276 00:11:59,568 --> 00:12:03,506 SENIOR RESEARCH ON TRANSFER 277 00:12:03,506 --> 00:12:06,675 ACROSS SEMI PERMEABLE MEMBRANES. 278 00:12:06,675 --> 00:12:10,212 SHE LOVES MASS TRANSPORT. HER 279 00:12:10,212 --> 00:12:13,082 FAVORITE EQUATION IS THE BERNULI 280 00:12:13,082 --> 00:12:13,349 EQUATION. 281 00:12:13,349 --> 00:12:15,618 WE ARE LUCKY TO HAVE MONICA. I 282 00:12:15,618 --> 00:12:17,653 WOULD LIKE TO SPEND A FEW 283 00:12:17,653 --> 00:12:18,988 MOMENTS SUMMARIZING -- EVERYONE 284 00:12:18,988 --> 00:12:22,658 HAS BEEN ASKING HER, WHAT IS 285 00:12:22,658 --> 00:12:23,959 YOUR PRIORITIES FOR NIH? WHAT IS 286 00:12:23,959 --> 00:12:25,561 GOING ON. HERE IT IS, STRAIGHT 287 00:12:25,561 --> 00:12:28,063 FROM MONICA. SHE'S ACTUALLY PUT 288 00:12:28,063 --> 00:12:31,867 ALL THE IC DIRECTORS THROUGH A 289 00:12:31,867 --> 00:12:34,103 SPRINT OVER THE LAST SIX WEEKS 290 00:12:34,103 --> 00:12:36,105 BECAUSE, AS SHE TOLD US, AFTER 291 00:12:36,105 --> 00:12:38,641 SHE WAS APPOINTED, THE EVOLUTION 292 00:12:38,641 --> 00:12:42,411 AND DECLARATION OF WHAT SHE 293 00:12:42,411 --> 00:12:45,047 BELIEVES IS MOST IMPORTANT IS 294 00:12:45,047 --> 00:12:46,348 NOT JUST SOMETHING THAT SHE WILL 295 00:12:46,348 --> 00:12:48,751 SORT OF SWOOP IN AND DECLARE BUT 296 00:12:48,751 --> 00:12:50,052 SOMETHING SHE REALLY WANTS TO 297 00:12:50,052 --> 00:12:52,221 BUILD CONSENSUS ABOUT WITH HER 298 00:12:52,221 --> 00:12:54,990 COLLEAGUES. THE LEADERSHIP AT 299 00:12:54,990 --> 00:12:57,259 NIH. HERE'S GUIDING PRINCIPLES 300 00:12:57,259 --> 00:12:59,728 SHE'S RECENTLY ARTICULATED AND 301 00:12:59,728 --> 00:13:01,096 HAS BEEN WORKING ON FOR SEVERAL 302 00:13:01,096 --> 00:13:04,066 WEEKS. THIS IS FROM MONICA: OUR 303 00:13:04,066 --> 00:13:06,936 WORK IS NOT FINISHED WHEN WE 304 00:13:06,936 --> 00:13:08,437 DELIVER SCIENTIFIC DISCOVERIES 305 00:13:08,437 --> 00:13:10,406 BUT FINISHED WHEN ALL ARE LIVING 306 00:13:10,406 --> 00:13:13,075 LONG AND HEALTHY LIVES. NIH 307 00:13:13,075 --> 00:13:15,211 RESEARCH ENCOMPASSES LABORATORY, 308 00:13:15,211 --> 00:13:16,212 CLINIC AND COMMUNITY. PATIENTS 309 00:13:16,212 --> 00:13:18,214 ARE PARTNERS IN DISCOVERY. TO 310 00:13:18,214 --> 00:13:20,649 TACKLE THE MOST PERSISTENT AND 311 00:13:20,649 --> 00:13:23,519 COMPLEX PROBLEMS, NIH AIMS TO 312 00:13:23,519 --> 00:13:25,654 BRING MORE MEMBERS OF THE PUBLIC 313 00:13:25,654 --> 00:13:27,590 INTO THE RESEARCH ENTERPRISE 314 00:13:27,590 --> 00:13:31,026 PARTNERS. INCOME, AGE, RACE, 315 00:13:31,026 --> 00:13:31,994 GEOGRAPHIC, DISABILITY STATUS 316 00:13:31,994 --> 00:13:35,064 SHOULD NOT BE BARRIERS FOR A 317 00:13:35,064 --> 00:13:36,398 PARTICIPATING IN RESEARCH OR 318 00:13:36,398 --> 00:13:38,434 BENEFIT ING FROM THE RESEARCH 319 00:13:38,434 --> 00:13:39,635 ADVANCES. SO YOU WILL HEAR HER 320 00:13:39,635 --> 00:13:41,437 VOICE AS SURGEON AND ENGINEER 321 00:13:41,437 --> 00:13:45,140 COMING THROUGH IN A LOT OF THESE 322 00:13:45,140 --> 00:13:48,143 STATEMENTS. YOU KNOW, REALLY 323 00:13:48,143 --> 00:13:50,079 UNDERSCORING OUR WORK IS NOT 324 00:13:50,079 --> 00:13:52,915 FINISHED WITH THE DISCOVERIES 325 00:13:52,915 --> 00:13:54,483 BUT FINISHED WHEN THE PRACTICAL 326 00:13:54,483 --> 00:13:56,285 APPLICATION ARE MOVING ALONG 327 00:13:56,285 --> 00:13:59,021 HEALTHY LIVES. PROGRESS IS 328 00:13:59,021 --> 00:14:00,923 ACCELERATED WHEN METHODS SUCH AS 329 00:14:00,923 --> 00:14:03,025 NEW ANALYTICS APPLIED TO 330 00:14:03,025 --> 00:14:05,327 EVERYONE. WHEN NEW DISCOVERIES 331 00:14:05,327 --> 00:14:06,629 ARE RAPIDLY AND EQUITABLY 332 00:14:06,629 --> 00:14:10,299 ADOPTED IN CLINICAL CARE. NIH IS 333 00:14:10,299 --> 00:14:12,401 COMMITTED TO HAR NASZING POWER 334 00:14:12,401 --> 00:14:15,371 OF AIML TO ADVANCE ACROSS 335 00:14:15,371 --> 00:14:18,007 DIVERSE FIELDS, DISEASES AND 336 00:14:18,007 --> 00:14:18,607 SCIENTIFIC COMMUNITIES SO I 337 00:14:18,607 --> 00:14:21,043 THINK THIS RESONATES WITH OUR 338 00:14:21,043 --> 00:14:23,178 COMMUNITY, ADVANCED SCIENTIFIC 339 00:14:23,178 --> 00:14:25,514 METHODS, NEW ANALYTICS AND 340 00:14:25,514 --> 00:14:27,316 TECHNOLOGIES. I WORKED HARD TO 341 00:14:27,316 --> 00:14:28,651 GET THAT WORD TECHNOLOGY IN 342 00:14:28,651 --> 00:14:30,552 THERE, IN HER LEXICON. I'M SO 343 00:14:30,552 --> 00:14:33,522 HAPPY TO SEE IT. ARE UNLOCKING 344 00:14:33,522 --> 00:14:35,057 POSSIBILITIES TO HARNESS DATA IN 345 00:14:35,057 --> 00:14:37,259 WAYS THAT ACHIEVE FASTER AND 346 00:14:37,259 --> 00:14:39,595 MORE DEFINITIVE RESULTS. NIH HAS 347 00:14:39,595 --> 00:14:41,897 LAUNCHED AND WILL CONTINUE TO 348 00:14:41,897 --> 00:14:45,634 LAUNCH INNOVATIVE AND AMBITIOUS 349 00:14:45,634 --> 00:14:48,070 FUSION OF BIOMEDICINE AND AL. ON 350 00:14:48,070 --> 00:14:50,139 THE BUDGET, WHICH EVERYONE IS 351 00:14:50,139 --> 00:14:52,308 CONCERNED ABOUT HERE ARE MONDAY 352 00:14:52,308 --> 00:14:55,311 DA'S COMMENTS: WE REMAIN HOPEFUL 353 00:14:55,311 --> 00:14:58,113 WE WILL NOT BE SUBJECT TO 354 00:14:58,113 --> 00:14:59,415 DRASTIC CUTS. HOWEVER EVEN A 355 00:14:59,415 --> 00:15:01,984 FLAT BUDGET WILL HAVE A 356 00:15:01,984 --> 00:15:03,385 SIGNIFICANT IMPACT. GREAT IDEAS 357 00:15:03,385 --> 00:15:05,821 AND POTENTIAL FOR NEW 358 00:15:05,821 --> 00:15:06,989 DISCOVERIES OBVIOUSLY WILL BE 359 00:15:06,989 --> 00:15:08,223 LOST. THERE IS A REAL CONCERN WE 360 00:15:08,223 --> 00:15:09,992 WILL LOSE A GENERATION OF EARLY 361 00:15:09,992 --> 00:15:14,463 CAREER INVESTIGATORS. THE IRP, 362 00:15:14,463 --> 00:15:18,167 THE INTRAMURAL PROGRAM IS 363 00:15:18,167 --> 00:15:22,237 SENSITIVE TO BUDGET CUTS SO SHE 364 00:15:22,237 --> 00:15:24,039 UNDERSCORES HOW PARTNERSHIP IS 365 00:15:24,039 --> 00:15:25,507 CRUCIAL GOING FORWARD. AGAIN, I 366 00:15:25,507 --> 00:15:27,910 THINK THAT RESONATES WITH OUR 367 00:15:27,910 --> 00:15:30,479 COMMUNITY. WE ARE NATURAL 368 00:15:30,479 --> 00:15:34,583 PARTNERSHIP BUILDERS, THRIVE AND 369 00:15:34,583 --> 00:15:36,385 LOOK TO BRING EFFORTS INTO 370 00:15:36,385 --> 00:15:38,253 APPLICATION AREAS ACROSS THE 371 00:15:38,253 --> 00:15:42,124 NIH. MONICA LOOKS AT THE NIH 372 00:15:42,124 --> 00:15:47,963 COLLECTIVELY AS AN AGENCY AND 373 00:15:47,963 --> 00:15:49,465 REALLY WANTS TO SORT OF BRING 374 00:15:49,465 --> 00:15:51,934 PEOPLE TOGETHER AS CLOSELY AS 375 00:15:51,934 --> 00:15:53,669 POSSIBLE IN COLLABORATION AND 376 00:15:53,669 --> 00:15:57,006 WORKING ON THESE KIND OF 377 00:15:57,006 --> 00:15:58,640 ARTICULATED GOALS. SO SINCE 378 00:15:58,640 --> 00:15:59,875 MONICA BROUGHT UP THE BUDGET, 379 00:15:59,875 --> 00:16:02,244 THAT IS A GOOD SEGUE FOR ME TO 380 00:16:02,244 --> 00:16:04,246 GO INTO A BUDGET UPDATE. I THINK 381 00:16:04,246 --> 00:16:06,048 AGAIN ALL OF YOU PROBABLY HAVE 382 00:16:06,048 --> 00:16:09,451 BEEN FOLLOWING THIS. WE ARE NOW, 383 00:16:09,451 --> 00:16:12,721 THANKFULLY, OPERATING UNDER 384 00:16:12,721 --> 00:16:13,622 CONTINUING RESOLUTION GOING 385 00:16:13,622 --> 00:16:16,091 THROUGH MARCH 8TH. IT IS AT THE 386 00:16:16,091 --> 00:16:19,261 SAME FY '23 APPROPRIATION LEVEL. 387 00:16:19,261 --> 00:16:20,763 IMPORTANTLY, THE TOP-LINE 388 00:16:20,763 --> 00:16:24,933 SPENDING AGREEMENT FOR FY-24 WAS 389 00:16:24,933 --> 00:16:27,436 REACHED JANUARY 8TH. SO THAT 390 00:16:27,436 --> 00:16:28,303 NON-DEFENSE DISCRETIONARY 391 00:16:28,303 --> 00:16:31,407 PORTION OF THE BUDGET, $773 392 00:16:31,407 --> 00:16:34,977 MILLION IS FLAT FROM FY23. THAT 393 00:16:34,977 --> 00:16:37,012 IS A REALLY GOOD PIECE OF NEWS. 394 00:16:37,012 --> 00:16:40,182 WHAT WE DON'T KNOW IS WHAT THE 395 00:16:40,182 --> 00:16:40,816 INDIVIDUAL APPROPRIATION BILLS 396 00:16:40,816 --> 00:16:43,652 WILL LOOK LIKE. THEY ARE UNDER 397 00:16:43,652 --> 00:16:45,320 DEVELOPMENT. HENCE THE 398 00:16:45,320 --> 00:16:46,321 CONTINUING RESOLUTION BECAUSE 399 00:16:46,321 --> 00:16:49,958 CONTINUE WAS IN ABSOLUTELY NO 400 00:16:49,958 --> 00:16:52,494 POSITION TO REALLY DEVELOP THOSE 401 00:16:52,494 --> 00:16:54,430 INDIVIDUAL APPROPRIATION BILLS 402 00:16:54,430 --> 00:16:56,732 BEFORE THE PREVIOUS DEADLINES. 403 00:16:56,732 --> 00:17:00,702 SO WHAT IS THE PRACTICAL IMPACT 404 00:17:00,702 --> 00:17:03,238 AT NIBIB? OUR INTERIM PAYLINE 405 00:17:03,238 --> 00:17:07,142 FOR PARENT RO1 ANNOUNCEMENTS IS 406 00:17:07,142 --> 00:17:08,310 14TH PERCENTILE, 19 FOR NEW 407 00:17:08,310 --> 00:17:09,445 INVESTIGATORS. MOST AWARDS ARE 408 00:17:09,445 --> 00:17:12,648 PAID AT REDUCED LEVELS PENDING 409 00:17:12,648 --> 00:17:15,284 FINAL FY24 APPROPRIATION. SO, 410 00:17:15,284 --> 00:17:17,419 YOU KNOW, THIS IS ALL -- WE HAVE 411 00:17:17,419 --> 00:17:19,221 KIND OF -- WE HAVE BEEN 412 00:17:19,221 --> 00:17:20,689 PREPARING FOR THIS IN OUR 413 00:17:20,689 --> 00:17:22,891 DISCUSSIONS WITH YOU GUYS. 414 00:17:22,891 --> 00:17:25,661 CERTAINLY INTERNALLY 415 00:17:25,661 --> 00:17:27,096 EXTENSIVELY. A FLAT BUDGET IS 416 00:17:27,096 --> 00:17:30,332 SORT OF OUR BEST-CASE SCENARIO. 417 00:17:30,332 --> 00:17:32,701 THERE MAY VERY WELL BE CUTS IN 418 00:17:32,701 --> 00:17:35,671 THIS NON-DEFENSE DISCRETIONARY 419 00:17:35,671 --> 00:17:37,272 AS THE INDIVIDUAL APPROPRIATION 420 00:17:37,272 --> 00:17:42,244 BILLS. THERE'S LOTS OF JOCKEYING 421 00:17:42,244 --> 00:17:44,713 FOR THESE INDIVIDUAL 422 00:17:44,713 --> 00:17:46,915 APPROPRIATION BILLS TO KEEP THEM 423 00:17:46,915 --> 00:17:48,650 AS FLAT AS POSSIBLE ACROSS -- 424 00:17:48,650 --> 00:17:50,385 AND NOT HAVE CUTS ESPECIALLY TO 425 00:17:50,385 --> 00:17:54,022 HHS. WE WILL SEE WHAT THE 426 00:17:54,022 --> 00:17:55,757 OUTCOME IS FOR THAT. I THINK, 427 00:17:55,757 --> 00:17:58,293 YOU KNOW, IT IS PRETTY -- WE ARE 428 00:17:58,293 --> 00:18:01,396 CONFIDENT YOU CAN EXPECT THAT 429 00:18:01,396 --> 00:18:10,405 THERE WILL BE CONTINUED 430 00:18:10,405 --> 00:18:12,307 CONSERVATIVE REDUCTION FOR 431 00:18:12,307 --> 00:18:16,578 AWARDS AND RESOURCES AS YOUNG AS 432 00:18:16,578 --> 00:18:18,413 POSSIBLE AS YOUNG INVESTIGATORS. 433 00:18:18,413 --> 00:18:21,683 AS MONICA POINTED OUT THEY OFTEN 434 00:18:21,683 --> 00:18:25,687 BEAR BRUNT IN BUDGET CUTS. SO 435 00:18:25,687 --> 00:18:30,092 THE SCIENCE POLICY AND 436 00:18:30,092 --> 00:18:32,694 COMMUNICATIONS, IF YOU REMEMBER 437 00:18:32,694 --> 00:18:35,230 IN -- IN JANUARY 2023 BEGAN 438 00:18:35,230 --> 00:18:38,567 PUTTING TOGETHER A 2022 YEAR IN 439 00:18:38,567 --> 00:18:40,335 REVIEW. THEY HAVE DONE ANOTHER 440 00:18:40,335 --> 00:18:41,904 FANTASTIC JOB WITH THIS. IT IS 441 00:18:41,904 --> 00:18:44,673 ACCESSIBLE ON OUR WEBSITE, THE 442 00:18:44,673 --> 00:18:47,809 2023 YEAR IN REVIEW. AND IN NEWS 443 00:18:47,809 --> 00:18:50,279 HIGHLIGHTS AND PROGRAM UPDATES, 444 00:18:50,279 --> 00:18:53,448 QUITE POPULAR WITH NEARLY 40,000 445 00:18:53,448 --> 00:18:55,684 VIEWS OF ALL THE RELEASE, ALL 446 00:18:55,684 --> 00:18:58,120 THAT INFORMATION. YOU CAN SEE A 447 00:18:58,120 --> 00:19:01,590 MAJOR, MAJOR THEME HERE IS 448 00:19:01,590 --> 00:19:03,992 ULTRASOUND. ULTRASOUND WITH AI, 449 00:19:03,992 --> 00:19:07,129 WEARABLE ULTRASOUND, ULTRASOUND 450 00:19:07,129 --> 00:19:09,097 USING TO DELIVER OXYGEN, TO 451 00:19:09,097 --> 00:19:11,300 INCREASE PROFUSION. PRINTING 452 00:19:11,300 --> 00:19:15,504 THROUGH TISSUE WITH 3D 453 00:19:15,504 --> 00:19:18,407 ULTRASOUND. ULTRASOUND SELFIES. 454 00:19:18,407 --> 00:19:19,875 LOT OF GREAT STORIES AND 455 00:19:19,875 --> 00:19:21,310 CONGRATULATIONS TO THE 456 00:19:21,310 --> 00:19:22,244 ULTRASOUND COMMUNITY FOR 457 00:19:22,244 --> 00:19:23,946 GENERATING SUCH BEAUTIFUL WORK. 458 00:19:23,946 --> 00:19:24,813 OF COURSE OTHER THINGS ARE NOTE 459 00:19:24,813 --> 00:19:27,316 BUD THAT JUMPED OUT SO I WANTED 460 00:19:27,316 --> 00:19:30,052 TO REINFORCE THAT THEME. ALSO IN 461 00:19:30,052 --> 00:19:32,621 SCIENCE HIGHLIGHTS AND PRESS 462 00:19:32,621 --> 00:19:35,324 RELEASES, WE HAVE HAD 50,000 463 00:19:35,324 --> 00:19:36,692 VIEWS THERE. THEMATICALLY WHAT 464 00:19:36,692 --> 00:19:39,094 IS VERY, VERY INTERESTING IS 465 00:19:39,094 --> 00:19:41,830 REALLY IN THE -- MONICA'S VERY 466 00:19:41,830 --> 00:19:42,297 FIRST COMMENTS . 467 00:19:42,297 --> 00:19:45,267 THE DISCOVERIES, TECHNOLOGIES 468 00:19:45,267 --> 00:19:47,436 AND APPLICATION TO IMPROVE 469 00:19:47,436 --> 00:19:49,605 HEALTH AND OUTCOMES FOR 470 00:19:49,605 --> 00:19:51,473 PATIENTS. LOTS OF INTEREST IN 471 00:19:51,473 --> 00:19:55,477 OUR RADAX TECH FETAL MONITORING 472 00:19:55,477 --> 00:19:59,915 CHALLENGE. THE RT ROING WEBSITE, 473 00:19:59,915 --> 00:20:02,951 MAKEMYTESTCOUNTY FOR RAPID 474 00:20:02,951 --> 00:20:05,254 ANTIGEN AND PROGRAM WHICH I WILL 475 00:20:05,254 --> 00:20:07,723 UPDATE IN THE SLIDES, WHICH 476 00:20:07,723 --> 00:20:09,992 OFFERS THE OPPORTUNITY TO GET 477 00:20:09,992 --> 00:20:12,027 TEST AND TREATMENT COMPLETELY IN 478 00:20:12,027 --> 00:20:14,296 YOUR HOME. LOTS OF INTEREST IN 479 00:20:14,296 --> 00:20:15,998 THAT. MANY PEOPLE HAVE 480 00:20:15,998 --> 00:20:20,636 SUBSCRIBED. IF YOU LOOK AT THE 481 00:20:20,636 --> 00:20:21,970 TESTTOTREAT.ORG AND CHECK OUT 482 00:20:21,970 --> 00:20:24,539 THAT WEBSITE. SO WE HAVE HAD 483 00:20:24,539 --> 00:20:28,810 SEVERAL NEW NIBIB STAFF JOIN US. 484 00:20:28,810 --> 00:20:30,112 I'D LIKE TO TAKE A MOMENT TO 485 00:20:30,112 --> 00:20:32,147 INTRODUCE THEM. YOU WILL BE 486 00:20:32,147 --> 00:20:35,217 INTERACTING WITH THEM OR HAVE 487 00:20:35,217 --> 00:20:38,787 ALREADY INTERACTED. I WILL JUST 488 00:20:38,787 --> 00:20:40,555 SAY BRIEF WORDS ABOUT EACH. ON 489 00:20:40,555 --> 00:20:51,366 THE LEFT, ROB-/* ROBBERRY, HIS 490 00:20:52,100 --> 00:20:54,036 STORY IS DIFFERENT. HE STARTED 491 00:20:54,036 --> 00:20:56,505 IN APPLIED SCIENCE. JANUARY 2ND 492 00:20:56,505 --> 00:20:58,407 OF THIS YEAR HE CAME FROM 493 00:20:58,407 --> 00:20:59,808 HARVARD MEDICAL SCHOOL , THE 494 00:20:59,808 --> 00:21:03,145 DIRECTOR OF BRAIN AND SPINAL 495 00:21:03,145 --> 00:21:06,014 CORD LAB FOR BRAIN IMAGING AT 496 00:21:06,014 --> 00:21:07,449 MGMH. HE HAS MORE THAN 20 YEARS 497 00:21:07,449 --> 00:21:10,786 IN TECHNICAL DEVELOPMENT OF MRI 498 00:21:10,786 --> 00:21:13,221 AND APPLICATIONS. WHEN HE WAS AT 499 00:21:13,221 --> 00:21:15,557 HARVARD, ASSISTANT PROFESSOR OF 500 00:21:15,557 --> 00:21:17,492 RADIOLOGY AND AFFILIATED FACULTY 501 00:21:17,492 --> 00:21:25,834 IN THE HARVARD MIT SLASH HST AT 502 00:21:25,834 --> 00:21:27,402 MIT. AND HELD THAT POSITION 503 00:21:27,402 --> 00:21:30,405 SINCE 2016. THIS IS FUN. THIS IS 504 00:21:30,405 --> 00:21:32,774 IN THE DEMOCRACY 2 OFFICE. HE 505 00:21:32,774 --> 00:21:42,684 SAW HIS SIGNATURE HANGING ON NA 506 00:21:42,684 --> 00:21:43,118 POS 507 00:21:43,118 --> 00:21:44,319 -- HANGING ON THAT POSTER WHEN 508 00:21:44,319 --> 00:21:46,955 HE WAS THE AWARDEE. THAT IS 509 00:21:46,955 --> 00:21:49,291 NEAT. ROB SAID HE IS A PRODUCT 510 00:21:49,291 --> 00:21:51,660 OF THIS. CERTAINLY CRITICAL 511 00:21:51,660 --> 00:21:52,894 COMPONENT, HE BRINGS THAT 512 00:21:52,894 --> 00:21:54,062 PERSPECTIVE TO HIS WORK AS 513 00:21:54,062 --> 00:21:57,466 PROGRAM DIRECTOR SO WE ARE SO 514 00:21:57,466 --> 00:22:04,806 GLAD TO HAVE HIM. MARIE DE SALVE 515 00:22:05,073 --> 00:22:07,909 DESALT, WHO I HAVE MENTIONED 516 00:22:07,909 --> 00:22:10,212 BASED AS A DATA SCHOLAR TWO 517 00:22:10,212 --> 00:22:11,947 YEARS HERE AT NIBIB, HE STARTED 518 00:22:11,947 --> 00:22:12,914 OFFICIALLY AS A PROGRAM 519 00:22:12,914 --> 00:22:15,751 DIRECTOR, WE ARE PLEASED TO SAY, 520 00:22:15,751 --> 00:22:19,287 IN SEPTEMBER OF 2023. HIS 521 00:22:19,287 --> 00:22:21,857 PORTFOLIOS IN ART OFFICIAL 522 00:22:21,857 --> 00:22:23,558 INTELLIGENCE IN DEVELOPMENTAL 523 00:22:23,558 --> 00:22:24,493 TECHNOLOGIES. HE IS A LEADING 524 00:22:24,493 --> 00:22:26,461 EXPERT -- I CAN ATTEST BECAUSE 525 00:22:26,461 --> 00:22:28,263 OF MANY CONVERSATIONS WE HAVE 526 00:22:28,263 --> 00:22:30,665 HAD IN QUANTITATIVE FUNCTIONAL 527 00:22:30,665 --> 00:22:34,069 IMAGE OF HUMAN LUNG USING PROTON 528 00:22:34,069 --> 00:22:38,039 MRI. PRIOR TO BECOMING A DATA 529 00:22:38,039 --> 00:22:39,708 SCHOLAR AT NIBIB HE WAS 530 00:22:39,708 --> 00:22:42,110 ASSISTANT PROFESSOR AT 531 00:22:42,110 --> 00:22:43,445 BIOENGINEERING AT UC SAN DIEGO. 532 00:22:43,445 --> 00:22:46,314 HIS TWO YEARS AS DATA SCHOLAR, 533 00:22:46,314 --> 00:22:47,682 WHICH IS A WONDERFUL, WONDERFUL 534 00:22:47,682 --> 00:22:50,852 PROGRAM THAT OUR OFFICE OF DATA 535 00:22:50,852 --> 00:22:51,920 SCIENCE RUNS PLAY ED A KEY ROLE 536 00:22:51,920 --> 00:22:54,055 IN ESTABLISHING IN THE ON GOING 537 00:22:54,055 --> 00:22:57,125 SUCCESS OF MIDRIC, MEDICAL 538 00:22:57,125 --> 00:22:59,161 IMAGING DATA RESOURCE CENTER, 539 00:22:59,161 --> 00:23:00,695 ONE OF OUR SIGNATURE PROGRAMS 540 00:23:00,695 --> 00:23:05,267 THAT CUTS ACROSS MANY DOMAINS IN 541 00:23:05,267 --> 00:23:08,570 IMAGING THAT WE SUPPORT. THAT 542 00:23:08,570 --> 00:23:12,774 WAS BETWEEN 2020 AND 2022. SO WE 543 00:23:12,774 --> 00:23:14,743 ARE GLAD TO HAVE HIM JOINING US 544 00:23:14,743 --> 00:23:16,411 NOW. I THINK DATA SCHOLAR IS THE 545 00:23:16,411 --> 00:23:18,480 WORD. TO GET CONNECTION TO THE 546 00:23:18,480 --> 00:23:20,682 NEXT PERSON JOINING, PROFESSOR E 547 00:23:20,682 --> 00:23:23,852 WONG, A DATA SCHOLAR IN DHIT. 548 00:23:23,852 --> 00:23:27,589 SHE JOINED US IN DECEMBER OF 549 00:23:27,589 --> 00:23:29,658 2023 ON SABBATICAL LEAVE FROM 550 00:23:29,658 --> 00:23:31,893 ACADEMIA. SHE IS AN ASSOCIATE 551 00:23:31,893 --> 00:23:34,563 PROFESSOR AND FORMER GRADUATE 552 00:23:34,563 --> 00:23:35,230 PROGRAM DIRECTOR AT DEPARTMENT 553 00:23:35,230 --> 00:23:37,098 OF MATHEMATICS AND STATISTICS AT 554 00:23:37,098 --> 00:23:39,401 THE UNIVERSITY OF MARYLAND, 555 00:23:39,401 --> 00:23:44,339 BALTIMORE COUNTY. SHE SERVED 556 00:23:44,339 --> 00:23:46,174 SINCE 2015 AND EXPERT IN 557 00:23:46,174 --> 00:23:47,776 CLINICAL DESIGN AND NOVEL 558 00:23:47,776 --> 00:23:49,911 STATISTICAL APPROACHES IN PUBLIC 559 00:23:49,911 --> 00:23:51,913 HEALTH AND APPLICATIONS. AT 560 00:23:51,913 --> 00:23:53,982 NIBIB WE ARE EXCITED TO SAY SHE 561 00:23:53,982 --> 00:23:56,051 IS WORKING WITH DR. ANDREW WHITE 562 00:23:56,051 --> 00:23:59,221 IN BHIT ON ANALYZING THE 563 00:23:59,221 --> 00:24:00,755 OVER-THE-COUNTER TESTING DATA 564 00:24:00,755 --> 00:24:02,491 GENERATED QUITE SIGNIFICANTLY 565 00:24:02,491 --> 00:24:08,930 FROM OUR RADAX PROGRAMS. WE ARE 566 00:24:08,930 --> 00:24:12,734 EXCITED TO START WITH THAT. 567 00:24:12,734 --> 00:24:16,838 FINALLY THERE IS ONE ADDITIONAL 568 00:24:16,838 --> 00:24:19,641 PROGRAM SPECIALIST. ADRIANA 569 00:24:19,641 --> 00:24:23,345 ALICO JOINED NIBIB IN 570 00:24:23,345 --> 00:24:25,113 OCTOBER 2023 AS A SCIENTIFIC 571 00:24:25,113 --> 00:24:25,981 INNOVATIVE PROGRAM SPECIALIST IN 572 00:24:25,981 --> 00:24:28,283 THE OFFICE OF THE DIRECTOR. 573 00:24:28,283 --> 00:24:33,688 SHE'S SUPPORTING ON GOING RADAX 574 00:24:33,688 --> 00:24:35,323 IN POSTPARTUM AND FETAL 575 00:24:35,323 --> 00:24:39,027 MONITORING AND DESIGNING AND 576 00:24:39,027 --> 00:24:40,328 MANAGING OTHER OPEN INNOVATIVE 577 00:24:40,328 --> 00:24:42,531 PROGRAMS IN CLOSE COLLABORATION 578 00:24:42,531 --> 00:24:45,867 WITH DR. TAYLOR GILLILAND. 579 00:24:45,867 --> 00:24:49,304 PREVIOUSLY ADRIANA, SHE'S HAD 580 00:24:49,304 --> 00:24:52,007 INTERESTING BACKGROUND SERVED AS 581 00:24:52,007 --> 00:24:53,375 CONTRACTOR IN WAR FAR TREATMENT 582 00:24:53,375 --> 00:24:54,776 DIVISION OF ARMY MEDICAL 583 00:24:54,776 --> 00:24:57,345 MATERIAL DEVELOPMENT ACTIVITY. 584 00:24:57,345 --> 00:24:59,881 SHE HELPED MANAGE AWARDS TO 585 00:24:59,881 --> 00:25:02,217 MEDICAL DEVICE COMPANIES, DEPLOY 586 00:25:02,217 --> 00:25:04,319 NOVEL AND MEDICAL EQUIPMENT TO 587 00:25:04,319 --> 00:25:07,556 THE WARFIGHTER AND RECEIVED HER 588 00:25:07,556 --> 00:25:11,359 BACHELORS IN BIOMEDICAL 589 00:25:11,359 --> 00:25:12,928 ENGINEERING FROM TULANE. 590 00:25:12,928 --> 00:25:15,363 ADRIANA, WE ARE REALLY GLAD TO 591 00:25:15,363 --> 00:25:20,001 HAVE YOU. YOU BRING AMAZING 592 00:25:20,001 --> 00:25:21,703 EXPERTISE THAT IS RELEVANT AND 593 00:25:21,703 --> 00:25:23,838 NEW DIMENSION TO SOME OF THE 594 00:25:23,838 --> 00:25:26,141 THINGS WE DO AT NIBIB. I WOULD 595 00:25:26,141 --> 00:25:28,009 LIKE TO ALSO SAY A FEW WORDS OF 596 00:25:28,009 --> 00:25:32,213 THANKS TO DEPARTING STAFF. PETER 597 00:25:32,213 --> 00:25:34,015 KIRSHNER, MANY OF YOU KNOW FOR 598 00:25:34,015 --> 00:25:36,718 TWO DECADES, A LITTLE OVER TWO 599 00:25:36,718 --> 00:25:39,621 DECADES HE MADE ENORMOUS 600 00:25:39,621 --> 00:25:41,156 CONTRIBUTIONS TO NIBIB, ADVISING 601 00:25:41,156 --> 00:25:44,092 ON MEDICAL TOPICS, PROMOTING THE 602 00:25:44,092 --> 00:25:46,695 UTILIZATION OF RELIABLE DATA FOR 603 00:25:46,695 --> 00:25:48,863 GUIDING APPLICATIONS OF 604 00:25:48,863 --> 00:25:50,565 DIAGNOSTIC TECHNOLOGIES. REALLY 605 00:25:50,565 --> 00:25:51,800 UNDERSTANDING AND ESTIMATING THE 606 00:25:51,800 --> 00:25:55,604 TRUE IMPACT OF IMAGING SCIENCE 607 00:25:55,604 --> 00:25:58,640 ADVANCES ON HEALTH CARE. PETER 608 00:25:58,640 --> 00:26:01,042 SERVED IN MANY ROLES WHILE IN 609 00:26:01,042 --> 00:26:04,446 NIBIB INCLUDING ACTING DIRECTOR 610 00:26:04,446 --> 00:26:10,118 OF THE INTRAMURAL PROGRAMS IN 611 00:26:10,118 --> 00:26:11,252 2003-206 SO INSTRMENTAL IN 612 00:26:11,252 --> 00:26:12,387 GETTING THEM OFF THE GROUND. THE 613 00:26:12,387 --> 00:26:16,291 CO -DIRECTOR OF THE NIBIB CDRH. 614 00:26:16,291 --> 00:26:18,693 THE FDA CDRH LABORATORY FOR 615 00:26:18,693 --> 00:26:20,295 ASSESSMENT OF MEDICAL IMAGING 616 00:26:20,295 --> 00:26:24,032 SYSTEMS FROM 2005-2008. HE ALSO 617 00:26:24,032 --> 00:26:25,734 HELPED CREATE THAT. SO WE ARE 618 00:26:25,734 --> 00:26:29,004 VERY GRATEFUL TO PETER FOR HIS 619 00:26:29,004 --> 00:26:30,872 WORK. HE ALSO HAS BACK GROUND, I 620 00:26:30,872 --> 00:26:34,676 SHOULD NOTE, AS A STAFF MEMBER 621 00:26:34,676 --> 00:26:37,979 AT OAKRIDGE NATIONAL LABORATORY. 622 00:26:37,979 --> 00:26:41,650 WE WERE VERY FORTUNATE TO HAVE 623 00:26:41,650 --> 00:26:44,419 HIS COLLABORATING INTERACTIONS 624 00:26:44,419 --> 00:26:47,122 AT OAKRIDGE AND DOT DURING THE 625 00:26:47,122 --> 00:26:50,759 POSITION WITH NIBIB. WE ARE ALSO 626 00:26:50,759 --> 00:26:53,595 THANKFUL TO RUDY MC ANDREW, WHO 627 00:26:53,595 --> 00:26:54,963 SERVED AS A SENIOR GRANTS 628 00:26:54,963 --> 00:26:56,097 MANAGEMENT SPECIALIST WITH 629 00:26:56,097 --> 00:26:57,932 OFFICE OF GRANTS MANAGEMENT FOR 630 00:26:57,932 --> 00:27:00,035 THE PAST EIGHT YEARS. IN HER 631 00:27:00,035 --> 00:27:03,338 ROLE SHE SERVED AS THE GRANTS 632 00:27:03,338 --> 00:27:07,409 MANAGEMENT LIAISON FOR OUR 633 00:27:07,409 --> 00:27:08,510 MEDTECH BLUEPRINT PROGRAM AND 634 00:27:08,510 --> 00:27:10,945 NATIONAL INSTITUTE OF AGING 635 00:27:10,945 --> 00:27:12,113 ALZHEIMER'S SUPPLEMENT PROGRAM. 636 00:27:12,113 --> 00:27:14,015 YOU HAVE HEARD A LOT ABOUT BOTH 637 00:27:14,015 --> 00:27:16,051 THESE PROGRAMS. INCREDIBLY 638 00:27:16,051 --> 00:27:18,420 IMPACTFUL PROGRAMS. WE ARE 639 00:27:18,420 --> 00:27:22,123 THANKFUL TO RUDY FOR NAVIGATING 640 00:27:22,123 --> 00:27:25,727 US THROUGH THAT. SO 641 00:27:25,727 --> 00:27:32,200 CONGRATULATIONS TO BEV RUS 642 00:27:32,200 --> 00:27:35,537 SHAVASTARI, PROGRAM DIRECTOR, 643 00:27:35,537 --> 00:27:39,808 INFO MAT IKS. RECEIVED AN 644 00:27:39,808 --> 00:27:41,042 ACHIEVEMENT AWARD FROM 645 00:27:41,042 --> 00:27:42,944 ENGINEERING MEDICINE AND BIOLOGY 646 00:27:42,944 --> 00:27:44,713 SOCIETY. I THINK THE CITATION 647 00:27:44,713 --> 00:27:46,748 REALLY SUMS IT UP WITH BERUSE 648 00:27:46,748 --> 00:27:49,017 FOR OUTSTANDING LEADERSHIP AND 649 00:27:49,017 --> 00:27:55,023 PIONEERING EFFORTS IN THE FIELD 650 00:27:55,023 --> 00:28:00,662 OF BIOMEDICAL FIELD AND 651 00:28:00,662 --> 00:28:02,764 REMARKABLE LEADER SHIP FOR YOUNG 652 00:28:02,764 --> 00:28:04,365 INVESTIGATORS. SO WE 653 00:28:04,365 --> 00:28:06,901 CONGRATULATE BERUSE FOR THAT 654 00:28:06,901 --> 00:28:09,304 AWARD AND SPOT-ON CITATION THAT 655 00:28:09,304 --> 00:28:13,208 DESCRIBES HIS IMPACT ON OUR 656 00:28:13,208 --> 00:28:14,743 COMMUNITY. SO I WILL CONCLUDE 657 00:28:14,743 --> 00:28:16,711 THIS SECTION OF THE DIRECTOR'S 658 00:28:16,711 --> 00:28:22,183 REPORT ON A SAD NOTE. WE LOST A 659 00:28:22,183 --> 00:28:26,588 DEAR COLLEGE, IGMA. TOO YOUNG. 660 00:28:26,588 --> 00:28:28,857 ING WAS A STAFF SCIENTIST IN THE 661 00:28:28,857 --> 00:28:31,292 TRACER AND CORE FACILITY AT 662 00:28:31,292 --> 00:28:36,030 NIBIB. HE CAME HERE IN 1993 AS A 663 00:28:36,030 --> 00:28:37,866 VISITING SCHOLAR AND JOINTED THE 664 00:28:37,866 --> 00:28:40,835 PET DEPARTMENT IN THE CLINICAL 665 00:28:40,835 --> 00:28:42,670 CENTER IN 1999 AND MOVED TO 666 00:28:42,670 --> 00:28:45,573 NIBIB AS WE WERE LAUNCHING THE 667 00:28:45,573 --> 00:28:47,575 INTRAMURAL PROGRAM IN 2004. HE 668 00:28:47,575 --> 00:28:50,211 WAS A WIDELY RESPECTED EXPERT IN 669 00:28:50,211 --> 00:28:54,349 MASS SPEC AND SEPARATION 670 00:28:54,349 --> 00:28:55,350 TECHNOLOGIES. MUCH SOUGHT AFTER 671 00:28:55,350 --> 00:28:58,787 GAEND ROUSE COLLABORATOR ON 672 00:28:58,787 --> 00:29:03,491 SMALL METAL LITES, MATERIAL 673 00:29:03,491 --> 00:29:05,059 CHARACTERIZATION. HE AUTHORED OR 674 00:29:05,059 --> 00:29:10,465 CO -AUTHORED OVER 100 SCIENTIFIC 675 00:29:10,465 --> 00:29:12,801 PUBLICATIONS, HAD TWO U.S. PAT 676 00:29:12,801 --> 00:29:18,306 TENTS AND KNOWN FOR HIS PROFOUND 677 00:29:18,306 --> 00:29:19,374 SINCERITY, CHEERFULNESS, 678 00:29:19,374 --> 00:29:22,110 EAGERNESS TO HELP. WE SEND OUR 679 00:29:22,110 --> 00:29:24,045 CONDOLENCES TO HIS FAMILY AND 680 00:29:24,045 --> 00:29:26,581 COLLEAGUES AND TAKE A MOMENT TO 681 00:29:26,581 --> 00:29:28,516 REMEMBER YING. WE LOST HIM AT 682 00:29:28,516 --> 00:29:35,356 THE END OF THE YEAR LAST YEAR. 683 00:29:35,356 --> 00:29:43,298 SO I WOULD LIKE TO MOVE INTO 684 00:29:43,298 --> 00:29:43,898 FUNDING OPPORTUNITIES AND 685 00:29:43,898 --> 00:29:45,700 ACTUALLY DRAW YOUR ATTENTION TO 686 00:29:45,700 --> 00:29:47,035 OUR VISION STATEMENT ON OUR 687 00:29:47,035 --> 00:29:49,637 WEBSITE, IF YOU HAVEN'T SEEN IT 688 00:29:49,637 --> 00:29:52,073 ALREADY. AND A CONSEQUENCE OF MY 689 00:29:52,073 --> 00:29:55,443 LAST PRESENTATION WITH YOUR 690 00:29:55,443 --> 00:29:57,245 FEEDBACK AND SUPPORT. OUR VISION 691 00:29:57,245 --> 00:29:58,446 TECHNOLOGIES TO SHAPE THE FUTURE 692 00:29:58,446 --> 00:30:01,516 OF HEALTH SAKE COMPONENT OF 693 00:30:01,516 --> 00:30:03,484 ROLLOUT OF THE PLAN, IN THE 694 00:30:03,484 --> 00:30:04,953 PROCESS OF DOING IN SMALL WAYS 695 00:30:04,953 --> 00:30:06,888 RIGHT NOW. HOPEFULLY IN MAY AND 696 00:30:06,888 --> 00:30:08,556 IN THE NEXT COUNCIL MEETING WE 697 00:30:08,556 --> 00:30:10,525 WILL HAVE COMPLETED THAT 698 00:30:10,525 --> 00:30:12,060 ROLLOUT. YOU WILL SEE SIGNS OF 699 00:30:12,060 --> 00:30:15,897 THAT ON OUR WEBSITE IN THE 700 00:30:15,897 --> 00:30:18,233 COMING MONTHS. THE FIRST KIND OF 701 00:30:18,233 --> 00:30:20,802 BIG STORY -- AND YOU HAVE BEEN 702 00:30:20,802 --> 00:30:21,536 FOLLOWING THIS FOR QUITE 703 00:30:21,536 --> 00:30:27,342 SOMETIME, IS RELEASE OF THE RFA 704 00:30:27,342 --> 00:30:32,680 ON ENHANCING ENGINEERING OR THE 705 00:30:32,680 --> 00:30:34,716 BETA PROGRAM AT HISTORICALLY 706 00:30:34,716 --> 00:30:37,485 BLACK PROGRAMS, HBCUs. SO THIS 707 00:30:37,485 --> 00:30:40,855 IS A CAPACITY BUILDING PROGRAM. 708 00:30:40,855 --> 00:30:46,227 ALBERT AAVILAR HAS TALKED AND 709 00:30:46,227 --> 00:30:49,430 PRESENTED. A TWO-PHASE UH-3 710 00:30:49,430 --> 00:30:51,099 PROGRAM. WE HAVE HAD LOTS OF 711 00:30:51,099 --> 00:30:53,301 INTEREST. ALBERT HAS TALKED TO 712 00:30:53,301 --> 00:30:55,370 MANY, MANY POTENTIAL APPLICANTS. 713 00:30:55,370 --> 00:30:57,672 DUE DATES -- AND WE ARE LOOKING 714 00:30:57,672 --> 00:30:59,340 FORWARD TO HOPEFULLY RECEIVING 715 00:30:59,340 --> 00:31:02,377 EXCELLENT APPLICATIONS, ARE 716 00:31:02,377 --> 00:31:04,279 JANUARY 29TH THIS YEAR, 717 00:31:04,279 --> 00:31:06,414 SEPTEMBER 30TH THIS YEAR AND 718 00:31:06,414 --> 00:31:07,448 SEPTEMBER 30TH NEXT YEAR. SO 719 00:31:07,448 --> 00:31:11,352 THAT IS THE NEAR-TERM PLAN FOR 720 00:31:11,352 --> 00:31:16,691 OUR CENTERS, OUR BEV ITA, THE 721 00:31:16,691 --> 00:31:17,892 OTHER BIGGEST CENTER PROGRAM 722 00:31:17,892 --> 00:31:21,596 THAT WILL BE EXCLUSIVELY 723 00:31:21,596 --> 00:31:23,097 SUPPORTED CAPACITY-BUILDING AND 724 00:31:23,097 --> 00:31:27,268 GROWTH TRAINING OPPORTUNITIES AT 725 00:31:27,268 --> 00:31:33,841 HBCUs. MANY OF YOU HAVE HEARD 726 00:31:33,841 --> 00:31:38,379 BEFORE THE HEEL, HELPING END 727 00:31:38,379 --> 00:31:41,549 ADDICTION LONG-TERM. A NIH 728 00:31:41,549 --> 00:31:43,351 INITIATIVE. FOCUSED NOT ONLY ON 729 00:31:43,351 --> 00:31:46,020 OPIOID USE DISORDER BUT ALSO 730 00:31:46,020 --> 00:31:48,456 UNDERSTANDING AND DEVELOPING 731 00:31:48,456 --> 00:31:50,892 APPROACHES TO MITIGATE PAIN. WE 732 00:31:50,892 --> 00:31:52,560 CALL THAT THE HEAL PAIN 733 00:31:52,560 --> 00:31:56,064 INITIATIVE. THIS IS A RECENT 734 00:31:56,064 --> 00:31:58,499 BRANCHOUT. ITS OPERATING WITH A 735 00:31:58,499 --> 00:31:59,400 NEW EXECUTIVE COMMITTEE. I'M A 736 00:31:59,400 --> 00:32:02,570 MEMBER OF THAT. A NEW STEERING 737 00:32:02,570 --> 00:32:04,505 COMMITTEE, DR. MARIAH BITMAN, 738 00:32:04,505 --> 00:32:07,308 ONE OF OUR PROGRAM DIRECTORS AT 739 00:32:07,308 --> 00:32:08,476 NIBIB IS ONE OF THE MEMBERS OF 740 00:32:08,476 --> 00:32:10,979 THE STEERING COMMITTEE. WE HAVE 741 00:32:10,979 --> 00:32:12,246 RECENTLY SIGNED ON TO AN 742 00:32:12,246 --> 00:32:13,614 INITIATIVE AT RFA THAT I THINK 743 00:32:13,614 --> 00:32:15,116 IS ALL LINED WITH OUR 744 00:32:15,116 --> 00:32:16,184 COMMUNITY'S WORK THAT EMPHASIZES 745 00:32:16,184 --> 00:32:19,387 THE DISCOVERY, DEVELOPMENT AND 746 00:32:19,387 --> 00:32:26,060 VALIDATION OF REAL-WORLD DIGITAL 747 00:32:26,060 --> 00:32:26,361 T 748 00:32:26,361 --> 00:32:28,629 END-POINTS USING DEVICES. THIS 749 00:32:28,629 --> 00:32:31,165 IS TO MONITOR PAIN, RESPONSE TO 750 00:32:31,165 --> 00:32:33,668 INTERVENTIONS AND IMPACT ON 751 00:32:33,668 --> 00:32:36,104 QUALITY OF LIFE. THESE 752 00:32:36,104 --> 00:32:38,606 END-POINTS ARE DEFINED IN THE 753 00:32:38,606 --> 00:32:41,442 RFA AS BIOSIGNATURES THAT CAN BE 754 00:32:41,442 --> 00:32:43,644 OBTAIN ED FROM FUNCTIONAL AND 755 00:32:43,644 --> 00:32:45,179 PHYSIOLOGICAL ASSESSMENTS 756 00:32:45,179 --> 00:32:46,914 CAPTURED BY REMOTE OR WEARABLE 757 00:32:46,914 --> 00:32:48,483 ADVICES. VERY MUCH ALIGNED WITH 758 00:32:48,483 --> 00:32:50,752 WHAT OUR COMMUNITY DOES IN 759 00:32:50,752 --> 00:32:53,421 EVENTS. ADDRESSES AN IMPORTANT 760 00:32:53,421 --> 00:32:56,858 NEED TO DEVELOP APPROACHES THAT 761 00:32:56,858 --> 00:32:59,794 CAN QUANTIFY OBJECTIVELY LEVELS 762 00:32:59,794 --> 00:33:02,463 OF PAIN IN INDIVIDUAL, WHICH IS 763 00:33:02,463 --> 00:33:04,365 A PERSISTENT ISSUE, PERSISTENT 764 00:33:04,365 --> 00:33:07,201 PROBLEM AND CHALLENGE IN 765 00:33:07,201 --> 00:33:08,903 TREATING PAIN. WE'VE PRESENTED 766 00:33:08,903 --> 00:33:12,907 AND GOTTEN INVOLVED IN IMAGING 767 00:33:12,907 --> 00:33:14,542 APPROACHES. NOW WITH EXPANSION 768 00:33:14,542 --> 00:33:16,010 OF THE HEAL PAIN INITIATIVE I 769 00:33:16,010 --> 00:33:19,347 THINK WE WILL HAVE AN IMPACT IN 770 00:33:19,347 --> 00:33:21,849 OTHER AREAS AS WELL. ANOTHER -- 771 00:33:21,849 --> 00:33:25,620 NOW THIS IS A NOTICE OF SPECIAL 772 00:33:25,620 --> 00:33:32,927 INTEREST, OR A NOSI, QUANTUM 773 00:33:32,927 --> 00:33:34,262 BIOIMPLEMENTATIONS. WE HAVE BEEN 774 00:33:34,262 --> 00:33:36,597 HAVING THESE CONVERSATIONS AND I 775 00:33:36,597 --> 00:33:39,333 THINK THERE IS EXCITEMENT AND 776 00:33:39,333 --> 00:33:41,969 MOMENTUM BUILDING UP. NOTABLY, 777 00:33:41,969 --> 00:33:44,038 OF COURSE OURS. BUT TRADITIONAL 778 00:33:44,038 --> 00:33:48,242 PARTNERS, NEI, HLBI, NIGS, WHICH 779 00:33:48,242 --> 00:33:50,078 SUPPORTS LOT OF THESE, END CAPS 780 00:33:50,078 --> 00:34:00,488 AND NCI. CONTACT OFROUZ 781 00:34:01,689 --> 00:34:03,524 ANDERSON. WE HOPE TO SEE IT 782 00:34:03,524 --> 00:34:06,994 EXPAND AS WE ARE STARTING TO SEE 783 00:34:06,994 --> 00:34:10,264 MORE AND MORE QUANTUM-SENSES 784 00:34:10,264 --> 00:34:12,700 TECHNOLOGIES, EVERYTHING FROM 785 00:34:12,700 --> 00:34:18,372 IMAGING TO MATERIALS AND 786 00:34:18,372 --> 00:34:19,107 BIOMATER 787 00:34:19,107 --> 00:34:21,309 BIOMATERIALS. AFROUZ IS LEADING 788 00:34:21,309 --> 00:34:23,277 THE COUNCIL IN FINLAND 789 00:34:23,277 --> 00:34:24,979 PARTNERSHIP. YOU WILL SEE SOME 790 00:34:24,979 --> 00:34:26,814 COME FROM NIH EVERY ONCE IN A 791 00:34:26,814 --> 00:34:28,483 WHILE THAT POINT OUT SPECIFIC 792 00:34:28,483 --> 00:34:32,820 AREAS OF INTEREST BOTH TO NIH 793 00:34:32,820 --> 00:34:33,521 COMMUNITY AS WELL AS 794 00:34:33,521 --> 00:34:35,089 INTERNATIONAL COLLABORATORS. IN 795 00:34:35,089 --> 00:34:37,125 THIS ONE CORE AREAS THAT OUR 796 00:34:37,125 --> 00:34:40,661 COMMUNITY WORKS IN, PLATONICS, 797 00:34:40,661 --> 00:34:41,529 ARTIFICIAL INTELLIGENCE, 798 00:34:41,529 --> 00:34:44,132 BIOECONOMY, MATERIALS, DIGITAL 799 00:34:44,132 --> 00:34:45,700 PRECISION CANCER MEDICINE ARE OF 800 00:34:45,700 --> 00:34:47,502 GREAT INTEREST TO OUR COLLEAGUES 801 00:34:47,502 --> 00:34:49,036 IN FINLAND. SORT OF BROADLY THE 802 00:34:49,036 --> 00:34:51,172 WAY THIS WORKS, IF YOU PUT AN 803 00:34:51,172 --> 00:34:52,807 APPLICATION TOGETHER WITH A 804 00:34:52,807 --> 00:34:56,844 COLLEAGUE FROM FINLAND AND IT 805 00:34:56,844 --> 00:35:00,781 RECEIVES FUNDING, OUR SIDE NIH 806 00:35:00,781 --> 00:35:03,184 WILL FUND THE APPROPRIATE FINISH 807 00:35:03,184 --> 00:35:06,220 AGENCY, THE RESEARCH COUNCIL OF 808 00:35:06,220 --> 00:35:07,989 FINLAND WOULD FUND THE FINISH 809 00:35:07,989 --> 00:35:09,390 INVESTIGATOR. NO MONEY FROM THE 810 00:35:09,390 --> 00:35:11,259 NIH WOULD GO TO FINLAND OR VICE 811 00:35:11,259 --> 00:35:13,361 VERSA, BUT IT IS DESIGNED TO 812 00:35:13,361 --> 00:35:15,897 ENCOURAGE THESE MULTI NATIONAL 813 00:35:15,897 --> 00:35:18,599 TYPES OF COLLABORATIONS. ANOTHER 814 00:35:18,599 --> 00:35:21,936 EXAMPLE OF -- AND PROBABLY THE 815 00:35:21,936 --> 00:35:25,039 MOST HIGHLY EVOLVED EXAMPLE OF 816 00:35:25,039 --> 00:35:26,908 THIS TYPE IS COLLABORATIVE 817 00:35:26,908 --> 00:35:28,743 RESEARCH AND COMPUTATIONAL 818 00:35:28,743 --> 00:35:32,079 MIRROR SCIENCE, CONTACT SHI TWAN 819 00:35:32,079 --> 00:35:34,549 IF YOU ARE INTERESTED. THIS 820 00:35:34,549 --> 00:35:36,017 INVOLVES POTENTIAL PARTNERSHIPS 821 00:35:36,017 --> 00:35:39,353 WITH SPAIN, JAPAN, ISRAEL, 822 00:35:39,353 --> 00:35:42,657 FRANCE AND GERMANY. ALSO WITH 823 00:35:42,657 --> 00:35:44,392 THE DEPARTMENT OF ENERGY. SO 824 00:35:44,392 --> 00:35:47,728 THIS IS A NEW ISSUANCE. THE NEXT 825 00:35:47,728 --> 00:35:50,364 APPLICATION DUE DATE HERE IS 826 00:35:50,364 --> 00:35:52,867 MARCH 7TH OF 2024. IT IS A 827 00:35:52,867 --> 00:35:55,770 REALLY WONDERFUL OPPORTUNITY TO 828 00:35:55,770 --> 00:35:57,939 ESTABLISH INTERNATIONAL 829 00:35:57,939 --> 00:35:58,773 COLLABORATIONS. SO PLEASE BUILD 830 00:35:58,773 --> 00:36:00,708 ON COLLABORATIONS YOU MAY HAVE 831 00:36:00,708 --> 00:36:04,478 AND GET SPECIFIC, DEDICATED 832 00:36:04,478 --> 00:36:07,348 FUNDING SUPPORT. FINALLY TO SORT 833 00:36:07,348 --> 00:36:10,685 OF CONCLUDE THIS PORTION OF MY 834 00:36:10,685 --> 00:36:12,220 PRESENTATION, WE ARE HIRING TWO 835 00:36:12,220 --> 00:36:13,888 MORE PROGRAM DIRECTOR POSITIONS. 836 00:36:13,888 --> 00:36:16,123 THESE HAVE BEEN OPEN FOR A 837 00:36:16,123 --> 00:36:18,559 WHILE. WE ARE HOPING TO INCREASE 838 00:36:18,559 --> 00:36:20,428 THE VISIBILITY AND EXPLAIN A 839 00:36:20,428 --> 00:36:22,096 LITTLE BETTER ABOUT WHAT THESE 840 00:36:22,096 --> 00:36:24,699 PROGRAM DIRECTOR POSITIONS ARE. 841 00:36:24,699 --> 00:36:27,134 SOMETIMES THE GOVERNMENT'S 842 00:36:27,134 --> 00:36:29,470 METHOD OF ADVERTISEMENT IS NOT 843 00:36:29,470 --> 00:36:31,272 NECESSARILY TARGETED TO THE 844 00:36:31,272 --> 00:36:33,040 RIGHT COMMUNITIES. SO ONE OF 845 00:36:33,040 --> 00:36:36,310 THEM IS IN IMAGE-GUIDED 846 00:36:36,310 --> 00:36:37,245 INTERVENTIONS. OBVIOUSLY ONE OF 847 00:36:37,245 --> 00:36:40,147 THE FASTEST GROWING AREAS IN 848 00:36:40,147 --> 00:36:42,183 MEDICINE. YOU CAN'T REALLY DO 849 00:36:42,183 --> 00:36:43,584 INTERVENTIONS SUCCESS FULLY 850 00:36:43,584 --> 00:36:46,887 WITHOUT BEING ABLE TO VISUALIZE 851 00:36:46,887 --> 00:36:49,757 THEM. IMAGE-GUIDED APPROACHES 852 00:36:49,757 --> 00:36:51,092 ARE -- TAKE ADVANTAGE OF 853 00:36:51,092 --> 00:36:52,860 ADVANCES IN TECHNOLOGIES THAT 854 00:36:52,860 --> 00:36:54,262 OUR COMMUNITY IS REALLY ON THE 855 00:36:54,262 --> 00:37:01,002 CUTTING EDGE OF DEVELOPING. GUIN 856 00:37:01,002 --> 00:37:03,337 LOU IS DIRECTOR IN DIVISION OF 857 00:37:03,337 --> 00:37:04,972 APPLIED SCIENCES AND TECHNOLOGY. 858 00:37:04,972 --> 00:37:06,107 PLEASE CONTACT HER IF YOU KNOW 859 00:37:06,107 --> 00:37:07,975 OF PEOPLE WHO MAY BE INTERESTED. 860 00:37:07,975 --> 00:37:09,844 YOU HAVE HEARD FROM MY DIRECTION 861 00:37:09,844 --> 00:37:11,779 OF PROGRAM DIRECTORS AND DATA 862 00:37:11,779 --> 00:37:12,613 SCHOLARS THE KIND OF 863 00:37:12,613 --> 00:37:15,483 INDIVIDUALS, YOU KNOW, IN OUR 864 00:37:15,483 --> 00:37:16,951 COMMUNITY WHO MAY BE INTERESTED 865 00:37:16,951 --> 00:37:19,186 IN THESE TYPES OF POSITIONS. THE 866 00:37:19,186 --> 00:37:21,622 SECOND ONE IS A PROGRAM DIRECTOR 867 00:37:21,622 --> 00:37:23,357 IN POINT OF CARE TECHNOLOGIES 868 00:37:23,357 --> 00:37:26,260 AND DIGITAL HEALTH. AGAIN 869 00:37:26,260 --> 00:37:28,963 CONTACT OUR DIVISION DIRECTOR 870 00:37:28,963 --> 00:37:30,331 BERUSE FOR INFORMATION ABOUT 871 00:37:30,331 --> 00:37:33,000 THIS. YOU ARE ALL VERY FAMILIAR 872 00:37:33,000 --> 00:37:36,637 WITH WHAT WE HAVE DONE IN POINT 873 00:37:36,637 --> 00:37:39,674 OF CARE. I WILL CONTINUE TO TALK 874 00:37:39,674 --> 00:37:42,176 IN AN UPDATE. THIS IS A CRITICAL 875 00:37:42,176 --> 00:37:44,979 POSITION. WE ARE HOPEFUL WE CAN 876 00:37:44,979 --> 00:37:47,081 BE SUCCESSFUL WHEN CREATING SOME 877 00:37:47,081 --> 00:37:48,416 EXPERTS HERE. SO NOW I WOULD 878 00:37:48,416 --> 00:37:52,219 LIKE TO UPDATE A LITTLE ON SOME 879 00:37:52,219 --> 00:37:55,289 OF OUR PROGRAMS THAT HAVE HAD 880 00:37:55,289 --> 00:37:58,559 UNIQUE SUCCESSES AND THAT ARE 881 00:37:58,559 --> 00:37:59,360 INTERESTING, EMERGING STORIES. 882 00:37:59,360 --> 00:38:00,795 YOU HAVE PROBABLY BEEN FOLLOWING 883 00:38:00,795 --> 00:38:02,697 THE THREAT OF MANY OF THESE 884 00:38:02,697 --> 00:38:04,999 STORIES. YOU HAVE HEARD ANDREW 885 00:38:04,999 --> 00:38:07,068 WHITE, OUR PROGRAM DIRECTOR, 886 00:38:07,068 --> 00:38:09,737 TALK ABOUT THE HOME TEST TREAT 887 00:38:09,737 --> 00:38:13,274 PROGRAM. HE'S GIVEN BOTH KIND OF 888 00:38:13,274 --> 00:38:15,309 THE INITIAL PILOT AND EXPANSION 889 00:38:15,309 --> 00:38:17,411 PHASE UPDATES. THE PILOT PHASE 890 00:38:17,411 --> 00:38:19,880 WAS LAUNCH ED A YEAR AGO. THE 891 00:38:19,880 --> 00:38:23,751 IDEA BEING YOU CAN TEST AT HOME 892 00:38:23,751 --> 00:38:25,886 IF YOU ARE A POSITIVE TEST. IN 893 00:38:25,886 --> 00:38:27,755 2023 THIS WAS JUST FOR COVID. IF 894 00:38:27,755 --> 00:38:31,092 YOU HAD A POSITIVE WITH THE 895 00:38:31,092 --> 00:38:33,694 RAPID ANTIGEN TEST, YOU COULD 896 00:38:33,694 --> 00:38:34,395 THROUGH THIS PROGRAM ACTUALLY 897 00:38:34,395 --> 00:38:38,566 GET PAXLOVID. WE EXPANDED BEYOND 898 00:38:38,566 --> 00:38:41,202 A SMALL AREA IN PENNSYLVANIA TO 899 00:38:41,202 --> 00:38:44,505 ATLANTA AND HOUSTON THAT WAS A 900 00:38:44,505 --> 00:38:49,710 PILOT EXPANSION. ALL THE WHILE 901 00:38:49,710 --> 00:38:53,047 WORKING ON MULTIPLEX TESTS, FOR 902 00:38:53,047 --> 00:38:55,583 COVID AND FLU. JUST AT THE END 903 00:38:55,583 --> 00:38:58,552 OF LAST YEAR, TIMED IT SO THAT 904 00:38:58,552 --> 00:39:01,088 WE WERE ABLE TO SORT OF CATCH 905 00:39:01,088 --> 00:39:02,890 THE WAVE OF COVID PANDA FLU 906 00:39:02,890 --> 00:39:04,992 EXPANDING AS WELL AS THE 907 00:39:04,992 --> 00:39:06,394 TECHNOLOGIES. THAT'S RECEIVED 908 00:39:06,394 --> 00:39:07,962 FAIR AMOUNT OF PUBLICITY AND 909 00:39:07,962 --> 00:39:09,730 ACCOUNTED FOR A LOT OF THOSE 910 00:39:09,730 --> 00:39:11,198 PAGE VIEWS. YOU HAVE SEEN SOME 911 00:39:11,198 --> 00:39:14,201 OF THIS PERHAPS IN THE POPULAR 912 00:39:14,201 --> 00:39:18,305 PRESS. SO JUST TO UPDATE FROM 913 00:39:18,305 --> 00:39:20,274 THAT DECEMBER OF 2023 LAUNCH OF 914 00:39:20,274 --> 00:39:24,011 THE PROGRAM, IT IS A COVID AND 915 00:39:24,011 --> 00:39:28,115 FLU NATIONWIDE PROGRAM. IT IS 916 00:39:28,115 --> 00:39:28,916 TESTTOTREAT.ORG. YOU CAN SEE 917 00:39:28,916 --> 00:39:31,185 THAT WEBSITE. WHAT IS UNIQUE 918 00:39:31,185 --> 00:39:33,254 ABOUT THIS, AT ITS CORE THE 919 00:39:33,254 --> 00:39:37,658 TECHNOLOGY IS THE LUCERA PCRU 920 00:39:37,658 --> 00:39:42,029 AND ISONUC TEST APPROVED FOR 921 00:39:42,029 --> 00:39:43,798 HOME USE. THIS IS AVAILABLE FOR 922 00:39:43,798 --> 00:39:46,033 ELIGIBLE PARTICIPANTS IN THIS 923 00:39:46,033 --> 00:39:50,104 PROGRAM. OUR RADAX ITAP PLAY ED 924 00:39:50,104 --> 00:39:53,474 A CRITICAL ROLE IN GETTING THAT 925 00:39:53,474 --> 00:39:54,074 VALIDA 926 00:39:54,074 --> 00:39:55,743 VALIDATED. LUCERA, SOME OF YOU 927 00:39:55,743 --> 00:39:58,446 MAY RECALL, WAS PURCHASED OUT OF 928 00:39:58,446 --> 00:40:00,181 BANKRUPTCY BY PFIZER. PFIZER 929 00:40:00,181 --> 00:40:05,453 ALSO MAKES PAXLOVID. SO IT IS 930 00:40:05,453 --> 00:40:07,922 SORT OF NESTED MARKET THAT THEY 931 00:40:07,922 --> 00:40:09,623 ARE LOOKING FOR BOTH THE 932 00:40:09,623 --> 00:40:11,625 DIAGNOSTIC TESTING AS WELL AS 933 00:40:11,625 --> 00:40:13,627 THERAPY. WE WILL SEE THAT THEME 934 00:40:13,627 --> 00:40:17,064 CONTINUE TO EMERGE IN BOTH THE 935 00:40:17,064 --> 00:40:19,200 DIAGNOSTICS AND THERAPEUTICS 936 00:40:19,200 --> 00:40:23,404 INDUSTRIES. SO THIS IS NOW A 937 00:40:23,404 --> 00:40:24,872 PARTNERSHIP BETWEEN US AND 938 00:40:24,872 --> 00:40:26,807 SEVERAL OTHER ORGANIZATIONS -- 939 00:40:26,807 --> 00:40:28,676 WELL, FROM THE VERY BEGINNING. 940 00:40:28,676 --> 00:40:31,545 WE HAVE WORKED WITH ASPER, CDC 941 00:40:31,545 --> 00:40:40,254 AND EMED IS THE TELEHEALTH OR 942 00:40:40,254 --> 00:40:41,689 PROVIDER THAT MANAGES THE 943 00:40:41,689 --> 00:40:42,957 CONFIRMATION OF TEST RESULTS AS 944 00:40:42,957 --> 00:40:44,925 WELL AS PRESCRIPTIONS 945 00:40:44,925 --> 00:40:47,161 INTERACTING WITH ONLINE 946 00:40:47,161 --> 00:40:48,462 PHARMACIES. SO THIS IS MADE 947 00:40:48,462 --> 00:40:49,864 POSSIBLE BY TWO FUNDAMENTAL 948 00:40:49,864 --> 00:40:53,934 ELEMENTS FROM OUR RADAX TECH 949 00:40:53,934 --> 00:40:57,104 PROGRAM. THE ITAP PROGRAM, 950 00:40:57,104 --> 00:40:59,940 ACCELERATED AUTHORIZATIONS OF 951 00:40:59,940 --> 00:41:04,144 MULTI -PLEX AS WELL AS DIGITAL 952 00:41:04,144 --> 00:41:06,213 MARS AND MAKEMYTEST COUNT 953 00:41:06,213 --> 00:41:07,681 REPORTING SYSTEM. HERE WE ARE 954 00:41:07,681 --> 00:41:10,484 TODAY. A QUICK UPDATE. NEARLY 955 00:41:10,484 --> 00:41:11,719 50,000 PEOPLE HAVE ENROLLED. 956 00:41:11,719 --> 00:41:13,587 THAT IS VERY, VERY CLOSE TO OUR 957 00:41:13,587 --> 00:41:16,257 TARGET, WHICH IS POWERED TO HELP 958 00:41:16,257 --> 00:41:17,892 ADDRESS SOME RESEARCH QUESTIONS. 959 00:41:17,892 --> 00:41:21,395 THE TELEHEALTH VISITS HAVE 960 00:41:21,395 --> 00:41:23,330 EXCEEDED OUR TARGET. THERE ARE 961 00:41:23,330 --> 00:41:25,432 OVER 5,000 OF THOSE. ALSO 962 00:41:25,432 --> 00:41:27,635 ANTI -VIRAL PRESCRIPTIONS THAT 963 00:41:27,635 --> 00:41:32,172 HAVE BEEN DELIVERED, OVER 4,000 964 00:41:32,172 --> 00:41:34,074 AGAIN EXCEEDING OUR TARGET THERE 965 00:41:34,074 --> 00:41:36,143 ARE RESEARCH QUESTIONS EMBEDDED 966 00:41:36,143 --> 00:41:39,146 IN UMAS, ONE OF THE KEY 967 00:41:39,146 --> 00:41:42,416 PERFORMING SITES IN POCTURN IS 968 00:41:42,416 --> 00:41:43,784 TAKING THE LEAD ON ADDRESSING 969 00:41:43,784 --> 00:41:46,420 THOSE QUESTIONS. THEY ARE 970 00:41:46,420 --> 00:41:48,756 BROADLY ABOUT PROGRAM USE, 971 00:41:48,756 --> 00:41:50,558 EFFICACY, IMPACT, SUSTAINABILITY 972 00:41:50,558 --> 00:41:52,126 IN POPULATIONS THAT HAVE LIMITED 973 00:41:52,126 --> 00:41:54,395 ACCESS TO HEALTH CARE. THAT IS 974 00:41:54,395 --> 00:42:00,000 THE FOCUS OF THIS PROGRAM. IT IS 975 00:42:00,301 --> 00:42:02,236 PROVIDE THESE RESOURCES TO 976 00:42:02,236 --> 00:42:04,338 INDIVIDUALS WHO HAVE LIMITED 977 00:42:04,338 --> 00:42:05,339 ACCESS. ANOTHER MAJOR EFFORT 978 00:42:05,339 --> 00:42:07,341 THAT I WANT TO UPDATE YOU ON -- 979 00:42:07,341 --> 00:42:09,009 AND YOU HAVE HEARD ME TALK ABOUT 980 00:42:09,009 --> 00:42:12,846 AND REFER AND ALLUDE TO IT 981 00:42:12,846 --> 00:42:14,214 SEVERAL TIMES IN PREVIOUS 982 00:42:14,214 --> 00:42:16,517 COUNCIL MEETINGS IS THIS NASUM 983 00:42:16,517 --> 00:42:19,587 REPORT ON DIGITAL TWINS. THE 984 00:42:19,587 --> 00:42:21,655 NASUM REPORT IS NOW OUT. IT 985 00:42:21,655 --> 00:42:24,291 ACTUALLY CAME OUT MID-DECEMBER 986 00:42:24,291 --> 00:42:26,827 LAST YEAR. NIBIB CO -SPONSORED 987 00:42:26,827 --> 00:42:29,930 IT. IT IS A CONSENSUS STUDY 988 00:42:29,930 --> 00:42:33,567 REPORT. THERE'S LOTS OF EXCITING 989 00:42:33,567 --> 00:42:36,670 INFORMATION IN THIS. I WANTED TO 990 00:42:36,670 --> 00:42:39,373 GIVE YOU A LITTLE BREAKING NEWS. 991 00:42:39,373 --> 00:42:42,142 CONTACT GRACE PANG WHO HAS 992 00:42:42,142 --> 00:42:43,310 CHAMPIONED AND CONTINUES TO 993 00:42:43,310 --> 00:42:46,280 CHAMPION IT ACROSS MANY AREAS OF 994 00:42:46,280 --> 00:42:48,215 MODELLING COMPUTATION WITHIN THE 995 00:42:48,215 --> 00:42:51,251 NIH. ONE OF THE IMPORTANT THINGS 996 00:42:51,251 --> 00:42:54,288 THIS REPORT HAS DONE IS DEVELOP 997 00:42:54,288 --> 00:42:58,092 THE DEFINITION THAT BUILDS ON 998 00:42:58,092 --> 00:43:00,661 PREVIOUS ONES, BUT IT IS A VERY 999 00:43:00,661 --> 00:43:01,895 ACCESSIBLE DEFINITION. I THINK 1000 00:43:01,895 --> 00:43:03,697 IF YOU ARE NOT INVOLVED IN 1001 00:43:03,697 --> 00:43:05,299 DIGITAL TWIN WORK, I THINK IT IS 1002 00:43:05,299 --> 00:43:07,768 A LITTLE OFFPUTTING. I THINK IT 1003 00:43:07,768 --> 00:43:09,470 IS MAYBE HARD TO UNDERSTAND WHAT 1004 00:43:09,470 --> 00:43:11,338 IS A DIGITAL TWIN UNLESS OF 1005 00:43:11,338 --> 00:43:14,208 COURSE YOU DO ENGINEERING. AND 1006 00:43:14,208 --> 00:43:16,176 DIGITAL TWINS HAVE REALLY BECOME 1007 00:43:16,176 --> 00:43:18,445 STANDARD IN ENGINEERING 1008 00:43:18,445 --> 00:43:20,180 CONSTRUCTION AND FABRICATION. 1009 00:43:20,180 --> 00:43:24,284 BUT IN HEALTH IT IS HARD TO 1010 00:43:24,284 --> 00:43:27,621 UNDERSTAND. THIS STANDARDIZED 1011 00:43:27,621 --> 00:43:29,923 DEFINITION IS I THINK EXTREMELY 1012 00:43:29,923 --> 00:43:32,559 USEFUL. MANY PEOPLE CAN CONNECT 1013 00:43:32,559 --> 00:43:35,329 WITH THIS. AND ALSO SORT OF 1014 00:43:35,329 --> 00:43:36,363 IMAGINE HOW THE WORK THEY ARE 1015 00:43:36,363 --> 00:43:38,666 DOING IN MODEL-BASED WHATEVER IT 1016 00:43:38,666 --> 00:43:40,968 IS, IMAGING OR MATERIALS, 1017 00:43:40,968 --> 00:43:43,637 DEVICES AND SO FORTH, COULD 1018 00:43:43,637 --> 00:43:46,373 STRONGLY BE CONNECTED TO DIGITAL 1019 00:43:46,373 --> 00:43:49,343 TWINS AND PERHAPS EVEN BE QUITE 1020 00:43:49,343 --> 00:43:52,446 RELEVANT AND MAYBE UTILIZED 1021 00:43:52,446 --> 00:43:55,582 RESOURCES DEVELOPED FOR DIGITAL 1022 00:43:55,582 --> 00:43:57,217 TWINS. THEY GIVE SEVERAL 1023 00:43:57,217 --> 00:43:58,552 EXAMPLES IN THE REPORT. I WILL 1024 00:43:58,552 --> 00:44:00,688 JUST SORT OF PULL OUT A CANCER 1025 00:44:00,688 --> 00:44:02,056 PATIENT EXAMPLE THAT IS 1026 00:44:02,056 --> 00:44:03,323 HIGHLIGHTED. YOU CAN SEE WHAT 1027 00:44:03,323 --> 00:44:05,626 I'M TALKING ABOUT THERE. IT 1028 00:44:05,626 --> 00:44:06,927 REQUIRES A VIRTUAL 1029 00:44:06,927 --> 00:44:11,331 REPRESENTATION. THOSE WOULD BE 1030 00:44:11,331 --> 00:44:13,367 MECHANISTIC AND EMPIRICAL MODELS 1031 00:44:13,367 --> 00:44:14,468 REPRESENTING TUMOR GROWTH AND SO 1032 00:44:14,468 --> 00:44:17,004 FORTH AND REQUIRE A PHYSICAL 1033 00:44:17,004 --> 00:44:18,605 COUNTERPART. COULD BE PATIENT 1034 00:44:18,605 --> 00:44:20,708 DATA FROM IMAGING, BLOOD TESTS 1035 00:44:20,708 --> 00:44:23,010 AND OTHER CRITICAL ASSESSMENTS 1036 00:44:23,010 --> 00:44:25,979 AND BIDIRECTIONAL INTERACTION SO 1037 00:44:25,979 --> 00:44:26,980 UPDATES THE VIRTUAL 1038 00:44:26,980 --> 00:44:28,749 REPRESENTATION TO REFLECT 1039 00:44:28,749 --> 00:44:29,650 CHARACTERISTICS OF THE 1040 00:44:29,650 --> 00:44:30,951 INDIVIDUAL PATIENT. INFORMS 1041 00:44:30,951 --> 00:44:32,519 CLINICAL DECISION, TREATMENTS 1042 00:44:32,519 --> 00:44:34,722 AND CLINICAL ASSESSMENTS. THOSE 1043 00:44:34,722 --> 00:44:37,591 COULD BE CLINICAL DECISION 1044 00:44:37,591 --> 00:44:40,461 SUPPORT OR ACTUAL CLINICAL 1045 00:44:40,461 --> 00:44:44,364 DECISIONS THAT ARE BANKABLE THAT 1046 00:44:44,364 --> 00:44:46,734 QUESTIONS WILL ACT ON. THESE NEW 1047 00:44:46,734 --> 00:44:49,236 CLINICAL ASSESSMENTS WOULD 1048 00:44:49,236 --> 00:44:51,438 INFORM AND THEN SUBSEQUENTLY 1049 00:44:51,438 --> 00:44:53,640 UPDATE THE DIGITAL TWIN. SO I 1050 00:44:53,640 --> 00:44:57,177 THINK A PRACTICAL AND RELATABLE 1051 00:44:57,177 --> 00:45:01,949 EXAMPLE ALL OF US CAN IDENTIFY 1052 00:45:01,949 --> 00:45:06,620 WITH. THERE IS A NOSI OUT FROM 1053 00:45:06,620 --> 00:45:09,089 NCI IN THE DIVISION OF DIGITAL 1054 00:45:09,089 --> 00:45:11,458 TWINS. IT IS CALLED THE DIGITAL 1055 00:45:11,458 --> 00:45:14,928 TWINS IN RADIATION ONCOLOGY. YOU 1056 00:45:14,928 --> 00:45:17,097 SHOULD TAKE A LOOK AT THAT. I 1057 00:45:17,097 --> 00:45:20,200 THINK NCI WILL BE RELEASING MORE 1058 00:45:20,200 --> 00:45:23,237 NOSI AND OTHER IC PERHAPS IN THE 1059 00:45:23,237 --> 00:45:24,972 NEAR FUTURE. GRACE IS LEADING 1060 00:45:24,972 --> 00:45:31,545 THE INTERAGENCY MODELLING AND 1061 00:45:31,545 --> 00:45:35,249 ANALYSIS GROURNGP, IMAC, WHICH 1062 00:45:35,249 --> 00:45:37,251 ROAD MAPPING. I THINK YOU WILL 1063 00:45:37,251 --> 00:45:38,719 SEE CONTINUED GROWTH AS PEOPLE 1064 00:45:38,719 --> 00:45:40,454 GET MORE AND MORE INVOLVED. THIS 1065 00:45:40,454 --> 00:45:42,856 REALLY DOVE TAILS BECAUSE OF THE 1066 00:45:42,856 --> 00:45:44,758 IMPORTANCE OF ARTIFICIAL 1067 00:45:44,758 --> 00:45:46,727 INTELLIGENCE IN DIGITAL TWINS 1068 00:45:46,727 --> 00:45:48,028 INTO SOMETHING I HAVE MENTIONED 1069 00:45:48,028 --> 00:45:50,564 IN PREVIOUS COUNCIL MEETINGSN. 1070 00:45:50,564 --> 00:45:55,202 JANUARY OF 2023, OSTP RELEASED A 1071 00:45:55,202 --> 00:46:01,809 REPORT ON STRENGTHENING AND DMOK 1072 00:46:01,809 --> 00:46:02,409 ADVERT 1073 00:46:02,409 --> 00:46:06,947 ADVERTISE -- DEMOCK ADVERTISING 1074 00:46:06,947 --> 00:46:08,182 THE DIVISION. THERE WAS A 1075 00:46:08,182 --> 00:46:09,783 INFRASTRUCTURE TO BROAD EN 1076 00:46:09,783 --> 00:46:11,685 RESOURCES THAT ARE ESSENTIAL SO 1077 00:46:11,685 --> 00:46:14,321 WHAT IN PRACTICAL TERMS IS THAT? 1078 00:46:14,321 --> 00:46:17,624 IT IS A NATIONAL AI RESEARCH 1079 00:46:17,624 --> 00:46:19,660 RESOURCE, OR NAIR. PHYSICALLY 1080 00:46:19,660 --> 00:46:22,396 THIS WOULD BE PHYSICALLY A 1081 00:46:22,396 --> 00:46:25,332 MATRIX ORGANIZATION BUT IT IS 1082 00:46:25,332 --> 00:46:27,467 ESTIMATED -- YOU KNOW, DON'T 1083 00:46:27,467 --> 00:46:31,972 HAVE A FULLY DEFINITIVE VIEW BUT 1084 00:46:31,972 --> 00:46:32,840 ACTIVELY ENGAGED IN THIS 1085 00:46:32,840 --> 00:46:36,877 PROCESS. IT IS ESTIMATED TO BE A 1086 00:46:36,877 --> 00:46:38,579 $2.6 BILLION, SIX-YEAR 1087 00:46:38,579 --> 00:46:40,547 INVESTMENT IN INFRASTRUCTURE FOR 1088 00:46:40,547 --> 00:46:42,282 ARTIFICIAL INTELLIGENCE. WHAT IS 1089 00:46:42,282 --> 00:46:43,517 VERY IMPORTANT IS THAT, YOU 1090 00:46:43,517 --> 00:46:45,686 KNOW, WE ARE NOT JUST -- IT WILL 1091 00:46:45,686 --> 00:46:50,524 BE LED BY NSF. BUT WE ARE NOT 1092 00:46:50,524 --> 00:46:53,360 BYSTANDERS. WE ARE ACTIVELY 1093 00:46:53,360 --> 00:46:55,596 PARTICIPATING IN NAIR AND IN 1094 00:46:55,596 --> 00:46:57,564 PARTICULAR A PILOT PROGRAM IN 1095 00:46:57,564 --> 00:47:01,401 2024 TO DEPLOY RESOURCES TO 1096 00:47:01,401 --> 00:47:04,171 EARLY NEAR USERS AND MIDRIC 1097 00:47:04,171 --> 00:47:05,806 SPECIFICALLY HAS BEEN SELECTED 1098 00:47:05,806 --> 00:47:09,543 AS A PILOT PROGRAM RESOURCE FOR 1099 00:47:09,543 --> 00:47:12,312 NAIR. RESOURCES, ACTIVITIES, 1100 00:47:12,312 --> 00:47:16,350 STRUCTURE AND PEOPLE INVOLVED IN 1101 00:47:16,350 --> 00:47:18,151 MIDRIC WILL BE INCREASINGLY 1102 00:47:18,151 --> 00:47:19,920 ENGAGED. I THINK WE HAVE A 1103 00:47:19,920 --> 00:47:24,992 UNIQUE OPPORTUNITY TO TAKE 1104 00:47:24,992 --> 00:47:26,059 LEADERSHIP ROLE AND NOT JUST 1105 00:47:26,059 --> 00:47:30,097 RELY ON THE NAIR INITIATIVE LED 1106 00:47:30,097 --> 00:47:32,466 BY THE PHYSICAL SCIENCE AND 1107 00:47:32,466 --> 00:47:34,334 COMPUTATIONAL COMMUNITY BUT THE 1108 00:47:34,334 --> 00:47:35,402 BIOMEDICAL COMMUNITY WILL BE 1109 00:47:35,402 --> 00:47:37,738 ABLE TO CONTRIBUTE STRONGLY, 1110 00:47:37,738 --> 00:47:39,907 THANKS TO OUR COLLEAGUES, BRAD, 1111 00:47:39,907 --> 00:47:43,343 CHRIS AND RUIZ, WHO HAVE REALLY 1112 00:47:43,343 --> 00:47:45,012 CHAMPIONED THIS ENGAGEMENT AND 1113 00:47:45,012 --> 00:47:47,247 PILOT PROJECT PROGRAM. 1114 00:47:47,247 --> 00:47:52,319 NOT ONLY THE NAIR IS ANOTHER 1115 00:47:52,319 --> 00:47:55,222 ENTITY THAT'S EMERGED TO TRY TO 1116 00:47:55,222 --> 00:47:57,190 CREATE UNIQUE RESOURCES AND 1117 00:47:57,190 --> 00:47:59,826 TOOLS THAT ARE WIDELY ACCESSIBLE 1118 00:47:59,826 --> 00:48:02,396 IN ARTIFICIAL INTELLIGENCE BUT 1119 00:48:02,396 --> 00:48:04,131 ARPAH, YOU MAY HAVE HEARD OF 1120 00:48:04,131 --> 00:48:05,799 THEIR BIOMEDICAL FABRIC TOOL 1121 00:48:05,799 --> 00:48:08,302 BOX. THERE WAS A NATIONAL CALL 1122 00:48:08,302 --> 00:48:09,536 FOR THIS. INFRASTRUCTURE FOR 1123 00:48:09,536 --> 00:48:17,444 DATA INGESTION, CURE RADIAT CURN 1124 00:48:17,444 --> 00:48:21,381 SHGS /* /* CURATION FOR AI 1125 00:48:21,381 --> 00:48:23,250 HEALTH CARE. I'M PLEASED TO SAY 1126 00:48:23,250 --> 00:48:27,387 OUR TEAM MIDRIC HAS BEEN FUNDED 1127 00:48:27,387 --> 00:48:36,897 BY ARPAH BY PERFORMERS, AN ARPA 1128 00:48:36,897 --> 00:48:37,998 PARTNERSHIP , A CONCRETE 1129 00:48:37,998 --> 00:48:40,300 PARTNERSHIP THAT WILL EXTEND OUR 1130 00:48:40,300 --> 00:48:43,770 MIDRIC ACTIVITIES, FOCUSED 1131 00:48:43,770 --> 00:48:46,840 AROUND COVID INTO CANCER. SO IT 1132 00:48:46,840 --> 00:48:51,345 EXTENDS ALL OF THE FUNCTIONAL 1133 00:48:51,345 --> 00:48:54,014 TOOLS IN OUR TOOL BOX INTO OTHER 1134 00:48:54,014 --> 00:48:55,782 AREAS. MANY OF THESE ARE A 1135 00:48:55,782 --> 00:49:01,555 RESULT OF OUR REALLY CRITICAL 1136 00:49:01,555 --> 00:49:09,363 AIML BIAS TOOL SINCE MIDRIC WAS 1137 00:49:09,363 --> 00:49:10,597 LAUNCHED. I ENCOURAGE YOU TO ALL 1138 00:49:10,597 --> 00:49:12,733 LOOK AT THE ESTIMATOR, SCAN THE 1139 00:49:12,733 --> 00:49:15,435 QR CODE, IF YOU HAVEN'T ALREADY. 1140 00:49:15,435 --> 00:49:18,238 THESE WILL BECOME FOUNDATIONAL, 1141 00:49:18,238 --> 00:49:19,306 THE IDENTIFICATION OF VARIOUS 1142 00:49:19,306 --> 00:49:22,776 SOURCES AND WAYS TO MITIGATE 1143 00:49:22,776 --> 00:49:26,680 THEM I THINK ARE GOING TO BECOME 1144 00:49:26,680 --> 00:49:28,548 FOUNDATIONAL IN TOOL BOXES 1145 00:49:28,548 --> 00:49:31,885 DEVELOPED FOR BOTH NAIR, ARPAH 1146 00:49:31,885 --> 00:49:36,323 AND MANY OTHER INITIATIVES IN AI 1147 00:49:36,323 --> 00:49:38,525 AROUND THE WORLD. SO SWITCHING 1148 00:49:38,525 --> 00:49:40,961 GEARS A LITTLE BIT WE HAVE 1149 00:49:40,961 --> 00:49:44,131 TALKED ABOUT RADAX AND IMPACT ON 1150 00:49:44,131 --> 00:49:45,966 NIBIB PROGRAMS. WE HAVE A NUMBER 1151 00:49:45,966 --> 00:49:50,404 OF EXAMPLES OF THAT IMPLICATION 1152 00:49:50,404 --> 00:49:54,174 GOING ON AT NIBIB WITH MULTIPLEX 1153 00:49:54,174 --> 00:49:58,011 TEST COMBINATION COVID AND FLU, 1154 00:49:58,011 --> 00:50:02,149 DEVELOPMENT OF IMPOX AND 1155 00:50:02,149 --> 00:50:04,484 MULTI SEX SEXUALLY TRANSMITTED 1156 00:50:04,484 --> 00:50:07,254 DISEASE TESTS. OUR EFFORTS TO DO 1157 00:50:07,254 --> 00:50:13,026 POINT OF CARE, HEPC TESTING AND 1158 00:50:13,026 --> 00:50:14,094 H.I.V. VIRAL LOAD. YOU HAVE 1159 00:50:14,094 --> 00:50:17,731 HEARD OF RADAX MATERNAL HEALTH 1160 00:50:17,731 --> 00:50:20,867 AND FETAL MONITORING 1161 00:50:20,867 --> 00:50:21,701 TECHNOLOGIES. FOR THE LAST 1162 00:50:21,701 --> 00:50:23,670 COUPLE OF YEARS WE HAVE BEEN 1163 00:50:23,670 --> 00:50:26,706 TALKING ABOUT HOW RADAX 1164 00:50:26,706 --> 00:50:29,743 PRINCIPLES HAVE BEEN EXTENDED TO 1165 00:50:29,743 --> 00:50:31,278 NEUROTECHNOLOGIES. WHAT IS 1166 00:50:31,278 --> 00:50:33,213 REALLY EXCITING ABOUT THE 1167 00:50:33,213 --> 00:50:35,315 NEUROTECHNOLOGY EXTENSION IS 1168 00:50:35,315 --> 00:50:39,052 THERE IS A BROAD GROUP OF 1169 00:50:39,052 --> 00:50:40,220 STAKEHOLDERS ACROSS NIH WITHIN 1170 00:50:40,220 --> 00:50:43,323 BLUEPRINT THAT HAVE ADOPTED 1171 00:50:43,323 --> 00:50:45,692 THESE TECHNOLOGIES AND REALLY 1172 00:50:45,692 --> 00:50:51,264 CRITICALLY ENGAGED IN ADVANCING 1173 00:50:51,264 --> 00:50:52,365 RADAXIFICATION, NOT JUST NIBIB 1174 00:50:52,365 --> 00:50:54,301 BUT ACROSS THE NIH. THIS EFFORT 1175 00:50:54,301 --> 00:50:57,270 HAS BEEN LED BY MULTIPLE ICs AND 1176 00:50:57,270 --> 00:51:00,807 A REALLY TALENTED GROUP OF 1177 00:51:00,807 --> 00:51:07,147 PROGRAM DIRECTORS ACROSS MANY 1178 00:51:07,147 --> 00:51:09,983 IIC 1179 00:51:09,983 --> 00:51:12,018 NOTABLY WITHIN NIBIB. WE HAVE 1180 00:51:12,018 --> 00:51:16,323 THE CHAMPIONING OF THE PROGRAM. 1181 00:51:16,323 --> 00:51:18,492 MICAH'S PLAYED INSTRMENTAL ROLE 1182 00:51:18,492 --> 00:51:20,527 IN GETTING THIS PROGRAM 1183 00:51:20,527 --> 00:51:22,762 LAUNCHED, MANAGING IT QUITE 1184 00:51:22,762 --> 00:51:24,364 STRATEGICALLY. SO I HAVE ASKED, 1185 00:51:24,364 --> 00:51:25,932 BECAUSE YOU ARE PROBABLY TIRED 1186 00:51:25,932 --> 00:51:28,368 OF HEARING MY VOICE, I HAVE 1187 00:51:28,368 --> 00:51:33,907 ASKED MIKE TO JUMP IN. HE HAS 1188 00:51:33,907 --> 00:51:35,342 EXTRAORDINARY EXPERTISE AND 1189 00:51:35,342 --> 00:51:37,077 VISION WITH THIS PROGRAM. MAYBE 1190 00:51:37,077 --> 00:51:40,881 MIKE ARE YOU READY TO JUMP ON 1191 00:51:40,881 --> 00:51:42,616 THE LINE AND -- GREAT. SO I WILL 1192 00:51:42,616 --> 00:51:44,317 RUN THE SLIDES. I HAVE A FEW. 1193 00:51:44,317 --> 00:51:46,887 YOU HAVE A TREAT. YOU CAN LISTEN 1194 00:51:46,887 --> 00:51:49,656 TO MIKE TALK ABOUT THE EVOLUTION 1195 00:51:49,656 --> 00:51:51,992 AND PURPOSE AND WHERE WE ARE 1196 00:51:51,992 --> 00:51:53,593 WITH THIS PROGRAM RIGHT NOW. 1197 00:51:53,593 --> 00:51:55,829 >> ABSOLUTELY. THANKS, BRUCE. 1198 00:51:55,829 --> 00:51:58,098 ABOUT TWO AND A THIRD WE 1199 00:51:58,098 --> 00:51:59,900 PRESENTED CONCEPT CLEARANCE TO 1200 00:51:59,900 --> 00:52:01,768 COUNCIL, LAYING OUT THE VISION 1201 00:52:01,768 --> 00:52:07,073 OF HOW THE PROGRAM IS STRUCK 1202 00:52:07,073 --> 00:52:07,507 CHU 1203 00:52:07,507 --> 00:52:10,510 STRUCTURED, WHERE IT STARTS AND 1204 00:52:10,510 --> 00:52:11,945 ENDS. WE WILL SHOW HOW THING S 1205 00:52:11,945 --> 00:52:14,314 HAVE BEEN REFINE ED IN THAT 1206 00:52:14,314 --> 00:52:16,783 TIME. THE PROGRAM STARTED AFTER 1207 00:52:16,783 --> 00:52:19,319 SUCCESSFUL CONCLUSION OF RO1s 1208 00:52:19,319 --> 00:52:22,389 AND APPLIED RESEARCH THAT NIH 1209 00:52:22,389 --> 00:52:23,823 NORMALLY FUNDS. ALL THE GREAT 1210 00:52:23,823 --> 00:52:26,493 WORK WE DO IN OUR NORMAL PAY 1211 00:52:26,493 --> 00:52:28,461 LINE. SO AFTER -- INVESTIGATOR 1212 00:52:28,461 --> 00:52:30,564 HAS DEMONSTRATED GOOD PROOF OF 1213 00:52:30,564 --> 00:52:32,065 CONCEPT WE KNOW IF WE INTERVENE 1214 00:52:32,065 --> 00:52:35,835 WE CAN DIAGNOSE OR TREAT 1215 00:52:35,835 --> 00:52:37,404 SOMETHING BUT DON'T KNOW HOW TO 1216 00:52:37,404 --> 00:52:39,206 GET TO MARKET. DON'T KNOW HOW TO 1217 00:52:39,206 --> 00:52:41,441 GET TO A PERSON HUMAN STUDY. 1218 00:52:41,441 --> 00:52:43,376 THAT SOUR ENTRY POINT. WE TAKE 1219 00:52:43,376 --> 00:52:46,146 THOSE PROJECTS THAT COME IN 1220 00:52:46,146 --> 00:52:47,514 THROUGH SOLICITATION. IF THEY 1221 00:52:47,514 --> 00:52:50,450 ARE AT SUCH EARLY STAGE, THEY 1222 00:52:50,450 --> 00:52:51,218 DON'T KNOW THE QUESTIONS OTHER 1223 00:52:51,218 --> 00:52:52,519 THAN BEING HERE TO WORK, THEY 1224 00:52:52,519 --> 00:52:56,189 HAVE DONE OTHER BASIC RESEARCH, 1225 00:52:56,189 --> 00:52:58,258 BPI OR OTHER NORMAL MECHANISMS 1226 00:52:58,258 --> 00:53:00,360 AND TAKE INTO WHAT WE CALL 1227 00:53:00,360 --> 00:53:02,229 SEEDLING, WHERE WE HELP THEM 1228 00:53:02,229 --> 00:53:03,663 SOLVE INITIAL PROBLEMS. ONCE 1229 00:53:03,663 --> 00:53:06,199 READY TAKE THEM INTO DEVELOPMENT 1230 00:53:06,199 --> 00:53:08,168 PROJECT, LARGER SCALE, SORT OF 1231 00:53:08,168 --> 00:53:10,437 RO1 IN SCALE AND GET READY FOR 1232 00:53:10,437 --> 00:53:12,272 PERSON HUMAN STUDY, THE GREEN 1233 00:53:12,272 --> 00:53:14,174 AND ORANGE BOXES. ON RIGHT YOU 1234 00:53:14,174 --> 00:53:16,610 WILL SEE TRANSLATOR BOX. THAT IS 1235 00:53:16,610 --> 00:53:19,479 LATER HUMAN STUDIES, 1236 00:53:19,479 --> 00:53:20,814 DEMONSTRATING INITIAL TRIAL FOR 1237 00:53:20,814 --> 00:53:22,716 SAFETY AND EFFECTIVENESS. IN 1238 00:53:22,716 --> 00:53:25,118 ADDITION TO GIVING THE 1239 00:53:25,118 --> 00:53:26,486 INVESTIGATORS CAPITAL WE GIVE 1240 00:53:26,486 --> 00:53:28,321 THEM RESOURCES, THINGS THEY NEED 1241 00:53:28,321 --> 00:53:31,891 TO BE SUCCESSFUL. WE DON'T JUST 1242 00:53:31,891 --> 00:53:33,026 GIVE MONEY BUT SOMETIMES 1243 00:53:33,026 --> 00:53:35,161 SOMEBODY HOPPING OUT OF ACADEMIC 1244 00:53:35,161 --> 00:53:37,097 LAB OR SMALL STARTUP, THEY DON'T 1245 00:53:37,097 --> 00:53:38,865 KNOW WHAT RESOURCES TO GET OR 1246 00:53:38,865 --> 00:53:41,167 HOW TO FIND OR NEGOTIATE, 1247 00:53:41,167 --> 00:53:43,336 BUSINESS AGREEMENTS. SO OUR 1248 00:53:43,336 --> 00:53:45,205 PROGRAM STARTS AT THAT POST 1249 00:53:45,205 --> 00:53:47,307 PROOF OF CONCEPT AND ENDS AFTER 1250 00:53:47,307 --> 00:53:48,642 THAT FEASIBILITY STUDY. LET ME 1251 00:53:48,642 --> 00:53:50,543 TELL YOU A LITTLE MORE ABOUT 1252 00:53:50,543 --> 00:53:52,746 THAT HUB PROCESS IN GREEN AND 1253 00:53:52,746 --> 00:53:56,716 ORANGE BOXES. NEXT. SO WE TAKE A 1254 00:53:56,716 --> 00:53:58,251 FUNNEL PROCESS, YOU SHOULD BE 1255 00:53:58,251 --> 00:53:59,886 FAMILY WITH THIS. WE ARE CALLING 1256 00:53:59,886 --> 00:54:01,988 IT A DOLPHIN TANK BECAUSE 1257 00:54:01,988 --> 00:54:03,223 DOLPHINS ARE KIND AND HELPFUL. 1258 00:54:03,223 --> 00:54:05,258 IT GOES THROUGH A NORMAL FUNNEL. 1259 00:54:05,258 --> 00:54:07,661 WE HAVE A PREPROPOSAL WHERE WE 1260 00:54:07,661 --> 00:54:09,129 GET WHERE WE TRY TO IDENTIFY 1261 00:54:09,129 --> 00:54:10,830 WHICH PROJECTS GET WITHIN 1262 00:54:10,830 --> 00:54:12,399 MISSION. WHICH MIGHT BE 1263 00:54:12,399 --> 00:54:14,401 SUCCESSFUL BUT WE DON'T KNOW 1264 00:54:14,401 --> 00:54:17,437 ENOUGH TO SO WE INVITE THEM TO 1265 00:54:17,437 --> 00:54:19,306 SUBMIT FULL PROPOSAL, THEN 1266 00:54:19,306 --> 00:54:20,907 ANOTHER REVIEW , A DEEP DIVE. 1267 00:54:20,907 --> 00:54:22,642 THEN NEXT WE ROUTE THEM THROUGH 1268 00:54:22,642 --> 00:54:25,078 ONE OF TWO PATHWAYS. DEVELOPMENT 1269 00:54:25,078 --> 00:54:27,113 PROJECT, WHICH I SAY IS A LARGER 1270 00:54:27,113 --> 00:54:28,882 EFFORT, OR SEEDLING. THE 1271 00:54:28,882 --> 00:54:30,150 SEEDLING, THEY DON'T HAVE THAT 1272 00:54:30,150 --> 00:54:32,519 PROOF OF CONCEPT ISSUE. THAT'S 1273 00:54:32,519 --> 00:54:33,853 BEEN RESOLVED BUT HAVE WEAKNESS 1274 00:54:33,853 --> 00:54:37,957 IN SOMEBODY RESOLVABLE WITH 1275 00:54:37,957 --> 00:54:39,592 SIX-MONTH, MINIMAL EFFORT FOR 1276 00:54:39,592 --> 00:54:40,827 THINGS DONE ON PAPER. 1277 00:54:40,827 --> 00:54:42,362 EFFECTIVELY LIKE COME UP WITH 1278 00:54:42,362 --> 00:54:44,264 REGULATORY PLAN, MORE DETAILS ON 1279 00:54:44,264 --> 00:54:46,433 THE PROJECT. WE ARE MISSING A 1280 00:54:46,433 --> 00:54:48,068 TEAM MEMBER, MISSING THE 1281 00:54:48,068 --> 00:54:50,070 CLINICAL EXPERTISE OR ADVOCATE 1282 00:54:50,070 --> 00:54:53,073 OR THIS KIND OF ENGINEERING 1283 00:54:53,073 --> 00:54:55,041 EXPERTISE. REFINE THE SCOPE OF 1284 00:54:55,041 --> 00:54:56,976 WORK. REALLY JUST DIAL IN WHAT 1285 00:54:56,976 --> 00:55:00,747 IS ACTUALLY TO BE DONE. THE LAST 1286 00:55:00,747 --> 00:55:03,350 ONE IS PROGRAM FOR ENHANCING 1287 00:55:03,350 --> 00:55:04,984 DIVERSE PERSPECTIVES. WE TAKE A 1288 00:55:04,984 --> 00:55:06,753 SIMILAR APPROACH TO BRAIN 1289 00:55:06,753 --> 00:55:08,221 INITIATIVE, PILOTING AND 1290 00:55:08,221 --> 00:55:09,422 SPEARHEADING ACROSS NIH TO MAKE 1291 00:55:09,422 --> 00:55:11,725 SURE PROJECTS COME IN AND FUNDED 1292 00:55:11,725 --> 00:55:14,427 BY NIH INCORPORATE DIVERSE 1293 00:55:14,427 --> 00:55:20,166 PERSPECTIVES FROM A COMMUNITY OF 1294 00:55:20,166 --> 00:55:21,835 INNOVATORS, END USERS AND 1295 00:55:21,835 --> 00:55:23,269 PATIENTS. SEEING HOW TO HELP 1296 00:55:23,269 --> 00:55:24,471 THOSE WEAKNESSES THAT CAN BE 1297 00:55:24,471 --> 00:55:27,640 DONE ON PAPER IN SIX MONTHS WITH 1298 00:55:27,640 --> 00:55:29,976 SOME MENTORSHIP. NEXT PLEASE. 1299 00:55:29,976 --> 00:55:32,145 NOW FOR DEVELOPMENT PROJECTS WE 1300 00:55:32,145 --> 00:55:36,783 HAVE TWO HUBS. U54 COPPER 1301 00:55:36,783 --> 00:55:38,184 AGREEMENTS. ONE THROUGH MASS 1302 00:55:38,184 --> 00:55:40,954 GENERAL CALLED SENATE. THEY HAVE 1303 00:55:40,954 --> 00:55:45,992 AN EN ENTITY CALLED SENTA AND 1304 00:55:45,992 --> 00:55:52,866 ONE FROM JOHNS HOPKINS CALLED 1305 00:55:52,866 --> 00:55:54,968 NEURO TECH HARBOR AND MONEY 1306 00:55:54,968 --> 00:55:58,338 PASSES TO THE INNOVATOR, WILL 1307 00:55:58,338 --> 00:56:00,540 RECEIVE UP TO $5,000 TO 1308 00:56:00,540 --> 00:56:03,343 INNOVATOR AS WELL AS IN-KIND 1309 00:56:03,343 --> 00:56:06,012 RESOURCE, PPD, ACTUALLY MEDICAL 1310 00:56:06,012 --> 00:56:09,916 PROVIDING RESOURCE. SO 1311 00:56:09,916 --> 00:56:12,485 PRE-CLINICAL STUDY, THE DESIGN 1312 00:56:12,485 --> 00:56:13,920 RESOURCE, REGULATORY SUPPORT, ET 1313 00:56:13,920 --> 00:56:15,789 CETERA, ET CETERA. NEXT PLEASE. 1314 00:56:15,789 --> 00:56:17,791 FOR THE SEEDLINGS THEY ARE RUN 1315 00:56:17,791 --> 00:56:21,394 ONLY OUT OF NEURO TECH HARBOR 1316 00:56:21,394 --> 00:56:23,096 OUT OF HOWARD UNIVERSITY. THEY 1317 00:56:23,096 --> 00:56:24,831 ARE MANAGING AND TRAIN ING THIS 1318 00:56:24,831 --> 00:56:27,434 COHORT OF BUDDING INNOVATORS AND 1319 00:56:27,434 --> 00:56:31,438 GIVING THEM UP TO $50,000 OF 1320 00:56:31,438 --> 00:56:34,374 FUNDS DIRECTLY WAS WELL AS AT 1321 00:56:34,374 --> 00:56:37,944 LEAST $50,000 OF IN KIND 1322 00:56:37,944 --> 00:56:40,246 SUPPORT. EVERYONE GETS A MENTOR, 1323 00:56:40,246 --> 00:56:41,347 TRANSLATING TO MEDICAL TECH, 1324 00:56:41,347 --> 00:56:43,116 USUALLY THE SAME FIELD OR SAME 1325 00:56:43,116 --> 00:56:44,150 TECHNOLOGY. AS WELL AS 1326 00:56:44,150 --> 00:56:46,453 REGULATORY CON SUPPORT WITH PPD 1327 00:56:46,453 --> 00:56:47,954 AND ENTREPRENEURIAL TRAINING. SO 1328 00:56:47,954 --> 00:56:49,556 EVERYONE GETS SOMETHING, IF THEY 1329 00:56:49,556 --> 00:56:51,925 ARE FUNDED. YOU KNOW, OUR JOB IS 1330 00:56:51,925 --> 00:56:55,094 TO TEE UP THE SEEDLINGS IF THEY 1331 00:56:55,094 --> 00:56:59,232 ARE READY IN THE NEXT ROUND. 1332 00:56:59,232 --> 00:57:04,404 NEXT SLIDE, PLEASE. WE HAVE MADE 1333 00:57:04,404 --> 00:57:06,172 AWARDS. MADE 36 PROJECTS OVER 1334 00:57:06,172 --> 00:57:08,208 THE LAST COUPLE YEARS ADDING UP 1335 00:57:08,208 --> 00:57:15,048 TO OVER 14 MILLION DIRECTLY TO 1336 00:57:15,048 --> 00:57:17,851 INNOVATORS. NOT INCLUSIVE OF THE 1337 00:57:17,851 --> 00:57:19,285 MEDICAL RESOURCES, ET CETERA. 1338 00:57:19,285 --> 00:57:22,121 THESE ARE FUNDED BY SEVEN 1339 00:57:22,121 --> 00:57:24,157 RESOURCE, AS WELL AS BRAIN 1340 00:57:24,157 --> 00:57:25,992 INITIATIVE. HILL PARTNERSHIP IS 1341 00:57:25,992 --> 00:57:27,760 PARTNERING IN SOME CAPACITIES. 1342 00:57:27,760 --> 00:57:29,262 WE HAVE A LOVELY SCIENCE 1343 00:57:29,262 --> 00:57:30,597 HIGHLIGHT ON THE WEBSITE. 1344 00:57:30,597 --> 00:57:32,098 ENCOURAGE YOU FOLLOW THAT LINK 1345 00:57:32,098 --> 00:57:33,900 AND READ MORE ABOUT PROJECTS WE 1346 00:57:33,900 --> 00:57:41,274 HAVE FUNDED. SEE THAT PROGRESS 1347 00:57:41,274 --> 00:57:41,708 BRE 1348 00:57:41,708 --> 00:57:42,342 PROGRESSION. I WOULD LIKE TO 1349 00:57:42,342 --> 00:57:44,944 HIGHLIGHT THIS. JULIA RECENTLY 1350 00:57:44,944 --> 00:57:50,116 MOVED TO UNIVERSITY AT ARIZONA 1351 00:57:50,116 --> 00:57:53,453 THIS MONTH. FOR NONADDICTIVE 1352 00:57:53,453 --> 00:57:55,555 TREATMENT FOR PAIN, LOW 1353 00:57:55,555 --> 00:57:58,491 INTENSITY ULTRASOUND TARGETING 1354 00:57:58,491 --> 00:58:04,397 THE DORSAL ROOT GANGLIA. WE 1355 00:58:04,397 --> 00:58:07,267 FUNDED HER IN THE PROJECT. MOST 1356 00:58:07,267 --> 00:58:09,202 FUNDED IN NOVEMBER SO DON'T HAVE 1357 00:58:09,202 --> 00:58:10,537 A LOT OF PROGRESS TO SHOW SO 1358 00:58:10,537 --> 00:58:13,706 WANT TO TALK ABOUT THIS WE 1359 00:58:13,706 --> 00:58:15,675 FUNDED FURTHER AGO IN PILOT. 1360 00:58:15,675 --> 00:58:17,410 STARTED WITH THIS SCHEMATIC 1361 00:58:17,410 --> 00:58:20,246 SKETCH GENERAL IDEAS AND FEW 1362 00:58:20,246 --> 00:58:21,114 PRECLINICAL STUDIES IN MICE 1363 00:58:21,114 --> 00:58:23,049 USING OFF-THE-SHELF TECHNOLOGY . 1364 00:58:23,049 --> 00:58:24,951 THE WAY WE TEND TO EVALUATE IN 1365 00:58:24,951 --> 00:58:27,287 THE PROGRAM IS WITH THIS GATES 1366 00:58:27,287 --> 00:58:29,556 WHEEL, THIS CIRCULAR DIAGRAM IN 1367 00:58:29,556 --> 00:58:31,691 THE MIDDLE THAT HAS FOUR AXISES 1368 00:58:31,691 --> 00:58:33,893 IN ORANGE, REGULATORY, MARKETING 1369 00:58:33,893 --> 00:58:35,895 GREEN, CLINICAL AND INSIDE 1370 00:58:35,895 --> 00:58:38,798 TRACK. GO FROM BASIC NEEDS 1371 00:58:38,798 --> 00:58:40,099 ASSESMENT, IDEA, PROOF OF 1372 00:58:40,099 --> 00:58:43,703 CONCEPT TO CLINICAL TRIALS AT 1373 00:58:43,703 --> 00:58:44,804 6:00, VALIDATION AND ULTIMATELY 1374 00:58:44,804 --> 00:58:47,941 STANDARD OF CARE AT 11:00 THERE. 1375 00:58:47,941 --> 00:58:49,475 THIS IS THE ASSESSMENT WHEN SHE 1376 00:58:49,475 --> 00:58:51,010 CAME IN WITH THE INITIAL 1377 00:58:51,010 --> 00:58:52,912 PROPOSAL INTO THE PILOT PROGRAM, 1378 00:58:52,912 --> 00:58:54,380 EQUIVALENT TO WHAT WE WOULD FUND 1379 00:58:54,380 --> 00:58:56,382 IN A SEEDLING. OVER THE LAST 1380 00:58:56,382 --> 00:59:00,386 COUPLE YEARS WE GAVE HER AN 1381 00:59:00,386 --> 00:59:02,055 INVESTMENT. SHE DEVELOPED, 1382 00:59:02,055 --> 00:59:03,256 WORKED WITH MENTOR AND SUBMITTED 1383 00:59:03,256 --> 00:59:05,592 FULL PROPOSAL AT WHICH POINT SHE 1384 00:59:05,592 --> 00:59:07,126 WAS GAUGED TO THE DIAGRAM IN 1385 00:59:07,126 --> 00:59:09,762 RIGHT, FAR MORE FILLED IN. A 1386 00:59:09,762 --> 00:59:11,464 SIGNIFICANT ADVANCE OF 1387 00:59:11,464 --> 00:59:12,498 TECHNOLOGY. MUCH CLEAR PICTURE 1388 00:59:12,498 --> 00:59:14,400 OF REGULATORY. STILL A LOT OF 1389 00:59:14,400 --> 00:59:17,103 GAPS. A HUGE ADVANCEMENTS IN THE 1390 00:59:17,103 --> 00:59:18,905 MARKETING PLAN. HUGE ADVANCES IN 1391 00:59:18,905 --> 00:59:20,106 CLINICAL THAT DEMONSTRATION WITH 1392 00:59:20,106 --> 00:59:22,375 LARGE ANIMAL MODEL. VIDEOS OF 1393 00:59:22,375 --> 00:59:24,010 THESE PIGS I SWEAR JUST -- AFTER 1394 00:59:24,010 --> 00:59:25,144 THE TREATMENT THEY LOOKED LIKE 1395 00:59:25,144 --> 00:59:27,513 THEY ARE DANCING. IT IS 1396 00:59:27,513 --> 00:59:29,682 HILARIOUS. IN THIS PROJECT SHE 1397 00:59:29,682 --> 00:59:31,417 GAVE THIS LOVELY QUOTE HERE 1398 00:59:31,417 --> 00:59:34,921 ABOUT HOW VALUABLE PROGRAM WAS 1399 00:59:34,921 --> 00:59:36,856 TO SUPPORT GUIDANCE, MENTOR, 1400 00:59:36,856 --> 00:59:39,258 PROJECT MANAGERS AND HELPING TO 1401 00:59:39,258 --> 00:59:42,261 BRING TECHNOLOGY TO PATIENTS 1402 00:59:42,261 --> 00:59:46,099 FASTER. THAN IF GRANTS BUT HAD 1403 00:59:46,099 --> 00:59:51,204 GOTTEN NORMAL ADVANCEMENT FROM 1404 00:59:51,204 --> 00:59:52,171 PARTIES. WE ARE LOOKING FOR 1405 00:59:52,171 --> 00:59:55,742 MORE. WE HAVE A SOLICITATION IN 1406 00:59:55,742 --> 01:00:02,515 FEBRUARY, EARLY FEBRUARY. I EN 1407 01:00:02,515 --> 01:00:02,849 KI 1408 01:00:02,849 --> 01:00:03,616 ENCOURAGE YOU TO CLICK AND 1409 01:00:03,616 --> 01:00:06,252 REFRESH THIS LINK. LOOKING AT 1410 01:00:06,252 --> 01:00:08,921 CENTERS, ALL THE WAY FROM 1411 01:00:08,921 --> 01:00:10,089 ADDICTION FROM ALCOHOL, 1412 01:00:10,089 --> 01:00:12,058 SUBSTANCE, ALZHEIMER'S RELATED 1413 01:00:12,058 --> 01:00:21,701 DMEN DEMENTIA AND FULL PANOPLY. 1414 01:00:21,701 --> 01:00:24,137 WE ARE EXCITED AND INTEND TO 1415 01:00:24,137 --> 01:00:26,372 FUND. WE WOULD LIKE YOU SUBMIT 1416 01:00:26,372 --> 01:00:28,207 PROPOSALS NOW YOU HAVE PROJECTS 1417 01:00:28,207 --> 01:00:31,144 OF THE TYPE OF PROJECTS. ALSO 1418 01:00:31,144 --> 01:00:33,212 HAVE THE CLINICAL PROGRAM THAT 1419 01:00:33,212 --> 01:00:34,547 HAS A SEAT DATE IN FEBRUARY AS 1420 01:00:34,547 --> 01:00:36,149 WELL. I WILL PASS IT BACK TO 1421 01:00:36,149 --> 01:00:37,550 BRUCE. IF YOU HAVE QUESTION, I 1422 01:00:37,550 --> 01:00:40,186 WILL ANSWER AT THE END, THANK 1423 01:00:40,186 --> 01:00:40,687 YOU. 1424 01:00:40,687 --> 01:00:43,322 >> THANK YOU, MIKE. WHAT MIKE 1425 01:00:43,322 --> 01:00:46,092 IMPLIED BUT MAYBE DIDN'T SAY 1426 01:00:46,092 --> 01:00:49,862 EXPLICITLY, ONE OF THE BRILLIANT 1427 01:00:49,862 --> 01:00:51,064 FUTURES IS WE ARE KIND OF LIKE 1428 01:00:51,064 --> 01:00:53,266 THE POINT GUARD, IF YOU LIKE 1429 01:00:53,266 --> 01:00:56,636 BASKETBALL METAPHORS, BECAUSE WE 1430 01:00:56,636 --> 01:00:59,305 WORK WITH OUR COLLEAGUES TO SORT 1431 01:00:59,305 --> 01:01:03,242 OF INSPIRE TAKING SHOTS ON GOAL. 1432 01:01:03,242 --> 01:01:04,577 IN OTHER WORDS, THEY ARE 1433 01:01:04,577 --> 01:01:08,748 SPENDING THE MONEY TO SUPPORT 1434 01:01:08,748 --> 01:01:11,050 THE TECHNOLOGIES. WE WORK 1435 01:01:11,050 --> 01:01:12,618 COLLABORATIVELY WITH THEM TO 1436 01:01:12,618 --> 01:01:13,853 EVALUATE, BRING IN RESOURCES 1437 01:01:13,853 --> 01:01:15,455 THAT CAN VALIDATE AND MOVE THEM 1438 01:01:15,455 --> 01:01:18,958 ALONG. FOR EXAMPLE, THIS ONE IS 1439 01:01:18,958 --> 01:01:22,595 FUNDED BY NIDA, NINDA. WE ARE 1440 01:01:22,595 --> 01:01:24,297 NOT EXPLICITLY FUNDING THE 1441 01:01:24,297 --> 01:01:26,165 DEVELOPMENT. PROVIDING A LOT OF 1442 01:01:26,165 --> 01:01:27,867 IN-KIND SUPPORT. THAT IS THE 1443 01:01:27,867 --> 01:01:29,936 NATURE AND CHARACTERISTIC. I 1444 01:01:29,936 --> 01:01:34,006 THINK A WONDERFUL MODEL FOR HOW 1445 01:01:34,006 --> 01:01:35,875 SMALL ICs CAN ARE HAVE AN 1446 01:01:35,875 --> 01:01:40,980 OUTSIZED IMPACT ACROSS HIH AND 1447 01:01:40,980 --> 01:01:43,316 BIOMEDICAL COMMUNITY. SO LET ME 1448 01:01:43,316 --> 01:01:47,120 MOVE INTO TRAINING AND 1449 01:01:47,120 --> 01:01:49,756 DISSEMINATION UPDATES. WE ARE 1450 01:01:49,756 --> 01:01:50,957 OBVIOUSLY VERY ACTIVE SO I HAVE 1451 01:01:50,957 --> 01:01:53,326 A FEW HIGHLIGHTS FOR YOU. ONE 1452 01:01:53,326 --> 01:01:56,229 BIG PIECE OF NEWS, YOU HAVE 1453 01:01:56,229 --> 01:02:02,235 PROBABLY FOLLOWED THE BSIP 1454 01:02:02,235 --> 01:02:04,804 PROGRAM, BIOMEDICAL SUMMER 1455 01:02:04,804 --> 01:02:07,340 INTERNSHIP, PIONEERED BY BOB, 1456 01:02:07,340 --> 01:02:09,909 SINCE THE BEGINNING OF NIBIBI. 1457 01:02:09,909 --> 01:02:13,846 STARTED TO SUPPORT ONLY SUMMER 1458 01:02:13,846 --> 01:02:15,481 INTERNSHIPS FOR BIOMEDICAL 1459 01:02:15,481 --> 01:02:16,849 ENGINEERING BECAUSE THERE WASN'T 1460 01:02:16,849 --> 01:02:19,986 MUCH IN EARLY 2000s AND DESIGNED 1461 01:02:19,986 --> 01:02:21,754 TO BUILD UP THAT POPULATION. 1462 01:02:21,754 --> 01:02:24,257 WITH MONU'S ARRIVAL AND CREATION 1463 01:02:24,257 --> 01:02:30,496 OF BETA CENTER AND AFTER TEN 1464 01:02:30,496 --> 01:02:31,564 EXTENSIVE DISCUSSIONS WITH BOB 1465 01:02:31,564 --> 01:02:35,334 WE HAVE BROUGHT THE PROGRAM 1466 01:02:35,334 --> 01:02:38,738 UNDER THE AEGIS OF DATA CENTER. 1467 01:02:38,738 --> 01:02:40,540 WE HAVE TWO TRACKS. THERE IS 1468 01:02:40,540 --> 01:02:44,644 MORE OF THE CLASSIC, WHICH 1469 01:02:44,644 --> 01:02:47,914 INVOLVES BME STUDENTS. IN FACT, 1470 01:02:47,914 --> 01:02:51,083 ENGINEERING AND COMPUTATIONAL 1471 01:02:51,083 --> 01:02:53,252 SCIENCE STUDENTS WHO HAVE HAD 1472 01:02:53,252 --> 01:02:54,253 SIGNIFICANT RESEARCH EXPERIENCE, 1473 01:02:54,253 --> 01:02:56,155 A FEW YEARS IN BIOMEDICAL 1474 01:02:56,155 --> 01:02:59,158 APPLICATIONS OF TECHNOLOGIES. SO 1475 01:02:59,158 --> 01:03:05,798 THAT PROGRAM IS REALLY DESIGN 1476 01:03:05,798 --> 01:03:07,633 SORT OF CAPTURE STUDENTS MOVING 1477 01:03:07,633 --> 01:03:09,302 TINT FOURTH YEAR AND ON A FAST 1478 01:03:09,302 --> 01:03:10,937 TRACK. ONE OF THE OTHER THINGS 1479 01:03:10,937 --> 01:03:18,411 WE ARE QUITE INTERESTED IN IS 1480 01:03:18,411 --> 01:03:20,146 HAVING STEM STUDENTS THAT DON'T 1481 01:03:20,146 --> 01:03:22,248 HAVE EXPERIENCE AND MAYBE NEVER 1482 01:03:22,248 --> 01:03:26,319 HAD OPPORTUNITY TO GET RESEARCH 1483 01:03:26,319 --> 01:03:27,920 EXPERIENCE AND MAYBE THEY ARE 1484 01:03:27,920 --> 01:03:29,322 NOT RESEARCH INTENSIVE. THIS 1485 01:03:29,322 --> 01:03:31,557 PROGRAM OPENS IT UP. THIS IS 1486 01:03:31,557 --> 01:03:37,763 WHAT WE CALL BISIM STEM, 1487 01:03:37,763 --> 01:03:40,166 COMPLEMENTARY TO BME AND WILL 1488 01:03:40,166 --> 01:03:41,133 EFFECTIVELY DOUBLE THE SIZE OF 1489 01:03:41,133 --> 01:03:43,402 THE PROGRAM. IT IS ACCESSIBLE 1490 01:03:43,402 --> 01:03:47,139 THROUGH DATA CENTER AND CONTACT 1491 01:03:47,139 --> 01:03:48,307 MONU. IF YOU HAVE STUDENTS WHO 1492 01:03:48,307 --> 01:03:50,309 ARE INTERESTED, WE THINK THIS IS 1493 01:03:50,309 --> 01:03:52,645 AN EXCITING WAY TO BRING PEOPLE 1494 01:03:52,645 --> 01:03:56,115 INTO THE FIELD WHO MAY NOT 1495 01:03:56,115 --> 01:03:57,149 NORMALLY OTHERWISE HAVE THOSE 1496 01:03:57,149 --> 01:03:58,551 OPPORTUNITIES, IN ADDITION TO 1497 01:03:58,551 --> 01:04:05,391 SUPPORTING KIND OF OUR 1498 01:04:05,391 --> 01:04:06,826 TRADITIONALTRADIT 1499 01:04:06,826 --> 01:04:08,828 TRADITIONAL CONSTITUENCY. FOR 1500 01:04:08,828 --> 01:04:10,897 THE FIRST TIME WE WERE ABLE TO 1501 01:04:10,897 --> 01:04:13,532 GIVE AWARDS AND ANNOUNCE WINNERS 1502 01:04:13,532 --> 01:04:15,701 AT THE -- AT A PLENARY SESSION, 1503 01:04:15,701 --> 01:04:25,978 THE NIBIB POLLEN PL EF /* /* -- 1504 01:04:25,978 --> 01:04:30,149 PLENARY. THEY GOT TO COME UP AND 1505 01:04:30,149 --> 01:04:35,221 HAVE THE PRESENTATION. THESE ARE 1506 01:04:35,221 --> 01:04:36,188 AWARDEES AVAILABLE FOR THE 1507 01:04:36,188 --> 01:04:38,157 CONCEPT TRAINING. WE HAVE 1508 01:04:38,157 --> 01:04:43,095 STUDENTS GOING INTO THAT. IT IS 1509 01:04:43,095 --> 01:04:45,197 PLAYING MORE ENGAGED ROLE. NOT 1510 01:04:45,197 --> 01:04:47,667 ONLY GIVE AWARDS BUT GIVE 1511 01:04:47,667 --> 01:04:53,806 RESOURCES TO PROMOTE INNOVATIVE, 1512 01:04:53,806 --> 01:04:55,574 ENTREPRENEURSHIP AND MORE. WE 1513 01:04:55,574 --> 01:04:58,277 HAVE A NEW DEBUT TO ANNOUNCE. 1514 01:04:58,277 --> 01:05:00,179 EACH YEAR WE HAVE BEEN ABLE TO 1515 01:05:00,179 --> 01:05:01,847 INCREASE. THIS YEAR IS NO 1516 01:05:01,847 --> 01:05:03,683 EXCEPTION. OUR TOTAL PRIZE PURSE 1517 01:05:03,683 --> 01:05:05,351 COMING UP TOWARD THIS YEAR'S 1518 01:05:05,351 --> 01:05:08,621 CHALLENGE IS $160,000 NOW. I 1519 01:05:08,621 --> 01:05:10,756 REFLECTS ADDITION OF A NEW PRIZE 1520 01:05:10,756 --> 01:05:14,427 IN 2024 FROM NIDDK. THAT IS THE 1521 01:05:14,427 --> 01:05:17,530 KIDNEY TECHNOLOGY DEVELOPMENT 1522 01:05:17,530 --> 01:05:20,266 PRIZE. SO WE HOPE THAT A LOT OF 1523 01:05:20,266 --> 01:05:25,404 YOU WILL BE INTER TESINTERESTED 1524 01:05:25,404 --> 01:05:26,872 APPLYING. THIS IS A NATIONAL 1525 01:05:26,872 --> 01:05:29,976 NEED TO DETECT KIDNEY DISEASE 1526 01:05:29,976 --> 01:05:30,676 APPROACHES AT EARLIER AND 1527 01:05:30,676 --> 01:05:33,746 EARLIER STAGES. I THINK THIS IS 1528 01:05:33,746 --> 01:05:37,283 A WONDERFUL OPPORTUNITY. DAVE 1529 01:05:37,283 --> 01:05:38,117 SOIS 1530 01:05:38,117 --> 01:05:39,218 OUR CHAMPION AND ENCOURAGE 1531 01:05:39,218 --> 01:05:40,686 PEOPLE TO REACH OUT AND CONTACT 1532 01:05:40,686 --> 01:05:43,122 HIM. WHEN YOU DO THE MATH, WITH 1533 01:05:43,122 --> 01:05:50,196 ALL THE PRIZES THAT WE'RE ARGUED 1534 01:05:50,196 --> 01:05:52,631 A SHGS /* /* -- WE'RE ARGUED 1535 01:05:52,631 --> 01:05:54,033 WARDING THERE IS A GOOD CHANCE 1536 01:05:54,033 --> 01:05:55,434 SO I ENCOURAGE PEOPLE TO GET 1537 01:05:55,434 --> 01:05:57,303 YOUR STUDENTS GOING. WE HAD A 1538 01:05:57,303 --> 01:05:58,804 REPORT NUMBER OF APPLICATIONS 1539 01:05:58,804 --> 01:06:02,074 LAST YEAR. HOPEFULLY THAT TREND 1540 01:06:02,074 --> 01:06:03,843 WILL CONTINUE. JUST A QUICK 1541 01:06:03,843 --> 01:06:05,544 REPORTING ON A COUPLE OF 1542 01:06:05,544 --> 01:06:08,280 WORKSHOPS. A REALLY GROUND 1543 01:06:08,280 --> 01:06:12,752 BREAKING SYNTHETIC BIOLOGY FOR 1544 01:06:12,752 --> 01:06:16,088 AGE AGING. I'M FOLLOWING 1545 01:06:16,088 --> 01:06:18,424 CLOSELY. YOU SEE THE ARROW. OF 1546 01:06:18,424 --> 01:06:21,727 COURSE WE ARE VERY, VERY 1547 01:06:21,727 --> 01:06:23,963 INTERESTED AND VERSING THIS 1548 01:06:23,963 --> 01:06:25,631 DIFFERENTIATION OR REVERSING 1549 01:06:25,631 --> 01:06:26,932 AGING. I THINK THIS HOLDS SOME 1550 01:06:26,932 --> 01:06:28,634 OF THE KEY. THERE WILL BE A LOT 1551 01:06:28,634 --> 01:06:33,372 OF ACTIVITY AND DISCUSSION AT 1552 01:06:33,372 --> 01:06:36,275 THIS WORKSHOP. CONTACT TUBA FEHR 1553 01:06:36,275 --> 01:06:37,476 FOR MORE INFORMATION. 1554 01:06:37,476 --> 01:06:39,078 UNFORTUNATELY WE DON'T HAVE A 1555 01:06:39,078 --> 01:06:42,348 VIDEO CAST BUT WE HAVE BOTH DAYS 1556 01:06:42,348 --> 01:06:47,219 OF THE ANNUAL CONSORTIUM 1557 01:06:47,219 --> 01:06:48,721 MEETING. SCAN THOSE CODES, 1558 01:06:48,721 --> 01:06:52,358 THANKS TO VERMONT, TUBA, NICOLE 1559 01:06:52,358 --> 01:06:54,093 FOR ORGANIZING AND OF COURSE TO 1560 01:06:54,093 --> 01:06:56,095 DAVE FOR CHAMPIONING THIS AREA 1561 01:06:56,095 --> 01:06:59,465 AND CREATING OPPORTUNITIES FOR 1562 01:06:59,465 --> 01:07:03,002 ALL OF OUR COMMUNITY IN 1563 01:07:03,002 --> 01:07:04,336 BIOMANUFACTURING. I WILL LINGER 1564 01:07:04,336 --> 01:07:07,139 ON THE VIDEO CAST. PLEASE BE 1565 01:07:07,139 --> 01:07:09,842 SURE TO SCAN THOSE CODES. THEY 1566 01:07:09,842 --> 01:07:11,310 ARE A VALUABLE RECORD WITH 1567 01:07:11,310 --> 01:07:13,012 INCREDIBLE INFORMATION AND TALKS 1568 01:07:13,012 --> 01:07:15,014 YOU CAN ACCESS. ANOTHER MAJOR 1569 01:07:15,014 --> 01:07:16,015 CONFERENCE THAT IS HAPPENING 1570 01:07:16,015 --> 01:07:18,484 WHERE WE HAVE VIDEO CASTS AND 1571 01:07:18,484 --> 01:07:20,453 OWE CAN SEE THE QR CODES OF DAY 1572 01:07:20,453 --> 01:07:23,756 ONE AND TWO, WAS THE POPTURN 1573 01:07:23,756 --> 01:07:24,890 CONFERENCE AND TECHNOLOGY SHOW 1574 01:07:24,890 --> 01:07:26,792 CASE. NOT JUST A CONFERENCE WITH 1575 01:07:26,792 --> 01:07:36,035 REN STATIONS AND TALKS. ACTUALLY 1576 01:07:36,035 --> 01:07:36,368 HA 1577 01:07:36,368 --> 01:07:40,139 WITH PRESENTATIONS. AN ENORMOUS 1578 01:07:40,139 --> 01:07:43,542 RESPONSE WITH MANY PEOPLE COMING 1579 01:07:43,542 --> 01:07:47,546 TO NATUR TO SEE AND ENGAGE. I 1580 01:07:47,546 --> 01:07:51,250 POINT OUT THIS PHOTO IN LOWER 1581 01:07:51,250 --> 01:07:52,885 LEFT-HAND CORNER, THERE ARE 1582 01:07:52,885 --> 01:07:54,487 FOLKS YOU MAY RECOGNIZE IN THAT. 1583 01:07:54,487 --> 01:07:57,756 THERE IS OF COURSE ME AND 1584 01:07:57,756 --> 01:08:00,025 TIFFANY, YOUR NIBIB 1585 01:08:00,025 --> 01:08:02,194 REPRESENTATIVES THERE. TIFFANY 1586 01:08:02,194 --> 01:08:05,598 IS THE LEADER AND CHAMPION OF 1587 01:08:05,598 --> 01:08:09,535 THIS CONFERENCE. TIFFANY HAS 1588 01:08:09,535 --> 01:08:11,003 MANAGED TO PUT TOGETHER AN 1589 01:08:11,003 --> 01:08:14,473 AMAZING, AMAZING COUPLE OF DAYS 1590 01:08:14,473 --> 01:08:16,809 WITH OUTSTANDING TOPICS AND 1591 01:08:16,809 --> 01:08:17,977 PANELS IN CONVERSATION. BUT YOU 1592 01:08:17,977 --> 01:08:22,748 WILL SEE A COUPLE OF NEW FACES. 1593 01:08:22,748 --> 01:08:29,455 THE NIBIB DIRECTOR GAVE THE TALK 1594 01:08:29,455 --> 01:08:32,858 AT THE CONFERENCE. WE WERE 1595 01:08:32,858 --> 01:08:35,895 GRATEFUL AND REINFORCED THE 1596 01:08:35,895 --> 01:08:37,196 EARLY FORMING POINTS THAT I 1597 01:08:37,196 --> 01:08:40,132 SHOWED AT THE BEGINNING OF MY 1598 01:08:40,132 --> 01:08:43,869 TALK SO WE ALL GOT TO HEAR FROM 1599 01:08:43,869 --> 01:08:45,671 HER. I THINK HER DEDICATION TO 1600 01:08:45,671 --> 01:08:47,072 COMING TO THAT SESSION I THINK 1601 01:08:47,072 --> 01:08:52,311 IS A STRONG REFLECTION OF HER 1602 01:08:52,311 --> 01:08:54,146 ENTHUSIASM AND WHAT WE HAVE BEEN 1603 01:08:54,146 --> 01:08:56,048 ABLE TO ACCOMPLISH AND HOPES FOR 1604 01:08:56,048 --> 01:08:58,584 IN FUTURE. YOU SEE REBECCA 1605 01:08:58,584 --> 01:09:01,120 RICHARDS CORDHAM ON THE RIGHT. 1606 01:09:01,120 --> 01:09:02,855 REBECCA IS ONE OF TWO NEW 1607 01:09:02,855 --> 01:09:05,291 CENTERS IN POPTURN AND THE 1608 01:09:05,291 --> 01:09:07,059 COMPETITION FOCUSSING ON POINT 1609 01:09:07,059 --> 01:09:08,594 OF CARE TECHNOLOGIES IN CANCER. 1610 01:09:08,594 --> 01:09:10,229 ABSOLUTELY CRITICAL AREA, 1611 01:09:10,229 --> 01:09:12,097 EXPANDING OUR PARTNERSHIP WITH 1612 01:09:12,097 --> 01:09:15,201 COLLEAGUES ACROSS THE NIH FOR 1613 01:09:15,201 --> 01:09:17,036 DEVELOPING CANCER-BASED 1614 01:09:17,036 --> 01:09:19,338 TECHNOLOGIES. WE ARE EXCITED TO 1615 01:09:19,338 --> 01:09:23,542 HAVE HER JOIN. A CLASSIC PHOTO, 1616 01:09:23,542 --> 01:09:28,280 GLAD TO SEE THEM BOTH. ANOTHER 1617 01:09:28,280 --> 01:09:30,249 PROGRAM THAT WE HAVE LAUNCHED, 1618 01:09:30,249 --> 01:09:32,885 YOU HAVE HEARD US TALK ABOUT THE 1619 01:09:32,885 --> 01:09:34,720 BEAMS CHALLENGE. SO I'M GOING TO 1620 01:09:34,720 --> 01:09:37,890 ANNOUNCE THE WINNERS OF THIS. IT 1621 01:09:37,890 --> 01:09:39,925 IS BIO MEDICAL ENGINEERING 1622 01:09:39,925 --> 01:09:42,228 ADAPTED FOR MIDDLE SCHOOLERS. IF 1623 01:09:42,228 --> 01:09:47,132 YOU WILL RECALL, IT WAS A CROWD 1624 01:09:47,132 --> 01:09:48,934 SOURCING EFFORT TO GET NEW 1625 01:09:48,934 --> 01:09:50,035 CURRICULUM MOST APPROPRIATELY 1626 01:09:50,035 --> 01:09:53,239 TARGETED TO MIDDLE SCHOOLERS AND 1627 01:09:53,239 --> 01:09:56,609 BEGIN TO GET GREATER EXPOSURE OF 1628 01:09:56,609 --> 01:09:57,776 BIOMEDICAL ENGINEERING AND 1629 01:09:57,776 --> 01:10:00,879 TECHNOLOGY TO THAT POPULATION. 1630 01:10:00,879 --> 01:10:02,381 THIS WAS LED BY JESS NEED IN OUR 1631 01:10:02,381 --> 01:10:03,849 COMMUNICATIONS OFFICE. HERE ARE 1632 01:10:03,849 --> 01:10:07,253 THE WINNERS. THE FIRST, 1633 01:10:07,253 --> 01:10:11,223 NANOPARTICLES FOR DRUG DELIVERY. 1634 01:10:11,223 --> 01:10:13,759 THIS INTRODUCES CONCEPTS 1635 01:10:13,759 --> 01:10:14,727 INCLUDING EXAMPLE PRESENTATIONS, 1636 01:10:14,727 --> 01:10:20,065 CASE STUDIES, LAB ACTIVITIES 1637 01:10:20,065 --> 01:10:22,801 DESIGNED TO BE AFFORDABLE AND 1638 01:10:22,801 --> 01:10:24,470 SIMPLE. THIS IS A BIOENGINEERING 1639 01:10:24,470 --> 01:10:26,505 GRAD OF JOHNS HOPKINS AND HAS 1640 01:10:26,505 --> 01:10:28,540 PASSION FOR EDUCATION AND 1641 01:10:28,540 --> 01:10:32,778 TRAINING. THE NEXT IS IN GENETIC 1642 01:10:32,778 --> 01:10:35,681 TELEPHONE. A STORY-DRIVEN 1643 01:10:35,681 --> 01:10:41,253 JOURNEY THROUGH D.N.A. AND GENE 1644 01:10:41,253 --> 01:10:46,058 EDITING. DESIGNED BY A TEAM FROM 1645 01:10:46,058 --> 01:10:48,961 GEORGIA TECH AND PROVIDES 1646 01:10:48,961 --> 01:10:52,598 INNOVATIVES AND TECHNIQUES LIKE 1647 01:10:52,598 --> 01:10:53,766 CRISPR THAT ALLOW US TO MODIFY 1648 01:10:53,766 --> 01:10:56,068 THEM. THE NEXT IS ENGINEERING 1649 01:10:56,068 --> 01:10:58,637 DESIGN PROCESS AND SURGICAL 1650 01:10:58,637 --> 01:11:03,842 ROBOTS, DESIGNED BY KIERA QUINN. 1651 01:11:03,842 --> 01:11:08,647 ALSO AN ALUM AND GRADUATE 1652 01:11:08,647 --> 01:11:10,883 STUDENT. I THINK STILL GRADUATE 1653 01:11:10,883 --> 01:11:12,518 STUDENT AT JOHNS HOPKINS AND 1654 01:11:12,518 --> 01:11:13,852 INTRODUCES THE CONCEPT IN 1655 01:11:13,852 --> 01:11:15,954 SURGICAL ROBOTS AND GETS 1656 01:11:15,954 --> 01:11:17,990 STUDENTS GOING IN HANDS-ON IN 1657 01:11:17,990 --> 01:11:20,225 TEAMS TO DESIGN, CREATE AND TEST 1658 01:11:20,225 --> 01:11:23,095 THEIR OWN SURGICAL ROBOT 1659 01:11:23,095 --> 01:11:25,564 PROTOTYPES. FINALLY A BIONA 1660 01:11:25,564 --> 01:11:27,232 MATERIALS CURRICULUM DESIGNED BY 1661 01:11:27,232 --> 01:11:30,402 A THIRD-YEAR GRAD STUDENT AT 1662 01:11:30,402 --> 01:11:34,039 MAYO CLINIC, DESIGNED BY KATYL 1663 01:11:34,039 --> 01:11:36,342 IDEN, INTRODUCES OPPORTUNITIES 1664 01:11:36,342 --> 01:11:37,943 TO BIOMATERIALS AND POTENTIAL 1665 01:11:37,943 --> 01:11:39,111 APPLICATIONS IN MEDICINE 1666 01:11:39,111 --> 01:11:40,179 DESIGNED TO INSPIRE NEW IDEAS 1667 01:11:40,179 --> 01:11:42,314 FOR HOW TO IMPROVE MATERIALS AND 1668 01:11:42,314 --> 01:11:44,183 HAVE DIRECT IMPACT ON HEALTH 1669 01:11:44,183 --> 01:11:46,552 CARE. SHE IS PARTICULARLY 1670 01:11:46,552 --> 01:11:48,721 INTERESTED IN ORTHOPEDIC 1671 01:11:48,721 --> 01:11:52,624 MATERIALS AND FOCUS ON KNEES, 1672 01:11:52,624 --> 01:11:55,427 BONES THAT BREAK, JOINT 1673 01:11:55,427 --> 01:11:56,662 REPLACEMENTS AND SO FORTH. WE 1674 01:11:56,662 --> 01:11:58,297 ARE EXCITED TO ANNOUNCEMENT. AS 1675 01:11:58,297 --> 01:12:00,599 THESE WILL BE ROLLED OUT THROUGH 1676 01:12:00,599 --> 01:12:02,501 MANY DIFFERENT CHANNELS. IF YOU 1677 01:12:02,501 --> 01:12:04,403 ARE INTER TESTED IN 1678 01:12:04,403 --> 01:12:07,339 COLLABORATING IN THIS PROCESS 1679 01:12:07,339 --> 01:12:12,611 PLEASE CONTACT JESS. I WILL NOT 1680 01:12:12,611 --> 01:12:14,646 INTRODUCE RICK YET. THAT IS A 1681 01:12:14,646 --> 01:12:17,049 SIGN MY PRESENTATION IS OVER. I 1682 01:12:17,049 --> 01:12:20,519 THINK WE CAN TAKE SOME QUESTIONS 1683 01:12:20,519 --> 01:12:20,886 NOW. 1684 01:12:20,886 --> 01:12:30,963 1685 01:12:36,635 --> 01:12:41,807 I HAVE LULLED EVERYONE TO 1686 01:12:41,807 --> 01:12:43,208 SLEEP, DAVE. 1687 01:12:43,208 --> 01:12:48,981 1688 01:12:48,981 --> 01:12:52,418 >> DOCTOR, THIS IS RANU. 1689 01:12:52,418 --> 01:12:54,319 FIRST OF ALL I CONGRATULATE YOUR 1690 01:12:54,319 --> 01:12:55,454 ENTIRE GROUP OF PEOPLE AT NIBIB 1691 01:12:55,454 --> 01:12:58,090 FOR CONTINUING TO AMAZE US WITH 1692 01:12:58,090 --> 01:12:59,391 ALL THE ACCOMPLISHMENTS YOU HAVE 1693 01:12:59,391 --> 01:13:01,026 AND WHAT YOU ARE ABLE TO PUT 1694 01:13:01,026 --> 01:13:02,995 FORTH. IT IS REALLY INTERESTING 1695 01:13:02,995 --> 01:13:05,764 TO SEE THAT YOU HAVE GOT FROM 1696 01:13:05,764 --> 01:13:07,366 THE FAR END YOU ARE TALKING 1697 01:13:07,366 --> 01:13:08,567 ABOUT TECHNOLOGIES THAT ARE 1698 01:13:08,567 --> 01:13:12,037 GOING INTO MIDDLE SCHOOL. AND 1699 01:13:12,037 --> 01:13:13,138 OBVIOUSLY THE UNDERGRADUATE 1700 01:13:13,138 --> 01:13:14,440 PROGRAMS ARE DOING WELL. IF 1701 01:13:14,440 --> 01:13:17,509 THERE ARE WAYS IN WHICH NIBIB 1702 01:13:17,509 --> 01:13:20,479 MIGHT BE ABLE TO ENGAGE WITH 1703 01:13:20,479 --> 01:13:25,551 EVEN THOSE HBCUs YOU HAVE 1704 01:13:25,551 --> 01:13:27,553 BROUGHT IN TO THIS PROGRAM OF 1705 01:13:27,553 --> 01:13:28,987 MAKING SURE SOME OF THIS 1706 01:13:28,987 --> 01:13:31,290 CURRICULUM IS BEING ABLE TO BE 1707 01:13:31,290 --> 01:13:33,625 DISTRIBUTED TO SCHOOLS THAT MAY 1708 01:13:33,625 --> 01:13:36,929 NOT BE TRADITIONALLY BIOMEDICAL 1709 01:13:36,929 --> 01:13:38,564 ENGINEERING OR TRADITIONALLY 1710 01:13:38,564 --> 01:13:40,232 STRONG STEM SCHOOLS OR REGIONS 1711 01:13:40,232 --> 01:13:42,568 THAT HAVE THOSE CAPACITIES, THAT 1712 01:13:42,568 --> 01:13:43,969 WOULD BE FANTASTIC. IF WE CAN 1713 01:13:43,969 --> 01:13:45,671 GET MIDDLE SCHOOLERS TO LOOK. I 1714 01:13:45,671 --> 01:13:47,339 DON'T KNOW HOW THAT MIGHT BE 1715 01:13:47,339 --> 01:13:49,875 ABLE TO BE BROUGHT IN. MAYBE 1716 01:13:49,875 --> 01:13:51,477 ANOTHER COMPETITION FOR THESE 1717 01:13:51,477 --> 01:13:53,579 PEOPLE TO DO THAT, TO GET IT OUT 1718 01:13:53,579 --> 01:13:56,014 THERE. I DON'T KNOW ABOUT THAT. 1719 01:13:56,014 --> 01:13:59,818 FANTASTIC TO SEE THE MIDRI C 1720 01:13:59,818 --> 01:14:02,621 BEING ENGAGED AND CANCER PARTNER 1721 01:14:02,621 --> 01:14:07,092 BEING PUT -- YOU KNOW, ADDED ON 1722 01:14:07,092 --> 01:14:12,564 INTO THE RADAXIFICATION, SO TO 1723 01:14:12,564 --> 01:14:16,268 SPEAK. I LIKE THAT MATH WAY IS 1724 01:14:16,268 --> 01:14:18,136 MOVING FORWARD. 1725 01:14:18,136 --> 01:14:19,905 >> THANK YOU. THANK YOU. YAH, 1726 01:14:19,905 --> 01:14:21,573 SO WE RELY ON OUR PARTNERSHIP 1727 01:14:21,573 --> 01:14:24,309 WITH ALL OF YOU. YOU KNOW, WE 1728 01:14:24,309 --> 01:14:26,645 VIEW THIS AS A GROUP EFFORT. SO 1729 01:14:26,645 --> 01:14:28,647 PLEASE REACH OUT TO US WITH 1730 01:14:28,647 --> 01:14:31,450 IDEAS IF YOU HAVE WAYS THAT YOU 1731 01:14:31,450 --> 01:14:34,353 WOULD LIKE TO INTEGRATE THE 1732 01:14:34,353 --> 01:14:36,054 CURRICULUM OR PATHWAYS, PLEASE 1733 01:14:36,054 --> 01:14:38,490 LET US KNOW. WE ARE JUST KIND OF 1734 01:14:38,490 --> 01:14:40,559 -- IT IS OUR FIRST EFFORT IN 1735 01:14:40,559 --> 01:14:43,328 THAT AREA WITH MIDDLE SCHOOLERS 1736 01:14:43,328 --> 01:14:45,964 BUT I THINK AS YOU ALTHOUGH IT 1737 01:14:45,964 --> 01:14:49,234 IS CRITICAL TO GET KIDS EXCITED 1738 01:14:49,234 --> 01:14:52,971 EARLY, AND ACROSS A WIDE RANGE 1739 01:14:52,971 --> 01:14:55,407 OF PROGRAMS ACROSS THE COUNTRY. 1740 01:14:55,407 --> 01:14:56,341 JUST GREAT OPPORTUNITIES SO WE 1741 01:14:56,341 --> 01:14:58,277 LOOK FORWARD TO PARTNERING WITH 1742 01:14:58,277 --> 01:15:04,216 ALL OF YOU GUYS. 1743 01:15:04,216 --> 01:15:07,686 >> SO ONCE AGAIN, I WILL ECHO 1744 01:15:07,686 --> 01:15:10,322 THE AMAZEMENT OF EVERYTHING YOU 1745 01:15:10,322 --> 01:15:14,493 ARE DOING. FIVE YEARS. KEEP ON 1746 01:15:14,493 --> 01:15:16,194 INNOVATING. THERE IS NO SLOWING 1747 01:15:16,194 --> 01:15:18,463 DOWN. BUILDING ON RANU'S 1748 01:15:18,463 --> 01:15:21,967 COMMENT, I WANTED TO SEE WHETHER 1749 01:15:21,967 --> 01:15:24,736 THERE MIGHT BE A VEHICLE, A 1750 01:15:24,736 --> 01:15:27,439 WEBSITE OR SOME OTHER RESOURCE 1751 01:15:27,439 --> 01:15:29,608 PAGE THAT OTHERS ON THE OUTSIDE 1752 01:15:29,608 --> 01:15:32,311 WOULD BE ABLE TO ACCESS OR SEE 1753 01:15:32,311 --> 01:15:34,980 THESE TYPES OF CURRICULAR 1754 01:15:34,980 --> 01:15:36,214 RESOURCES. IN PARTICULAR A WAY 1755 01:15:36,214 --> 01:15:39,051 TO REALLY CONNECT WITH THE 1756 01:15:39,051 --> 01:15:41,620 TEACHERS BECAUSE, YOU KNOW, WE 1757 01:15:41,620 --> 01:15:42,888 CAN DEVELOP ALL THESE GREAT 1758 01:15:42,888 --> 01:15:44,656 THINGS AT THE STUDENT LEVEL BUT 1759 01:15:44,656 --> 01:15:46,158 THEY REALLY NEED TO BE 1760 01:15:46,158 --> 01:15:47,859 IMPLEMENTED BY THE TEACHERS. 1761 01:15:47,859 --> 01:15:50,963 JUST THINKING ALONG THAT LINE. 1762 01:15:50,963 --> 01:15:52,731 >> YAH, ABSOLUTELY. THAT IS 1763 01:15:52,731 --> 01:15:55,200 EXACTLY WHAT THE COMPS TEAM IS 1764 01:15:55,200 --> 01:15:59,037 WORKING ON AS A NEXT STEP. SO 1765 01:15:59,037 --> 01:16:01,406 THERE'S SOME LIKE CLOSED 1766 01:16:01,406 --> 01:16:03,008 CAPTIONING AND ADDITIONAL 1767 01:16:03,008 --> 01:16:04,509 OPTIMIZATION OF ALL THE 1768 01:16:04,509 --> 01:16:07,679 MATERIALS THAT WE WILL DO NOW. 1769 01:16:07,679 --> 01:16:10,649 AND ALL OF OUR KIND OF ON GOING 1770 01:16:10,649 --> 01:16:12,117 PARTNERSHIPS, TRADITIONAL ONES 1771 01:16:12,117 --> 01:16:14,286 LIKE WITH NSF, WE WILL GO 1772 01:16:14,286 --> 01:16:18,890 THROUGH THOSE AVENUES. AGAIN I 1773 01:16:18,890 --> 01:16:21,159 THINK THEY WILL BE WIDE BY 1774 01:16:21,159 --> 01:16:23,095 AVAILABLE FOR DISTRIBUTION. YOU 1775 01:16:23,095 --> 01:16:25,097 SHOULD TAKE THEM AND DISTRIBUTE 1776 01:16:25,097 --> 01:16:27,332 IN YOUR PARTICULAR NETWORKS. 1777 01:16:27,332 --> 01:16:29,334 LET'S KEEP THIS GOING. I MEAN, I 1778 01:16:29,334 --> 01:16:31,503 THINK THERE ARE A LOT OF 1779 01:16:31,503 --> 01:16:34,006 OPPORTUNITIES. WE JUST DID THIS 1780 01:16:34,006 --> 01:16:38,076 WITH A SORT OF, YOU KNOW, A CALL 1781 01:16:38,076 --> 01:16:40,712 OUT INTERNALLY INITIALLY FOR 1782 01:16:40,712 --> 01:16:42,648 GREAT IDEAS. OUR TEAM WON THIS. 1783 01:16:42,648 --> 01:16:45,250 BUT IT WAS REALLY JUST WITH 1784 01:16:45,250 --> 01:16:48,253 $25,000, YOU KNOW, OF DIRECTOR'S 1785 01:16:48,253 --> 01:16:51,056 FUNDS. SO THAT WAS SPLIT FOUR 1786 01:16:51,056 --> 01:16:54,860 WAYS EFFECTIVELY BETWEEN EACH 1787 01:16:54,860 --> 01:16:57,596 GROUP. AS YOU KNOW, OUR STUDENTS 1788 01:16:57,596 --> 01:16:59,264 AND GRADUATES ARE SO 1789 01:16:59,264 --> 01:17:02,534 ENTHUSIASTIC AND PASSIONATE. 1790 01:17:02,534 --> 01:17:04,102 MANY OF OUR COMMUNITY ARE DOING 1791 01:17:04,102 --> 01:17:06,872 THIS FOR FUN. SO THIS IS KIND OF 1792 01:17:06,872 --> 01:17:09,074 OPPORTUNITY TO TAP INTO THAT 1793 01:17:09,074 --> 01:17:10,375 ENERGY AND I'D LIKE TO SEE US DO 1794 01:17:10,375 --> 01:17:14,312 MORE OF IT. IT IS THERE. WE ALL 1795 01:17:14,312 --> 01:17:16,848 KNOW IT IS THERE. SO, YOU KNOW, 1796 01:17:16,848 --> 01:17:19,985 DEFINITELY A GREAT THING FOR US 1797 01:17:19,985 --> 01:17:23,288 TO DO, THANK YOU. LET'S SEE. I 1798 01:17:23,288 --> 01:17:26,591 THINK IT IS JENNIFER IS NEXT. 1799 01:17:26,591 --> 01:17:27,826 THEN SAM. 1800 01:17:27,826 --> 01:17:29,728 >> HI. SO I WANTED TO SAY 1801 01:17:29,728 --> 01:17:32,497 FIVE YEARS, WOW. YOU KNOW THSHGS 1802 01:17:32,497 --> 01:17:35,300 HAS BEEN A REALLY EXCITING FIVE 1803 01:17:35,300 --> 01:17:36,702 YEAR, SO CONGRATULATIONS AND 1804 01:17:36,702 --> 01:17:38,437 THANK YOU FOR LEADING FOR THESE 1805 01:17:38,437 --> 01:17:39,504 FIVE YEARS. YOU HAVE OBVIOUSLY 1806 01:17:39,504 --> 01:17:42,140 DONE A LOT OF AMAZING THINGS. A 1807 01:17:42,140 --> 01:17:44,209 LOT OF PROGRAMS. YOU JUST 1808 01:17:44,209 --> 01:17:45,410 PRESENTED NOW. WE HAVE HEARD YOU 1809 01:17:45,410 --> 01:17:47,279 TALK ABOUT IN THE PAST. I WANTED 1810 01:17:47,279 --> 01:17:49,381 TO ASK IF, YOU KNOW, YOU HAD A 1811 01:17:49,381 --> 01:17:51,683 VISION FOR FIVE YEARS FROM 1812 01:17:51,683 --> 01:17:52,818 TODAY. REALLY WHAT YOU THOUGHT 1813 01:17:52,818 --> 01:17:54,286 THE MOST IMPORTANT TOP IBS ARE 1814 01:17:54,286 --> 01:17:57,656 AND WHAT YOU'D LIKE TO HAVE 1815 01:17:57,656 --> 01:17:59,825 ACCOMPLISHED FIVE YEARS FROM 1816 01:17:59,825 --> 01:18:00,759 NOW. 1817 01:18:00,759 --> 01:18:01,259 1818 01:18:01,259 --> 01:18:07,499 >> WOW. OKAY. I'LL TRY TO 1819 01:18:07,499 --> 01:18:09,334 MAKE THIS VERY BRIEF BECAUSE I 1820 01:18:09,334 --> 01:18:12,170 WANT TO GET RICK IN. YOU KNOW, 1821 01:18:12,170 --> 01:18:14,506 PART OF THAT VISION IS REALLY 1822 01:18:14,506 --> 01:18:16,308 EMBEDDED IN A VARIETY OF 1823 01:18:16,308 --> 01:18:19,711 DIFFERENT LAYERS IN ALL OF THESE 1824 01:18:19,711 --> 01:18:20,779 ACTIVITIES IN THIS PRESENTATION. 1825 01:18:20,779 --> 01:18:24,916 YOU KNOW, WE ARE SEEING A 1826 01:18:24,916 --> 01:18:27,319 NATIONAL SHIFT IN PASSION FOR 1827 01:18:27,319 --> 01:18:30,589 THE AI OPPORTUNITY AND THREAT. I 1828 01:18:30,589 --> 01:18:33,158 THINK WE ARE IN A VERY IMPORTANT 1829 01:18:33,158 --> 01:18:35,894 POSITION TO BE ABLE -- YOU KNOW, 1830 01:18:35,894 --> 01:18:37,662 WE ARE ALWAYS WORRIED ABOUT THE 1831 01:18:37,662 --> 01:18:41,032 PROPER USE OF AI VERSUS 1832 01:18:41,032 --> 01:18:43,034 POTENTIAL DESTRUCTIVE POWER OF 1833 01:18:43,034 --> 01:18:45,470 AI. WE ARE UNIQUELY POSITIONED 1834 01:18:45,470 --> 01:18:49,074 TO MAINTAIN PROPER USAGE OF AI 1835 01:18:49,074 --> 01:18:50,942 AND NEED TO REALLY EXPAND OUR 1836 01:18:50,942 --> 01:18:53,145 VOICES AND EXPERTISE TO GET 1837 01:18:53,145 --> 01:18:54,713 INVOLVED IN THAT DISCUSSION. I 1838 01:18:54,713 --> 01:18:57,816 DO NOT WANT TO SEE A NATIONAL AI 1839 01:18:57,816 --> 01:18:59,918 RESEARCH RESOURCE EMERGE WITHOUT 1840 01:18:59,918 --> 01:19:03,488 STRONG ENGAGEMENT AND 1841 01:19:03,488 --> 01:19:06,024 PARTICIPATION FROM OUR 1842 01:19:06,024 --> 01:19:08,627 COMMUNITY. THIS REALLY SPEAKS TO 1843 01:19:08,627 --> 01:19:12,330 MANY OF THE RAPIDLY MOVING 1844 01:19:12,330 --> 01:19:14,466 TECHNOLOGIES YOU HAVE SEEN NOW. 1845 01:19:14,466 --> 01:19:17,669 OUR REFERENCE TO QUANTUM SENSES 1846 01:19:17,669 --> 01:19:19,337 AND QUANTUM TECHNOLOGIES. WE 1847 01:19:19,337 --> 01:19:20,806 KNOW THAT CAN DRAMATICALLY 1848 01:19:20,806 --> 01:19:22,340 CHANGE, POTENTIALLY 1849 01:19:22,340 --> 01:19:23,041 GAME-CHANGING OPPORTUNITIES FOR 1850 01:19:23,041 --> 01:19:25,644 A LOT OF WHAT WE DO. ULTIMATELY 1851 01:19:25,644 --> 01:19:30,482 LIMITED BY MATERIALS SO CONNECTS 1852 01:19:30,482 --> 01:19:33,218 INTO THE BUY BIOMATERIALS WORK. 1853 01:19:33,218 --> 01:19:36,054 IN A SENSE WE HAVE REALLY 1854 01:19:36,054 --> 01:19:37,856 ARTICULATED THE FOUNDATION OF 1855 01:19:37,856 --> 01:19:40,826 WHAT WE DO. IN THE NEXT FIVE 1856 01:19:40,826 --> 01:19:42,861 YEARS WE'LL CONTINUE TO EXPAND 1857 01:19:42,861 --> 01:19:45,797 THE CUTTING EDGE FROM A 1858 01:19:45,797 --> 01:19:47,399 DISCOVERY POINT OF VIEW. BUT 1859 01:19:47,399 --> 01:19:49,201 ALSO WITH ATTRIBUTION TO 1860 01:19:49,201 --> 01:19:51,369 MONICA'S ENTHUSIASM WE ARE NOT 1861 01:19:51,369 --> 01:19:53,672 DONE UNTIL WE CAN MOVE SOME OF 1862 01:19:53,672 --> 01:19:56,074 THESE CONCEPTS. THINGS THAT WE 1863 01:19:56,074 --> 01:19:57,509 ARE THE EXPERTS IN BUT DON'T 1864 01:19:57,509 --> 01:20:01,079 WANT TO LET CULTURE AND 1865 01:20:01,079 --> 01:20:05,083 STRUCTURE WHICH TENDS TO BE 1866 01:20:05,083 --> 01:20:06,785 CONSERVATIVE SLOW US DOWN FROM 1867 01:20:06,785 --> 01:20:09,187 MOVING THEM FORWARD TO BENEFIT 1868 01:20:09,187 --> 01:20:11,256 OUR HUMAN HEALTH. OUR COMMUNITY 1869 01:20:11,256 --> 01:20:15,227 I THINK IS ENGAGED AND EXCITED 1870 01:20:15,227 --> 01:20:18,129 BY DOING THAT SO WE CAN DRIVE 1871 01:20:18,129 --> 01:20:19,731 THAT FORWARD AND REFLECT THAT AS 1872 01:20:19,731 --> 01:20:22,133 WELL. I SEE RICK IS ON. HE IS 1873 01:20:22,133 --> 01:20:24,769 PART OF THAT FUTURE. HE WILL 1874 01:20:24,769 --> 01:20:27,038 TALK ABOUT THE EXPOSUM. THIS 1875 01:20:27,038 --> 01:20:29,674 WILL LIKELY BE PART OF OUR 1876 01:20:29,674 --> 01:20:31,309 ELECTRONIC HEALTH RECORDS. 1877 01:20:31,309 --> 01:20:32,644 EVERYONE'S ELECTRONIC HEALTH 1878 01:20:32,644 --> 01:20:34,279 RECORDS, AS WE MOVE FORWARD. HOW 1879 01:20:34,279 --> 01:20:37,048 DO WE DO THAT? HOW DO WE GET 1880 01:20:37,048 --> 01:20:38,516 THIS KIND OF INFORMATION BETTER 1881 01:20:38,516 --> 01:20:39,851 INTEGRATED. AT THE CORE IT IS 1882 01:20:39,851 --> 01:20:42,754 ABOUT TECHNOLOGIES. SO JENNIFER, 1883 01:20:42,754 --> 01:20:45,357 MAYBE A PLATONIC WEST WE'LL HAVE 1884 01:20:45,357 --> 01:20:47,759 MORE TIME. MAYBE NOT BECAUSE YOU 1885 01:20:47,759 --> 01:20:49,394 ARE PRESIDENT. BUT YOU WILL SORT 1886 01:20:49,394 --> 01:20:57,068 OF SEE THAT EMERGE ALSO IN THAT 1887 01:20:57,068 --> 01:20:58,670 CLINICAL TRANSLATION SESSION 1888 01:20:58,670 --> 01:21:01,206 MONDAY NIGHT. 1889 01:21:01,206 --> 01:21:02,207 >> THANK YOU. 1890 01:21:02,207 --> 01:21:05,510 1891 01:21:05,510 --> 01:21:08,947 >> WERE THERE ANY OTHER 1892 01:21:08,947 --> 01:21:16,087 HAND S? 1893 01:21:16,087 --> 01:21:19,291 >> YEAH SAM. YOU MAY BE ON 1894 01:21:19,291 --> 01:21:20,292 MUTE. 1895 01:21:20,292 --> 01:21:21,226 >> THANK YOU BRUCE FOR THE 1896 01:21:21,226 --> 01:21:25,263 EXCELLENT VIEW. I WAS GOING TO 1897 01:21:25,263 --> 01:21:28,466 FOLLOW UP ON THE QUESTION ABOUT 1898 01:21:28,466 --> 01:21:29,601 STRATEGIC PLAN FOR NIBIB MOVING 1899 01:21:29,601 --> 01:21:35,273 INTO THE NEXT FIVE YEARS. WE ARE 1900 01:21:35,273 --> 01:21:38,877 -- RELEASED THE RFI LAST YEAR 1901 01:21:38,877 --> 01:21:40,278 SOMETIME ABOUT IT. WHAT IS 1902 01:21:40,278 --> 01:21:41,846 STATUS OF THAT. SECONDLY, YOU 1903 01:21:41,846 --> 01:21:46,584 HAVE DONE AN AMAZING JOB FOR 1904 01:21:46,584 --> 01:21:51,356 RESOURCES FROM DIFFERENT AREAS 1905 01:21:51,356 --> 01:21:54,826 TO EXPAND OPPORTUNITIES FOR 1906 01:21:54,826 --> 01:21:57,762 NIBIB. THESE ARE FIRST. GIVEN 1907 01:21:57,762 --> 01:22:00,198 IMPORTANCE OF TECHNOLOGY AND 1908 01:22:00,198 --> 01:22:01,933 HEALTH CARE TODAY, HOW IT IS 1909 01:22:01,933 --> 01:22:06,104 GROWING AS WE SEE EVERY DAY, 1910 01:22:06,104 --> 01:22:08,006 WHAT SHOULD BE DONE INTO CREASE 1911 01:22:08,006 --> 01:22:12,377 THE BUDGET FOR NIBIB MOVING INTO 1912 01:22:12,377 --> 01:22:15,280 THE FUTURE? 1913 01:22:15,280 --> 01:22:17,782 >> WELL, OKAY SAM. FIRST ON 1914 01:22:17,782 --> 01:22:21,786 THE STRATEGIC PLAN, YOU SAW THE 1915 01:22:21,786 --> 01:22:23,254 ROLLOUT OF KEY ATTRIBUTES OF 1916 01:22:23,254 --> 01:22:25,056 THAT. THE VISION, THE MISSION, 1917 01:22:25,056 --> 01:22:27,459 THE DETAILS AND SO FORTH IN THE 1918 01:22:27,459 --> 01:22:29,494 LAST COUNCIL MEETING. WE HAVE 1919 01:22:29,494 --> 01:22:31,763 HAD LOTS OF GREAT FEEDBACK, 1920 01:22:31,763 --> 01:22:35,467 AFFIRMATIVE FEEDBACK, SO WE ARE 1921 01:22:35,467 --> 01:22:38,870 IN THE PROCESS OF TURN ING THAT 1922 01:22:38,870 --> 01:22:39,371 INTO A PRODUCT . 1923 01:22:39,371 --> 01:22:41,873 THE VARIOUS WAYS OF 1924 01:22:41,873 --> 01:22:45,410 DISSEMINATING. YOU CAN SEE MY 1925 01:22:45,410 --> 01:22:46,244 BACKGROUND. THE VISION AND SOME 1926 01:22:46,244 --> 01:22:48,146 OF THESE THINGS ARE BRANDED. I 1927 01:22:48,146 --> 01:22:50,448 HOPE THE NEXT COUNCIL WILL HAVE 1928 01:22:50,448 --> 01:22:51,750 THAT MORE COMPLETE ROLLOUT WITH 1929 01:22:51,750 --> 01:22:54,019 A VARIETY OF EXAMPLES. YOU KNOW, 1930 01:22:54,019 --> 01:22:57,422 KIND OF THING THAT WE CAN 1931 01:22:57,422 --> 01:22:59,457 DISTRIBUTE AND DISSEMINATE AMONG 1932 01:22:59,457 --> 01:23:00,859 COLLEAGUES AND BROADER 1933 01:23:00,859 --> 01:23:02,827 COMMUNITY. BUT THE ESSENTIAL 1934 01:23:02,827 --> 01:23:06,531 PRINCIPLES ARE UNCHANGED. THE 1935 01:23:06,531 --> 01:23:12,070 TECHNOLOGY ITSELF. OUR 1936 01:23:12,070 --> 01:23:15,373 PARTNERSHIPS IN INNOVATION. THE 1937 01:23:15,373 --> 01:23:18,143 IMPORTANCE OF TRAINING, 1938 01:23:18,143 --> 01:23:19,978 MULTI -LINGUAL WHO SPEAK THE 1939 01:23:19,978 --> 01:23:22,113 LANGUAGE OF TECHNOLOGY AS WELL 1940 01:23:22,113 --> 01:23:23,481 AS BIOLOGY AND MEDICINE. THOSE 1941 01:23:23,481 --> 01:23:25,683 ARE THREE GUIDING PRINCIPLES. 1942 01:23:25,683 --> 01:23:26,651 BECAUSE WE CAN'T REMEMBER THAT 1943 01:23:26,651 --> 01:23:31,356 MUCH MORE THAN THREE THINGS. SO 1944 01:23:31,356 --> 01:23:36,528 THAT IS KIND OF IT. OKAY. WHAT 1945 01:23:36,528 --> 01:23:40,532 WAS PART B. 1946 01:23:40,532 --> 01:23:42,167 >> BUDGET. 1947 01:23:42,167 --> 01:23:46,504 >> OH YAH. I CONVENIENTLY 1948 01:23:46,504 --> 01:23:50,041 FORGOT THAT ONE. YOU KNOW, WE 1949 01:23:50,041 --> 01:23:52,644 WILL NEVER GIVE UP ON THAT. BUT 1950 01:23:52,644 --> 01:23:55,280 YOU KNOW, WE PURSUE MULTIPLE 1951 01:23:55,280 --> 01:23:59,184 PATHS SIMULTANEOUSLY. CERTAINLY 1952 01:23:59,184 --> 01:24:02,487 WE NEVER PREDICTED THE 1953 01:24:02,487 --> 01:24:04,756 OPPORTUNITY TO CONTRIBUTE TO THE 1954 01:24:04,756 --> 01:24:06,724 NATIONAL TESTING INFRASTRUCTURE 1955 01:24:06,724 --> 01:24:09,527 DURING THE PANDEMIC AT SUCH 1956 01:24:09,527 --> 01:24:12,530 SCALE. NO MATTER EVEN IF I DID 1957 01:24:12,530 --> 01:24:15,166 SAY NAIVELY WHEN I CAME TO NIBIB 1958 01:24:15,166 --> 01:24:17,368 I'LL DOUBLE THE BUDGET. I DIDN'T 1959 01:24:17,368 --> 01:24:18,269 ACTUALLY THINK THAT WOULD 1960 01:24:18,269 --> 01:24:21,906 HAPPEN. SO WE REMAIN OPTIMISTIC 1961 01:24:21,906 --> 01:24:23,508 AND ENGAGED AND FORTUNATE TO 1962 01:24:23,508 --> 01:24:25,910 HAVE A CHAMPION LIKE MONICA -- 1963 01:24:25,910 --> 01:24:30,181 NOT LIKE MONICA. MONICA IS A 1964 01:24:30,181 --> 01:24:32,884 CHAMPION FOR THE KINDS OF THINGS 1965 01:24:32,884 --> 01:24:36,187 WE DO AND BRINGING RIGHT TO THE 1966 01:24:36,187 --> 01:24:40,325 FOREFRONT AND EXPLAINING AND 1967 01:24:40,325 --> 01:24:42,127 ARTICULATING TO CONGRESS THE 1968 01:24:42,127 --> 01:24:49,501 IMPORTANCE OF TECHNOLOGIES, 1969 01:24:49,501 --> 01:24:56,107 DATA. SHE IS VERY VERY /* 1970 01:24:56,107 --> 01:24:57,976 FOCUSED ON THIS IN OUR TENURE AS 1971 01:24:57,976 --> 01:25:00,011 THE NIH DIRECTOR. WE WILL KEEP 1972 01:25:00,011 --> 01:25:02,046 DOING WHAT WE DO. PRACTICALLY 1973 01:25:02,046 --> 01:25:04,249 SPEAKING WE LOOK FORWARD TO ALL 1974 01:25:04,249 --> 01:25:05,483 YOU AND BROADER COMMUNITY BEING 1975 01:25:05,483 --> 01:25:09,387 ABLE TO USE THEIR VOICE TO BRING 1976 01:25:09,387 --> 01:25:15,693 ATTENTION TO THAT. CYNTHIA F 1977 01:25:15,693 --> 01:25:16,828 >> CONGRATULATION IN FIVE 1978 01:25:16,828 --> 01:25:18,163 YEARS, ACCOMPLISHING SO MUCH. I 1979 01:25:18,163 --> 01:25:20,832 THINK MIDRIC IS ONE OF THE 1980 01:25:20,832 --> 01:25:22,233 SHINING EXAMPLES OF WHAT YOU 1981 01:25:22,233 --> 01:25:24,135 HAVE ACCOMPLISHED. YOU AND I GO 1982 01:25:24,135 --> 01:25:25,870 BACK TO THOSE EARLY DISCUSSIONS 1983 01:25:25,870 --> 01:25:27,906 WHEN YOU WERE NEW AS A DIRECTOR 1984 01:25:27,906 --> 01:25:29,774 ABOUT WHAT WE COULD DO IN THE 1985 01:25:29,774 --> 01:25:33,178 DATA SCIENCE AREA. WHEN MIDRIC 1986 01:25:33,178 --> 01:25:37,248 WAS FORMED AROUND COVID WE HAD A 1987 01:25:37,248 --> 01:25:44,822 BLANK SLATE. THERE WERE NO COVID 1988 01:25:44,822 --> 01:25:45,790 DEPOSITORIES. I'M EXCITED TO SEE 1989 01:25:45,790 --> 01:25:47,792 IT MOVE INTO CANCER. THERE'S A 1990 01:25:47,792 --> 01:25:49,994 LOT OF OTHERS IN THAT DOMAIN. 1991 01:25:49,994 --> 01:25:53,731 WONDER ING IF YOU SEE POTENTIAL 1992 01:25:53,731 --> 01:26:01,940 BARRIERS THERE OR OTHER 1993 01:26:01,940 --> 01:26:04,175 COLLABORATIONS AND NOT RUN INTO 1994 01:26:04,175 --> 01:26:05,310 OTHER GROUPS LIKE THE CANCER 1995 01:26:05,310 --> 01:26:06,110 IMAGE ARCHIVE. 1996 01:26:06,110 --> 01:26:07,912 >> YAH THAT, IS SUCH A GREAT 1997 01:26:07,912 --> 01:26:09,781 QUESTION. AS I HAVE LOOKED, 1998 01:26:09,781 --> 01:26:11,583 PARTICULARLY IN CANCER AND MORE 1999 01:26:11,583 --> 01:26:13,017 TRADITIONAL DOMAINS, I THINK 2000 01:26:13,017 --> 01:26:17,121 THEY ARE MISSING WHAT MIDRC 2001 01:26:17,121 --> 01:26:19,991 BRINGS IS A UNIQUE SORT OF 2002 01:26:19,991 --> 01:26:23,861 PHYSICS TO MEDICINE PERSPECTIVE 2003 01:26:23,861 --> 01:26:25,163 WITH THAT KIND OF ATTENTION TO 2004 01:26:25,163 --> 01:26:35,707 SOURCE OF THE DATA. THERE ARE A 2005 01:26:36,040 --> 01:26:38,443 LOT OF PEOPLE WHO DRIVE BUT NOT 2006 01:26:38,443 --> 01:26:41,212 A LOT THAT CAN BUILD OR REPAIR 2007 01:26:41,212 --> 01:26:44,148 CARS. THAT HOW I FEEL ACROSS OUR 2008 01:26:44,148 --> 01:26:45,617 RESPECTIVE COMMUNITIES IN DATA 2009 01:26:45,617 --> 01:26:46,684 SCIENCE, WE HAVE A UNIQUE FEEL 2010 01:26:46,684 --> 01:26:48,353 FOR WHERE THE DATA COMES FROM. 2011 01:26:48,353 --> 01:26:51,589 YOU KNOW, WE ARE RIGHT AT THE 2012 01:26:51,589 --> 01:26:53,024 MACHINE LEVEL OF DATA 2013 01:26:53,024 --> 01:26:54,192 GENERATION. SO I THINK THAT IS 2014 01:26:54,192 --> 01:26:56,894 ONE OF THE THINGS THAT COMES 2015 01:26:56,894 --> 01:26:59,163 THROUGH VERY CLEARLY IN MANY 2016 01:26:59,163 --> 01:27:02,333 MIDRC, THAT SPIRIT. OF COURSE 2017 01:27:02,333 --> 01:27:10,141 CANCER WAS ON OPPORTUNISTIC, 2018 01:27:10,141 --> 01:27:11,542 WHERE THE OPPORTUNITY WAS. WE 2019 01:27:11,542 --> 01:27:14,178 KNEW WE HAD TO EXPAND BEYOND 2020 01:27:14,178 --> 01:27:20,351 COVID AND BIOMEDICAL FABRIC FROM 2021 01:27:20,351 --> 01:27:22,453 ARPAH WAS FOCUSED ON CANCER. SO 2022 01:27:22,453 --> 01:27:23,988 THAT HOPEFULLY WILL HAVE OTHER 2023 01:27:23,988 --> 01:27:26,357 OPPORTUNITIES AND OTHER AREAS. 2024 01:27:26,357 --> 01:27:29,494 BUT, YOU KNOW, STICKING WITH OUR 2025 01:27:29,494 --> 01:27:32,030 UNIQUE PERSPECTIVE IN EXPERTISE, 2026 01:27:32,030 --> 01:27:34,365 I THINK IT BRINGS SOMETHING 2027 01:27:34,365 --> 01:27:36,567 DIFFERENT TO MUCH OF THE WORK 2028 01:27:36,567 --> 01:27:39,470 THAT'S BEEN GOING ON IN AI. THEN 2029 01:27:39,470 --> 01:27:41,272 OF COURSE ALL THAT HAS CHANGED 2030 01:27:41,272 --> 01:27:43,841 JUST RECENTLY WITH THE EXPANSION 2031 01:27:43,841 --> 01:27:50,915 OF LARGE LARNGUAGE MODELS 2032 01:27:50,915 --> 01:27:52,183 GENERATIVE AI. WHAT WE WERE 2033 01:27:52,183 --> 01:27:54,152 DOING IS A LITTLE DIFFERENT AND 2034 01:27:54,152 --> 01:27:55,953 EVEN MORE CRITICALLY DEPENDENT 2035 01:27:55,953 --> 01:27:57,722 ON HAVING EXPERTS WHO UNDERSTAND 2036 01:27:57,722 --> 01:27:59,357 WHERE DID THE DATA COME FROM IN 2037 01:27:59,357 --> 01:28:01,125 THE FIRST PLACE. WHERE ARE 2038 01:28:01,125 --> 01:28:02,860 POTENTIAL BIASES. THERE ARE MANY 2039 01:28:02,860 --> 01:28:04,562 OF THOSE SOURCES. SO THAT IS 2040 01:28:04,562 --> 01:28:07,465 SORT OF THE GENERAL ROAD MAP. 2041 01:28:07,465 --> 01:28:08,733 RANU, MAYBE WE WILL MAKE THIS 2042 01:28:08,733 --> 01:28:13,137 THE LAST. I SEE RICK ON. I THINK 2043 01:28:13,137 --> 01:28:16,107 DAVE, WAS HE SUPPOSED TO START 2044 01:28:16,107 --> 01:28:17,742 15 MINUTES AGO? 2045 01:28:17,742 --> 01:28:20,812 >> NO, WE ARE QUITE PRECISELY 2046 01:28:20,812 --> 01:28:24,082 ALMOST SPOT-ON ON HIS 12:30. 2047 01:28:24,082 --> 01:28:26,818 WELL-DONE, BRUCE AND TEAM. 2048 01:28:26,818 --> 01:28:28,052 >> GOOD, GOOD. 2049 01:28:28,052 --> 01:28:31,089 >> IF YOU WANT ME TO GO ON I 2050 01:28:31,089 --> 01:28:32,590 CAN. I WAS CURIOUS YOU ARE DOING 2051 01:28:32,590 --> 01:28:35,360 THINGS WITH FETAL MONITORING. 2052 01:28:35,360 --> 01:28:36,861 BUT WHERE DO YOU THINK NIBIB 2053 01:28:36,861 --> 01:28:42,600 MIGHT GO WITH INITIATIVES FOR 2054 01:28:42,600 --> 01:28:44,235 MATERNAL HELP AS WELL AS 2055 01:28:44,235 --> 01:28:44,802 PEDIATRIC HELP. 2056 01:28:44,802 --> 01:28:48,539 >> YAH, THOSE ARE WONDERFUL 2057 01:28:48,539 --> 01:28:51,409 PARTNERSHIPS THAT WE'RE SO 2058 01:28:51,409 --> 01:28:55,680 EXCITED BY WORKING TOGETHER BY 2059 01:28:55,680 --> 01:29:00,051 THE NIBIB, NURSING INSTITUTE. 2060 01:29:00,051 --> 01:29:01,753 THE CLASSIC ROLE FOR US, WE 2061 01:29:01,753 --> 01:29:03,221 UNDERSTAND TECHNOLOGIES, WHERE 2062 01:29:03,221 --> 01:29:05,523 THEY COME FROM. THE COMMUNITY 2063 01:29:05,523 --> 01:29:06,624 THAT'S DEVELOPING THEM. THESE 2064 01:29:06,624 --> 01:29:10,261 ARE URGENT NEEDS THAT HAVE BEEN 2065 01:29:10,261 --> 01:29:11,496 ARTICULATED BY OUR COLLEAGUES. 2066 01:29:11,496 --> 01:29:13,364 SO WE ARE FORTUNATE TO GET THESE 2067 01:29:13,364 --> 01:29:17,602 PROGRAMS LAUNCHED AND TOGETHER. 2068 01:29:17,602 --> 01:29:20,204 THE RADAX MATERNAL HEALTH ARE IN 2069 01:29:20,204 --> 01:29:22,440 THE FINAL STAGES. THERE ARE TEN 2070 01:29:22,440 --> 01:29:25,777 SEMI FINALISTS. I BELIEVE AT THE 2071 01:29:25,777 --> 01:29:31,082 END O OF THE MONTH, THE PROGRAM 2072 01:29:31,082 --> 01:29:33,551 FOLKS, THERE WILL BE A DAY OF 2073 01:29:33,551 --> 01:29:35,420 PITCHES IN THOSE TECHNOLOGIES. I 2074 01:29:35,420 --> 01:29:36,754 MAY HAVE POINTED OUT IN ONE OF 2075 01:29:36,754 --> 01:29:38,723 THE PRESENTATIONS, AT LEAST FOUR 2076 01:29:38,723 --> 01:29:40,925 ARE QUITE PROMISING-LOOKING, 2077 01:29:40,925 --> 01:29:43,094 VIABLE TECHNOLOGIES FOR 2078 01:29:43,094 --> 01:29:44,729 CONTINUOUS BLOOD PRESSURE 2079 01:29:44,729 --> 01:29:46,397 MONITORING. NOT THE OCCASIONALLY 2080 01:29:46,397 --> 01:29:49,867 WORKING COMMERCIAL DEVICES THAT 2081 01:29:49,867 --> 01:29:54,305 WE ARE QUITE FAMILIAR WITH WUNLD 2082 01:29:54,305 --> 01:29:56,140 BE LESS OBTRUSIVE .ENTER NOT 2083 01:29:56,140 --> 01:29:57,341 REQUIRE, YOU KNOW, LIKE 2084 01:29:57,341 --> 01:30:00,077 CUFF LESS APPROACHES. SO WE HOPE 2085 01:30:00,077 --> 01:30:03,314 WE CAN SIMULATE REAL 2086 01:30:03,314 --> 01:30:08,619 TRANSFORMATIONAL TRANCE 2087 01:30:08,619 --> 01:30:09,220 INAUGU 2088 01:30:09,220 --> 01:30:10,188 TRANSFORMATIONAL TECHNOLOGIES. 2089 01:30:10,188 --> 01:30:12,590 FETAL TECHNOLOGIES ARE ABOUT THE 2090 01:30:12,590 --> 01:30:13,991 SAME AS THEY HAVE BEEN QUITE 2091 01:30:13,991 --> 01:30:17,762 SOMETIME. IN OUR CONVERSATIONS, 2092 01:30:17,762 --> 01:30:23,267 PARTICULARLY WITH EXPERTS THIS 2093 01:30:23,267 --> 01:30:24,402 SEEMS AN OPPORTUNITY TO JUMP 2094 01:30:24,402 --> 01:30:25,736 START THIS. THE GATES FOUNDATION 2095 01:30:25,736 --> 01:30:27,538 IS A CRITICAL PARTNER. THEY 2096 01:30:27,538 --> 01:30:29,040 ACTUALLY CONTRIBUTED A MILLION 2097 01:30:29,040 --> 01:30:31,776 TO THAT FETAL MONITORING TECH. 2098 01:30:31,776 --> 01:30:35,346 WE HAVE CONVERSATIONS WITH 2099 01:30:35,346 --> 01:30:38,382 MULTIPLE GATES FOUNDATION 2100 01:30:38,382 --> 01:30:39,817 GROUPS. THERE ARE ACTUALLY MANY 2101 01:30:39,817 --> 01:30:41,853 GROUPS WITHIN THE GATES 2102 01:30:41,853 --> 01:30:43,221 FOUNDATION INTERESTED IN 2103 01:30:43,221 --> 01:30:45,122 PARTNERING TO EXPAND 2104 01:30:45,122 --> 01:30:48,493 TECHNOLOGIES AND DIFFERENT FOCUS 2105 01:30:48,493 --> 01:30:52,129 AREAS FROM TB AND HIV AND 2106 01:30:52,129 --> 01:30:53,164 TECHNOLOGIES THAT INCLUDE 2107 01:30:53,164 --> 01:30:55,666 WEARABLE AS WELL AS VOLATILE 2108 01:30:55,666 --> 01:30:57,735 ORGANIC SENSING. SO I THINK WE 2109 01:30:57,735 --> 01:31:04,041 HAVE OPENED UP A WHOLE NEW WORLD 2110 01:31:04,041 --> 01:31:06,677 FOR THINKING ABOUT PARTNERSHIPS. 2111 01:31:06,677 --> 01:31:08,346 NOT JUST COME FROM NIH BUT 2112 01:31:08,346 --> 01:31:09,847 MULTIPLE INSTITUTES. WE CAN 2113 01:31:09,847 --> 01:31:11,249 REACH OUT TO FOUNDATIONS. WE 2114 01:31:11,249 --> 01:31:13,050 HAVE PATHWAYS. AGAIN, WE ARE 2115 01:31:13,050 --> 01:31:16,954 JUST REFLECTING ALL OF YOU. OUR 2116 01:31:16,954 --> 01:31:20,024 BIOENGINEERING COMMUNITY, OUR 2117 01:31:20,024 --> 01:31:21,959 ENGINEERING COMMUNITY IS AGILE 2118 01:31:21,959 --> 01:31:23,861 AND IS READY TO DEVELOP PROGRAMS 2119 01:31:23,861 --> 01:31:25,730 AND STRUCTURE TO SOLVE PROBLEMS. 2120 01:31:25,730 --> 01:31:28,833 NOT JUST RESIDE IN A PROGRAMMING 2121 01:31:28,833 --> 01:31:30,635 STRUCTURE. I THINK WE HAVE SOME 2122 01:31:30,635 --> 01:31:39,744 CAPACITY AND FLEXIBILITY TO DO 2123 01:31:39,744 --> 01:31:43,347 THAT. SO AM I ACTUALLY ON TIME? 2124 01:31:43,347 --> 01:31:50,021 THAT IS ALMOST UNHEARD OF. 2125 01:31:50,021 --> 01:31:52,423 >> DAVID GEORGE: NO COMMENT, 2126 01:31:52,423 --> 01:31:54,525 THIS IS GREAT. IMPRESSIVE. YOU 2127 01:31:54,525 --> 01:31:58,095 DO BETTER THAN DO I AT THE 2128 01:31:58,095 --> 01:31:59,130 COUNCIL MEETINGS. 2129 01:31:59,130 --> 01:32:00,631 >> I CAN'T SAY I'M BATTING A 2130 01:32:00,631 --> 01:32:02,633 THOUSAND AT BEING ON TIME, OR 2131 01:32:02,633 --> 01:32:03,701 CLOSE TO IT. 2132 01:32:03,701 --> 01:32:07,338 IF I COULD JUST SHARE MY SLIDES 2133 01:32:07,338 --> 01:32:12,643 FOR JUST A SECOND. IT IS SUCH A 2134 01:32:12,643 --> 01:32:16,247 COOL PICTURE. AND I'LL GO BACK 2135 01:32:16,247 --> 01:32:18,249 FROM THE HOLLYWOOD SQUARES. YOU 2136 01:32:18,249 --> 01:32:21,118 KNOW, I'M JUST SO DELIGHTED TO 2137 01:32:21,118 --> 01:32:23,521 INTRODUCE RICK. MY FEELING IS 2138 01:32:23,521 --> 01:32:25,389 SUMMARIZED BY LIKE THIS IMAGE. 2139 01:32:25,389 --> 01:32:27,525 THIS IS SUCH A GREAT IMAGE. AS 2140 01:32:27,525 --> 01:32:31,262 WE KNOW, IMAGES HAVE LOTS OF 2141 01:32:31,262 --> 01:32:33,030 INFORMATION CONTENT. THIS 2142 01:32:33,030 --> 01:32:35,766 CAPTURES SO MUCH OF RICK. BOTH 2143 01:32:35,766 --> 01:32:38,603 HIS KNOWLEDGE AND HIS JOY AND 2144 01:32:38,603 --> 01:32:42,673 HIS WONDERFUL SENSE OF HUMOR. SO 2145 01:32:42,673 --> 01:32:46,077 I WILL TAKE THAT DOWN NOW AND GO 2146 01:32:46,077 --> 01:32:47,845 BACK AND I'M GOING TO INTRODUCE 2147 01:32:47,845 --> 01:32:50,014 RICK MORE FORMALLY WITH A FEW 2148 01:32:50,014 --> 01:32:51,916 MORE WORDS. YOU KNOW, RICK THIS 2149 01:32:51,916 --> 01:32:54,185 IS AN IMAGING AND TECHNOLOGY 2150 01:32:54,185 --> 01:32:56,253 GROUPS. I HAD TO SHOW AN IMAGE 2151 01:32:56,253 --> 01:32:57,989 THAT SAYS MANY THINGS. 2152 01:32:57,989 --> 01:32:59,357 >> THAT IS GREAT. NEVER KNEW 2153 01:32:59,357 --> 01:33:01,959 IT WAS MAKING SUCH AN 2154 01:33:01,959 --> 01:33:02,293 IMPRESSION. 2155 01:33:02,293 --> 01:33:06,731 >> I ANALYZED IT INTENSIVELY. 2156 01:33:06,731 --> 01:33:09,000 IT IS ALL IN THE FREQUENCY 2157 01:33:09,000 --> 01:33:09,266 DOMAIN. 2158 01:33:09,266 --> 01:33:10,534 >> OKAY. 2159 01:33:10,534 --> 01:33:13,237 >> SO WE ARE REALLY LUCKY TO 2160 01:33:13,237 --> 01:33:15,539 HAVE RICK HERE. HE IS THE 2161 01:33:15,539 --> 01:33:18,643 DIRECTOR OF NATIONAL INSTITUTE 2162 01:33:18,643 --> 01:33:20,811 OF ENVIRONMENTAL HEALTH SCIENCES 2163 01:33:20,811 --> 01:33:22,880 AND DIRECTOR OF THE NATIONAL 2164 01:33:22,880 --> 01:33:24,115 TOXICOLOGY PROGRAM, WHICH I 2165 01:33:24,115 --> 01:33:27,618 DIDN'T QUITE KNOW. THAT IS A 2166 01:33:27,618 --> 01:33:30,421 THREE-AGENCY NATIONAL PROGRAM. 2167 01:33:30,421 --> 01:33:34,158 RICK LEADS THAT. PRIOR TO 2168 01:33:34,158 --> 01:33:35,726 BECOMING DIRECTOR OF NIEHS IN 2169 01:33:35,726 --> 01:33:41,065 JUNE OF 2020 HE SERVED AS DEPUTY 2170 01:33:41,065 --> 01:33:43,968 DIRECTOR OF NIEHS SO WAS ABLE TO 2171 01:33:43,968 --> 01:33:46,504 ABOUT TEN YEARS, NINE, TEN 2172 01:33:46,504 --> 01:33:48,839 YEARS, BUILD AND DIG IN AND GET 2173 01:33:48,839 --> 01:33:50,408 THOSE EXPERIENCES ABSOLUTELY 2174 01:33:50,408 --> 01:33:53,244 CRITICAL TO FORMULATION OF HIS 2175 01:33:53,244 --> 01:33:58,382 VISION. RICK, SCIENTIFICALLY IS 2176 01:33:58,382 --> 01:34:05,990 AMAZING. A MAMALIAN GENETICIST 2177 01:34:05,990 --> 01:34:08,759 AND HELPS IN OBESITY AND KIDNEY 2178 01:34:08,759 --> 01:34:10,928 DISEASE, HE'S MADE IMPORTANT 2179 01:34:10,928 --> 01:34:11,996 CONTRIBUTIONS TO UNDERSTANDING 2180 01:34:11,996 --> 01:34:13,831 MOLECULAR MECHANISMS OF HOW 2181 01:34:13,831 --> 01:34:15,066 ENVIRONMENTAL AGENTS INFLUENCE 2182 01:34:15,066 --> 01:34:23,207 THE EPIGENETIC EXPRESS OF GENES. 2183 01:34:23,207 --> 01:34:24,809 I FEEL LIKE I COULD TALK TO RICK 2184 01:34:24,809 --> 01:34:26,610 FOR HOURS. I'M HOPING YOU MAY 2185 01:34:26,610 --> 01:34:28,879 TOUCH A LITTLE IN YOUR 2186 01:34:28,879 --> 01:34:31,348 PRESENTATION. SOME OF RICK'S 2187 01:34:31,348 --> 01:34:32,616 REALLY QUITE IMPRESSIVE 2188 01:34:32,616 --> 01:34:35,219 EXPERIENCE, HE WAS THE PRESIDENT 2189 01:34:35,219 --> 01:34:38,055 AND CEO OF JACKSON LAB IN MAINE. 2190 01:34:38,055 --> 01:34:41,425 HE WAS ALSO THE DIRECTOR OF THE 2191 01:34:41,425 --> 01:34:45,429 LAB'S NCI DESIGNATED CENTER, ONE 2192 01:34:45,429 --> 01:34:46,530 OF THE FEW SCIENCE CANCER 2193 01:34:46,530 --> 01:34:50,301 CENTERS IN THE COUNTRY. 2194 01:34:50,301 --> 01:34:51,435 INCREDIBLY IMPORTANT ROLE. PRIOR 2195 01:34:51,435 --> 01:34:53,838 TO LEADING THE JACKSON LAB RICK 2196 01:34:53,838 --> 01:34:56,741 HAD MAJOR LEADERSHIP POSITIONS 2197 01:34:56,741 --> 01:34:58,409 IN ACADEMIA, GOVERNMENT AND 2198 01:34:58,409 --> 01:35:02,046 INDUSTRY, INCLUDING CSO AT LINKS 2199 01:35:02,046 --> 01:35:03,948 THERAPEUTIC, ALSO AT PARK DAVIS 2200 01:35:03,948 --> 01:35:05,916 SO SPENT SOME TIME IN 2201 01:35:05,916 --> 01:35:08,586 CALIFORNIA. PROFESSOR OF 2202 01:35:08,586 --> 01:35:11,088 PEDIATRICS, GENETICS AND 2203 01:35:11,088 --> 01:35:12,256 PHARMACOLOGY AT CASE. AT THE 2204 01:35:12,256 --> 01:35:14,024 TIME I DIDN'T QUITE REALIZE BUT 2205 01:35:14,024 --> 01:35:16,694 WE OVERLAPPED AT OAKRIDGE 2206 01:35:16,694 --> 01:35:22,366 NATIONAL LAB WHEN I WORKED FOR 2207 01:35:22,366 --> 01:35:25,336 BOTIM, DANNY NUTON. WE HAD 2208 01:35:25,336 --> 01:35:26,237 WONDERFUL CONVERSATIONS ABOUT 2209 01:35:26,237 --> 01:35:28,939 HIS TIME AND MY TIME AT OAKRIDGE 2210 01:35:28,939 --> 01:35:30,975 NATIONAL LAB. FINALLY, YOU KNOW, 2211 01:35:30,975 --> 01:35:33,144 VERY IMPORTANTLY, HE IS A 2212 01:35:33,144 --> 01:35:35,346 PASSION NATURAL AND INCREDIBLY 2213 01:35:35,346 --> 01:35:37,348 ARTICULATE ADVOCATE FOR 2214 01:35:37,348 --> 01:35:39,350 EXPANDING OUR UNDERSTANDING OF 2215 01:35:39,350 --> 01:35:42,419 THE EXPOSUM AND QUANTITATIVELY 2216 01:35:42,419 --> 01:35:44,722 MEASURING ITS ROLE IN HUMAN 2217 01:35:44,722 --> 01:35:46,557 HEALTH AND DISEASE. HE'S DONE 2218 01:35:46,557 --> 01:35:49,026 SIMPLY TRULY AN AMAZING JOB 2219 01:35:49,026 --> 01:35:51,996 EDUCATING ME AND COLLEAGUES 2220 01:35:51,996 --> 01:35:56,000 ACROSS THE NIH ON CRITICAL 2221 01:35:56,000 --> 01:36:00,004 IMPORTANCE. WE ARE ALWAYS 2222 01:36:00,004 --> 01:36:03,274 ARGUING FROM OUR PERSPECTIVE 2223 01:36:03,274 --> 01:36:05,509 THAT PRECISION MEDICINE HAS TO 2224 01:36:05,509 --> 01:36:07,511 BE LED BY PRECISION DIAGNOSTICS. 2225 01:36:07,511 --> 01:36:09,947 WHEN YOU LISTEN TO RICK IT IS 2226 01:36:09,947 --> 01:36:12,783 EASY TO MAKE THAT CONNECTION 2227 01:36:12,783 --> 01:36:14,919 THAT CRITICAL EXPOSUM 2228 01:36:14,919 --> 01:36:16,787 INFORMATION THAT CAN BE ACQUIRE 2229 01:36:16,787 --> 01:36:18,355 AND INTERPRETED USING SIMILAR 2230 01:36:18,355 --> 01:36:21,025 AND HIGHLY COMPATIBLE 2231 01:36:21,025 --> 01:36:23,060 METHODOLOGIES WE USE IN OUR 2232 01:36:23,060 --> 01:36:24,261 COMMUNITY, THEY HAVE TO MOVE 2233 01:36:24,261 --> 01:36:30,234 INTO THE EXPOSUM AS WELL. RICK, 2234 01:36:30,234 --> 01:36:32,536 I'M GOING TO HAND IT TO YOU TO 2235 01:36:32,536 --> 01:36:34,438 TAKE OFF AND EDUCATE US ON THESE 2236 01:36:34,438 --> 01:36:37,508 TOPICS THANK YOU FOR BEING HERE. 2237 01:36:37,508 --> 01:36:38,209 >> RICK WOYCHIK: TERRIFIC. WANT 2238 01:36:38,209 --> 01:36:41,178 TO DOUBLE-CHECK, YOU CAN HEAR 2239 01:36:41,178 --> 01:36:41,378 ME? 2240 01:36:41,378 --> 01:36:42,146 >> YES. 2241 01:36:42,146 --> 01:36:42,813 >> RICK WOYCHIK: ALWAYS GOOD TO 2242 01:36:42,813 --> 01:36:44,415 KNOW THE ZOOM IS WORKING. THANKS 2243 01:36:44,415 --> 01:36:46,283 SO MUCH FOR THE INVITATION TO BE 2244 01:36:46,283 --> 01:36:48,485 HERE. IT'S BEEN DELIGHTFUL 2245 01:36:48,485 --> 01:36:49,987 WORKING WITH YOU MANY IN SO MANY 2246 01:36:49,987 --> 01:36:52,857 WAYS. I MUST SAY I HAVE ENJOYED 2247 01:36:52,857 --> 01:36:55,092 ALL THE DISCUSSIONS WE HAVE HAD 2248 01:36:55,092 --> 01:36:57,528 ABOUT POTENTIAL PARTNERSHIPS 2249 01:36:57,528 --> 01:37:00,464 BETWEEN OUR INSTITUTES AND 2250 01:37:00,464 --> 01:37:01,866 CENTERS AT THE NIH. SO WHAT I 2251 01:37:01,866 --> 01:37:04,068 WILL TALK ABOUT IS SOME OF THE 2252 01:37:04,068 --> 01:37:05,769 RESEARCH PRIORITIES AT NIEHS. I 2253 01:37:05,769 --> 01:37:14,845 WILL TALK ABOUT EXPOSUM AND 2254 01:37:14,845 --> 01:37:16,280 THINGS WE ARE DOING AND 2255 01:37:16,280 --> 01:37:18,015 HOPEFULLY ANSWER QUESTIONS AND 2256 01:37:18,015 --> 01:37:20,251 EXPLORE ARE THERE THINGS 2257 01:37:20,251 --> 01:37:20,985 SPECIFICALLY GOING FORWARD WE 2258 01:37:20,985 --> 01:37:22,253 ARE NOT CURRENTLY DOING. LET ME 2259 01:37:22,253 --> 01:37:24,488 START BY TELLING YOU LITTLE 2260 01:37:24,488 --> 01:37:27,358 ABOUT NIEHS. SO WE GO TO THE 2261 01:37:27,358 --> 01:37:34,465 NEXT SLIDE. I WANT TO THANK -- 2262 01:37:34,465 --> 01:37:37,134 WHERE IS HEATHER, TERRIFIC. THIS 2263 01:37:37,134 --> 01:37:40,104 IS ONE OF THE 26 CENTERS AT THE 2264 01:37:40,104 --> 01:37:42,139 NIEHS. WHY IT IS LOCATED IN 2265 01:37:42,139 --> 01:37:44,174 CENTRAL NORTH CAROLINA IN 2266 01:37:44,174 --> 01:37:46,810 RESEARCH TRIANGLE PARK? THERE IS 2267 01:37:46,810 --> 01:37:48,712 A GOOD SCIENTIFIC REASON AND 2268 01:37:48,712 --> 01:37:50,814 GOOD POLITICAL. THE GOOD 2269 01:37:50,814 --> 01:37:54,251 SCIENTIFIC IS THE WORK WE DO IS 2270 01:37:54,251 --> 01:37:55,085 FOCUSED ON ENVIRONMENT AND 2271 01:37:55,085 --> 01:37:57,187 PUBLIC HEALTH. IF THE NIEHS IS 2272 01:37:57,187 --> 01:37:59,123 GOING TO POSITION INSTITUTE 2273 01:37:59,123 --> 01:38:01,792 DEDICATED TO PUBLIC HEALTH AND 2274 01:38:01,792 --> 01:38:03,127 ENVIRONMENT, RTP IS JUST DOWN 2275 01:38:03,127 --> 01:38:05,462 THE STREET FROM UNIVERSITY OF 2276 01:38:05,462 --> 01:38:06,830 NORTH CAROLINA SCHOOL OF PUBLIC 2277 01:38:06,830 --> 01:38:07,965 HEALTH, ONE OF THE BEST SCHOOLS 2278 01:38:07,965 --> 01:38:10,367 IN THE COUNTRY. DUKE UNIVERSITY, 2279 01:38:10,367 --> 01:38:12,303 WHICH IS VERY CLOSE BY HAS A 2280 01:38:12,303 --> 01:38:15,773 VERY STRONG PROGRAM IN THE 2281 01:38:15,773 --> 01:38:17,341 ENVIRONMENT. NORTH CAROLINA 2282 01:38:17,341 --> 01:38:20,177 STATE HAS A FABULOUS AND VERY 2283 01:38:20,177 --> 01:38:21,278 STRONG PROGRAM, TOXICOLOGY 2284 01:38:21,278 --> 01:38:23,047 SCIENCE. IT JUST MAKES A LOT OF 2285 01:38:23,047 --> 01:38:25,082 SENSE. IF YOU ARE GOING TO 2286 01:38:25,082 --> 01:38:26,417 LOCATE INSTITUTE DEDICATED TO 2287 01:38:26,417 --> 01:38:29,887 THE ENVIRONMENT YOU'D PUT IN 2288 01:38:29,887 --> 01:38:31,522 CENTER OF NORTH CAROLINA. TURNS 2289 01:38:31,522 --> 01:38:33,691 OUT THE GOOD POLITICAL REASON IS 2290 01:38:33,691 --> 01:38:38,495 THE GOVERNOR OF NORTH CAROLINA 2291 01:38:38,495 --> 01:38:43,067 DELIVERS NORTH CAROLINA TO 2292 01:38:43,067 --> 01:38:48,872 KENNEDY IN THE ELECTION SO QUID 2293 01:38:48,872 --> 01:38:50,207 PRO QUO WAS WHEN THE GOVERNMENT 2294 01:38:50,207 --> 01:38:52,543 NEEDED ANCHOR TENANT FOR THIS 2295 01:38:52,543 --> 01:38:54,645 MODEL, KIND OF A SILICON VALLEY 2296 01:38:54,645 --> 01:38:56,780 HERE, HE NEED ED THIS , NIEHS IS 2297 01:38:56,780 --> 01:38:59,083 THAT ANCHOR TENANT. WE ARE PROUD 2298 01:38:59,083 --> 01:39:02,019 AND DELIGHTED TO BE HERE. IT IS 2299 01:39:02,019 --> 01:39:04,521 GREAT TO HAVE THIS OPPORTUNITY 2300 01:39:04,521 --> 01:39:06,223 TO INTERACT WITH THE STRONG 2301 01:39:06,223 --> 01:39:08,359 ACADEMIC ORGANIZATIONS IN 2302 01:39:08,359 --> 01:39:10,694 CENTRAL NORTH CAROLINA. SO WE 2303 01:39:10,694 --> 01:39:12,863 HAVE JUST LIKE MANY OF THE 2304 01:39:12,863 --> 01:39:19,903 OTHER, WE HAVE OUR INTRA 2305 01:39:19,903 --> 01:39:22,573 INTRAMURAL LABORATORIES AND THIS 2306 01:39:22,573 --> 01:39:25,042 LAB THIS COLLABORATED WITH THE 2307 01:39:25,042 --> 01:39:27,478 FDA AROUND TOXICOLOGY PROGRAM. 2308 01:39:27,478 --> 01:39:29,646 WE BRING INNOVATIVE NEW 2309 01:39:29,646 --> 01:39:31,815 TECHNOLOGIES AND APPROACHES TO 2310 01:39:31,815 --> 01:39:32,983 STUDY TOXICOLOGY, IN 2311 01:39:32,983 --> 01:39:34,418 COLLABORATION WITH OTHER FEDERAL 2312 01:39:34,418 --> 01:39:36,520 AGENCIES TO TAKE ON SOME OF THE 2313 01:39:36,520 --> 01:39:38,956 BIG CHALLENGES ON A NATIONAL 2314 01:39:38,956 --> 01:39:42,393 SCALE IN TOXICOLOGY SCIENCE. WE 2315 01:39:42,393 --> 01:39:47,798 HAVE THE EXTRA MURLAL FUNDING, 2316 01:39:47,798 --> 01:39:50,267 DRT, RESEARCH AND TRAINING AND A 2317 01:39:50,267 --> 01:39:56,040 SMALL PROGRAM HERE. IT IS AN 2318 01:39:56,040 --> 01:39:58,342 INSTITUTE DEDICATED -- THE NEXT 2319 01:39:58,342 --> 01:39:58,542 SLIDE. 2320 01:39:58,542 --> 01:40:01,211 IF YOU WANT TO KNOW WHAT WE DO, 2321 01:40:01,211 --> 01:40:02,613 LOOK AT THE MISSION AND 2322 01:40:02,613 --> 01:40:04,248 DIVISION. ONE OF MY FIRST JOBS 2323 01:40:04,248 --> 01:40:06,650 WAS WORK WITH OUR DIRECTOR, 2324 01:40:06,650 --> 01:40:09,686 LINDA BRAMBAUM, TO START THE 2325 01:40:09,686 --> 01:40:11,622 PROCESS. WE ARE GOING THROUGH 2326 01:40:11,622 --> 01:40:14,358 THE THIRD REVISION.LY TALK ABOUT 2327 01:40:14,358 --> 01:40:17,461 SOME OF THOSE AREAS IN A MINUTE. 2328 01:40:17,461 --> 01:40:19,596 THE MISSION OF NIEHS IS TO 2329 01:40:19,596 --> 01:40:20,764 DISCOVER HOW THE ENVIRONMENT 2330 01:40:20,764 --> 01:40:23,200 AFFECTS PEOPLE IN ORDER TO 2331 01:40:23,200 --> 01:40:24,268 PROMOTE HEALTHIER LIVES. AS 2332 01:40:24,268 --> 01:40:26,437 BRUCE AND I HAVE TALKED IN GREAT 2333 01:40:26,437 --> 01:40:28,906 DETAIL, I'M A GENETICIST BY 2334 01:40:28,906 --> 01:40:31,075 TRAINING BUT DOM REALIZE IF YOU 2335 01:40:31,075 --> 01:40:34,478 WANT TO IMPLEMENT ON POSITION 2336 01:40:34,478 --> 01:40:36,313 AND UNDERSTAND THE ETIOLOGY OF 2337 01:40:36,313 --> 01:40:39,183 HUMAN DISEASE IT HAS TO GO 2338 01:40:39,183 --> 01:40:41,318 BEYOND SEQUENCING GENOMES AND 2339 01:40:41,318 --> 01:40:42,453 THINGS THAT CONTRIBUTE TO 2340 01:40:42,453 --> 01:40:43,454 DISEASE. THAT IS CLEARLY 2341 01:40:43,454 --> 01:40:44,721 IMPORTANT BUT THE ENVIRONMENT 2342 01:40:44,721 --> 01:40:46,657 CAN MAKE PEOPLE SICK OR CAN HELP 2343 01:40:46,657 --> 01:40:48,725 PEOPLE STAY HEALTHY. WE HAVE TO 2344 01:40:48,725 --> 01:40:51,061 FACTOR THAT INTO THE EQUATION. 2345 01:40:51,061 --> 01:40:52,963 SO THE VISION OF NIEHS IS TO 2346 01:40:52,963 --> 01:40:55,265 PROVIDE GLOBAL LEADERSHIP FOR 2347 01:40:55,265 --> 01:40:55,933 INNOVATIVE RESEARCH THAT 2348 01:40:55,933 --> 01:40:58,335 IMPROVES PUBLIC HEALTH BY 2349 01:40:58,335 --> 01:40:59,336 PREVENTING DISEASE AND 2350 01:40:59,336 --> 01:41:01,071 DISABILITY. THE PREVENTING PART 2351 01:41:01,071 --> 01:41:07,344 IS A DIF REN S DIFFERENTIAL FOR 2352 01:41:07,344 --> 01:41:08,779 US. WE WORK WITH CANCER BUT LIKE 2353 01:41:08,779 --> 01:41:11,348 TO THINK WE CAN IDENTIFY 2354 01:41:11,348 --> 01:41:13,150 POTENTIALLY ENVIRONMENTAL 2355 01:41:13,150 --> 01:41:13,851 EXPOSURES THAT WOULD TRIGGER 2356 01:41:13,851 --> 01:41:15,986 CANCER TO PREVENT EXPOSURE TO 2357 01:41:15,986 --> 01:41:18,288 SOME OF THOSE ELEMENTS AND 2358 01:41:18,288 --> 01:41:19,223 PREVENT CANCER IN THE FIRST 2359 01:41:19,223 --> 01:41:21,191 PLACE. THAT IS A LITTLE ABOUT 2360 01:41:21,191 --> 01:41:23,260 NIEHS AND OUR MISSION AND 2361 01:41:23,260 --> 01:41:24,661 VISION. LET'S GO TO THE NEXT 2362 01:41:24,661 --> 01:41:27,297 SLIDE . 2363 01:41:27,297 --> 01:41:29,867 THE LIMITED TIME I HAVE, LET'S 2364 01:41:29,867 --> 01:41:32,603 DIG INTO SOME OF THE EMERGING 2365 01:41:32,603 --> 01:41:35,172 SCIENTIFIC PRIORITY AREAS. SO WE 2366 01:41:35,172 --> 01:41:36,740 ARE CURRENTLY IN OUR NEXT ROUND 2367 01:41:36,740 --> 01:41:38,709 OF STRATEGIC PLANNING. WE HAVE 2368 01:41:38,709 --> 01:41:41,478 REACHED OUT TO THE GLOBAL 2369 01:41:41,478 --> 01:41:49,820 ENVIRONMENTAL HEALTH SCIENCE AND 2370 01:41:49,820 --> 01:41:50,454 BIOMEDICAL COMMUNITIES AND 2371 01:41:50,454 --> 01:41:52,222 ASKING WHAT SHOULD WE FOCUS ON. 2372 01:41:52,222 --> 01:41:57,895 I TRY TO COVER SEVERAL. ONE, AS 2373 01:41:57,895 --> 01:42:01,298 BRUCE INDICATED, IS EXPOSUM. WE 2374 01:42:01,298 --> 01:42:03,000 HAVE LAUNCH ED THIS PROGRAM WE 2375 01:42:03,000 --> 01:42:05,068 CALL PRECISION ENVIRONMENTAL 2376 01:42:05,068 --> 01:42:07,371 HEALTH THAT. IS THE RECOGNITION 2377 01:42:07,371 --> 01:42:08,872 THAT PEOPLE RESPOND TO 2378 01:42:08,872 --> 01:42:10,807 ENVIRONMENTAL EXPOSURE. THE 2379 01:42:10,807 --> 01:42:14,378 POSITIVE OR NEGATIVE 2380 01:42:14,378 --> 01:42:14,912 ENVIRONMENTAL EXPOSURES 2381 01:42:14,912 --> 01:42:17,014 DIFFERENTLY BASED ON DIFFERENT 2382 01:42:17,014 --> 01:42:18,515 GENETICS AND BIOLOGY. WE ARE 2383 01:42:18,515 --> 01:42:19,783 TRYING TO FIGURE HOW DO WE 2384 01:42:19,783 --> 01:42:22,352 DEVELOP A PROGRAM THAT BUILDS ON 2385 01:42:22,352 --> 01:42:24,021 THE PRECISION MEDICINE PROGRAM 2386 01:42:24,021 --> 01:42:29,426 BUT FACTORS THE EXPOSUM AND 2387 01:42:29,426 --> 01:42:31,929 ENVIRONMENT SO I WILL TALK ABOUT 2388 01:42:31,929 --> 01:42:34,097 THE TRANSLATION OF TOXICOLOGY. 2389 01:42:34,097 --> 01:42:36,667 THERE IS A BIG NIEHS-WIDE EFFORT 2390 01:42:36,667 --> 01:42:38,402 THAT NIEHS IS PARTICIPATING IN 2391 01:42:38,402 --> 01:42:40,070 CLIMATE CHANGE AND HEALTH.LY 2392 01:42:40,070 --> 01:42:42,005 TALK BRIEFLY ABOUT THAT. VERY 2393 01:42:42,005 --> 01:42:44,208 BRIEFLY ABOUT ENVIRONMENTAL 2394 01:42:44,208 --> 01:42:48,745 JUSTICE, COMPUTATIONAL DATA AND 2395 01:42:48,745 --> 01:42:52,916 SCIENCE. FOCUSSING ON EXPOSUM, 2396 01:42:52,916 --> 01:42:56,253 THE TRANSLATION TO BIOMEDICINE 2397 01:42:56,253 --> 01:42:58,055 AND TOXICOLOGY. LET'S START WITH 2398 01:42:58,055 --> 01:43:01,091 THE EXPOSUM.ENTERTHIS IS A 2399 01:43:01,091 --> 01:43:05,963 CONCEPT ORIGINALLY PROMOTED IN 2400 01:43:05,963 --> 01:43:10,334 CRISIS WILDE IN 2005. HE 2401 01:43:10,334 --> 01:43:11,401 RECOGNIZED IF WE TRULY WANT TO 2402 01:43:11,401 --> 01:43:14,238 UNDERSTAND THE IMPACT OF THE 2403 01:43:14,238 --> 01:43:15,439 ENVIRONMENT WE HAVE TO GET 2404 01:43:15,439 --> 01:43:21,011 BEYOND STUDYING ONE EXPOSURE AT 2405 01:43:21,011 --> 01:43:26,583 A TIME. THIS WAS HAPPENING 2406 01:43:26,583 --> 01:43:29,319 SIMILAR TO GENOME PROJECT. IF WE 2407 01:43:29,319 --> 01:43:31,321 WANT TO UNDERSTAND THE PROJECT 2408 01:43:31,321 --> 01:43:32,889 WE HAVE TO UNDERSTAND ONE GENE 2409 01:43:32,889 --> 01:43:35,092 VARIANT AT A TIME. HE BUILD ON 2410 01:43:35,092 --> 01:43:36,960 THE GENOME CONCEPT AND PROPOSED 2411 01:43:36,960 --> 01:43:41,965 THIS EXPOSUM. SO THE EXPOSUM IN 2412 01:43:41,965 --> 01:43:43,834 THE LOWER PANEL IN BLUE HE IS 2413 01:43:43,834 --> 01:43:44,935 BASICALLY SAYING IF YOU WANT TO 2414 01:43:44,935 --> 01:43:46,670 UNDERSTAND THE IMPACT OF THE 2415 01:43:46,670 --> 01:43:49,239 ENVIRONMENT IT CAN'T JUST BE 2416 01:43:49,239 --> 01:43:53,043 ABOUT ONE FLAME RETARDANT OR ONE 2417 01:43:53,043 --> 01:43:57,981 PESTICIDE OR PM25 IN AIR 2418 01:43:57,981 --> 01:43:59,483 POLLUTION. WE ARE EXPOSED TO ALL 2419 01:43:59,483 --> 01:44:01,752 THESE THINGS IN THE WATER AND 2420 01:44:01,752 --> 01:44:04,454 SOIL. WE NEED TO BUILD A 2421 01:44:04,454 --> 01:44:05,856 FRAMEWORK , A RESEARCH FRAMEWORK 2422 01:44:05,856 --> 01:44:08,425 THAT ALLOWS US TO FACTOR ALL 2423 01:44:08,425 --> 01:44:09,960 THESE DIFFERENT ELEMENTS, THE 2424 01:44:09,960 --> 01:44:11,295 PHYSICAL AND CHEMICAL ELEMENTS 2425 01:44:11,295 --> 01:44:12,963 INTO THE EQUATION. THAT IS WHERE 2426 01:44:12,963 --> 01:44:14,698 BRUCE AND I WERE TALKING OF 2427 01:44:14,698 --> 01:44:18,268 THAT. WE NEED HELP IN NIBIB CAN 2428 01:44:18,268 --> 01:44:20,003 BE A VERY IMPORTANT PARTNER WITH 2429 01:44:20,003 --> 01:44:22,339 US IN DEVELOPING SOME OF THESE 2430 01:44:22,339 --> 01:44:25,208 TOOLS. BUT CAN'T BE ALSO JUST 2431 01:44:25,208 --> 01:44:26,910 ABOUT THE PHYSICAL AND CHEMICAL 2432 01:44:26,910 --> 01:44:32,749 ELEMENTS, AS SHOWN ON BANTIB BO 2433 01:44:32,749 --> 01:44:34,384 THIS IS A SCIENCE ARTICLE BY 2434 01:44:34,384 --> 01:44:38,789 SOME OF OUR GRANTEES. VERMILION 2435 01:44:38,789 --> 01:44:40,791 AND MILLER IN PARTICULAR. 2436 01:44:40,791 --> 01:44:41,625 PROMOTE ING THIS CONCEPT AND 2437 01:44:41,625 --> 01:44:43,260 DEVELOP THIS DIAGRAM. IT IS NOT 2438 01:44:43,260 --> 01:44:45,228 JUST ABOUT THE PHYSICAL CHEMICAL 2439 01:44:45,228 --> 01:44:50,033 BUT HOUSEHOLD INCOME, SOCIAL 2440 01:44:50,033 --> 01:44:51,601 CAPITAL, CULTURAL NORMAL, 2441 01:44:51,601 --> 01:44:52,769 PSYCHOSOCIAL STRESS. WE 2442 01:44:52,769 --> 01:44:54,938 RECOGNIZE THIS IS A MAJOR 2443 01:44:54,938 --> 01:44:56,740 FACTOR, MAJOR ENVIRONMENTAL 2444 01:44:56,740 --> 01:44:58,642 FACTOR THAT CAN BE INFLUENCING 2445 01:44:58,642 --> 01:45:00,177 HEALTH AND WELL-BEING BUT SHOULD 2446 01:45:00,177 --> 01:45:02,145 BE ABOUT PHYSICAL ACTIVITY, 2447 01:45:02,145 --> 01:45:04,047 SLEEP BEHAVIOR, SMOKING, DIET IS 2448 01:45:04,047 --> 01:45:06,917 A BIG ONE. WE ACTUALLY KNOW IN 2449 01:45:06,917 --> 01:45:08,452 ENVIRONMENTAL HEALTH SCIENCES 2450 01:45:08,452 --> 01:45:09,686 COMMUNITY THERE ARE MANY 2451 01:45:09,686 --> 01:45:10,921 ELEMENTS OF THE DIET CAN 2452 01:45:10,921 --> 01:45:14,658 POSITIVELY INFLUENCE HEALTH. IN 2453 01:45:14,658 --> 01:45:22,232 FACT, SOME CAN MITIGATE SOME OF 2454 01:45:22,232 --> 01:45:22,532 T 2455 01:45:22,532 --> 01:45:25,001 THESE IN THE PANEL. WE NEED TO 2456 01:45:25,001 --> 01:45:30,674 FACTOR ALL THESE THINGS INTO THE 2457 01:45:30,674 --> 01:45:35,078 EQUATION. SO THAT IS WHAT 2458 01:45:35,078 --> 01:45:36,847 EXPOSUM IS. I REMEMBER WHEN 2459 01:45:36,847 --> 01:45:38,648 TALKING WITH FRANCIS COLLINS, HE 2460 01:45:38,648 --> 01:45:41,385 SAID RICK THIS IS GREAT. I AGREE 2461 01:45:41,385 --> 01:45:43,253 WE NEED TO FACTOR THESE THINGS 2462 01:45:43,253 --> 01:45:45,355 INTO THE EQUATION. HOW DO WE DO 2463 01:45:45,355 --> 01:45:47,657 AN EXPERIMENT? WE NEED AN 2464 01:45:47,657 --> 01:45:48,725 OPERATIONAL DEFINITION. YOU 2465 01:45:48,725 --> 01:45:50,894 CAN'T DO EVERYTHING. THERE IS 2466 01:45:50,894 --> 01:45:52,062 ALSO THE RECOGNITION THAT 2467 01:45:52,062 --> 01:45:53,597 ACTUALLY WAS INTRIGUING TO TALK 2468 01:45:53,597 --> 01:45:56,066 ABOUT PEDIATRIC EXPOSURES 2469 01:45:56,066 --> 01:45:58,068 BECAUSE WE HAVE DATA -- ACTUALLY 2470 01:45:58,068 --> 01:46:00,470 DATA FROM MY OWN LAB TO INDICATE 2471 01:46:00,470 --> 01:46:02,372 EXPOSURE DURING PREGNANCY. NOW 2472 01:46:02,372 --> 01:46:03,573 BEGINNING TO UNDERSTAND 2473 01:46:03,573 --> 01:46:05,909 EXPOSURES TO THE PARENTS BEFORE 2474 01:46:05,909 --> 01:46:08,712 CONCEPTION CAN BE INFLUENCING 2475 01:46:08,712 --> 01:46:11,181 HOW GENES ARE OPERATING MUCH 2476 01:46:11,181 --> 01:46:13,817 LATER IN LIFE. WE NEED A 2477 01:46:13,817 --> 01:46:15,051 OPERATIONAL DEFINITION. THE 2478 01:46:15,051 --> 01:46:17,320 SECOND POINT IS KEY. THAT IS WHY 2479 01:46:17,320 --> 01:46:18,989 I'M SO HAPPY TO BE PRESENTING TO 2480 01:46:18,989 --> 01:46:20,957 ALL OF YOU. WE ARE GOING TO HAVE 2481 01:46:20,957 --> 01:46:23,360 TO BUILD NEW TECHNOLOGIES TO 2482 01:46:23,360 --> 01:46:25,595 STUDY THE EXPO SUM. THAT ARE 2483 01:46:25,595 --> 01:46:27,164 HIGH THROUGHPUT, LOW COST, THAT 2484 01:46:27,164 --> 01:46:29,733 WE CAN APPLY TO POTENTIALLY 2485 01:46:29,733 --> 01:46:31,334 MILLIONS OF DIFFERENT 2486 01:46:31,334 --> 01:46:32,869 INDIVIDUALS. CAPTURING THIS 2487 01:46:32,869 --> 01:46:35,172 DATA. AS BRUCE INDICATED WE LOVE 2488 01:46:35,172 --> 01:46:38,341 TO THINK THAT YOU EVENTUALLY AND 2489 01:46:38,341 --> 01:46:41,578 HOPEFULLY IN NEARER TERM THAN 2490 01:46:41,578 --> 01:46:43,213 LONGER TERM THAT PHYSICIANS 2491 01:46:43,213 --> 01:46:44,948 WOULD COME TO BEDSIDE WITH NOT 2492 01:46:44,948 --> 01:46:46,082 ONLY SEQUENCE AND BETTER 2493 01:46:46,082 --> 01:46:47,517 UNDERSTANDING OF GENETIC 2494 01:46:47,517 --> 01:46:49,553 PREDISPOSITION BUT WHAT ARE SOME 2495 01:46:49,553 --> 01:46:53,557 OF THE EXPOSURES THAT COULD BE 2496 01:46:53,557 --> 01:47:04,000 WORKING POTENTIALLY SIN 2497 01:47:07,370 --> 01:47:08,772 SYNERGYSTICALLY TO BIOLOGICAL 2498 01:47:08,772 --> 01:47:10,140 FUTURES TO UNDERSTAND THE 2499 01:47:10,140 --> 01:47:12,476 ETIOLOGY OF HUMAN DISEASE. THERE 2500 01:47:12,476 --> 01:47:18,548 IS THIS PRAGMATIC EXPOSUM. LIKE 2501 01:47:18,548 --> 01:47:19,115 THE GENOME PROJECT . 2502 01:47:19,115 --> 01:47:22,652 THE BOLD VISION IN THE 80s, 2503 01:47:22,652 --> 01:47:24,688 WHERE WE WILL SEQUENCE THE 2504 01:47:24,688 --> 01:47:26,056 GENOME AND DO THIS STUFF THAT 2505 01:47:26,056 --> 01:47:27,691 WILL TRANSFORM GENETICS BUT IN 2506 01:47:27,691 --> 01:47:30,093 THE EARLY DAYS I DON'T THINK 2507 01:47:30,093 --> 01:47:31,328 ANYONE KNEW HOW WE WERE GOING TO 2508 01:47:31,328 --> 01:47:32,562 ACTUALLY DO IT. SO WE STARTED 2509 01:47:32,562 --> 01:47:33,997 WITH TECHNOLOGIES WE HAD 2510 01:47:33,997 --> 01:47:35,232 AVAILABLE. MANY OF YOU MAY 2511 01:47:35,232 --> 01:47:38,702 REMEMBER SOME OF THOSE CDNA 2512 01:47:38,702 --> 01:47:40,770 CLONES SPOTTED MICRO ARRAYS ON 2513 01:47:40,770 --> 01:47:42,439 SLIDES, SO THAT WAS A STEP IN 2514 01:47:42,439 --> 01:47:45,408 THE RIGHT DIRECTION. OF COURSE 2515 01:47:45,408 --> 01:47:46,576 ULTIMATELY WE DIDN'T REALLY 2516 01:47:46,576 --> 01:47:48,178 UNDERSTAND HOW ULTIMATELY WE 2517 01:47:48,178 --> 01:47:50,313 COULD BE LOOKING AT WHOLE GENOME 2518 01:47:50,313 --> 01:47:52,382 SEQUENCES AND DOING RNA SEEK AND 2519 01:47:52,382 --> 01:47:54,918 TYPE THINGS WE CAN DO TODAY. SO 2520 01:47:54,918 --> 01:47:56,853 STARTING WITH THINGS WE CAN DO 2521 01:47:56,853 --> 01:48:00,590 WITH UNDERSTANDING THAT WE NEED 2522 01:48:00,590 --> 01:48:02,626 TO DEVELOP BOLD AND INNOVATIVE 2523 01:48:02,626 --> 01:48:05,061 HIGH THROUGHPUT, LOW COST 2524 01:48:05,061 --> 01:48:08,164 STRATEGIES TO CAPTURE THE 2525 01:48:08,164 --> 01:48:10,033 EXPOSUM. LET'S GO TO THE NEXT 2526 01:48:10,033 --> 01:48:14,037 SLIDE. HOW ARE WE GOING TO DO 2527 01:48:14,037 --> 01:48:16,139 THIS? WHAT WE HAVE TO DO IS GET 2528 01:48:16,139 --> 01:48:18,074 PEOPLE WORKING TOGETHER. UP 2529 01:48:18,074 --> 01:48:20,777 UNTIL THIS POINT SINCE 2005 2530 01:48:20,777 --> 01:48:24,581 PEOPLE HAVE BEEN THROWING OUT 2531 01:48:24,581 --> 01:48:27,384 THE TERM EXPOSUMN. REALITY THEY 2532 01:48:27,384 --> 01:48:32,389 ARE STUDYING ONE EXPOSURE. THE 2533 01:48:32,389 --> 01:48:35,392 OTHER QUESTION IS THE BIG 2534 01:48:35,392 --> 01:48:42,198 QUESTION IS WHERE DO THESE FIT? 2535 01:48:42,198 --> 01:48:46,069 CAN WE CAPTURE CHANGES THAT SAY 2536 01:48:46,069 --> 01:48:47,904 FOR EXAMPLE DURING PREGNANCY 2537 01:48:47,904 --> 01:48:49,506 THAT CAN PREDISPOSE CHANGES IN 2538 01:48:49,506 --> 01:48:50,941 THE WAY THE GENES ARE WORKING 2539 01:48:50,941 --> 01:48:54,010 LATER IN LIFE. SO WE NEED TO 2540 01:48:54,010 --> 01:48:57,080 DEVELOP THIS CONCEPTUAL 2541 01:48:57,080 --> 01:48:58,715 FRAMEWORK. SO WHAT WE HAVE DONE 2542 01:48:58,715 --> 01:49:01,284 IS WE HAVE MET AND TALKED ABOUT 2543 01:49:01,284 --> 01:49:03,353 DEVELOP ING THIS GLOBAL RESEARCH 2544 01:49:03,353 --> 01:49:05,055 COORDINATION TO ACCELERATE 2545 01:49:05,055 --> 01:49:07,257 PRECISION ENVIRONMENTAL HEALTH. 2546 01:49:07,257 --> 01:49:09,526 AGAIN I WILL TALK ABOUT THIS IN 2547 01:49:09,526 --> 01:49:11,795 A MINUTE. WE NEED TO DEVELOP A 2548 01:49:11,795 --> 01:49:14,297 COMMONLY AGREED FRAMEWORK FOR 2549 01:49:14,297 --> 01:49:16,566 THE ECONOMICS, PROMOTE BEST 2550 01:49:16,566 --> 01:49:18,735 PRACTICES, DATA SHARING AND 2551 01:49:18,735 --> 01:49:20,737 BUILD GLOBAL EXPOSUM COMMUNITY 2552 01:49:20,737 --> 01:49:22,505 TO FOSTER NATIONAL AND 2553 01:49:22,505 --> 01:49:33,016 INTERNATIONAL COLLABORATION. 2554 01:49:34,584 --> 01:49:36,319 THERE ARE THREE AND WE ARE 2555 01:49:36,319 --> 01:49:38,188 WORKING THROUGH DEVELOPING THEM. 2556 01:49:38,188 --> 01:49:39,723 THE KEY IS DEVELOP THAT GLEE 2557 01:49:39,723 --> 01:49:40,156 BALL COMMUNITY . 2558 01:49:40,156 --> 01:49:42,092 THE EUROPEAN UNION HAS BEEN 2559 01:49:42,092 --> 01:49:44,027 WORKING ON DEVELOPING RESEARCH 2560 01:49:44,027 --> 01:49:46,997 STRATEGIES FOR EXPOSOMICS FOR A 2561 01:49:46,997 --> 01:49:48,431 NUMBER OF YEARS. WE DON'T WANT 2562 01:49:48,431 --> 01:49:50,367 TO COMPETE WITH THEM. WE WANT TO 2563 01:49:50,367 --> 01:49:51,568 WORK COLLABORATIVELY WITH THEM. 2564 01:49:51,568 --> 01:49:57,540 THAT IS WHERE I THINK THE GENOME 2565 01:49:57,540 --> 01:50:00,377 PROJECT, INITIALLY WHEN 2566 01:50:00,377 --> 01:50:02,846 LAUNCHED, ONE GROUP AND ONE 2567 01:50:02,846 --> 01:50:07,283 COUNTRY COMPETING. ONCE WE 2568 01:50:07,283 --> 01:50:09,753 DEDECIDE TO FRANCIS COLLINS 2569 01:50:09,753 --> 01:50:13,289 CREDIT, ONCE WE STARTED 2570 01:50:13,289 --> 01:50:19,529 COLLABORATING THE JOB GOT DONE. 2571 01:50:19,529 --> 01:50:20,930 THE SPIRIT OF COLLABORATION 2572 01:50:20,930 --> 01:50:22,766 DECIDE WHAT THIS IS, WHAT DATA 2573 01:50:22,766 --> 01:50:25,068 DO WE COLLECT, WHERE DOES DA 2574 01:50:25,068 --> 01:50:28,872 SHARING AND DATA MANAGEMENT 2575 01:50:28,872 --> 01:50:30,974 PLANS AND THAT HAS TO BE AN 2576 01:50:30,974 --> 01:50:33,343 IMPORTANT PART BECAUSE ARE 2577 01:50:33,343 --> 01:50:33,977 COLLECTING ALL THESE DIFFERENT 2578 01:50:33,977 --> 01:50:37,213 TYPE OF DATA PART OF THE 2579 01:50:37,213 --> 01:50:38,815 FRAMEWORK. SO THAT IS WHAT WE 2580 01:50:38,815 --> 01:50:44,120 HOPE TO DO. NEXT SLIDE. THE GOOD 2581 01:50:44,120 --> 01:50:47,490 NEWS IS IN COLLABORATION, NOT ON 2582 01:50:47,490 --> 01:50:50,927 HERE. WE HAVE FULL SUPPORT FROM 2583 01:50:50,927 --> 01:50:57,634 BRUCE AND OTHERS. SO WE ARE 2584 01:50:57,634 --> 01:50:59,102 FUNDING A CENTER FOR RESEARCH 2585 01:50:59,102 --> 01:51:02,972 COORDINATION. WE RELEASED A NOFO 2586 01:51:02,972 --> 01:51:08,812 IN SEPTEMBER. REVIEWING 2587 01:51:08,812 --> 01:51:10,246 APPLICATIONS AND HOPE TO HAVE 2588 01:51:10,246 --> 01:51:12,215 THIS FUNDED IN THE SUMMER . 2589 01:51:12,215 --> 01:51:14,117 THE IDEA IS THIS IS GOING TO BE 2590 01:51:14,117 --> 01:51:17,087 DEDICATED TO WORKING WITH GLOBAL 2591 01:51:17,087 --> 01:51:21,091 COMMUNITY TO OPERATIONAL IZE 2592 01:51:21,091 --> 01:51:29,666 EXPOSUM SCIENCE SO TUNED AS WE 2593 01:51:29,666 --> 01:51:31,034 FLESH OUT DETAILS BRUCE AND I 2594 01:51:31,034 --> 01:51:32,702 WILL DISCUSS THESE THINGS. WE 2595 01:51:32,702 --> 01:51:35,338 ARE LOOKING FORWARD TO 2596 01:51:35,338 --> 01:51:38,908 COOPERATION AND COLLABORATION 2597 01:51:38,908 --> 01:51:40,977 WITH NIBIB. THE NEXT SLIDE, THAT 2598 01:51:40,977 --> 01:51:42,445 IS THE EXPOSUM. I HAVE LIMITED 2599 01:51:42,445 --> 01:51:46,249 TIME SO I CAN'T GO INTO GREAT 2600 01:51:46,249 --> 01:51:50,720 DETAIL IN ALL THESE SIX AREAS. 2601 01:51:50,720 --> 01:52:01,264 SO THIS IS ONE I'M INTERESTED IN 2602 01:52:02,298 --> 01:52:04,567 AND ADDRESSES THE RESPONSE. THE 2603 01:52:04,567 --> 01:52:07,337 FACT, JUST LIKE PRECISION 2604 01:52:07,337 --> 01:52:10,039 MEDICINE, WE ALL DON'T RESPOND 2605 01:52:10,039 --> 01:52:14,410 TO A BEGIN TREATMENT OR SAME 2606 01:52:14,410 --> 01:52:15,512 PREDISPOSITION TO DISEASE. IT IS 2607 01:52:15,512 --> 01:52:18,148 A FUNCTION OF OUR INDIVIDUAL 2608 01:52:18,148 --> 01:52:20,750 GENETICS. WE ARE ARGUING 2609 01:52:20,750 --> 01:52:24,988 POTENTIALLY PART OF YOUREN 2610 01:52:24,988 --> 01:52:27,357 EPIGENETIC HERITAGE. THIS IS 2611 01:52:27,357 --> 01:52:33,897 BUILDING ON PRECISION MEDICINE 2612 01:52:33,897 --> 01:52:35,698 BUT BRINGING GENE EFFECTS INTO 2613 01:52:35,698 --> 01:52:38,835 THE EQUATION. THE GOAL, AS MANY 2614 01:52:38,835 --> 01:52:41,571 GRANTEES HAVE DEFINED THIS, THE 2615 01:52:41,571 --> 01:52:46,376 GOAL IS GENETICS AND EPIGENETICS 2616 01:52:46,376 --> 01:52:50,647 DATA. G BY E BY D. ONE OF THE 2617 01:52:50,647 --> 01:52:51,948 CHALLENGES IN PRECISION 2618 01:52:51,948 --> 01:52:55,118 ENVIRONMENTAL HEALTH AS WE HAVE 2619 01:52:55,118 --> 01:52:58,621 WITH PRECISION MEDICINE IS THERE 2620 01:52:58,621 --> 01:53:01,891 IS NO SINGLE GEEN THAT HAS THE 2621 01:53:01,891 --> 01:53:04,594 VARIATION, NO GENE THAT IS 2622 01:53:04,594 --> 01:53:05,829 EPIGENETICALLY IDENTIFIED THAT 2623 01:53:05,829 --> 01:53:08,731 CAN BE INFLUENCING OUTCOMES AS A 2624 01:53:08,731 --> 01:53:10,733 CONSEQUENCE OF EXPOSURES. MOST 2625 01:53:10,733 --> 01:53:21,244 ARE FALLING INTO THE COMPLEX 2626 01:53:21,878 --> 01:53:22,846 TRAITS. THERE ARE POTENTIALLY 2627 01:53:22,846 --> 01:53:24,280 HUNDREDS OF THOUGHS OF THE GENES 2628 01:53:24,280 --> 01:53:26,182 THAT CAN BE INFLUENCING HOW AN 2629 01:53:26,182 --> 01:53:30,320 INDIVIDUAL RESPONDS TO THE 2630 01:53:30,320 --> 01:53:32,088 ENVIRONMENT. AGAIN THIS FALLS 2631 01:53:32,088 --> 01:53:33,623 INTO THIS CATEGORY OF COMPLEX 2632 01:53:33,623 --> 01:53:36,125 TRAITS. DO WE HAVE TO DO THIS? 2633 01:53:36,125 --> 01:53:38,061 BUILD ALL THE TOOLS TO MANAGE 2634 01:53:38,061 --> 01:53:41,531 COMPLEX TRAITS ON OUR OWN IN 2635 01:53:41,531 --> 01:53:42,665 ENVIRONMENTAL HEALTH SCIENCES 2636 01:53:42,665 --> 01:53:46,135 COMMUNITY OR LATCH ONTO OTHER 2637 01:53:46,135 --> 01:53:49,372 PROGRAMS THAT HAVE TAKE N ON 2638 01:53:49,372 --> 01:53:50,740 THIS CHALLENGE AND SO THAT IS 2639 01:53:50,740 --> 01:53:56,279 WHAT WE HAVE DECIDED TO DO. NEXT 2640 01:53:56,279 --> 01:53:57,914 SLIDE, I JUST WANT TO CALL YOUR 2641 01:53:57,914 --> 01:54:01,184 ATTENTION TO THE FACT THERE IS A 2642 01:54:01,184 --> 01:54:04,254 NEW COLLABORATION CALLED 2643 01:54:04,254 --> 01:54:06,022 INTERNATIONAL COMMON DISEASE 2644 01:54:06,022 --> 01:54:10,059 ALLIANCE. THIS WAS AN AN LINES 2645 01:54:10,059 --> 01:54:11,628 LAUNCHED IN SEPTEMBER OF 2019. I 2646 01:54:11,628 --> 01:54:13,263 WAS THE REPRESENTATIVE FROM 2647 01:54:13,263 --> 01:54:16,199 NIEHS WHO PARTICIPATED ON THIS. 2648 01:54:16,199 --> 01:54:18,234 ERIC LANDER AND FRANCIS COLLINS 2649 01:54:18,234 --> 01:54:22,005 CALLED TOGETHER THE GLOBAL 2650 01:54:22,005 --> 01:54:24,040 GENETICS COMMUNITY. BASICALLY 2651 01:54:24,040 --> 01:54:26,843 PRESENT ED A CHALLENGE. IF WE 2652 01:54:26,843 --> 01:54:30,313 TRULY WANT TO WORK OUT COMPLEX 2653 01:54:30,313 --> 01:54:32,548 TRAITS, WE ARE GOING TO NEED 2654 01:54:32,548 --> 01:54:34,984 LARGE COHORTS BECAUSE MAY 2655 01:54:34,984 --> 01:54:36,753 POTENTIALLY BE HUNDREDS OF 2656 01:54:36,753 --> 01:54:38,254 DIFFERENT GENES AND VARIANTS 2657 01:54:38,254 --> 01:54:40,757 THAT CAN CONTRIBUTE TO MEDICALLY 2658 01:54:40,757 --> 01:54:49,732 RELEVANT DISEASE PHENOTYPES. SO 2659 01:54:49,732 --> 01:54:51,935 DO WE ALL WORK IN COMPETITION 2660 01:54:51,935 --> 01:54:56,940 WITH EACH OTHER OR ON A GLOBAL 2661 01:54:56,940 --> 01:55:04,580 COMMUNITY KIND OF DEVELOP COMMON 2662 01:55:04,580 --> 01:55:06,349 COMPLEX TOOLS TO SEEM LESSLY 2663 01:55:06,349 --> 01:55:08,618 SHARE DATA. WE TALKED ABOUT THE 2664 01:55:08,618 --> 01:55:10,453 CHALLENGE, MAPPING TO MECHANISMS 2665 01:55:10,453 --> 01:55:11,988 TO MEDICINE. BUT THE BOTTOM LINE 2666 01:55:11,988 --> 01:55:16,159 IS WE NOW HAVE THIS COMMON -- 2667 01:55:16,159 --> 01:55:17,160 INTERNATIONAL COMMON DISEASE 2668 01:55:17,160 --> 01:55:18,695 ALLIANCE. SO THE STRATEGY WE ARE 2669 01:55:18,695 --> 01:55:23,333 USING IS, LET'S BUILD ON THE 2670 01:55:23,333 --> 01:55:26,736 ICDA. LET'S BRING TO THE ICDA 2671 01:55:26,736 --> 01:55:29,005 THE NEED TO COLLECT THIS DATA 2672 01:55:29,005 --> 01:55:32,308 AND INTEGRATE THAT INTO THE 2673 01:55:32,308 --> 01:55:34,377 DATABASES DEVELOPED TO STUDY 2674 01:55:34,377 --> 01:55:36,012 COMPLEX TRAITS. HOPEFULLY THIS 2675 01:55:36,012 --> 01:55:39,482 WILL BE ENORMOUSLY HELPFUL AS 2676 01:55:39,482 --> 01:55:41,851 RELATES TO STUDYING THE 2677 01:55:41,851 --> 01:55:43,953 ENVIRONMENT EFFECTS. THE NEXT 2678 01:55:43,953 --> 01:55:45,822 SLIDE. THE TANGIBLE STEP WE HAVE 2679 01:55:45,822 --> 01:55:47,623 TAKEN IN THIS DIRECTION IS WE 2680 01:55:47,623 --> 01:55:49,859 CAN WORK IN OUR OWN BACKYARD. 2681 01:55:49,859 --> 01:55:52,729 MANY OF YOU ARE SURE ARE AWARE 2682 01:55:52,729 --> 01:55:55,231 OF THE ALL OF US, ONE MILLION 2683 01:55:55,231 --> 01:55:57,433 COHORT, THAT IS AT THE CORE OF 2684 01:55:57,433 --> 01:55:59,669 THE PRECISION MEDICINE PROGRAM 2685 01:55:59,669 --> 01:56:01,037 AT THE NIH. THIS IS ABOUT 2686 01:56:01,037 --> 01:56:03,840 TREATMENT AND CARE. IT IS REALLY 2687 01:56:03,840 --> 01:56:05,708 PROVIDES ACCESS TO EXPANSIVE 2688 01:56:05,708 --> 01:56:08,211 HEALTH DATA FROM DIVERSE 2689 01:56:08,211 --> 01:56:11,214 POPULATIONS. SO WE ARE LUCKY 2690 01:56:11,214 --> 01:56:16,819 ENOUGH THAT JOSH DEN DAI NY, THE 2691 01:56:16,819 --> 01:56:21,657 CEO AND JEFF GINSBURG, OF THE 2692 01:56:21,657 --> 01:56:23,326 PROGRAM THEY UNDERSTAND THE 2693 01:56:23,326 --> 01:56:24,627 ENVIRONMENT PLAYS A CRITICALLY 2694 01:56:24,627 --> 01:56:28,231 IMPORTANT ROLE. NEXT SLIDE. SO 2695 01:56:28,231 --> 01:56:29,699 WORKING TOGETHER WITH JEFF AND 2696 01:56:29,699 --> 01:56:31,634 WITH JOSH AND THEIR COLLEAGUES 2697 01:56:31,634 --> 01:56:33,403 -- MANY OF THEIR COLLEAGUES 2698 01:56:33,403 --> 01:56:35,872 ACROSS THE ALL OF US PROGRAM, WE 2699 01:56:35,872 --> 01:56:37,573 ARE NOW INCLUDING INTO THIS -- 2700 01:56:37,573 --> 01:56:39,008 YOU KNOW, WE GOT THE PIECE OF 2701 01:56:39,008 --> 01:56:42,745 THE PIE. THE ENVIRONMENTAL DATA. 2702 01:56:42,745 --> 01:56:45,581 WE ARE INTEGRATING THAT INTO THE 2703 01:56:45,581 --> 01:56:46,883 DATASETS COLLECTED AS PART OF 2704 01:56:46,883 --> 01:56:49,585 THE ALL OF US PRECISION 2705 01:56:49,585 --> 01:56:53,356 MEDICINE. SO NEXT SLIDE. SO WE 2706 01:56:53,356 --> 01:56:55,024 ARE DOING INTEGRATING 2707 01:56:55,024 --> 01:56:59,362 ENVIRONMENT IN PHASES. SO THE 2708 01:56:59,362 --> 01:57:00,830 PHASE I IS INCREASING 2709 01:57:00,830 --> 01:57:01,898 RECOGNITION IF YOU KNOW WHERE 2710 01:57:01,898 --> 01:57:04,567 SOMEONE LIVES OR WHERE THEY HAVE 2711 01:57:04,567 --> 01:57:08,171 LIVED, SAY DURING PREGNANCY OR 2712 01:57:08,171 --> 01:57:10,273 WHERE THEY WORK OR WHETHER THEY 2713 01:57:10,273 --> 01:57:11,741 HAVE WORKED, KNOWING SOMETHING 2714 01:57:11,741 --> 01:57:14,210 ABOUT THE GIS COORDINATES CAN 2715 01:57:14,210 --> 01:57:15,645 HELP US TO UNDERSTAND WHAT ARE 2716 01:57:15,645 --> 01:57:18,981 THEIR LEVELS OF XING POE SURE TO 2717 01:57:18,981 --> 01:57:22,752 DIFFERENT ENVIRONMENTAL 2718 01:57:22,752 --> 01:57:24,887 TOXICANTS. FOR EXAMPLE, AIR 2719 01:57:24,887 --> 01:57:25,888 POLLUTIONF YOU LIVE NEXT TO THE 2720 01:57:25,888 --> 01:57:28,257 A MAJOR FREEWAY, THE 2721 01:57:28,257 --> 01:57:29,258 ENVIRONMENTAL HEALTH SCIENCES 2722 01:57:29,258 --> 01:57:30,893 COMMUNITY HAS DEVELOPED ROBUST 2723 01:57:30,893 --> 01:57:33,196 TOOLS TO HELP US CORRELATE THE 2724 01:57:33,196 --> 01:57:39,168 ENVIRONMENTAL EXPOSURES FROM 2725 01:57:39,168 --> 01:57:41,370 PM2.5, THE PARTICULATE MATTER TO 2726 01:57:41,370 --> 01:57:42,772 INDIVIDUALS. THE FIRST PHASE IS 2727 01:57:42,772 --> 01:57:47,043 GO BACK, AS THEY ARE DOING. 2728 01:57:47,043 --> 01:57:48,744 INTEGRATE THE GIS COORDINATES 2729 01:57:48,744 --> 01:57:50,246 INTO DATA SETS FOR ALL THE 2730 01:57:50,246 --> 01:57:51,247 INDIVIDUALS THAT ARE PART OF THE 2731 01:57:51,247 --> 01:57:53,716 ALL OF US PROGRAM. THE SECOND 2732 01:57:53,716 --> 01:57:56,319 PHASE, AND THIS IS WHERE I THINK 2733 01:57:56,319 --> 01:57:59,388 NIBIB CAN HEM US, DEVELOP THOSE 2734 01:57:59,388 --> 01:58:03,626 TOOLS. THE BIOINFORMATICS AND 2735 01:58:03,626 --> 01:58:06,129 COMPETITIONAL TOOLS TO CORRELATE 2736 01:58:06,129 --> 01:58:08,331 THE GIS LOCATION, WHERE YOU LIVE 2737 01:58:08,331 --> 01:58:11,634 AND WORK, WITH THE EXPOSURE TO 2738 01:58:11,634 --> 01:58:17,740 DIFFERENT TOXICANTS. PHASE 3 IS 2739 01:58:17,740 --> 01:58:20,176 MUCH MORE ELABORATE TO 2740 01:58:20,176 --> 01:58:22,044 INCORPORATE A MORE DETAILED 2741 01:58:22,044 --> 01:58:25,148 ANALYSIS LOOKING AT EPI GENETICS 2742 01:58:25,148 --> 01:58:28,818 AND MORE THOROUGH ANALYSIS OF 2743 01:58:28,818 --> 01:58:30,119 DIFFERENT CHEMICALS THAT MAY BE 2744 01:58:30,119 --> 01:58:31,687 PRESENT. I DON'T HAVE TIME TO GO 2745 01:58:31,687 --> 01:58:33,489 THROUGH THE DETAILS. THAT IS 2746 01:58:33,489 --> 01:58:36,759 WHAT WE ARE DOING IS ADVANCING 2747 01:58:36,759 --> 01:58:38,728 PHASE 3 TRIAL USING A SMALL 2748 01:58:38,728 --> 01:58:43,065 COHORT OF THE ALL OF US TO STUDY 2749 01:58:43,065 --> 01:58:49,438 TYPE 2 DIABETES. IN THE INTEREST 2750 01:58:49,438 --> 01:58:51,641 OF TIME LET'S GO TO THE NEXT 2751 01:58:51,641 --> 01:58:56,379 SLIDE. AS AN EXAMPLE IF YOU HAVE 2752 01:58:56,379 --> 01:58:58,581 GEOSPATIAL DATA YOU CAN CROSS 2753 01:58:58,581 --> 01:59:00,349 CONFERENCE THE AIR QUALITY 2754 01:59:00,349 --> 01:59:02,785 MODELS. YOU CAN FOR EXAMPLE GET 2755 01:59:02,785 --> 01:59:05,755 AN ESTIMATE WHAT PEOPLE WERE 2756 01:59:05,755 --> 01:59:09,825 BREATHING AS CONSEQUENCE OF THE 2757 01:59:09,825 --> 01:59:11,494 CANADIAN WILDFIRES THIS LAST 2758 01:59:11,494 --> 01:59:13,095 JULY. WE HAVE DAILY CLIMATE 2759 01:59:13,095 --> 01:59:18,301 DATA. WE HAVE THE CDC SOCIAL 2760 01:59:18,301 --> 01:59:21,437 VULNERABILITY INDEX. SO IF YOU 2761 01:59:21,437 --> 01:59:22,972 LIVE WHERE SOMEONE WORKS IT 2762 01:59:22,972 --> 01:59:26,242 GIVES YOU BETTER SENSE OF WHAT 2763 01:59:26,242 --> 01:59:28,611 TYPES OF EXPOSURE THEY HAVE BEEN 2764 01:59:28,611 --> 01:59:29,612 EXPERIENCING. ULTIMATELY WE 2765 01:59:29,612 --> 01:59:31,814 WOULD LIKE TO GO BEYOND USING 2766 01:59:31,814 --> 01:59:34,450 GIS DATA BUT LOCATING MORE 2767 01:59:34,450 --> 01:59:36,752 DETAIL AT SOME OF THE PARAMETERS 2768 01:59:36,752 --> 01:59:42,892 AND CORRELATING THAT WITH FULL 2769 01:59:42,892 --> 01:59:45,561 SACRUMS TO DO THE COMPLICATED 2770 01:59:45,561 --> 01:59:47,129 EXPERIMENTS. LET'S GO TO THE 2771 01:59:47,129 --> 01:59:49,732 NEXT SLIDE. SO I'M GOING TO JUST 2772 01:59:49,732 --> 01:59:52,835 ANOTHER AREA OF FOCUS IS, YOU 2773 01:59:52,835 --> 01:59:54,070 KNOW, THE TRADITIONALLY WE HAVE 2774 01:59:54,070 --> 01:59:56,706 DONE A LOT OF WORK IN 2775 01:59:56,706 --> 01:59:59,875 TOXICOLOGY. TRADITIONALLY YOU 2776 01:59:59,875 --> 02:00:06,382 TAKE SOME RATS OR GIVEN IM BRED 2777 02:00:06,382 --> 02:00:08,918 STRAIN OR BACKGROUND. DOSE THESE 2778 02:00:08,918 --> 02:00:11,320 MICE AT -- WITH DIFFERENT 2779 02:00:11,320 --> 02:00:12,455 CHEMICALS AT DIFFERENT DOSES AND 2780 02:00:12,455 --> 02:00:15,925 COUNT LUMPS AND BUMPS, CANCER 2781 02:00:15,925 --> 02:00:18,861 AND LOOK AT DEATHS OVER A PERIOD 2782 02:00:18,861 --> 02:00:21,430 OF TIME. THAT GAVE YOU SOME 2783 02:00:21,430 --> 02:00:22,999 ESTIMATE WHETHER SOMETHING IS 2784 02:00:22,999 --> 02:00:25,735 POTENTIALLY CANCER PROMOTING OR 2785 02:00:25,735 --> 02:00:29,705 CANCER CAUSING OR WHETHER CAUSES 2786 02:00:29,705 --> 02:00:31,240 NEUROLOGICAL DISEASE. SO WHAT WE 2787 02:00:31,240 --> 02:00:32,975 HAVE COME TO RECOGNIZE IS WE 2788 02:00:32,975 --> 02:00:34,677 TRULY WANT TO UNDERSTAND THE 2789 02:00:34,677 --> 02:00:36,178 IMPACT OF THE ENVIRONMENT, WE 2790 02:00:36,178 --> 02:00:38,381 HAVE TO GET BEYOND JUST THESE 2791 02:00:38,381 --> 02:00:42,485 EXPOSURE ASSESSMENTS. SO THERE 2792 02:00:42,485 --> 02:00:45,021 SAKE FOCUS IN GETTING AT THE 2793 02:00:45,021 --> 02:00:47,423 MOLECULAR MECHANISMS, DRUGS AND 2794 02:00:47,423 --> 02:00:51,360 ENVIRONMENTAL TOXICANTS AFFECT 2795 02:00:51,360 --> 02:00:54,096 BIOLOGY BY INTERFERING WITH THE 2796 02:00:54,096 --> 02:00:59,869 NORMAL PATTERNS OF GENE 2797 02:00:59,869 --> 02:01:01,671 EXPRESSION. WHAT ARE THOSE 2798 02:01:01,671 --> 02:01:04,440 IMPACTED BY DIFFERENT CHEMICAL 2799 02:01:04,440 --> 02:01:08,377 EXPOSURES OR BY EXPOSOMIC 2800 02:01:08,377 --> 02:01:10,413 EXPOSURES. SO FOR EXAMPLE HOW IS 2801 02:01:10,413 --> 02:01:15,451 THE EPIGENOME CHANGED AS 2802 02:01:15,451 --> 02:01:17,186 CONSEQUENCE OF EXPOSURE. SO THIS 2803 02:01:17,186 --> 02:01:21,390 IS A BIG FOCUS OF OUR SECOND 2804 02:01:21,390 --> 02:01:24,226 DIVISION CALLED DIVISION OF 2805 02:01:24,226 --> 02:01:26,595 TOXICOLOGY SO THAT WORK CLOSELY 2806 02:01:26,595 --> 02:01:30,166 WITH CDC AND FDA AS PART OF THE 2807 02:01:30,166 --> 02:01:32,368 PROGRAM. WE ARE VERY INTERESTED 2808 02:01:32,368 --> 02:01:35,104 IN DEVELOPING LARGE DATA SETS 2809 02:01:35,104 --> 02:01:37,139 USING AI AND ML. IT WAS A TREAT 2810 02:01:37,139 --> 02:01:39,608 TO HEAR A LITTLE ABOUT THE 2811 02:01:39,608 --> 02:01:44,180 INTEREST IN AI AND NML. SO DO IT 2812 02:01:44,180 --> 02:01:45,715 EFFECTIVELY YOU HAVE O ARE HAVE 2813 02:01:45,715 --> 02:01:48,150 GOOD DATA SETS THAT. IS WHY WE 2814 02:01:48,150 --> 02:01:50,052 ARE FOCUSSING. ALSO, PROBABLY 2815 02:01:50,052 --> 02:01:52,455 MOST IMPORTANTLY, IS WE ARE 2816 02:01:52,455 --> 02:01:53,789 INTERESTED IN DEVELOPING THE 2817 02:01:53,789 --> 02:01:56,892 MICRO PHYSIOLOGICAL 3D SYSTEMS 2818 02:01:56,892 --> 02:01:59,261 DERIVED FROM IPSCs AND 2819 02:01:59,261 --> 02:02:03,399 DEVELOPMENT OF THE NABS OR NEW 2820 02:02:03,399 --> 02:02:05,701 APPROACH METHODOLOGIES. AGAIN, I 2821 02:02:05,701 --> 02:02:07,136 DON'T HAVE TIME. I'M KIND OF 2822 02:02:07,136 --> 02:02:08,637 RUNNING OUT OF TIME ALREADY. I 2823 02:02:08,637 --> 02:02:10,206 WANT TO CALL YOUR ATTENTION. 2824 02:02:10,206 --> 02:02:11,874 BRUCE IS PROBABLY TALKED TO YOU 2825 02:02:11,874 --> 02:02:15,745 ABOUT THIS ALREADY. IT IS A NEW 2826 02:02:15,745 --> 02:02:24,387 EMERGING CONCEPT CALLED -- 2827 02:02:24,387 --> 02:02:30,092 COMPLIMENTARY RI 2828 02:02:30,092 --> 02:02:36,499 EXPERIMENTATION. THIS IS ABOUT 2829 02:02:36,499 --> 02:02:37,433 DEVELOPING, 2830 02:02:37,433 --> 02:02:38,701 DEVELOPING, STANDARDIZING 2831 02:02:38,701 --> 02:02:39,735 METHODOLOGIES THAT CAN CHANGE 2832 02:02:39,735 --> 02:02:42,071 THE WAY WE DO BASIC AND CLINICAL 2833 02:02:42,071 --> 02:02:43,606 SCIENCE. IT IS ABOUT DEVELOPING 2834 02:02:43,606 --> 02:02:46,275 THESE NEW TOOLS SO YOU CAN TEST 2835 02:02:46,275 --> 02:02:49,745 YOUR DRUGS OR TEST DIFFERENT 2836 02:02:49,745 --> 02:02:51,614 CHEMICAL AGENTS. TO GET BETTER 2837 02:02:51,614 --> 02:02:54,583 SENSE OF WHAT SPECIFIC 2838 02:02:54,583 --> 02:03:01,490 BIOLOGICAL PROCESSES ARE YOU PER 2839 02:03:01,490 --> 02:03:05,161 TUSH G /* /* -- PERTURBING. WE 2840 02:03:05,161 --> 02:03:08,264 ARE NOT GOING TO SAY H IS GOING 2841 02:03:08,264 --> 02:03:15,404 TOAL LI TO ELIMINATE THE NEED O 2842 02:03:15,404 --> 02:03:17,907 MODELS BUT COMPLEMENT IT. AS 2843 02:03:17,907 --> 02:03:20,309 BRUCE INDICATED, THE FORMER 2844 02:03:20,309 --> 02:03:21,811 DIRECTOR OF JACKSON LABORATORY, 2845 02:03:21,811 --> 02:03:24,580 I CAN SAY THERE IS STILL A ROLE 2846 02:03:24,580 --> 02:03:26,348 FOR MICE IN BIOMEDICAL SCIENCE. 2847 02:03:26,348 --> 02:03:28,984 THIS IS A WAY TO COMPLEMENT AND 2848 02:03:28,984 --> 02:03:32,188 BRING SAY DIVERSE SET OF HUMAN 2849 02:03:32,188 --> 02:03:33,856 GENOMES IN FORM OF POPULATIONS 2850 02:03:33,856 --> 02:03:37,893 OF IPSLs TO BEAR ON BETTER 2851 02:03:37,893 --> 02:03:38,527 UNDERSTANDING INDIVIDUAL 2852 02:03:38,527 --> 02:03:42,364 VARIATION AS RELATES TO, YOU 2853 02:03:42,364 --> 02:03:46,168 KNOW -- AS RELATES TO 2854 02:03:46,168 --> 02:03:49,905 TOXILOGICAL OUTCOMES. LET ME -- 2855 02:03:49,905 --> 02:03:54,477 ACTUALLY IN INTEREST OF TIME SO 2856 02:03:54,477 --> 02:03:56,612 CAN WE GO TO END TO LOOK AT WAYS 2857 02:03:56,612 --> 02:03:58,147 WE ARE COLLABORATING ALREADY? 2858 02:03:58,147 --> 02:04:00,115 I'M GOING TO SKIP OVER A FEW. 2859 02:04:00,115 --> 02:04:02,718 THERE ARE CURRENT COLLABORATIONS 2860 02:04:02,718 --> 02:04:04,186 BETWEEN NIEHS AND NIBIB. I DON'T 2861 02:04:04,186 --> 02:04:06,856 HAVE TIME TO GO THROUGH ALL OF 2862 02:04:06,856 --> 02:04:10,993 THEM. SO BRUCE THANK YOU FOR 2863 02:04:10,993 --> 02:04:13,729 YOUR WILLINGNESS TO WORK WITH 2864 02:04:13,729 --> 02:04:16,499 US. THERE IS THIS MACHINE 2865 02:04:16,499 --> 02:04:18,601 ENABLED TRACKING FOR 2866 02:04:18,601 --> 02:04:21,070 CROSS-SPECIES EXTRAPOLATION. I 2867 02:04:21,070 --> 02:04:22,972 DON'T KNOW ALL THE DETAILS BUT 2868 02:04:22,972 --> 02:04:27,443 OUR DBM -- HEAD OF OUR 2869 02:04:27,443 --> 02:04:29,879 VETERINARY SERVICES HERE IN OUR 2870 02:04:29,879 --> 02:04:32,815 -- VETERINARY RESEARCH PROGRAMS, 2871 02:04:32,815 --> 02:04:34,884 ANDRE COBBLE, EXCITED WORKING 2872 02:04:34,884 --> 02:04:37,286 WITH YOU. DEVELOPING NATIVE NEW 2873 02:04:37,286 --> 02:04:38,988 TOOLS FOR HOW DO WE WORK AT 2874 02:04:38,988 --> 02:04:41,190 THIS, HOW DO WE LOOK AT MICE AND 2875 02:04:41,190 --> 02:04:45,361 LOOK AT BEHAVIORS ASSOCIATED 2876 02:04:45,361 --> 02:04:47,329 CHANGES ASSOCIATED WITH 2877 02:04:47,329 --> 02:04:48,797 ENVIRONMENTAL EXPOSURE. NEXT 2878 02:04:48,797 --> 02:04:51,033 SLIDE. YOU PROBABLY ARE ALREADY 2879 02:04:51,033 --> 02:04:52,801 AWARE OF THIS BUT NIBIB HAS BEEN 2880 02:04:52,801 --> 02:04:54,770 WORKING WITH US AND OTHER 2881 02:04:54,770 --> 02:04:57,172 INSTITUTES AND CENTERS AROUND 2882 02:04:57,172 --> 02:04:59,508 DEVELOPING TISSUE CHAPS. SO 2883 02:04:59,508 --> 02:05:00,676 THERE IS A LOT OF FUTURE AND 2884 02:05:00,676 --> 02:05:02,611 DEVELOPING THESE TYPES OF 2885 02:05:02,611 --> 02:05:04,680 TISSUES SO WE CAN BETTER 2886 02:05:04,680 --> 02:05:06,949 UNDERSTAND ENVIRONMENTAL 2887 02:05:06,949 --> 02:05:16,025 EXPOSURES ONNED HOW THE PATH-- 2888 02:05:16,025 --> 02:05:19,261 HOW THEY ARE DISRUPTED. MY 2889 02:05:19,261 --> 02:05:23,732 CHALLENGE AS GENETICS AND GENOME 2890 02:05:23,732 --> 02:05:26,068 MAKES PERSON WE HAVE PHENOMENAL 2891 02:05:26,068 --> 02:05:27,703 CAPABILITIES. WHO WOULD ARE 2892 02:05:27,703 --> 02:05:31,140 THOUGHT IN 80s WE WOULD SEQUENCE 2893 02:05:31,140 --> 02:05:35,077 THE ENTIRE GENOME LESS THAN A 2894 02:05:35,077 --> 02:05:43,352 THOUSAND, CAPTURE 2895 02:05:43,352 --> 02:05:45,588 METHYLATIOTION, PROTENOMICS. WE 2896 02:05:45,588 --> 02:05:47,256 NEED TO BRING INTEREST TO BEAR 2897 02:05:47,256 --> 02:05:52,428 ON TAPES TYPES OF CAPABILITIES 2898 02:05:52,428 --> 02:05:53,562 AND THE ENVIRONMENT. THAT IS WHY 2899 02:05:53,562 --> 02:05:55,998 WE NEED YOUR HELP. JUST GOING 2900 02:05:55,998 --> 02:05:58,467 THROUGH HERE, AS BRUCE INDICATED 2901 02:05:58,467 --> 02:06:00,769 I THINK WE ARE DESPERATELY IN 2902 02:06:00,769 --> 02:06:04,206 NEED OF INNOVATIVE THINKING ON 2903 02:06:04,206 --> 02:06:10,679 WHOLE AREA OF EXPOSUM AND 2904 02:06:10,679 --> 02:06:11,647 PRECISION ENVIRONMENTAL HEALTH, 2905 02:06:11,647 --> 02:06:13,916 BRING THE DATA SETS TO BETTER 2906 02:06:13,916 --> 02:06:16,151 UNDERSTAND HOW COMPLEX GENETIC 2907 02:06:16,151 --> 02:06:20,255 TRAITS WORK TOGETHER WITH 2908 02:06:20,255 --> 02:06:24,026 COMPLEXEN BY GENETIC TRAITS TO 2909 02:06:24,026 --> 02:06:26,095 ULTIMATELY TRIGGER DISEASE 2910 02:06:26,095 --> 02:06:28,230 PHENOTYPES. SO MAY BE DIFFERENT 2911 02:06:28,230 --> 02:06:29,765 NEUROLOGICAL DISORDERS THAT ARE 2912 02:06:29,765 --> 02:06:35,270 SAY THE GENETICS ORREN GENETICS 2913 02:06:35,270 --> 02:06:36,472 PRIMES THE INDIVIDUAL TO DEVELOP 2914 02:06:36,472 --> 02:06:38,941 THE DISEASE BUT EXPOSURE TO THAT 2915 02:06:38,941 --> 02:06:41,343 PESTICIDE THAT MAY TRIGGER THE 2916 02:06:41,343 --> 02:06:43,779 PHENOTYPE. IN THIS WHOLE AREA OF 2917 02:06:43,779 --> 02:06:45,481 PREDICTIVE TOXICOLOGY, NEW 2918 02:06:45,481 --> 02:06:46,949 APPROACH METHODOLOGIES ARE 2919 02:06:46,949 --> 02:06:48,584 CRITICALLY IMPORTANT. I THINK 2920 02:06:48,584 --> 02:06:51,620 THAT IS AN AREA RIPE FOR 2921 02:06:51,620 --> 02:06:52,521 OPPORTUNITIES COLLABORATION 2922 02:06:52,521 --> 02:06:54,490 BETWEEN NIBIB AND NIEHS. WE ARE 2923 02:06:54,490 --> 02:06:57,893 THE BIOLOGISTS SO WE NEED TO GET 2924 02:06:57,893 --> 02:07:01,296 WORKING TOGETHER WITH ALL OF YOU 2925 02:07:01,296 --> 02:07:04,466 AT NIBIB. LET'S GO TO THE NEXT 2926 02:07:04,466 --> 02:07:06,201 SLIDE. I THINK THAT IS IT. THANK 2927 02:07:06,201 --> 02:07:08,070 YOU ALL FOR THIS OPPORTUNITY. 2928 02:07:08,070 --> 02:07:09,371 HOPEFULLY THIS GIVES YOU A 2929 02:07:09,371 --> 02:07:10,973 LITTLE SENSE OF SOME OF THE 2930 02:07:10,973 --> 02:07:12,741 THINGS WE ARE DOING. MOST 2931 02:07:12,741 --> 02:07:15,778 IMPORTANTLY SOME OF THE HUGE 2932 02:07:15,778 --> 02:07:18,080 AREAS OF CHALLENGE. WE ARE THE 2933 02:07:18,080 --> 02:07:20,549 BIOLOGISTS. WE HAVE TO BE 2934 02:07:20,549 --> 02:07:21,884 WORKING WITH THE TECHNOLOGISTS 2935 02:07:21,884 --> 02:07:27,723 TO COME UP WITH INNOVATIVE NEW 2936 02:07:27,723 --> 02:07:30,426 STRATEGIES LIKE WE DID AT THE 2937 02:07:30,426 --> 02:07:33,529 OAK LABORATORY, RIGHT BRUCE? I 2938 02:07:33,529 --> 02:07:36,265 HAD MANY OPPORTUNITIES INTERFACE 2939 02:07:36,265 --> 02:07:39,802 WITH KWAN AND OTHERS. WHEN YOU 2940 02:07:39,802 --> 02:07:41,503 BRING PEOPLE WITH DIFFERENT 2941 02:07:41,503 --> 02:07:42,604 CAPABILITIES AND EXPERTISE 2942 02:07:42,604 --> 02:07:44,673 TOGETHER, MAGIC CAN HAPPEN. LET 2943 02:07:44,673 --> 02:07:46,842 ME STOP AT THIS POINT. HAPPY TO 2944 02:07:46,842 --> 02:07:48,944 ADDRESS COMMENTS OR QUESTIONS. 2945 02:07:48,944 --> 02:07:49,111 2946 02:07:49,111 --> 02:07:51,680 2947 02:07:51,680 --> 02:07:53,282 >> THANK YOU, RICK. 2948 02:07:53,282 --> 02:07:53,382 2949 02:07:56,685 --> 02:08:00,355 AGAIN THANKS FOR THE INVITE. 2950 02:08:00,355 --> 02:08:04,359 GREAT TO BE HERE. I SEE DAN'S 2951 02:08:04,359 --> 02:08:07,429 HAND IS UP. DAN, WHY DON'T YOU 2952 02:08:07,429 --> 02:08:08,964 LEAD US OFF. 2953 02:08:08,964 --> 02:08:11,166 >> ABSOLUTELY. SO THANK YOU, 2954 02:08:11,166 --> 02:08:13,402 DR. WOYCHIK FOR COMING AND TAKE 2955 02:08:13,402 --> 02:08:15,637 TIMING TO INTRODUCE US TO YOUR 2956 02:08:15,637 --> 02:08:16,672 INSTITUTE'S PRIORITIES. I 2957 02:08:16,672 --> 02:08:18,173 ACTUALLY WANTED TO FOLLOW UP ON 2958 02:08:18,173 --> 02:08:20,008 THE LAST FEW SLIDES THAT YOU 2959 02:08:20,008 --> 02:08:22,811 SHOWED, WHICH ARE SORT OF THE 2960 02:08:22,811 --> 02:08:24,179 PROVOCATIVE SLIDES FOR US TOOL 2961 02:08:24,179 --> 02:08:24,546 DEVELOPERS. 2962 02:08:24,546 --> 02:08:25,147 >> YEP. 2963 02:08:25,147 --> 02:08:28,450 >> I WANTED TO ASK MAYBE -- 2964 02:08:28,450 --> 02:08:30,753 TO DIG IN A LITTLE MORE ABOUT 2965 02:08:30,753 --> 02:08:32,955 WHAT TYPES OF TECHNOLOGIES THAT 2966 02:08:32,955 --> 02:08:35,624 MIGHT FALL IN AN IB WHEEL HOUSE, 2967 02:08:35,624 --> 02:08:38,927 MOST NEEDED, IN YOUR VIEW NOW, 2968 02:08:38,927 --> 02:08:41,230 TO ASSESS ENVIRONMENTAL HEALTH. 2969 02:08:41,230 --> 02:08:43,632 WHICH NEED TO BE CONTINUOUS AS 2970 02:08:43,632 --> 02:08:47,469 OPPOSED TO SPORADIC. YOU SHOWED 2971 02:08:47,469 --> 02:08:53,942 GEE YOU KNOW -- GEOSPATIAL. IS 2972 02:08:53,942 --> 02:08:55,677 IT A CHIP OR IMAGING HAVE A ROLE 2973 02:08:55,677 --> 02:08:57,780 TO PLAY? OTHER TYPES OF SENSORS 2974 02:08:57,780 --> 02:09:00,415 YOU SEE AS PARTICULARLY KEY? 2975 02:09:00,415 --> 02:09:04,920 >> WELL, IT IS -- THERE ARE 2976 02:09:04,920 --> 02:09:06,021 MANY DIFFERENT OPPORTUNITIES 2977 02:09:06,021 --> 02:09:09,992 HERE. SO LONGITUDINAL -- THE 2978 02:09:09,992 --> 02:09:12,060 ABILITY TO DO LONGITUDINAL 2979 02:09:12,060 --> 02:09:14,062 TESTING IS IMPORTANT. ONE OF THE 2980 02:09:14,062 --> 02:09:17,833 OTHER THINGS PARENTS ARE EXPOSED 2981 02:09:17,833 --> 02:09:20,435 TO PRIOR TO CONCEIVING CHILD ONE 2982 02:09:20,435 --> 02:09:22,070 OF THE THINGS MOTHERS ARE 2983 02:09:22,070 --> 02:09:23,739 EXPOSED TO, THESE ARE CRITICALLY 2984 02:09:23,739 --> 02:09:27,109 IMPORTANT TIME FRAMES. WE CAN'T 2985 02:09:27,109 --> 02:09:29,478 JUST TAKE A SNAPSHOT AT SOMEONE 2986 02:09:29,478 --> 02:09:31,446 IN ADULTS AND PREDICT WHAT IS 2987 02:09:31,446 --> 02:09:33,215 LIKELY TO BE HAPPENING. WHAT ARE 2988 02:09:33,215 --> 02:09:35,551 THE HEALTH EFFECTS ASSOCIATED 2989 02:09:35,551 --> 02:09:37,553 WITH THAT EXPOSURE. BUT THERE 2990 02:09:37,553 --> 02:09:40,923 HAS TO BE A LONGITUDINAL 2991 02:09:40,923 --> 02:09:42,624 ELEMENT. SO I KNOW THERE IS A 2992 02:09:42,624 --> 02:09:47,963 GREAT DEAL OF INTEREST IN HIGH 2993 02:09:47,963 --> 02:09:50,132 RESOLUTION MASS SPECTROMETRY. 2994 02:09:50,132 --> 02:09:52,301 TAKE A MILLILITER OF BLOOD, BACK 2995 02:09:52,301 --> 02:09:54,570 TO THIS EXPOSUM, A LOT OF WORK 2996 02:09:54,570 --> 02:09:56,238 GOING ON IN DIFFERENT 2997 02:09:56,238 --> 02:09:57,573 LABORATORIES. TAKE LESS THAN A 2998 02:09:57,573 --> 02:10:00,776 ML OF BLOOD AND DO A THOROUGH 2999 02:10:00,776 --> 02:10:02,377 ANALYSIS. SO SOME OF THE 3000 02:10:02,377 --> 02:10:04,880 GRANTEES HAVE DONE THIS. WE KNOW 3001 02:10:04,880 --> 02:10:07,950 THERE ARE 600 CHEMICAL SPE SIS 3002 02:10:07,950 --> 02:10:10,185 THAT CAN BE IDENTIFIED IN A ML 3003 02:10:10,185 --> 02:10:11,887 THAT CAN HELP US BETTER 3004 02:10:11,887 --> 02:10:13,622 UNDERSTAND WHAT IS YOUR CURRENT 3005 02:10:13,622 --> 02:10:17,025 STATUS, WHAT IS YOUR LEVEL OF 3006 02:10:17,025 --> 02:10:19,862 LED, WHAT ABOUT CHLORINATED 3007 02:10:19,862 --> 02:10:20,963 SUBSTANCES OR TEFLON BUT OVER 3008 02:10:20,963 --> 02:10:25,534 THE COURSE OF TIME. SOME WILL 3009 02:10:25,534 --> 02:10:28,637 CLAIRE, SOME ARE NOT. I THINK 3010 02:10:28,637 --> 02:10:31,173 THINGS LIKE HI RESOLUTION MASS 3011 02:10:31,173 --> 02:10:32,841 SPEC. I WANT TO PUT IN A PLUG 3012 02:10:32,841 --> 02:10:37,679 FOR WE HAVE TO FIGURE OUT THE 3013 02:10:37,679 --> 02:10:42,551 EPIGENETIC CONSEQUENCES. 3014 02:10:42,551 --> 02:10:43,619 UNFORTUNATELY BRUCE I DIDN'T 3015 02:10:43,619 --> 02:10:45,454 HAVE TIME TO TALK ABOUT THIS IN 3016 02:10:45,454 --> 02:10:48,090 MY OWN LAB BUT WE DID AN 3017 02:10:48,090 --> 02:10:51,994 EXPERIMENT WHERE WE TREATED 3018 02:10:51,994 --> 02:10:54,162 PREGNANT FEMALE -- OF COURSE 3019 02:10:54,162 --> 02:10:56,632 FEMALE. MOTHERS WITH A SPECIFIC 3020 02:10:56,632 --> 02:10:58,667 PESTICIDE DURING PREGNANCY. WE 3021 02:10:58,667 --> 02:11:04,206 CAN GO IN AND SHOW EPIGENETIC 3022 02:11:04,206 --> 02:11:06,041 CHANGES THAT PERSIST. OO ANOTHER 3023 02:11:06,041 --> 02:11:07,743 AREA OF TECHNOLOGY DEVELOPMENT 3024 02:11:07,743 --> 02:11:13,782 IS TO BE ABLE TO DO A THOROUGH 3025 02:11:13,782 --> 02:11:18,086 INEXPENSIVE EN PIGENETIC 3026 02:11:18,086 --> 02:11:27,129 ACCESSMENT. DOING THESE WE CAN 3027 02:11:27,129 --> 02:11:29,064 CORRELATE THE EPIGENETIC CHANGES 3028 02:11:29,064 --> 02:11:33,302 DURING THE EXPOSUM. WE KNOW SOME 3029 02:11:33,302 --> 02:11:38,874 HAPPEN DURING SIGH SI 3030 02:11:38,874 --> 02:11:41,410 PSYCHOSOMATIC STRESS AND SOME 3031 02:11:41,410 --> 02:11:45,047 DURING SMOKING. IN FACT, IN MANY 3032 02:11:45,047 --> 02:11:48,116 WAYS EXPOSUM MAY BE THE 3033 02:11:48,116 --> 02:11:50,118 EPIGENOME SO MAY BE THINGS IN 3034 02:11:50,118 --> 02:11:53,488 EXPOSUM THAT WE DON'T KNOW WERE 3035 02:11:53,488 --> 02:11:56,024 THERE BUT WE ARE PAYING 3036 02:11:56,024 --> 02:11:58,560 ATTENTION TO CHANGES IN EXPOSUM 3037 02:11:58,560 --> 02:12:00,028 THAT CHANGE WAY GENES ARE 3038 02:12:00,028 --> 02:12:01,897 WORKING. DAN, I COULD GO ON. 3039 02:12:01,897 --> 02:12:03,498 DOES THAT GIVE YOU SENSE OF SOME 3040 02:12:03,498 --> 02:12:05,667 OF THE THINGS THAT WE COULD BE 3041 02:12:05,667 --> 02:12:06,234 DOING TOGETHER? 3042 02:12:06,234 --> 02:12:08,537 >> NO, THAT IS GREAT. 3043 02:12:08,537 --> 02:12:10,639 CERTAINLY THE EMPHASIS ON 3044 02:12:10,639 --> 02:12:12,774 LONGITUDINAL TESTING, THAT IS 3045 02:12:12,774 --> 02:12:16,211 SOMETHING I THINK IS AN ON GOING 3046 02:12:16,211 --> 02:12:21,116 THEME IN A LOT OF BIOMEDICAL 3047 02:12:21,116 --> 02:12:22,351 TECHNOLOGY DEVELOPMENT. I'M 3048 02:12:22,351 --> 02:12:23,919 GOING TO GO THINK ON IT MORE, 3049 02:12:23,919 --> 02:12:24,252 THANK YOU. 3050 02:12:24,252 --> 02:12:26,288 >> I HOPE ALL OF YOU , IN 3051 02:12:26,288 --> 02:12:27,456 FACT, I THINK BRUCE IS DOING A 3052 02:12:27,456 --> 02:12:29,925 LOT OF THINKING. THANKS FOR THIS 3053 02:12:29,925 --> 02:12:31,593 OPPORTUNITY. I HOPE COLLECTIVELY 3054 02:12:31,593 --> 02:12:35,163 WE CAN ALL BE THINKING ABOUT 3055 02:12:35,163 --> 02:12:38,433 TRANSFORM TIF TECHNOLOGIES WE 3056 02:12:38,433 --> 02:12:43,105 CAN BRING TO BEAR ON 3057 02:12:43,105 --> 02:12:44,373 EXPOSUMOMICS. SIMON? 3058 02:12:44,373 --> 02:12:46,908 >> THAT WAS A 3059 02:12:46,908 --> 02:12:48,243 THOUGHT-PROVOKING AND WONDERFUL 3060 02:12:48,243 --> 02:12:49,845 PRESENTATION. YOU MADE THE POINT 3061 02:12:49,845 --> 02:12:51,346 WE NEED TO GET BEYOND JUST 3062 02:12:51,346 --> 02:12:55,250 MEASURING ONE THING AT A TIME. 3063 02:12:55,250 --> 02:12:57,219 OBVIOUSLY THAT MAKES SENSE. AS I 3064 02:12:57,219 --> 02:12:59,154 THINK ABOUT THE EXPOSUM IT IS 3065 02:12:59,154 --> 02:13:00,389 INFINITE. SO MANY THINGS WE HAVE 3066 02:13:00,389 --> 02:13:02,891 TO FACTOR IN. YOU ALREADY MADE 3067 02:13:02,891 --> 02:13:05,894 THE POINT IN THE GENOMICS SPACE, 3068 02:13:05,894 --> 02:13:06,962 TRYING TO GET TO ANSWERS WHERE 3069 02:13:06,962 --> 02:13:08,730 WE HAVE HUNDREDS OF GENES OF 3070 02:13:08,730 --> 02:13:11,333 INTEREST REQUIRES COHORTS IN 3071 02:13:11,333 --> 02:13:13,235 TENS OF MILLION, HERE SEEMS WE 3072 02:13:13,235 --> 02:13:16,304 WILL BE AT HIGHER ORDER FOR 3073 02:13:16,304 --> 02:13:17,939 COHORTS. SO STRIKES ME WE WILL 3074 02:13:17,939 --> 02:13:20,609 HAVE TO FOCUS DOWN SOMEWHAT AND 3075 02:13:20,609 --> 02:13:22,644 BE IN BETWEEN MEASURING ONE 3076 02:13:22,644 --> 02:13:24,012 THING AND EVERYTHING. SO WHAT 3077 02:13:24,012 --> 02:13:26,481 ARE THE PRIORS? WHERE DO WE 3078 02:13:26,481 --> 02:13:31,253 FOCUS IN THE SHORTER TERM OUR 3079 02:13:31,253 --> 02:13:31,520 EFFORTS? 3080 02:13:31,520 --> 02:13:33,455 >> I THINK FOCUSSING ON THE 3081 02:13:33,455 --> 02:13:34,990 SHORTER TERM AND SOME OF THINGS 3082 02:13:34,990 --> 02:13:43,365 I JUST MENTIONED, THE EPIGENITIC 3083 02:13:43,365 --> 02:13:45,400 CHANGE, MASS SPEC, AND IT CAN'T 3084 02:13:45,400 --> 02:13:49,504 BE UNLIMITED. THAT IS 3085 02:13:49,504 --> 02:13:50,572 MEANINGLESS. FRANCIS EXPLAINED I 3086 02:13:50,572 --> 02:13:52,874 KNOW HOW TO DO THE EXPERIMENT, 3087 02:13:52,874 --> 02:13:55,377 SEQUENCE THE GENOME, BUT WHAT IS 3088 02:13:55,377 --> 02:13:56,812 IT? THAT IS WHY THERE IS A GREAT 3089 02:13:56,812 --> 02:13:59,347 DEAL OF FOCUS ON OPERATIONIZING 3090 02:13:59,347 --> 02:14:01,316 THE EXPOSUM. WHAT ARE THINGS WE 3091 02:14:01,316 --> 02:14:03,018 SHOULD BE COLLECTING THAT ARE 3092 02:14:03,018 --> 02:14:05,954 GOING TO TRULY BE INFORMATIVE OF 3093 02:14:05,954 --> 02:14:08,423 THE TYPES OF ENVIRONMENTAL 3094 02:14:08,423 --> 02:14:11,059 EXPOSURES LIKELY TO BE CAUSING 3095 02:14:11,059 --> 02:14:15,363 -- WELL, CAUSING DELETERIOUS 3096 02:14:15,363 --> 02:14:17,566 SIDE EFFECTS OR MOW MOATING 3097 02:14:17,566 --> 02:14:20,168 HEALTH? THAT IS THE CENTER I 3098 02:14:20,168 --> 02:14:22,070 DESCRIBE , THE BIG FOCUS. IS 3099 02:14:22,070 --> 02:14:23,705 BRINGING -- NOT JUST 3100 02:14:23,705 --> 02:14:25,907 ENVIRONMENTAL HEALTH SCIENCES 3101 02:14:25,907 --> 02:14:28,043 BUT THE BROADER BIOMEDICAL 3102 02:14:28,043 --> 02:14:29,611 COMMUNITY TOGETHER. WHAT ARE THE 3103 02:14:29,611 --> 02:14:31,780 CRITICAL THINGS WE NEED TO 3104 02:14:31,780 --> 02:14:35,317 MONITOR. WHAT CAN WE DO WITH A 3105 02:14:35,317 --> 02:14:37,452 SENSE OF LONGITUDINAL 3106 02:14:37,452 --> 02:14:39,721 CAPABILITIES THAT WILL TRULY BE 3107 02:14:39,721 --> 02:14:42,023 RELEVANT TO STUDYING THE 3108 02:14:42,023 --> 02:14:43,558 EXPOSUM. THERE IS ALSO THE VERY 3109 02:14:43,558 --> 02:14:45,360 IMPORTANT PART OF THE EXPOSUM IS 3110 02:14:45,360 --> 02:14:47,562 THE DATA MANAGEMENT TOOLS. THAT 3111 02:14:47,562 --> 02:14:51,700 IS SOMETHING I WANT YOU TO ALL 3112 02:14:51,700 --> 02:14:53,768 THINK ABOUT RIGHT NOW. SO 3113 02:14:53,768 --> 02:14:56,071 GETTING BEYOND ONE EXPOSURE AT A 3114 02:14:56,071 --> 02:14:58,740 TIME. FOR EXAMPLE HIGH 3115 02:14:58,740 --> 02:15:01,610 RESOLUTION MASS SPEC SO CAN BE 3116 02:15:01,610 --> 02:15:04,412 LOOKING AT EXPOSURE TO 3117 02:15:04,412 --> 02:15:06,047 POTENTIALLY 600 CHEMICALS. WHAT 3118 02:15:06,047 --> 02:15:09,584 IS DATA MANAGEMENT SYSTEM WE CAN 3119 02:15:09,584 --> 02:15:11,052 IMPLEMENT SO PEOPLE DOING ONE 3120 02:15:11,052 --> 02:15:13,455 EXPOSURE AT A TIME, WHY NOT 3121 02:15:13,455 --> 02:15:15,357 DEVELOP A DATA MANAGEMENT SO 3122 02:15:15,357 --> 02:15:25,667 THEIR SEAM LESSLY 3123 02:15:29,638 --> 02:15:31,139 INTEGRATE. ONE GROUP IS OZONE 3124 02:15:31,139 --> 02:15:32,807 BUT IS THERE A SYSTEM YOU CAN 3125 02:15:32,807 --> 02:15:34,543 INTEGRATE IT TOGETHER SO THE 3126 02:15:34,543 --> 02:15:37,779 EXPOSUM REALLY BECOMES YOUR DATA 3127 02:15:37,779 --> 02:15:41,249 MANAGEMENT. IT IS THE DATA 3128 02:15:41,249 --> 02:15:43,618 MANAGEMENT ARCHIVE IS REALLY THE 3129 02:15:43,618 --> 02:15:45,487 EXPOSUM. SO SIMON, DOES THAT 3130 02:15:45,487 --> 02:15:45,854 HELP? 3131 02:15:45,854 --> 02:15:47,923 >> YAH, I THINK, YOU KNOW, 3132 02:15:47,923 --> 02:15:50,592 THIS FIRST STEP OF DEFINING 3133 02:15:50,592 --> 02:15:52,928 OPERATIONALLY WHAT THE EXPOSUM 3134 02:15:52,928 --> 02:15:56,631 IS IS REALLY IMPORTANT FOR US 3135 02:15:56,631 --> 02:15:57,999 THEN TO SET STAGE FOR WHAT 3136 02:15:57,999 --> 02:16:00,135 TECHNOLOGIES NEED TO BE 3137 02:16:00,135 --> 02:16:01,269 DEVELOPED. SO I WANT TO 3138 02:16:01,269 --> 02:16:03,238 UNDERSTAND THAT. IT WOULD BE 3139 02:16:03,238 --> 02:16:05,507 EASIER TO FOCUS OUR EFFORTS. 3140 02:16:05,507 --> 02:16:07,576 >> I TOTALLY AGREE THAT. IS 3141 02:16:07,576 --> 02:16:08,777 WHY WE ARE FUND ING THIS CENTER 3142 02:16:08,777 --> 02:16:11,580 TO ESSENTIALLY TAKE ON THE 3143 02:16:11,580 --> 02:16:13,248 CHALLENGES OF WHAT IS IT WE ARE 3144 02:16:13,248 --> 02:16:15,617 GOING TO BE MEASURING? WHAT DO 3145 02:16:15,617 --> 02:16:18,653 WE HAVE THE CAPABILITIES OF 3146 02:16:18,653 --> 02:16:19,921 DOING? WHAT IS CRITICALLY 3147 02:16:19,921 --> 02:16:21,923 IMPORTANT? WHAT I BRING TO THE 3148 02:16:21,923 --> 02:16:23,758 WHOLE PICTURE IS RECOGNITION FOR 3149 02:16:23,758 --> 02:16:27,262 MY OWN LAB. IF YOU WANT TO 3150 02:16:27,262 --> 02:16:29,264 UNDERSTAND THE ETIOLOGY, IT HAS 3151 02:16:29,264 --> 02:16:32,000 TO GO BEYOND SEQUENCING GENOMES. 3152 02:16:32,000 --> 02:16:37,038 AS A GENETICIST I CAN SAY THAT 3153 02:16:37,038 --> 02:16:40,375 SO HOW DO WE ADD THE 3154 02:16:40,375 --> 02:16:41,710 ENVIRONMENT? WE HAVE TO 3155 02:16:41,710 --> 02:16:43,478 OPERATIONAL IZE THIS IN A WAY WE 3156 02:16:43,478 --> 02:16:45,280 KNOW WHAT DATA TO COLLECT. HOW 3157 02:16:45,280 --> 02:16:46,948 DO WE INTEGRATE THIS DATA 3158 02:16:46,948 --> 02:16:50,018 TOGETHER IN WAY WE CAN 3159 02:16:50,018 --> 02:16:51,486 ULTIMATELY KIND OF BRING TO BEAR 3160 02:16:51,486 --> 02:16:56,725 THAT VISION THAT I OUTLINED AT 3161 02:16:56,725 --> 02:16:58,627 BEGINNING. IS POSITION IS AT THE 3162 02:16:58,627 --> 02:17:00,262 PATIENT'S BED. YOU HAVE 3163 02:17:00,262 --> 02:17:02,831 KNOWLEDGE OF NOT JUST GENOME BUT 3164 02:17:02,831 --> 02:17:03,832 EXPOSED TO THE ENVIRONMENT. IT 3165 02:17:03,832 --> 02:17:06,635 IS SHOCKING RIGHT NOW. 3166 02:17:06,635 --> 02:17:07,369 PHYSICIANS DON'T ASK PEOPLE 3167 02:17:07,369 --> 02:17:10,272 WHERE DO YOU WORK. IF YOU ARE A 3168 02:17:10,272 --> 02:17:11,873 WELDER, GUESS WHAT? YOU ARE 3169 02:17:11,873 --> 02:17:14,042 EXPOSED TO HEAVY METALS IN A WAY 3170 02:17:14,042 --> 02:17:15,543 SOMEONE WORKING AT A DAYCARE 3171 02:17:15,543 --> 02:17:17,979 CENTER IS NOT. SO WE JUST NEED 3172 02:17:17,979 --> 02:17:22,050 TO BRING THAT RIGOR TO HOW DO WE 3173 02:17:22,050 --> 02:17:24,286 CAPTURE THAT DATA? ARE WE INTE 3174 02:17:24,286 --> 02:17:26,821 GRATED INTO ELECTRONIC HEALTH 3175 02:17:26,821 --> 02:17:29,057 RECORDS. WE NEED YOUR HELP. THE 3176 02:17:29,057 --> 02:17:30,759 THING YOU CAN BRING IS 3177 02:17:30,759 --> 02:17:32,494 REALISTICALLY WHAT CAN WE EXPECT 3178 02:17:32,494 --> 02:17:34,129 TO ACTUALLY DEVELOP TOOLS TO GET 3179 02:17:34,129 --> 02:17:36,598 BEYOND ONE EXPOSURE AT A TIME? 3180 02:17:36,598 --> 02:17:38,566 WHAT IS REALISTIC AND WHAT ARE 3181 02:17:38,566 --> 02:17:41,803 THINGS THAT ARE POTENTIALLY 3182 02:17:41,803 --> 02:17:44,072 SCALEABLE? RNA SEEK IS A GREAT 3183 02:17:44,072 --> 02:17:45,674 EXAMPLE. I WOULD HAVE NEVER 3184 02:17:45,674 --> 02:17:47,309 IMAGINED WE WOULD HAVE THE 3185 02:17:47,309 --> 02:17:49,511 CAPABILITY OF DOING RNA SEEK IN 3186 02:17:49,511 --> 02:17:52,180 EARLY 1980s WHEN WE FIRST 3187 02:17:52,180 --> 02:17:54,015 STARTED GENOME PROJECT. IT WAS 3188 02:17:54,015 --> 02:17:55,850 TRYING TO -- IT WAS REALLY THE 3189 02:17:55,850 --> 02:17:58,053 IDEA WE HAVE TO GET ONE GEEN AT 3190 02:17:58,053 --> 02:18:02,057 A TIME. CAPTURING THE ENTIRE 3191 02:18:02,057 --> 02:18:05,493 TRANSCRIPT. THAT WAS THE DRIVER. 3192 02:18:05,493 --> 02:18:07,228 STARTING WITH THE VISION WE CAN 3193 02:18:07,228 --> 02:18:09,431 DEVELOP TO ENABLE THIS. WE NEED 3194 02:18:09,431 --> 02:18:10,332 YOUR HELP. 3195 02:18:10,332 --> 02:18:10,999 >> THANK YOU. 3196 02:18:10,999 --> 02:18:12,600 >> OKAY. JOYCE, LOOKS LIKE 3197 02:18:12,600 --> 02:18:14,636 YOU WERE NEXT. 3198 02:18:14,636 --> 02:18:16,071 >> YES HI. THANK YOU VERY 3199 02:18:16,071 --> 02:18:17,505 MUCH. I THOUGHT THAT WAS 3200 02:18:17,505 --> 02:18:21,076 EXCITING. TO ME I THINK IT IS A 3201 02:18:21,076 --> 02:18:22,610 GREAT OPPORTUNITY BETWEEN NIEHS. 3202 02:18:22,610 --> 02:18:25,613 AS YOU SAID THERE IS A LOT OF 3203 02:18:25,613 --> 02:18:27,482 ENABLING TECHNOLOGIES. I THOUGHT 3204 02:18:27,482 --> 02:18:29,351 IT WAS EXCITING YOU SHOWING THE 3205 02:18:29,351 --> 02:18:31,653 ORGANS ON A CHIP AND FROM THE 3206 02:18:31,653 --> 02:18:33,688 BIOLOGY SIDE LOOKING AT 3207 02:18:33,688 --> 02:18:39,027 NON-TRADITIONAL MODELS, 3208 02:18:39,027 --> 02:18:41,029 DRASOPHOLI AND AS WELL. LIKE 3209 02:18:41,029 --> 02:18:42,330 WHEN THE DOCTOR ASKS WHERE 3210 02:18:42,330 --> 02:18:44,499 SOMEONE LIVES OR WORKS, THAT ALL 3211 02:18:44,499 --> 02:18:48,269 SPEAKS TO THE MONITORING. FROM A 3212 02:18:48,269 --> 02:18:50,004 DIAGNOSTIC VIEW, AS YOU PROBABLY 3213 02:18:50,004 --> 02:18:55,343 KNOW THAT, IS DIAGNOSTIC WITH 3214 02:18:55,343 --> 02:18:56,811 THERENOSTIC. WITH THERAPEUTIC, I 3215 02:18:56,811 --> 02:18:58,913 HAVEN'T SEEN THAT. I WASN'T ABLE 3216 02:18:58,913 --> 02:19:00,882 TO JOIN UNTIL YOUR TALK. I JUST 3217 02:19:00,882 --> 02:19:04,052 CAME BACK FROM TEACHING. SO I 3218 02:19:04,052 --> 02:19:06,020 I'M JUST CURIOUS WHAT YOUR 3219 02:19:06,020 --> 02:19:07,489 THOUGHTS ARE ON ONCE YOU HAVE 3220 02:19:07,489 --> 02:19:12,460 THAT INFORMATION. I THINK NIBIB 3221 02:19:12,460 --> 02:19:14,496 TYPE WORK CAN HELP FROM THE THER 3222 02:19:14,496 --> 02:19:16,831 PETE IK SIDE. IT IS NOT JUST A 3223 02:19:16,831 --> 02:19:21,302 DIAGNOSIS TO SAY WHAT? IS IT 3224 02:19:21,302 --> 02:19:22,737 BIOREMEDIATION. SO I'M CURES IF 3225 02:19:22,737 --> 02:19:24,139 YOU AND BRUCE HAVE HAD 3226 02:19:24,139 --> 02:19:24,706 DISCUSSIONS ON THAT. 3227 02:19:24,706 --> 02:19:27,008 >> I THINK THAT IS A GREAT 3228 02:19:27,008 --> 02:19:28,343 QUESTION. I GUESS FROM MY POINT 3229 02:19:28,343 --> 02:19:30,545 OF VIEW IS IF YOU WANT TO 3230 02:19:30,545 --> 02:19:33,148 DEVELOP A THERAPEUTIC, YOU HAVE 3231 02:19:33,148 --> 02:19:35,316 TO UNDERSTAND WHAT IS 3232 02:19:35,316 --> 02:19:37,886 MISBEHAVING IN AN INDIVIDUAL, 3233 02:19:37,886 --> 02:19:42,824 OKAY. SO WE ARE GETTING BETTER 3234 02:19:42,824 --> 02:19:45,627 AT UNDERSTANDING HOW GENE 3235 02:19:45,627 --> 02:19:48,196 VARIANTS CAN TRIGGER MISBEHAVIOR 3236 02:19:48,196 --> 02:19:52,867 OF GENES AND BIOLOGICAL 3237 02:19:52,867 --> 02:19:54,869 PATHWAYS. BUT I THINK WE ARE 3238 02:19:54,869 --> 02:19:56,604 REALIZE THERE YOU GO ARE CERTAIN 3239 02:19:56,604 --> 02:19:58,640 ENVIRONMENTAL EXPOSURES THAT CAN 3240 02:19:58,640 --> 02:20:00,608 TRIGGER SAY PARKINSON'S, CAN 3241 02:20:00,608 --> 02:20:01,576 TRIGGER IN FACT, WORKING 3242 02:20:01,576 --> 02:20:04,479 TOGETHER WITH YOUR GENETICS TO 3243 02:20:04,479 --> 02:20:06,714 TRIGGER ALZHEIMER'S. SO THAT IS 3244 02:20:06,714 --> 02:20:09,484 WHY I WILL OFTEN SAY IT IS 3245 02:20:09,484 --> 02:20:12,153 GETTING AT THE FUNDAMENTAL 3246 02:20:12,153 --> 02:20:13,955 UNDERSTANDING OF ETIOLOGY OF 3247 02:20:13,955 --> 02:20:16,257 HUMAN THE DISEASE. WHAT IS 3248 02:20:16,257 --> 02:20:18,526 MISBEHAVING AND HAPPENING AT 3249 02:20:18,526 --> 02:20:22,764 MOLECULAR LEVEL? IS THERE SAY 3250 02:20:22,764 --> 02:20:26,468 THE GENES OR SEGMENT INDIVIDUAL 3251 02:20:26,468 --> 02:20:29,471 UP TO DEVELOP PARKINSON'S AND AS 3252 02:20:29,471 --> 02:20:31,339 ENVIRONMENTAL TRIGGER THAT 3253 02:20:31,339 --> 02:20:32,507 TRIGGERS THE PHENOTYPE BUT WHAT 3254 02:20:32,507 --> 02:20:36,478 IT IS ABOUT THE ENVIRONMENTAL 3255 02:20:36,478 --> 02:20:39,013 TRIGGER? THERE NEEDS TO BE 3256 02:20:39,013 --> 02:20:41,249 CONTINUITY. WHERE DOES THAT FIT 3257 02:20:41,249 --> 02:20:43,318 INTO THE WHOLE ETIOLOGY OF HUMAN 3258 02:20:43,318 --> 02:20:44,219 DISEASE. ONCE YOU WANT TO 3259 02:20:44,219 --> 02:20:48,156 DEVELOP A THERAPY, YOU WILL LOOK 3260 02:20:48,156 --> 02:20:51,192 AT THE ENTIRE PATHWAY. WHERE ARE 3261 02:20:51,192 --> 02:20:53,695 POINTS OF POTENTIAL 3262 02:20:53,695 --> 02:20:54,896 INTERVENTION? ARE THERE 3263 02:20:54,896 --> 02:20:56,397 INTERVENTIONS THAT MAY BE 3264 02:20:56,397 --> 02:20:58,666 DIFFERENT IF SOMEONE IS 3265 02:20:58,666 --> 02:20:59,367 DEVELOPING PARKINSONS FOR 3266 02:20:59,367 --> 02:21:01,569 STRICTLY GENETIC REASONS VERSUS 3267 02:21:01,569 --> 02:21:02,804 INDIVIDUALS DEVELOPING 3268 02:21:02,804 --> 02:21:04,672 PARKINSONS FOR STRICTLY 3269 02:21:04,672 --> 02:21:06,174 ENVIRONMENTAL REASONS AND 3270 02:21:06,174 --> 02:21:10,411 DEVELOPING PARKINSON'S FOR GENE 3271 02:21:10,411 --> 02:21:11,546 REASONS. BASICALLY TO ANSWER 3272 02:21:11,546 --> 02:21:13,414 YOUR QUESTION IT IS ABOUT 3273 02:21:13,414 --> 02:21:14,816 FUNDAMENTALS, TOTALLY 3274 02:21:14,816 --> 02:21:16,384 UNDERSTANDING THE ETIOLOGY OF 3275 02:21:16,384 --> 02:21:18,119 HUMAN DISEASE. THAT ANSWER YOUR 3276 02:21:18,119 --> 02:21:18,386 QUESTION? 3277 02:21:18,386 --> 02:21:20,855 >> IT DOES BUT I THINK IT IS 3278 02:21:20,855 --> 02:21:21,923 ALSO PRESENTING A POTENTIAL 3279 02:21:21,923 --> 02:21:23,324 OPPORTUNITY WHERE IT IS THINKING 3280 02:21:23,324 --> 02:21:26,427 ABOUT LIKE YOU DON'T NECESSARILY 3281 02:21:26,427 --> 02:21:36,938 HAVE TO UNDERSTAND EVERYTHING 3282 02:21:37,772 --> 02:21:40,008 BUT LOWERING EXPOSURE. THAT WILL 3283 02:21:40,008 --> 02:21:43,111 BE DIFFERENT THAN WATER. SAY INI 3284 02:21:43,111 --> 02:21:46,314 HA 3285 02:21:46,314 --> 02:21:50,151 HAVEI I NVIVO BY REMEDIATION. 3286 02:21:50,151 --> 02:21:52,720 THAT HAS BEEN 30 YEARS IN THE 3287 02:21:52,720 --> 02:21:53,788 COMMUNITY. SO I'M CURIOUS 3288 02:21:53,788 --> 02:21:55,290 LEVERAGING THAT, AS THEY SAY. 3289 02:21:55,290 --> 02:21:57,058 >> I GUESS GETTING AT YOUR 3290 02:21:57,058 --> 02:21:58,192 QUESTION IS ABOUT THE PREVENTION 3291 02:21:58,192 --> 02:21:59,027 PART OF THIS. 3292 02:21:59,027 --> 02:21:59,827 >> RIGHT. 3293 02:21:59,827 --> 02:22:00,762 >> SO YOUR UNDERSTANDING 3294 02:22:00,762 --> 02:22:03,364 SOMETHING IS BAD FOR YOU. 3295 02:22:03,364 --> 02:22:03,798 >> YES. 3296 02:22:03,798 --> 02:22:05,567 >> WHAT ARE THE TYPES OF 3297 02:22:05,567 --> 02:22:07,035 TECHNOLOGIES -- IN FACT, THAT, 3298 02:22:07,035 --> 02:22:10,438 IS ANOTHER WHOLE ELEMENT, 3299 02:22:10,438 --> 02:22:18,346 COLLABORATION WITHIN NIBIB. WE 3300 02:22:18,346 --> 02:22:24,619 KNOW IN FACT, IN CENTRAL NIKE 3301 02:22:24,619 --> 02:22:27,155 NORTH CAROLINA, I THINK DUPONT 3302 02:22:27,155 --> 02:22:28,556 CONTAMINATED THE WATER SUPPLIES. 3303 02:22:28,556 --> 02:22:32,927 IN FACT, MY WIFE IS A REALTOR. 3304 02:22:32,927 --> 02:22:37,832 SO SHE ALWAYS -- WHEN TALKING 3305 02:22:37,832 --> 02:22:38,933 PEOPLE AROUND THEY DO THIS 3306 02:22:38,933 --> 02:22:41,669 TESTING AND THERE ARE A LOT OF 3307 02:22:41,669 --> 02:22:42,870 SURPRISES. SO ARE THERE 3308 02:22:42,870 --> 02:22:49,477 TECHNOLOGIES WE CAN BE DEVE 3309 02:22:49,477 --> 02:22:51,279 DEVELOPING TO BE CLEANING UP 3310 02:22:51,279 --> 02:22:55,316 INDIVIDUAL HOMES SUPPLY? I JUST 3311 02:22:55,316 --> 02:22:55,650 GO 3312 02:22:55,650 --> 02:22:57,652 GOT BACK FROM INDIA, JET LAG SO 3313 02:22:57,652 --> 02:22:59,520 HOPEFULLY THIS IS MAKING SENSE. 3314 02:22:59,520 --> 02:23:00,788 THE AIR POLLUTION IS CHOKING. 3315 02:23:00,788 --> 02:23:03,458 THE TWO WEEKS I WAS THERE THE 3316 02:23:03,458 --> 02:23:05,593 BEST IT GOT WAS SERIOUSLY 3317 02:23:05,593 --> 02:23:10,064 UNHEALTHY. 200 TO 300 PARTS PER 3318 02:23:10,064 --> 02:23:11,599 MILLION. ARE THERE TECHNOLOGIES 3319 02:23:11,599 --> 02:23:13,635 THAT PEOPLE THAT DO LOW-COST AIR 3320 02:23:13,635 --> 02:23:19,207 CLEANERS WITHIN A HOUSEHOLD? SO 3321 02:23:19,207 --> 02:23:23,011 I THINK THERE ARE A LOT OF 3322 02:23:23,011 --> 02:23:24,479 TECHNOLOGIES FOR MITIGATION 3323 02:23:24,479 --> 02:23:25,647 AAND 3324 02:23:25,647 --> 02:23:26,481 ADAPTING TO THAT ENVIRONMENT. 3325 02:23:26,481 --> 02:23:27,949 DOES THAT ANSWER THE OTHER PART? 3326 02:23:27,949 --> 02:23:30,351 >> YAH, THANK YOU. I'M JUST 3327 02:23:30,351 --> 02:23:31,886 SAYING ALSO TO THINK NOT 3328 02:23:31,886 --> 02:23:35,289 NECESSARILY JUST IN THE WATER 3329 02:23:35,289 --> 02:23:40,928 BUT IN THE PERSON TOO. SO ARE 3330 02:23:40,928 --> 02:23:42,864 THERE THINGS WITH LED. I LEARNED 3331 02:23:42,864 --> 02:23:46,167 WHEN I WAS IN INDIA STRIKINGLY 3332 02:23:46,167 --> 02:23:48,469 IT IS AMAZING WE KNOW HOW BAD 3333 02:23:48,469 --> 02:23:52,407 LED IS. THERE IS NO SAFE LEVEL 3334 02:23:52,407 --> 02:23:54,042 OF LED. THERE ARE PEOPLE DYING 3335 02:23:54,042 --> 02:23:55,977 OF LEAD POISONING ACROSS INDIA. 3336 02:23:55,977 --> 02:23:57,412 I THINK IT IS PARTLY BECAUSE 3337 02:23:57,412 --> 02:23:59,647 THERE ARE -- KIND OF GETS TO THE 3338 02:23:59,647 --> 02:24:02,417 SOCIAL DETERMINANTS OF HEALTH. 3339 02:24:02,417 --> 02:24:04,252 THERE ARE PEOPLE WHOSE BUSINESS 3340 02:24:04,252 --> 02:24:09,357 IS RECYCLE LED ACETATE 3341 02:24:09,357 --> 02:24:18,833 BATTERIES. SO SOME THINGS ARE 3342 02:24:18,833 --> 02:24:20,601 UNIMAGINE B 3343 02:24:20,601 --> 02:24:31,245 UNIMAGINABLE. CAN THERE BOTHE 3344 02:24:31,245 --> 02:24:31,979 THERAPEUTICS TO PROMOTE THIS? 3345 02:24:31,979 --> 02:24:32,747 >> THANK YOU. 3346 02:24:32,747 --> 02:24:34,382 >> BRUCE, LAST STOP. LOT OF 3347 02:24:34,382 --> 02:24:36,517 WORK WE HAVE TO BE DOING 3348 02:24:36,517 --> 02:24:39,220 TOGETHER. ZANE, LOOKS LIKE YOU 3349 02:24:39,220 --> 02:24:39,987 HAVE A QUESTION. 3350 02:24:39,987 --> 02:24:42,590 >> RICK, THANK YOU FOR THE 3351 02:24:42,590 --> 02:24:45,193 TALK. I WILL MAKE A QUICK 3352 02:24:45,193 --> 02:24:45,793 COMMENT ABOUT WHAT SOMETHING 3353 02:24:45,793 --> 02:24:47,261 JOYCE SAID. IF YOU CAN GET 3354 02:24:47,261 --> 02:24:48,429 PATIENTS TO TELL THE TRUTH IN 3355 02:24:48,429 --> 02:24:50,998 THE FIRST PLACE YOU'D PROBABLY 3356 02:24:50,998 --> 02:24:54,635 SEE A IMPROVEMENT IN HEALTH 3357 02:24:54,635 --> 02:24:57,171 CARE. BETTER OFF. THE OTHER 3358 02:24:57,171 --> 02:24:57,939 INFORMATION YOU ARE ASKING IN 3359 02:24:57,939 --> 02:25:00,041 REGARD TO THIS -- MY REAL 3360 02:25:00,041 --> 02:25:02,510 QUESTION BOILS DOWN TO WHERE 3361 02:25:02,510 --> 02:25:07,115 DOES THE NEW MICROBIOMICS OR THE 3362 02:25:07,115 --> 02:25:12,353 OTHER ASPECTS OF THE GUT 3363 02:25:12,353 --> 02:25:13,621 MICROBIOME FIT? THAT SEEMS LIKE 3364 02:25:13,621 --> 02:25:15,423 A FIRST STEP TO MANY. I MEAN 3365 02:25:15,423 --> 02:25:17,825 THAT, IS PROBABLY YOUR BIGGEST 3366 02:25:17,825 --> 02:25:20,061 EXPOSURE TO CHEMICALS, BIGGEST 3367 02:25:20,061 --> 02:25:21,662 EXPOSURE TO ANY KIND OF A 3368 02:25:21,662 --> 02:25:24,398 CHANGE. JUST CURIOUS ON YOUR 3369 02:25:24,398 --> 02:25:24,799 TAKE. 3370 02:25:24,799 --> 02:25:25,967 >> I GUESS YOUR QUESTION IS 3371 02:25:25,967 --> 02:25:32,373 WHERE DOES THE MICROBIOME? 3372 02:25:32,373 --> 02:25:33,441 >> YES. 3373 02:25:33,441 --> 02:25:35,443 >> EXACTLY. GREAT QUESTION. 3374 02:25:35,443 --> 02:25:37,845 ANSWER IS INDIGO HARVEST. WHAT 3375 02:25:37,845 --> 02:25:40,515 WE ARE DISCOVERING IS SOME OF 3376 02:25:40,515 --> 02:25:43,618 THE POTENTIALLY POWERFUL EFFECTS 3377 02:25:43,618 --> 02:25:45,620 OF DIFFERENT CHEMICAL AGENTS ON 3378 02:25:45,620 --> 02:25:49,323 HUMAN HEALTH MAY BE THROUGH 3379 02:25:49,323 --> 02:25:53,528 CHANGING COMPOSITION OF THE MY 3380 02:25:53,528 --> 02:25:54,862 CROWBIOME. TOMORROW I'M TALKING 3381 02:25:54,862 --> 02:26:04,238 TO DENTAL AND CRANIOFACIAL 3382 02:26:04,238 --> 02:26:07,241 GROUP. THERE IS EVIDENCE ORGANO 3383 02:26:07,241 --> 02:26:08,910 PHOSPHATES CAN BE CHANGING THE 3384 02:26:08,910 --> 02:26:11,612 ORAL MICROBIOME. THINGS WE NEED 3385 02:26:11,612 --> 02:26:13,314 TO PAY ATTENTION TO. THE GOOD 3386 02:26:13,314 --> 02:26:16,184 NEWS IS WE HAVE CONSCIOUSNESS OF 3387 02:26:16,184 --> 02:26:19,253 IMPORTANCE OF THE MICROBIOME. 3388 02:26:19,253 --> 02:26:28,296 AND WE JUST NEED TO BE DEVE 3389 02:26:28,296 --> 02:26:30,932 DEVELOPING STRATEGIES IN THE 3390 02:26:30,932 --> 02:26:34,769 ORAL AND GUT MICROBIOME. THESE 3391 02:26:34,769 --> 02:26:36,137 ARE CRITICALLY IMPORTANT FOR 3392 02:26:36,137 --> 02:26:39,740 MAINTAIN TRAINING GOOD HEALTH. 3393 02:26:39,740 --> 02:26:41,409 THAT ANSWER YOUR QUESTION? 3394 02:26:41,409 --> 02:26:42,176 >> THANK YOU. 3395 02:26:42,176 --> 02:26:44,245 >> SOUNDS GOOD. BRUCE. 3396 02:26:44,245 --> 02:26:45,146 >> BRUCE TROMBERG: I'M GOING TO 3397 02:26:45,146 --> 02:26:46,981 BE THE CLOSER. I'M GOING TO WRAP 3398 02:26:46,981 --> 02:26:50,551 THIS UP WITH A FEW COMMENTS. 3399 02:26:50,551 --> 02:26:54,422 MAYBE WE CAN GET ONE MORE ROUND 3400 02:26:54,422 --> 02:27:01,562 OF DISCUSSION. IT STRIKES ME A 3401 02:27:01,562 --> 02:27:04,165 LOT OF DISCUSSION IS PREDICATED 3402 02:27:04,165 --> 02:27:05,800 ON HAVING VALIDATED SYSTEMS, 3403 02:27:05,800 --> 02:27:08,002 SURROGATES FOR HUMANS. WE WOULD 3404 02:27:08,002 --> 02:27:10,938 LIKE TO SOLVE THE MYSTERY IN 3405 02:27:10,938 --> 02:27:15,443 HUMANS BUT THE MICROFIZZ LOGICS, 3406 02:27:15,443 --> 02:27:17,645 WE KEEP RETURNING TO NOVEL 3407 02:27:17,645 --> 02:27:19,413 METHODS. GETTING A FORM OF 3408 02:27:19,413 --> 02:27:21,282 STANDARDIZATION SO THEY CAN BE 3409 02:27:21,282 --> 02:27:23,451 REPRODUCED AND DISTRIBUTED 3410 02:27:23,451 --> 02:27:26,387 WIDELY. THE SOLUTION OF THE 3411 02:27:26,387 --> 02:27:28,723 PROBLEM -- THE PROBLEM APPEARS 3412 02:27:28,723 --> 02:27:29,891 QUIETEN FINISH IN IT WITH LOTS 3413 02:27:29,891 --> 02:27:32,226 OF VARIABLES. THE ONLY WAY TO 3414 02:27:32,226 --> 02:27:35,997 MAKE HEADWAY IS GET INFINITE OR 3415 02:27:35,997 --> 02:27:38,099 SEMI -INFINITE NUMBER OF PEOPLE 3416 02:27:38,099 --> 02:27:39,901 WORKING ON SAME PLATFORMS 3417 02:27:39,901 --> 02:27:40,701 APPROACHING PROBLEM FROM VARIETY 3418 02:27:40,701 --> 02:27:44,739 OF DIFFERENT ANGLES. I THINK IT 3419 02:27:44,739 --> 02:27:46,374 UNDERSCORES WHAT WE ALL KNOW, 3420 02:27:46,374 --> 02:27:48,376 SENSE OF URGENCY. I'M SPEAKING 3421 02:27:48,376 --> 02:27:51,979 IN PARTICULAR TO BIOMATERIALS 3422 02:27:51,979 --> 02:27:55,917 FOLKS ON COUNCIL. WE NEED TO GET 3423 02:27:55,917 --> 02:27:58,452 THE BIOECONOMY CRANKED UP AND 3424 02:27:58,452 --> 02:28:01,289 GETTING A AGREEMENT SO THESE CAN 3425 02:28:01,289 --> 02:28:03,824 BE MANUFACTURED. WE KNOW THEY 3426 02:28:03,824 --> 02:28:05,426 WORK BEAUTIFULLY IN INDIVIDUAL 3427 02:28:05,426 --> 02:28:06,661 LABORATORIES. WE CAN'T HAVE JUST 3428 02:28:06,661 --> 02:28:08,863 A BUNCH OF BOUTIQUES. WE NEED TO 3429 02:28:08,863 --> 02:28:12,099 GET THOSE VALIDATED AND 3430 02:28:12,099 --> 02:28:13,334 DISTRIBUTED. THAT IS ONE 3431 02:28:13,334 --> 02:28:16,037 INTERESTING THING. I THINK THE 3432 02:28:16,037 --> 02:28:19,040 SPIN-OFF ON THAT, RELATED TO 3433 02:28:19,040 --> 02:28:22,310 IMAGING TOO, IS HOW DO WE GET 3434 02:28:22,310 --> 02:28:24,378 THESE ALSO GENERATED IN SOMEWHAT 3435 02:28:24,378 --> 02:28:27,348 STANDARD AND PREDICTABLE WAYS 3436 02:28:27,348 --> 02:28:30,885 TOWARD AN INDIVIDUAL HUMAN. WE 3437 02:28:30,885 --> 02:28:32,787 WANT TO HAVE OUR PERSONAL 3438 02:28:32,787 --> 02:28:34,255 AVATARS TO UNDERSTAND WHAT'S 3439 02:28:34,255 --> 02:28:36,657 HAPPENED TO US. WE CAN IMAGE 3440 02:28:36,657 --> 02:28:45,232 THAT IN MI MICRO PHYSIOLOGY SYS 3441 02:28:45,232 --> 02:28:46,968 AND TEST OUT THE 3442 02:28:46,968 --> 02:28:47,702 APPROACHES.ENTERTHIS IS 3443 02:28:47,702 --> 02:28:49,103 SOMETHING THAT'S GONE ON A LOT. 3444 02:28:49,103 --> 02:28:50,571 BUT TO DEVELOP APPROACHES THAT 3445 02:28:50,571 --> 02:28:52,306 ARE RELIABLE AND WE HAVE 3446 02:28:52,306 --> 02:28:55,142 CONFIDENCE IN THE PLATFORM TO 3447 02:28:55,142 --> 02:28:56,844 HELP US UNDERSTAND WITHOUT DOING 3448 02:28:56,844 --> 02:29:00,381 EXPERIMENTS ON THE ENTIRE HUMAN 3449 02:29:00,381 --> 02:29:06,354 FIRST WHAT IS GOING ON. RICK 3450 02:29:06,354 --> 02:29:16,831 SENDS ME GREAT PAPERS. SEND ME 3451 02:29:16,831 --> 02:29:24,605 FROM END ENDOCRINE SOCIETY. SO 3452 02:29:24,605 --> 02:29:27,475 DEVELOPING FOR IMAGE SINGLE 3453 02:29:27,475 --> 02:29:29,643 CELLS, HE ADAPTED THAT TO LOOK 3454 02:29:29,643 --> 02:29:34,081 AT NANO PARTICLES, NANO PLASTICS 3455 02:29:34,081 --> 02:29:38,185 IN WATER THAT COMES FROM YOUR 3456 02:29:38,185 --> 02:29:40,588 PLASTIC WATER BOTTLE AND 3457 02:29:40,588 --> 02:29:42,823 IDENTIFIED TEN TO THE FIFTH 3458 02:29:42,823 --> 02:29:45,192 PRIMARILY NANO BUT SOME MICRO 3459 02:29:45,192 --> 02:29:47,361 PARTICLES PER LITER. YOU KNOW, 3460 02:29:47,361 --> 02:29:51,365 LIKE A SHOCKGLY HIGH NUMBER. SO 3461 02:29:51,365 --> 02:29:57,571 I THINK THERE IS SYNERGY AND 3462 02:29:57,571 --> 02:29:59,040 OVERLAP DEVELOPED BY OUR 3463 02:29:59,040 --> 02:30:02,777 COMMUNITY. MAYBE UNKNOWN-KNOWNS. 3464 02:30:02,777 --> 02:30:10,818 SO WE KNOW THESE ARE END 3465 02:30:10,818 --> 02:30:20,294 ENDOCRINE DISRUP TORS. 250 3466 02:30:20,294 --> 02:30:22,396 BILLION DUE TO THIS. OBVIOUSLY A 3467 02:30:22,396 --> 02:30:24,165 HUGE HEALTH CARE AND ECONOMIC 3468 02:30:24,165 --> 02:30:30,838 IMPACT. SO THERE WILL PROBABLY 3469 02:30:30,838 --> 02:30:41,215 BE PHENOTYPE SIGNATURES OF THESE 3470 02:30:41,215 --> 02:30:41,615 KNO 3471 02:30:41,615 --> 02:30:44,018 KNOWN DISRUPTORS YOU CAN TUNE 3472 02:30:44,018 --> 02:30:54,428 INTO. SO WE CAN LOOK AT 3473 02:30:55,429 --> 02:30:57,131 EXPOSURES THAT WAY. THERAPIES TO 3474 02:30:57,131 --> 02:30:58,232 REVERSE IN SOME SPECIFIC 3475 02:30:58,232 --> 02:31:01,135 TARGETED WAYS. JUST SOME RANDOM 3476 02:31:01,135 --> 02:31:02,670 THOUGHTS, TRYING TO TIE ALL THIS 3477 02:31:02,670 --> 02:31:06,474 STUFF TOGETHER. SOME OF THE 3478 02:31:06,474 --> 02:31:09,410 OPPORTUNITIES FOR OUR COMMUNITY, 3479 02:31:09,410 --> 02:31:10,811 RICK, WE ARE GRATEFUL FOR YOUR 3480 02:31:10,811 --> 02:31:11,712 PRESENTATION. THANK YOU FOR 3481 02:31:11,712 --> 02:31:14,582 SENDING ME A LOT OF THIS 3482 02:31:14,582 --> 02:31:17,818 INFORMATION. ENCOURAGING THIS 3483 02:31:17,818 --> 02:31:19,920 WONDERFUL, WONDERFUL DISCUSSION. 3484 02:31:19,920 --> 02:31:20,821 >> RICK WOYCHIK: BRUCE, THE KEY 3485 02:31:20,821 --> 02:31:22,022 IS WE NEED TO BE WORKING 3486 02:31:22,022 --> 02:31:22,289 TOGETHER . 3487 02:31:22,289 --> 02:31:25,993 THE BIOLOGISTS, THE THINGS WE 3488 02:31:25,993 --> 02:31:27,161 DO, WE WOULD NEVER IMAGINE HOW 3489 02:31:27,161 --> 02:31:31,098 WE CAN SOLVE SOME OF THESE 3490 02:31:31,098 --> 02:31:32,833 PROBLEMS. TAKES ME BACK TO 3491 02:31:32,833 --> 02:31:34,001 OAKRIDGE DAYS THERE WERE 3492 02:31:34,001 --> 02:31:36,837 DEVELOPING PARTNERSHIPS WITH 3493 02:31:36,837 --> 02:31:38,639 QUAN AND OTHERS. THESE WERE 3494 02:31:38,639 --> 02:31:40,107 INNOVATIVE SOLUTIONS I WOULD 3495 02:31:40,107 --> 02:31:41,976 HAVE NEVER THOUGHT OF DOING. SO 3496 02:31:41,976 --> 02:31:45,446 THAT IS THE KEY THING HERE. 3497 02:31:45,446 --> 02:31:47,047 DEFINED WHAT IS THE EXPOSUM AND 3498 02:31:47,047 --> 02:31:49,483 WHAT ARE CAPABILITIES WE CAN 3499 02:31:49,483 --> 02:31:51,085 BRING TO BEAR. CAN'T BE 3500 02:31:51,085 --> 02:31:52,353 EVERYTHING ABOUT EVERYTHING BUT 3501 02:31:52,353 --> 02:31:55,689 LET'S CARVE OUT WHAT CAN WE 3502 02:31:55,689 --> 02:31:57,958 MEASURE. THEN OPERATIONAL IZE 3503 02:31:57,958 --> 02:31:59,994 THIS IN WAY THAT POSITIONS AND 3504 02:31:59,994 --> 02:32:02,196 COLLECTS DATA AND CORRELATES 3505 02:32:02,196 --> 02:32:05,032 THIS WITH HUMAN HEALTH. THANKS 3506 02:32:05,032 --> 02:32:08,269 AGAIN FOR THIS INVITE. ALWAYS 3507 02:32:08,269 --> 02:32:09,203 EXCITING TO ENGAGE IN A 3508 02:32:09,203 --> 02:32:10,004 DISCUSSION WITH YOU. 3509 02:32:10,004 --> 02:32:12,072 >> YOU ARE NOT OFF THE HOOK 3510 02:32:12,072 --> 02:32:17,478 YET. I SEE SOHE HAS HAND UP. 3511 02:32:17,478 --> 02:32:18,679 >> QUICK COMMENT JUST ON 3512 02:32:18,679 --> 02:32:22,149 PLASTICS ALONE. I WANT TO FIRST 3513 02:32:22,149 --> 02:32:24,151 OF ALL SAY THIS IS A FANTASTIC 3514 02:32:24,151 --> 02:32:27,221 INITIATIVE. I REALLY LOOK 3515 02:32:27,221 --> 02:32:32,359 FORWARD TO GREAT OUTCOMES. I'M 3516 02:32:32,359 --> 02:32:33,093 AT THE NATIONAL SCIENCE 3517 02:32:33,093 --> 02:32:35,362 FOUNDATION. WE HAD A PROGRAM 3518 02:32:35,362 --> 02:32:36,897 CALLED ELIMINATION OF END OF 3519 02:32:36,897 --> 02:32:42,836 LIFE PLASTICS. WE HAVE A 40 3520 02:32:42,836 --> 02:32:44,838 MILLION, 20 PROJECTS, EACH OF 3521 02:32:44,838 --> 02:32:45,873 THEM 2 MILLION THAT ARE 3522 02:32:45,873 --> 02:32:48,108 INTERACTIVE, TRYING TO FIGURE 3523 02:32:48,108 --> 02:32:50,344 OUT TECHNOLOGIES TO RESOLVE 3524 02:32:50,344 --> 02:32:52,179 ISSUE OF PLASTICS AND ELIMINATE 3525 02:32:52,179 --> 02:32:53,447 FROM THE ENVIRONMENT THAT. IS A 3526 02:32:53,447 --> 02:32:56,450 DIFFERENT QUESTION. IN THE 3527 02:32:56,450 --> 02:32:59,153 COURSE OF PREPARING THE 3528 02:32:59,153 --> 02:33:00,821 SOLICITATION AND ALSO IN THE 3529 02:33:00,821 --> 02:33:04,091 COURSE OF -- IDEAS IN ITSELF, I 3530 02:33:04,091 --> 02:33:06,527 REMEMBER THE PANELIS THAT WOULD 3531 02:33:06,527 --> 02:33:08,963 COME, THEY WOULD ALWAYS ARGUE 3532 02:33:08,963 --> 02:33:11,165 THAT PALACE TIBS NOT THAT BAD. 3533 02:33:11,165 --> 02:33:16,537 WE DON'T -- PLASTICS NOT THAT 3534 02:33:16,537 --> 02:33:18,272 BAD. WE DON'T HAVE GOOD EVIDENCE 3535 02:33:18,272 --> 02:33:20,207 FROM BIG IMPACTS FROM PLASTICS. 3536 02:33:20,207 --> 02:33:23,811 SO WE HAD A HARD TIME SELLING 3537 02:33:23,811 --> 02:33:26,981 THE INITIATIVES AND HAVING A 3538 02:33:26,981 --> 02:33:29,917 GOOD SUBSTANTIAL INVESTMENT IN 3539 02:33:29,917 --> 02:33:33,320 ADDRESSING THE PLASTICS ISSUE. 3540 02:33:33,320 --> 02:33:36,624 SO I REALLY WOULD LOVE TO SEE 3541 02:33:36,624 --> 02:33:39,827 SOME GOOD EVIDENCE COME OUT OF 3542 02:33:39,827 --> 02:33:41,562 THIS INITIATIVE. ESPECIALLY IN 3543 02:33:41,562 --> 02:33:42,029 THAT AREA. 3544 02:33:42,029 --> 02:33:43,564 >> WE WOULD LOVE TO SEE THE 3545 02:33:43,564 --> 02:33:44,765 SAME THING. IN FACT, GETTING 3546 02:33:44,765 --> 02:33:47,401 BACK TO THAT ORIGINAL PICTURE 3547 02:33:47,401 --> 02:33:51,205 THAT BRUCE SHOWED, WHAT I DO IS 3548 02:33:51,205 --> 02:33:54,775 EVERY MONTH I INTERVIEW SOMEONE 3549 02:33:54,775 --> 02:33:55,542 DOING INNOVATIVE STUFF OR 3550 02:33:55,542 --> 02:33:58,412 WORKING IN AREA THAT IS A REAL 3551 02:33:58,412 --> 02:33:59,580 CHALLENGE. LAST YEAR I 3552 02:33:59,580 --> 02:34:02,483 INTERVIEWED DOUG WALKER, DOING A 3553 02:34:02,483 --> 02:34:06,053 LOT OF MASS SPEC WORK. SO THAT 3554 02:34:06,053 --> 02:34:08,455 WAS ALL ABOUT DISCUSSING 3555 02:34:08,455 --> 02:34:09,023 CHALLENGES ASSOCIATED WITH 3556 02:34:09,023 --> 02:34:10,691 ANALYZING PLASTICS. I ENCOURAGE 3557 02:34:10,691 --> 02:34:12,860 YOU TAKE A LOOK AT THE 3558 02:34:12,860 --> 02:34:14,795 DIRECTOR'S CORNER FROM LAST 3559 02:34:14,795 --> 02:34:17,197 YEAR. BUT THIS IS SOMETHING WE 3560 02:34:17,197 --> 02:34:19,800 HAVE TO SOLVE. THERE IS A LOT OF 3561 02:34:19,800 --> 02:34:21,969 DISCUSSION GOING ON WITH INCOME 3562 02:34:21,969 --> 02:34:28,876 TAX -- WITH THE NATIONAL 3563 02:34:28,876 --> 02:34:30,411 TOXICOLOGY PROGRAM. IT IS 3564 02:34:30,411 --> 02:34:31,679 SOCIALING AND THE ARTICLE WAS 3565 02:34:31,679 --> 02:34:33,147 STRIKING TO REALIZE WHAT WE ARE 3566 02:34:33,147 --> 02:34:34,715 BEING EXPOSED TO. IT IS 3567 02:34:34,715 --> 02:34:36,850 COMPLICATED BECAUSE IT IS NOT 3568 02:34:36,850 --> 02:34:38,952 JUST THE CHEMICAL COMPOSITION OF 3569 02:34:38,952 --> 02:34:42,289 SOME OF PLASTICS. USED TO BE 3570 02:34:42,289 --> 02:34:49,763 SIMPLE. BPA, PLASTICIZER. WE 3571 02:34:49,763 --> 02:34:51,899 DISCOVERED ORIGINALLY IN BABY 3572 02:34:51,899 --> 02:34:54,935 BOTTLES BUT IT IS NOW ABOUT A 3573 02:34:54,935 --> 02:34:58,772 WHOLE VARIETY OF THER TYPES OF 3574 02:34:58,772 --> 02:35:04,411 PLAS 3575 02:35:04,411 --> 02:35:05,512 PLASTICS. IT COULD BE THE 3576 02:35:05,512 --> 02:35:09,616 PHYSICAL TYPES. THINKING 3577 02:35:09,616 --> 02:35:18,926 ASBESTOS AND NANO PA PART CALLS 3578 02:35:18,926 --> 02:35:20,561 IT /* /* PARTICLES. IT IS 3579 02:35:20,561 --> 02:35:21,929 COMPLICATED. ONE WE NEED HELP. 3580 02:35:21,929 --> 02:35:25,766 ONE WE REALLY HAVE TO TACKLE THE 3581 02:35:25,766 --> 02:35:26,367 PROBLEM. 3582 02:35:26,367 --> 02:35:29,837 SAMUEL, LOOKS LIKE YOU HAVE 3583 02:35:29,837 --> 02:35:30,604 A QUESTION. 3584 02:35:30,604 --> 02:35:32,740 >> YES, DR. WOYCHIK, THANK 3585 02:35:32,740 --> 02:35:39,680 YOU FOR THIS EXCITING DISCU 3586 02:35:39,680 --> 02:35:41,014 DISCUSSION. THE PROBLEM HAS SO 3587 02:35:41,014 --> 02:35:45,018 MANY DIMENSIONS TO IT THAT MAKES 3588 02:35:45,018 --> 02:35:47,221 IT VERY CHALLENGING. DOES YOUR 3589 02:35:47,221 --> 02:35:51,358 INSTITUTE HAVE A KIND OF 3590 02:35:51,358 --> 02:35:52,559 PRIORITIZED DATABASE WHERE WE 3591 02:35:52,559 --> 02:35:53,861 CAN LOOK AND SEE WAYS OF 3592 02:35:53,861 --> 02:36:00,667 CREATING A MULTIPLEX ANALYSIS OF 3593 02:36:00,667 --> 02:36:02,436 SAMPLES AND COME UP WITH THE 3594 02:36:02,436 --> 02:36:03,904 APPROPRIATE TECHNOLOGIES TO 3595 02:36:03,904 --> 02:36:08,675 ADDRESS THEM IN FUTURE? 3596 02:36:08,675 --> 02:36:11,345 >> SO I GUESS MY RESPONSE TO 3597 02:36:11,345 --> 02:36:14,615 THE QUESTION IS THERE ARE MANY 3598 02:36:14,615 --> 02:36:21,054 DIFFERENT ELEMENTS SO THAT WAS 3599 02:36:21,054 --> 02:36:22,523 PART OF THE MOTIVATION FOR THE 3600 02:36:22,523 --> 02:36:24,858 CENTER. THE CENTER HAS TO BE 3601 02:36:24,858 --> 02:36:26,527 ABOUT OPERATIONALIZING IT. WHAT 3602 02:36:26,527 --> 02:36:29,396 ARE THE THINGS THAT WE SHOULD BE 3603 02:36:29,396 --> 02:36:33,867 FOCUSSING ON CAPTURING? NOW WE 3604 02:36:33,867 --> 02:36:37,004 HAVE LOTS OF DATABASES THAT 3605 02:36:37,004 --> 02:36:38,572 AREN'T TERRIBLY BE GRATED. THAT 3606 02:36:38,572 --> 02:36:40,140 IS ANOTHER ISSUE THAT BRUCE AND 3607 02:36:40,140 --> 02:36:44,511 I TALKED A LOT ABOUT. SO I THINK 3608 02:36:44,511 --> 02:36:45,679 PAYING ATTENTION TO WHERE IS THE 3609 02:36:45,679 --> 02:36:47,448 SCIENCE GOING. THAT HAS TO NOT 3610 02:36:47,448 --> 02:36:49,550 BE JUST ENVIRONMENTAL HEALTH 3611 02:36:49,550 --> 02:36:52,986 SCIENTIST BUT WORKING 3612 02:36:52,986 --> 02:36:55,689 REALISTICALLY WITH TECHNOLOGY. 3613 02:36:55,689 --> 02:36:59,359 WHAT CAN WE ACTUALLY 3614 02:36:59,359 --> 02:37:01,094 REALISTICALLY EXPECT TO DO SO I 3615 02:37:01,094 --> 02:37:02,696 MODEL THE THIS ON THE WORK 3616 02:37:02,696 --> 02:37:04,832 THAT'S BEEN DONE IN THE GENOME 3617 02:37:04,832 --> 02:37:07,100 PROJECT. SO WE STARTED OFF WITH 3618 02:37:07,100 --> 02:37:10,904 A BOLD VISION AND HAVE TO FIGURE 3619 02:37:10,904 --> 02:37:13,207 HOT HOW DO WE CHIZLE AWAY? JUST 3620 02:37:13,207 --> 02:37:17,711 LIKE GENOMICS. IT IS NOT ONE 3621 02:37:17,711 --> 02:37:25,652 THING. IT IS OTHER THINGS, CHIPS 3622 02:37:25,652 --> 02:37:29,122 AND ENVIRONMENT BUT EXPOSOMES, 3623 02:37:29,122 --> 02:37:31,325 SO NOT JUST ONE THING. TO ANSWER 3624 02:37:31,325 --> 02:37:33,327 YOUR QUESTION THERE ISN'T AN 3625 02:37:33,327 --> 02:37:36,730 AREA FOCUS NOW THAT I CAN POINT 3626 02:37:36,730 --> 02:37:37,998 TO THAT I WOULD SUGGEST YOU 3627 02:37:37,998 --> 02:37:41,301 FOCUS ON. LET'S FOLLOW THE 3628 02:37:41,301 --> 02:37:44,004 PROGRESS WE ARE MAKING IN 3629 02:37:44,004 --> 02:37:46,406 DEFINING WHAT IS THE EXPOSUM. WE 3630 02:37:46,406 --> 02:37:48,442 DO HAVE -- I DIDN'T HAVE TIME TO 3631 02:37:48,442 --> 02:37:52,145 COVER BUT WE HAVE CENTERS. ONE 3632 02:37:52,145 --> 02:37:55,949 IS AT MOUNT SINAI WHERE WE CHURP 3633 02:37:55,949 --> 02:37:57,518 THIS FROM HIGH RESOLUTION MASS 3634 02:37:57,518 --> 02:38:00,320 SPEC AND VARIETY OF THER TOOLS 3635 02:38:00,320 --> 02:38:03,156 SO THOSE ARE AVAILABLE. AT THIS 3636 02:38:03,156 --> 02:38:05,993 POINT AS THIS EMERGING LET'S NOT 3637 02:38:05,993 --> 02:38:14,167 LATCH ONTO SOMETHING. WE ARE AT 3638 02:38:14,167 --> 02:38:18,105 THE POINT OF LET'S THINK 3639 02:38:18,105 --> 02:38:19,573 CREATIVELY. THE TIMING IS GREAT. 3640 02:38:19,573 --> 02:38:22,409 I NEED YOUR HELP, BRUCE. LET'S 3641 02:38:22,409 --> 02:38:23,710 COME UP WITH THE INNOVATIVE 3642 02:38:23,710 --> 02:38:25,078 STRATEGIES I WOULDN'T HAVE 3643 02:38:25,078 --> 02:38:26,179 THOUGHT OF AND YOU WOULDN'T HAVE 3644 02:38:26,179 --> 02:38:28,682 THOUGHT OF. LET'S SEE IF WE CAN 3645 02:38:28,682 --> 02:38:30,350 DO THAT COLLABORATIVELY. SAMUEL, 3646 02:38:30,350 --> 02:38:33,086 DOES THAT ANSWER YOUR QUESTION? 3647 02:38:33,086 --> 02:38:33,453 3648 02:38:33,453 --> 02:38:38,625 >> YES, THANK YOU VERY MUCH. 3649 02:38:38,625 --> 02:38:38,792 3650 02:38:38,792 --> 02:38:42,462 >> OKAY. SO LET'S THANK RICK 3651 02:38:42,462 --> 02:38:46,633 AGAIN. I WILL TURN IT OVER TO 3652 02:38:46,633 --> 02:38:47,334 DAVE. 3653 02:38:47,334 --> 02:38:47,534 3654 02:38:47,534 --> 02:38:49,202 >> THANKS AGAIN FOR THIS 3655 02:38:49,202 --> 02:38:52,205 OPPORTUNITY TO BE HERE. I LOOK 3656 02:38:52,205 --> 02:38:54,775 FORWARD TO MORE INDEPTH 3657 02:38:54,775 --> 02:38:55,108 DISCUSSION. 3658 02:38:55,108 --> 02:38:56,577 >> THANK YOU SO MUCH. 3659 02:38:56,577 --> 02:38:58,111 >> TAKE CARE. 3660 02:38:58,111 --> 02:38:58,912 >> THANK YOU. 3661 02:38:58,912 --> 02:38:59,212 >> BYE. 3662 02:38:59,212 --> 02:38:59,313 3663 02:39:00,647 --> 02:39:03,350 >> THANK YOU, EVERYONE. 3664 02:39:03,350 --> 02:39:07,120 EXCELLENT DISCUSSION. THE 3665 02:39:07,120 --> 02:39:09,089 CHALLENGES FACED THERE, AS THE 3666 02:39:09,089 --> 02:39:10,424 COMMENTS SUGGESTED. VERY GOOD. 3667 02:39:10,424 --> 02:39:12,159 NOW WE ARE GOING TO MOVE INTO 3668 02:39:12,159 --> 02:39:14,861 TWO CONCEPT CLEARANCES FROM -- 3669 02:39:14,861 --> 02:39:22,336 GIVEN BY TWO OF OUR NIBIB 3670 02:39:22,336 --> 02:39:25,539 COLLEAGUES. HIS BACKGROUND ON 3671 02:39:25,539 --> 02:39:26,940 THE NIB PROGRAM OFFICERS 3672 02:39:26,940 --> 02:39:30,877 RECOMMEND CONCEPTS WHICH YOU 3673 02:39:30,877 --> 02:39:34,348 DESCRIBE THE SCOPE AND OBJECTIVE 3674 02:39:34,348 --> 02:39:38,018 FOR NEINITIATIVES WE MIGHT WANTO 3675 02:39:38,018 --> 02:39:39,987 PURSUE. THE OTHER IS CLEARANCE 3676 02:39:39,987 --> 02:39:41,521 WHERE WE RECEIVE PUBLIC ADVICE 3677 02:39:41,521 --> 02:39:44,791 AND MERITS ON POTENTIAL 3678 02:39:44,791 --> 02:39:47,861 INITIATIVES FROM COUNCILMEMBERS. 3679 02:39:47,861 --> 02:39:58,305 SO DR. AFRUOZA ANDERSON. 3680 02:39:59,039 --> 02:40:00,140 >> AFROUZ ANDERSON: THANK YOU, 3681 02:40:00,140 --> 02:40:02,275 DAVID. I HOPE YOU CAN HEAR ME. 3682 02:40:02,275 --> 02:40:03,977 GOOD MORNING AND GOOD AFTERNOON 3683 02:40:03,977 --> 02:40:05,612 TO THE COUNCIL MEMBERS. TODAY 3684 02:40:05,612 --> 02:40:12,619 I'M PRESENTING A CONCEPT AND 3685 02:40:12,619 --> 02:40:15,455 HOPE TO RECEIVE COMMENTS. I'M 3686 02:40:15,455 --> 02:40:18,725 PROGRAM DIRECTOR AT THE 3687 02:40:18,725 --> 02:40:22,629 INSTITUTE OF TECHNOLOGY. WHY 3688 02:40:22,629 --> 02:40:24,164 SPECIFICALLY WORKING WITH THIS 3689 02:40:24,164 --> 02:40:31,972 CONCEPT IS BECAUSE THE GAP 3690 02:40:31,972 --> 02:40:34,641 WITHIN THE MEDICAL ADVISE 3691 02:40:34,641 --> 02:40:36,743 COMMUNITY. WE KNOW THERE IS GAP 3692 02:40:36,743 --> 02:40:39,279 IN TERMS OF REPEATABILITY, 3693 02:40:39,279 --> 02:40:44,251 PRODUCEABILITY AND KWAN FIING WE 3694 02:40:44,251 --> 02:40:44,885 CURRENTLY HAVE. ONE OF THE MOST 3695 02:40:44,885 --> 02:40:48,021 RECENT EXAMPLE IS RELATED TO THE 3696 02:40:48,021 --> 02:40:51,224 OPT TOM TRI DEVICES. WHEN THERE 3697 02:40:51,224 --> 02:40:54,761 IS A NEED, MENTAL CONDITION, 3698 02:40:54,761 --> 02:40:55,529 PHYSIOLOGICAL CONDITION AND 3699 02:40:55,529 --> 02:40:59,332 CONTENT. SO WE ARE TRYING TO 3700 02:40:59,332 --> 02:41:02,669 THINK ABOUT IN TERMS OF BRINGING 3701 02:41:02,669 --> 02:41:06,073 QUALITY CONTROL TO MARKET FOR 3702 02:41:06,073 --> 02:41:11,344 MEDICAL IMAGING. REDUCING THE 3703 02:41:11,344 --> 02:41:13,980 MEASUREMENT WITHIN AND BETWEEN 3704 02:41:13,980 --> 02:41:16,216 AND MAKING SURE DO NOT NEED TO 3705 02:41:16,216 --> 02:41:18,719 WORRY ABOUT ACCESSING THESE IN 3706 02:41:18,719 --> 02:41:24,891 ORDER TO HELP WITH COSTS. SO 3707 02:41:24,891 --> 02:41:27,194 OVER ARCHING GOAL WOULD BE 3708 02:41:27,194 --> 02:41:28,862 ACCELERATE PRODUCTION AND 3709 02:41:28,862 --> 02:41:30,464 FACILITATE REGULATORY APPROVE 3710 02:41:30,464 --> 02:41:32,165 FOR TRANSLATION OF MEDICAL 3711 02:41:32,165 --> 02:41:42,676 DEVICES FOR THE CLINICAL USE. 3712 02:41:44,878 --> 02:41:49,449 HERE I'M SHOWING EXAMPLES. SO WE 3713 02:41:49,449 --> 02:41:59,192 WOULD LIKE TO HAVE A PULL 3714 02:41:59,192 --> 02:42:00,994 MULTI -PRONGED APPROACH, THE 3715 02:42:00,994 --> 02:42:02,963 FIRST APPROACH WE STARTED 3716 02:42:02,963 --> 02:42:07,334 BUILDING IN 2021 IN RESPONSE TO 3717 02:42:07,334 --> 02:42:17,844 THE COUNCIL WAS NIBIB LIBRARY. 3718 02:42:17,844 --> 02:42:19,880 THAT WAS ONE APPROACH. FROM THAT 3719 02:42:19,880 --> 02:42:23,350 WE TRYING TO TAKE THREE 3720 02:42:23,350 --> 02:42:24,885 ADDITIONAL APPROACHES. ONE SEX 3721 02:42:24,885 --> 02:42:27,454 PANDA TO THE CENTER WE HAVE 3722 02:42:27,454 --> 02:42:30,023 HEARD ABOUT PREVIOUSLY AND 3723 02:42:30,023 --> 02:42:32,626 LEVERAGE WITHIN COMMUNITY. THE 3724 02:42:32,626 --> 02:42:36,863 LAST MORE -- LARGER SCALE WOULD 3725 02:42:36,863 --> 02:42:38,799 BE TO ADVANCE THE UNIVERSITY 3726 02:42:38,799 --> 02:42:41,368 PARTNERSHIP. I WILL GO THROUGH 3727 02:42:41,368 --> 02:42:43,403 SOME OF THESE EXAMPLE AND DETAIL 3728 02:42:43,403 --> 02:42:48,875 OF SOME FOR A CONCEPT. SO 3729 02:42:48,875 --> 02:42:54,881 EXISTING IN CREATION OF THE 3730 02:42:54,881 --> 02:43:04,224 MEDICAL PHANTOM WORKING GROUP 3731 02:43:04,224 --> 02:43:05,792 WAS TO CREATE RESOURCE SO THEY 3732 02:43:05,792 --> 02:43:07,127 COULD HAVE ACCESS TO STANDARD 3733 02:43:07,127 --> 02:43:11,164 AND BE ABLE TO DO THE ROUND 3734 02:43:11,164 --> 02:43:12,833 ROBIN. THESE ARE CALIBRATED, 3735 02:43:12,833 --> 02:43:19,973 TESTED AND CURATED AND HAS 3736 02:43:19,973 --> 02:43:23,610 ANALYSIS TOOLS RELATED. IN 2021 3737 02:43:23,610 --> 02:43:25,979 WHEN THE LIBRARY WAS ESTABLISHED 3738 02:43:25,979 --> 02:43:28,248 IT WAS STARTED WITH MOSTLY MRI 3739 02:43:28,248 --> 02:43:32,018 SUCH AS BREAST, DIFFUSION AND 3740 02:43:32,018 --> 02:43:35,255 TOWARD 2024 THE GOAL TO EXPAND 3741 02:43:35,255 --> 02:43:38,558 OR OTHER IMAGE MODALITIES AND MR 3742 02:43:38,558 --> 02:43:43,697 PHANTOM, IT HAS SOME OF THE MSK 3743 02:43:43,697 --> 02:43:50,637 PHANTOMS, BUT HOPE IS EXPAND 3744 02:43:50,637 --> 02:43:55,475 THESE IMAGING. SOME STATISTICS, 3745 02:43:55,475 --> 02:43:59,179 THERE ARE 12 IN LIBRARY. WE HAVE 3746 02:43:59,179 --> 02:44:04,718 HAD TWO -- FIRST TWO OF 28, LOTS 3747 02:44:04,718 --> 02:44:06,620 OF PUBLICATION RELATED. ONE 3748 02:44:06,620 --> 02:44:10,857 THING I WANT TO HIGHLIGHT IS 3749 02:44:10,857 --> 02:44:13,593 THAT THE VALUE OF THE LIBRARY 3750 02:44:13,593 --> 02:44:15,295 BEYOND JUST THE LENDING SIECHLT 3751 02:44:15,295 --> 02:44:18,498 I CAN HIGHLIGHT IT THROUGH THE 3752 02:44:18,498 --> 02:44:22,068 STORY THEY HAVE HAD. THIS IS 3753 02:44:22,068 --> 02:44:32,045 MULTI PARTNERSHIP STORY WHERE 3754 02:44:32,045 --> 02:44:36,249 THEY ARE DEVELOPED THROUGH NIHD 3755 02:44:36,249 --> 02:44:38,551 AND NIBIB AND QUANTITATIVE 3756 02:44:38,551 --> 02:44:42,756 PROFILED THE PLAN OF DESIGN. 3757 02:44:42,756 --> 02:44:45,358 FROM HERE THE PHANTOM LIBRARY 3758 02:44:45,358 --> 02:44:47,961 SPECIFICALLY IN THIS CASE 3759 02:44:47,961 --> 02:44:51,598 CALIBRATED AND TRACED OF 3760 02:44:51,598 --> 02:44:58,238 PHANTOMS, THEY HAVE THE PARTNER 3761 02:44:58,238 --> 02:45:01,408 HELPED. THIS NOT ONLY SUPPORTED 3762 02:45:01,408 --> 02:45:06,346 THE DEVELOPMENT O OF NEURAL AND 3763 02:45:06,346 --> 02:45:08,181 TISSUE BUT PROVIDED REFERENCE 3764 02:45:08,181 --> 02:45:10,450 DATA FOR CALIBRATION AND MOST 3765 02:45:10,450 --> 02:45:11,818 IMPORTANTLY ASSISTED WITH 3766 02:45:11,818 --> 02:45:15,956 CREATION OF NEW MODALITIES AND 3767 02:45:15,956 --> 02:45:19,292 HELPING TO BE DEVELOPING FOR THE 3768 02:45:19,292 --> 02:45:24,731 THERAPY AND MR. SO YOU CAN SEE 3769 02:45:24,731 --> 02:45:26,466 BROAD ASPECT TOWARD DEVELOPMENT 3770 02:45:26,466 --> 02:45:30,403 AND CREATING NEW PARTNERSHIP. SO 3771 02:45:30,403 --> 02:45:34,407 AS PART OF FIRST CONCEPT AND GET 3772 02:45:34,407 --> 02:45:36,977 TO EXPEND THE PHANTOM LIBRARY 3773 02:45:36,977 --> 02:45:38,578 AND WE ARE TRYING TO CONNECT THE 3774 02:45:38,578 --> 02:45:40,680 FEDERAL AGENCIES AND IMAGING 3775 02:45:40,680 --> 02:45:43,583 COMMUNITY IN ORDER TO SHARE AND 3776 02:45:43,583 --> 02:45:45,518 DISSIMILAR NATE THIS PHANTOM AND 3777 02:45:45,518 --> 02:45:48,121 RELATED RESOURCES. TO DO THIS WE 3778 02:45:48,121 --> 02:45:50,790 ARE THINKING ABOUT ESTABLISHMENT 3779 02:45:50,790 --> 02:45:52,859 OF PHANTOM LIBRARY WITHIN THE 3780 02:45:52,859 --> 02:45:54,861 DATA CENTER TO CREATE SECOND 3781 02:45:54,861 --> 02:45:58,965 SITE FOR CURRENT LIBRARY WE 3782 02:45:58,965 --> 02:46:00,700 HAVE. TO GET THIS STARTED WOULD 3783 02:46:00,700 --> 02:46:02,202 LIKE TO START WITH EXISTING 3784 02:46:02,202 --> 02:46:06,506 PHANTOM AT THE FCA AND TRANSFER 3785 02:46:06,506 --> 02:46:08,808 THIS INCLUDE THE OC PHANTOM. AS 3786 02:46:08,808 --> 02:46:14,414 I MENTIONED ONE EXAMPLE, MODULE 3787 02:46:14,414 --> 02:46:22,188 PHANTOM WITH MELAMINE WITH 3788 02:46:22,188 --> 02:46:23,490 TISSUE VARIABILITY AND WOULD 3789 02:46:23,490 --> 02:46:25,592 LIKE TO SEND TO SHARE WITH THE 3790 02:46:25,592 --> 02:46:29,496 COMMUNITY. AS PARTNER IN THIS 3791 02:46:29,496 --> 02:46:32,465 INITIATIVE WOULD LIKE TO 3792 02:46:32,465 --> 02:46:33,900 CHARACTERIZE AS NEEDED. OUR HOPE 3793 02:46:33,900 --> 02:46:36,469 IS DEVELOP BEST PRACTICES, CURE 3794 02:46:36,469 --> 02:46:39,839 RADIATION AND COMPREHENSIVE 3795 02:46:39,839 --> 02:46:45,045 DOCUMENTATION SO WE CAN HAVE 3796 02:46:45,045 --> 02:46:48,948 PHANTOMS DISSEMINATED TO PUBLIC. 3797 02:46:48,948 --> 02:46:51,651 OUR NEXT APPROACH IS TO SUPPORT 3798 02:46:51,651 --> 02:46:54,454 EXISTING PHANTOM WITHIN 3799 02:46:54,454 --> 02:46:57,390 COMMUNITY AND ALSO SUPPORT 3800 02:46:57,390 --> 02:46:58,224 OPTIMIZATION, CHARACTERIZATION 3801 02:46:58,224 --> 02:47:01,561 OF THIS WITHIN A COMMUNITY. WE 3802 02:47:01,561 --> 02:47:04,097 CAN LEVERAGE EXISTING 3803 02:47:04,097 --> 02:47:05,565 DEVELOPMENT AND SHARING. AGAIN 3804 02:47:05,565 --> 02:47:08,101 OUR HOPE IS DEVELOP REPRODUCIBLE 3805 02:47:08,101 --> 02:47:10,103 AND CALIBRATED PHANTOM FOR ALL 3806 02:47:10,103 --> 02:47:13,773 DIFFERENT MODALITIES. THIS 3807 02:47:13,773 --> 02:47:17,043 INCLUDE OPTICAL MRI AND ACOUSTIC 3808 02:47:17,043 --> 02:47:19,145 AND ULTRA ACCUSE TIM AND 3809 02:47:19,145 --> 02:47:22,649 CREATING THE BEST PRACTICES 3810 02:47:22,649 --> 02:47:25,485 RELEVANT DOCUMENTATION. OUR HOPE 3811 02:47:25,485 --> 02:47:29,189 IS INCORPORATE WITHIN BETA 3812 02:47:29,189 --> 02:47:31,524 CENTER AND HAVE THE PARTNER TO 3813 02:47:31,524 --> 02:47:33,093 CAPTURE PHANTOMS AS THEY COME IN 3814 02:47:33,093 --> 02:47:37,497 FROM THE COMMUNITY AND CURE RATE 3815 02:47:37,497 --> 02:47:41,835 THIS AS THEY COME THROUGH THE 3816 02:47:41,835 --> 02:47:45,405 LIBRARY. ON MORE LARGER SCALE 3817 02:47:45,405 --> 02:47:47,006 APPROACH IS TO ADVANCE THROUGH 3818 02:47:47,006 --> 02:47:50,143 INDUSTRY ACADEMIC PARTNERSHIP. 3819 02:47:50,143 --> 02:47:51,911 MORE OF FIRST OF ITS KIND 3820 02:47:51,911 --> 02:47:53,980 CONCEPT IN TERMS OF CREATING 3821 02:47:53,980 --> 02:48:00,253 MULTI SECTOR COLLABORATIVE 3822 02:48:00,253 --> 02:48:04,224 EFFORT. WE ARE STARTING WITH 3823 02:48:04,224 --> 02:48:05,758 OPTICAL PHANTOM BUT OUR HOPE IS 3824 02:48:05,758 --> 02:48:07,994 TO EXTEND BEYOND THAT. THIS IS 3825 02:48:07,994 --> 02:48:10,730 -- OUR HOPE IS ALSO FOR THIS 3826 02:48:10,730 --> 02:48:13,366 PARTNERSHIP TO BE ABLE TO 3827 02:48:13,366 --> 02:48:15,301 FACILITATE REGULATORY APPROVAL 3828 02:48:15,301 --> 02:48:17,203 AND ACCELERATE TRANSLATION OF 3829 02:48:17,203 --> 02:48:20,874 DEVICES. WE ARE TAKING WHOLE 3830 02:48:20,874 --> 02:48:22,909 HOLISTIC APPROACH HERE. MODEL 3831 02:48:22,909 --> 02:48:27,147 THINKING OF HAVING HEAD BASED ON 3832 02:48:27,147 --> 02:48:28,748 INTERAGENCY COLLABORATIVE MODEL 3833 02:48:28,748 --> 02:48:30,517 OF THE INDUSTRY UNIVERSITY 3834 02:48:30,517 --> 02:48:32,585 COLLABORATIVE CENTER , IRC 3835 02:48:32,585 --> 02:48:36,923 MODEL, BASED ON NSF. HERE IS 3836 02:48:36,923 --> 02:48:42,562 THAT UNIVERSITY PROVIDE CENTER 3837 02:48:42,562 --> 02:48:44,697 AND BUILDING AND PROVIDING THE 3838 02:48:44,697 --> 02:48:46,900 SUPPORT IN TERMS OF WHAT IS 3839 02:48:46,900 --> 02:48:48,735 NEEDED FOR THE INDUSTRIAL 3840 02:48:48,735 --> 02:48:50,436 MARKETS. GOVERNMENT AGENCIES CAN 3841 02:48:50,436 --> 02:48:53,473 SUPPORT RND USE OF THE FACILITY, 3842 02:48:53,473 --> 02:48:57,076 PROVIDE GUIDANCE. FOR EXAMPLE 3843 02:48:57,076 --> 02:48:59,779 TOWARD REGULATORY ASSISTANCE OF 3844 02:48:59,779 --> 02:49:02,582 PHANTOMS DEVELOPED. I HOPE FOR 3845 02:49:02,582 --> 02:49:12,292 THE IRC BASED MODEL IS CREATE A 3846 02:49:12,292 --> 02:49:14,060 NOVEL PHANTOM RELATED TO IMAGING 3847 02:49:14,060 --> 02:49:15,728 STANDARDS THAT CAN BE 3848 02:49:15,728 --> 02:49:17,130 INCORPORATED WITHIN CURRENT 3849 02:49:17,130 --> 02:49:18,831 EXISTING STANDARDS AND 3850 02:49:18,831 --> 02:49:22,302 INCORPORATED WITHIN BETA 3851 02:49:22,302 --> 02:49:24,270 CENTERS. SO AS ARE COMING IN AND 3852 02:49:24,270 --> 02:49:25,138 DEVELOPED THROUGH THE 3853 02:49:25,138 --> 02:49:27,574 MULTI AGENCY MODEL, WILL BE 3854 02:49:27,574 --> 02:49:34,047 DISSEMINATED THROUGH THE PHANTOM 3855 02:49:34,047 --> 02:49:35,782 LIBRARY. WITH THAT I WOULD LIKE 3856 02:49:35,782 --> 02:49:39,285 TO THANK MANY AMAZING 3857 02:49:39,285 --> 02:49:43,323 COLLABORATORS. DR. LU, ALICE 3858 02:49:43,323 --> 02:49:46,025 MOTH, DR. GOING, GILL AND BRUCE 3859 02:49:46,025 --> 02:49:48,761 AND NIB DR. FLAT MORGAN AND 3860 02:49:48,761 --> 02:49:49,963 WHITEMAN FOR THEIR SUPPORT AS 3861 02:49:49,963 --> 02:49:53,933 ARE THE FDA COLLEAGUES HERE 3862 02:49:53,933 --> 02:49:56,369 TODAY. NES COLLEAGUE HELP 3863 02:49:56,369 --> 02:49:59,372 IMMENSELY FOR THE LIBRARY. TRAP 3864 02:49:59,372 --> 02:50:02,242 MEDICAL IMAGING PHANTOM GROUP, 3865 02:50:02,242 --> 02:50:03,343 COMPROMISE DIFFERENT INSTITUTE 3866 02:50:03,343 --> 02:50:09,949 AS WELL AS VA HOSPITAL, NSF AND 3867 02:50:09,949 --> 02:50:11,317 OFFICE OF COMMUNICATION. WITH 3868 02:50:11,317 --> 02:50:13,319 THAT I WOULD LIKE TO END MY 3869 02:50:13,319 --> 02:50:16,256 PRESENTATION AND HAPPY TO ANSWER 3870 02:50:16,256 --> 02:50:26,799 QUESTION YOU MIGHT HAVE. I SEE 3871 02:50:31,304 --> 02:50:34,774 JENNIFER'S HAND IS UP. 3872 02:50:34,774 --> 02:50:36,309 >> THANK YOU. THAT IS EXCITED 3873 02:50:36,309 --> 02:50:37,677 AND NEEDED BY THE COMMUNITY. 3874 02:50:37,677 --> 02:50:38,811 WANTED TO MAKE A COMMENT ABOUT 3875 02:50:38,811 --> 02:50:41,514 THE DEVELOPMENT OF PHANTOMS FOR 3876 02:50:41,514 --> 02:50:42,915 OPTICAL IMAGING. I THINK THEY 3877 02:50:42,915 --> 02:50:45,018 ARE PARTICULARLY NEEDED THERE. 3878 02:50:45,018 --> 02:50:46,352 SO I REAL APPRECIATE THAT. ONE 3879 02:50:46,352 --> 02:50:48,655 OF THE OTHER CHALLENGES WITH 3880 02:50:48,655 --> 02:50:51,324 OPTICAL IMAGING IS IT IS LESS 3881 02:50:51,324 --> 02:50:53,459 ESTABLISHED FIELD, AT LEAST FOR 3882 02:50:53,459 --> 02:50:55,828 MOST OPTICAL MODALITIES. CT 3883 02:50:55,828 --> 02:50:57,797 THERE, IS A WHOLE VARIETY OF 3884 02:50:57,797 --> 02:51:02,135 SYSTEMS. WORK ON DIFFERPRINCIPL 3885 02:51:02,135 --> 02:51:03,336 HAVE DIFFERENT WAYS TO ACQUIRE 3886 02:51:03,336 --> 02:51:06,906 AND PROCESS SIGNAL. I HOPE THAT 3887 02:51:06,906 --> 02:51:09,142 AS PART THERE COULD BE GUIDANCE. 3888 02:51:09,142 --> 02:51:10,677 MAYBE NOT EVEN REALISTIC TO SAY 3889 02:51:10,677 --> 02:51:13,446 WHAT PARAMETERS YOU SHOULD USE 3890 02:51:13,446 --> 02:51:15,515 WHEN IMAGING BUT HOW TO DOCUMENT 3891 02:51:15,515 --> 02:51:18,084 WHICH PARAMETERS SHOULD BE 3892 02:51:18,084 --> 02:51:20,987 DOCUMENTED I THINK WOULD BE A 3893 02:51:20,987 --> 02:51:21,354 HUGE HELP. 3894 02:51:21,354 --> 02:51:23,356 >> THANK YOU. ABSOLUTELY. 3895 02:51:23,356 --> 02:51:28,728 THAT IS PART OF OUR HOPE FOR 3896 02:51:28,728 --> 02:51:30,630 THESE BEING DEVELOPED. THIS IS 3897 02:51:30,630 --> 02:51:34,233 BROAD. OUR HOPE IS START WITH 3898 02:51:34,233 --> 02:51:37,937 COUPLE OF THESE TO BRING THIS TO 3899 02:51:37,937 --> 02:51:39,739 POINT OF WHAT OTHER SIGNAL, HOW 3900 02:51:39,739 --> 02:51:44,310 LOOK LIKE, WHAT ARE SOME OF THE 3901 02:51:44,310 --> 02:51:48,848 BASIC TO BE INCLUDED. DEFINITELY 3902 02:51:48,848 --> 02:51:53,553 POINT WELL TAKEN. THANK YOU. 3903 02:51:53,553 --> 02:51:54,821 DOCTOR, SEE YOUR HAND UP. 3904 02:51:54,821 --> 02:51:56,522 >> YES. THANK YOU FOR THE 3905 02:51:56,522 --> 02:51:57,323 PRESENTATION. I UNDERSTAND THIS 3906 02:51:57,323 --> 02:51:59,158 IS A REALLY COMPLEX AREA, FOR 3907 02:51:59,158 --> 02:52:02,628 SURE. THE HEADWAY YOU ARE MAKING 3908 02:52:02,628 --> 02:52:05,064 IS WELCOME. FOR SURE. I WONDER 3909 02:52:05,064 --> 02:52:08,034 WHAT YOU MIGHT THINK ABOUT THE 3910 02:52:08,034 --> 02:52:09,469 ROLE OF OPEN SOURCE 3911 02:52:09,469 --> 02:52:11,204 DISSEMINATION IN SOME ASPECTS. 3912 02:52:11,204 --> 02:52:14,440 NOT NECESSARILY BY ALL THE 3913 02:52:14,440 --> 02:52:16,776 PHANTOM DEVELOPMENT. I THINK IF 3914 02:52:16,776 --> 02:52:24,450 I'M WONDERING IS THERE A 3915 02:52:24,450 --> 02:52:26,352 STRIPPED DOWN LOCALLY PRODUCED 3916 02:52:26,352 --> 02:52:28,788 WITH RAPID GUIDELINES, RAPID 3917 02:52:28,788 --> 02:52:29,722 TECHNOLOGY, PARTICULARLY WITH 3918 02:52:29,722 --> 02:52:31,424 NEED FOR VERIFICATION OR 3919 02:52:31,424 --> 02:52:34,727 CALIBRATION. JUST INTERESTED IN 3920 02:52:34,727 --> 02:52:44,971 YOUR THOUGHT, THANKS. WE ARE 3921 02:52:44,971 --> 02:52:47,774 HOPING ON A BROADER APPROACH. 3922 02:52:47,774 --> 02:52:49,308 AND FOCUSSING ON SPECIFIC AREAS 3923 02:52:49,308 --> 02:52:56,115 OF THE PHANTOM DEVELOPMENT. YOU 3924 02:52:56,115 --> 02:52:57,850 MENTIONED THE SPECIFIC WORDING. 3925 02:52:57,850 --> 02:52:59,585 IF YOU CAN REPEAT THAT AGAIN FOR 3926 02:52:59,585 --> 02:52:59,886 ME. 3927 02:52:59,886 --> 02:53:02,355 >> I WAS JUST CURIOUS ABOUT 3928 02:53:02,355 --> 02:53:04,357 ROLE THAT OPEN SOURCE MIGHT PLAY 3929 02:53:04,357 --> 02:53:06,225 AS A COMPLEMENT -- 3930 02:53:06,225 --> 02:53:07,427 >> OPEN SOURCE, EVERYTHING 3931 02:53:07,427 --> 02:53:11,731 HAS GOOD AND BAD. WE ARE HOPING 3932 02:53:11,731 --> 02:53:14,901 THAT A COMMUNITY CAN USE THESE. 3933 02:53:14,901 --> 02:53:19,205 CAN GIVE FEEDBACK FROM PHANTOM 3934 02:53:19,205 --> 02:53:21,407 USERS. SO TENDING THESE TO THE 3935 02:53:21,407 --> 02:53:23,910 COMMUNITY AND FOR EXAMPLE AS 3936 02:53:23,910 --> 02:53:25,445 EXAMPLE. TRYING TO INTRODUCE 3937 02:53:25,445 --> 02:53:29,182 SOME. IT WILL COME BACK TO WHILE 3938 02:53:29,182 --> 02:53:35,087 THIS WORKED OR INTRACK TIF 3939 02:53:35,087 --> 02:53:37,557 MODEL. THEY CAN TELL US WHAT 3940 02:53:37,557 --> 02:53:41,260 SHOULD BE DONE. THIS PARTICULAR 3941 02:53:41,260 --> 02:53:44,063 PRACTICE. WORK BETTER FOR US IF 3942 02:53:44,063 --> 02:53:47,467 CAN INTEGRATE WITHIN OUR MODEL. 3943 02:53:47,467 --> 02:53:53,139 SO THAT IS ONE HOPE. KNOW FDA 3944 02:53:53,139 --> 02:53:54,474 HAS OPEN SOURCE. YOU CAN ALLUDE 3945 02:53:54,474 --> 02:53:59,145 TO THAT AS WELL. HOW GOING TO 3946 02:53:59,145 --> 02:54:00,012 INCORPORATE THAT WITHIN OUR 3947 02:54:00,012 --> 02:54:01,080 SYSTEM. 3948 02:54:01,080 --> 02:54:04,851 >> I WILL JUST ADD TO YOUR 3949 02:54:04,851 --> 02:54:07,353 ANSWER. THE FDA SIDE, ALL IS 3950 02:54:07,353 --> 02:54:09,155 OPEN SOURCE. WE HAVE A CATALOG. 3951 02:54:09,155 --> 02:54:12,625 HAD INSTRUCTIONS ON HOW TO BUILD 3952 02:54:12,625 --> 02:54:14,260 EVERY ONE WE ARE PUTTING INTO 3953 02:54:14,260 --> 02:54:17,230 THIS. THE ISSUE YOU ARE RUNNING 3954 02:54:17,230 --> 02:54:19,899 IT, 82% OF DEVICE COMPANIES ARE 3955 02:54:19,899 --> 02:54:21,367 SMALL. I DON'T HAVE A SPECIALIST 3956 02:54:21,367 --> 02:54:22,668 OR SOMEBODY THAT CAN BUILD IT 3957 02:54:22,668 --> 02:54:24,070 THAT. IS WHERE THE PHANTOM 3958 02:54:24,070 --> 02:54:29,175 LIBRARY COMES IN. IS THE ABILITY 3959 02:54:29,175 --> 02:54:31,310 TO AUGMENT, WHERE THEY DON'T 3960 02:54:31,310 --> 02:54:33,012 HAVE RESOURCES TO ACTUALLY 3961 02:54:33,012 --> 02:54:35,281 REPLICATE THAT PHANTOM. WE 3962 02:54:35,281 --> 02:54:36,315 ABSOLUTELY WOULD LOVE EVERYBODY 3963 02:54:36,315 --> 02:54:38,017 TAKE WHAT WE PUT AND BUILD IT. 3964 02:54:38,017 --> 02:54:40,052 BUT THEY DON'T HAVE THE 3965 02:54:40,052 --> 02:54:41,521 RESOURCES. ESPECIALLY LIKE THE 3966 02:54:41,521 --> 02:54:44,690 OCT PHANTOM -- WE HAVE OPTICS 3967 02:54:44,690 --> 02:54:47,426 FAN ON THE THAT REQUIRES A 3968 02:54:47,426 --> 02:54:48,928 NANOSCRIBE. THERE IS ONLY A FEW 3969 02:54:48,928 --> 02:54:50,429 IN COUNTRY AVAILABLE TO ANYBODY. 3970 02:54:50,429 --> 02:54:55,234 SO WE ARE TRYING TO AUGMENT THAT 3971 02:54:55,234 --> 02:55:01,140 OVERALL CAPABILITY. SO WE TRYING 3972 02:55:01,140 --> 02:55:03,342 TO MAKE THIS OPEN SOURCE SO THE 3973 02:55:03,342 --> 02:55:05,378 ENTIRE COMMUNITY CAN 3974 02:55:05,378 --> 02:55:06,479 BENEFIT .ENTER 3975 02:55:06,479 --> 02:55:10,416 >> I SEE YOUR HAND IS UP. 3976 02:55:10,416 --> 02:55:12,151 3977 02:55:12,151 --> 02:55:15,288 >> VERY EXCITING WORK. THANK 3978 02:55:15,288 --> 02:55:16,722 YOU FOR THE EFFORT. I KNOW 3979 02:55:16,722 --> 02:55:19,492 SITCOM MRI KATED, AS THEY 3980 02:55:19,492 --> 02:55:22,528 SAY .ENTER WE HAVE HAD INTEREST 3981 02:55:22,528 --> 02:55:24,463 IN TISSUE PHANTOM, ESPECIALLY 3982 02:55:24,463 --> 02:55:26,566 AFTER THE DISCUSSION OF WORKING 3983 02:55:26,566 --> 02:55:30,102 ON CHIP FOR IMAGING. HAS THAT 3984 02:55:30,102 --> 02:55:31,437 BEEN PART OF DISCUSSION OR I 3985 02:55:31,437 --> 02:55:34,473 APPRECIATE YOUR THOUGHTS, THANK 3986 02:55:34,473 --> 02:55:34,674 YOU. 3987 02:55:34,674 --> 02:55:36,709 >> ABSOLUTELY. I KNOW SOME OF 3988 02:55:36,709 --> 02:55:39,211 THE EXAMPLE WAS MOSTLY RELATED 3989 02:55:39,211 --> 02:55:41,147 TO OPTICAL BUT THIS IS JUST THE 3990 02:55:41,147 --> 02:55:43,249 START, BEGINNING. OUR HOPE IS WE 3991 02:55:43,249 --> 02:55:45,418 CAN HAVE A WIDE VARIETY OF 3992 02:55:45,418 --> 02:55:48,754 PHANTOMS FOR AS MENTIONED FOR 3993 02:55:48,754 --> 02:55:51,390 THOR TISSUE IMAGING PHANTOM. NOT 3994 02:55:51,390 --> 02:55:54,961 JUST OPTICAL IMAGING. WE HAVE A 3995 02:55:54,961 --> 02:55:56,829 WHOLE LIBRARY MR BUT AS 3996 02:55:56,829 --> 02:55:59,165 EXPANDING WILL DEFINITELY TAKE 3997 02:55:59,165 --> 02:56:02,168 THAT INTO CONSIDERATION AND 3998 02:56:02,168 --> 02:56:04,003 MAKING SURE. WE WOULD LOVE TO 3999 02:56:04,003 --> 02:56:05,771 HAVE YOUR INPUT. WE NEED INPUT 4000 02:56:05,771 --> 02:56:07,340 FROM THE COMMUNITY SO MAKE SURE 4001 02:56:07,340 --> 02:56:09,475 AS YOU ARE GOING THROUGH THIS 4002 02:56:09,475 --> 02:56:11,177 AND THINKING OF THE NEW PHANTOMS 4003 02:56:11,177 --> 02:56:12,912 OR TYPES, PLEASE LET US KNOW 4004 02:56:12,912 --> 02:56:16,082 THAT. WILL HELP US BUILD THIS 4005 02:56:16,082 --> 02:56:17,350 LIBRARY BETTER AND MORE USEFUL 4006 02:56:17,350 --> 02:56:22,588 FOR THE COMMUNITY AS WELL. 4007 02:56:22,588 --> 02:56:26,692 >> I WILL ADD IN AGAIN 4008 02:56:26,692 --> 02:56:29,095 BECAUSE FDA IS VERY INVOLVED. A 4009 02:56:29,095 --> 02:56:31,364 LOT IS TISSUE BOUND. LOT OF 4010 02:56:31,364 --> 02:56:33,532 THINGS YOU TRY TO PROVE IN 4011 02:56:33,532 --> 02:56:34,600 SAFETY AND EFFECTIVENESS WHEN 4012 02:56:34,600 --> 02:56:37,436 YOU COME TO AGENCY ARE DIFFICULT 4013 02:56:37,436 --> 02:56:39,138 TO PRO IF YOU DON'T HAVE A 4014 02:56:39,138 --> 02:56:41,874 TISSUE PHANTOM, SOMETHING THAT 4015 02:56:41,874 --> 02:56:44,210 REPLICATES WHAT YOU TRYING TO 4016 02:56:44,210 --> 02:56:45,878 OBSERVE. A LOT IS FISH YOU 4017 02:56:45,878 --> 02:56:48,681 PHANTOM BASED. OTHERS IS OPEN OF 4018 02:56:48,681 --> 02:56:50,016 COURSE TO WHATEVER IS MOST 4019 02:56:50,016 --> 02:56:52,918 IMPORTANT TO MEDICAL DEVICE 4020 02:56:52,918 --> 02:56:55,655 COMMUNITY AND THEIR NEEDS. 4021 02:56:55,655 --> 02:56:58,891 >> YOUR HAND IS UP. 4022 02:56:58,891 --> 02:57:04,897 >> YAH, THANK YOU. AS I WAS 4023 02:57:04,897 --> 02:57:06,565 LISTENING I WAS A LITTLE 4024 02:57:06,565 --> 02:57:11,337 CONFUSED HERE IN THAT THERE IS 4025 02:57:11,337 --> 02:57:17,843 AN INTRAMURAL AT BETA CENTER. IS 4026 02:57:17,843 --> 02:57:19,478 THIS A CONCEPT THAT WOULD SEEK 4027 02:57:19,478 --> 02:57:23,149 AT SOME POINT PROGRAMS THAT 4028 02:57:23,149 --> 02:57:26,652 WOULD BRING IN EXTRAMURAL PEOPLE 4029 02:57:26,652 --> 02:57:30,056 TO BUILD THESE PHANTOMS, THEN 4030 02:57:30,056 --> 02:57:33,459 GET DISTRIBUTED WITHIN THE 4031 02:57:33,459 --> 02:57:35,027 INTRAMURAL PROGRAM THROUGH BETA? 4032 02:57:35,027 --> 02:57:39,432 I DON'T BELIEVE THESE ARE BUILT 4033 02:57:39,432 --> 02:57:43,903 INTERNALLY IN INTERMURAL 4034 02:57:43,903 --> 02:57:44,637 PROGRAM. PERHAPS YOU COULD GIVE 4035 02:57:44,637 --> 02:57:47,306 CLARITY ABOUT WHAT IS THIS FOR 4036 02:57:47,306 --> 02:57:50,810 FOR SUPPORTING BURN BUILDING OF 4037 02:57:50,810 --> 02:57:54,480 THESE? IN WHICH CASE WITH WHICH 4038 02:57:54,480 --> 02:57:57,216 COMMUNITY? ASPECT DISTRIBUTING 4039 02:57:57,216 --> 02:58:01,520 THESE INTRAMURALLY OR 4040 02:58:01,520 --> 02:58:01,887 EXTRAMURALLY. 4041 02:58:01,887 --> 02:58:03,956 >> THANK YOU. SO BETA STERN 4042 02:58:03,956 --> 02:58:08,260 WAS CREATED AS A COMMUNITY TO 4043 02:58:08,260 --> 02:58:11,297 BRING ALL THE IC AND NIH TO WORK 4044 02:58:11,297 --> 02:58:14,667 ON COMMON PROBLEM AND BE ABLE TO 4045 02:58:14,667 --> 02:58:18,537 COMMUNICATE WITH OUTSIDE SUCH AS 4046 02:58:18,537 --> 02:58:19,338 UNIVERSITY, INDUSTRY OR WHOEVER 4047 02:58:19,338 --> 02:58:20,840 IS INTERESTED. THE CONCEPT OF 4048 02:58:20,840 --> 02:58:25,077 YOUR THINKING, AS I MENTIONED I 4049 02:58:25,077 --> 02:58:28,981 HAD THE LIBRARY PREVIOUSLY SO 4050 02:58:28,981 --> 02:58:31,584 CURRENTLY THE DECISIVENESS SO 4051 02:58:31,584 --> 02:58:34,787 TRYING TO REPLICATE EXACT SAME 4052 02:58:34,787 --> 02:58:36,555 MODEL THROUGH THE BETA CENTER. 4053 02:58:36,555 --> 02:58:38,824 SO BETA CENTER WILL BE RESOURCE 4054 02:58:38,824 --> 02:58:40,693 FOR OUTSIDE COMMUNITY AND 4055 02:58:40,693 --> 02:58:42,695 UNIVERSITIES FOR EXAMPLE SHARE 4056 02:58:42,695 --> 02:58:49,502 PHANTOM, RECEIVE FPHANTOM, LEAR 4057 02:58:49,502 --> 02:58:51,003 AND USE FOR DEVICES THEY 4058 02:58:51,003 --> 02:58:55,341 CURRENTLY HAVE. IT WOULD BE AS A 4059 02:58:55,341 --> 02:58:58,878 RESOURCE CENTER TO SHARE WITH 4060 02:58:58,878 --> 02:59:00,412 THE COMMUNITY. THAT WOULD BE THE 4061 02:59:00,412 --> 02:59:07,119 MAIN PURPOSE OF THE BETA STECEN. 4062 02:59:07,119 --> 02:59:08,954 >> IF I UNDERSTAND, BETA 4063 02:59:08,954 --> 02:59:10,422 CENTER WOULD BE SUPPORTED IN 4064 02:59:10,422 --> 02:59:15,027 THEIR EFFORT TO BE LIKING A 4065 02:59:15,027 --> 02:59:17,229 GATOR OF PHANTOM AND DISTRIBUTOR 4066 02:59:17,229 --> 02:59:21,901 BUT THEY ARE NOT MAKING THOSE? 4067 02:59:21,901 --> 02:59:23,035 >> NO. 4068 02:59:23,035 --> 02:59:25,304 >> THERE IS NO NEW PHANTOMS 4069 02:59:25,304 --> 02:59:30,843 CREATED IN THIS PROCESS? LIKE 4070 02:59:30,843 --> 02:59:33,813 NIV IS NOT SUPPORTING BUT 4071 02:59:33,813 --> 02:59:36,549 SUPPORTING INTRAMURAL BETA 4072 02:59:36,549 --> 02:59:44,323 CENTER TO BEING A THE 4073 02:59:44,323 --> 02:59:44,723 AGGREGATOR. 4074 02:59:44,723 --> 02:59:46,892 >> IT COULD GO BOTH WAYS. AS 4075 02:59:46,892 --> 02:59:49,695 YOU ARE ENVISIONING, AS THESE 4076 02:59:49,695 --> 02:59:54,266 ARE BEING DEVELOPED FROM THE 4077 02:59:54,266 --> 02:59:57,937 MODEL, WE ARE HOPING RESOURCE 4078 02:59:57,937 --> 03:00:02,775 SHARING PART THESE CAN BE 4079 03:00:02,775 --> 03:00:05,811 DISTRIBUTED, THEY CAN BE SENT TO 4080 03:00:05,811 --> 03:00:06,946 CENTER AND DISSEMINATED TO 4081 03:00:06,946 --> 03:00:10,115 PUBLIC AS GOVERNMENT RESOURCE SO 4082 03:00:10,115 --> 03:00:12,284 THE NEW PHANTOMS DEVELOPED BY 4083 03:00:12,284 --> 03:00:13,285 THE COMMUNITY OR CURRENTLY 4084 03:00:13,285 --> 03:00:16,856 EXISTING FOR EXAMPLE IN TERMS OF 4085 03:00:16,856 --> 03:00:18,591 FDA WHERE THEY ARE CURRENT AND 4086 03:00:18,591 --> 03:00:21,927 SHARED THROUGH BETA CENTER THAT 4087 03:00:21,927 --> 03:00:27,299 CAN BE SHARED TOWARD THE 4088 03:00:27,299 --> 03:00:29,435 COMMUNITY. AT THIS POINT NOT 4089 03:00:29,435 --> 03:00:31,337 ENVISIONS BUT DEFINITELY AGAIN 4090 03:00:31,337 --> 03:00:34,306 POINT WELL TAKEN. CAN GO AHEAD 4091 03:00:34,306 --> 03:00:37,843 AND THINK ABOUT THOSE. BUT I SAW 4092 03:00:37,843 --> 03:00:40,913 YOU CAME ONLINE. IF YOU HAVE ANY 4093 03:00:40,913 --> 03:00:41,847 OTHER COMMENTS I WOULD 4094 03:00:41,847 --> 03:00:42,514 APPRECIATE IT. 4095 03:00:42,514 --> 03:00:44,016 >> SURE. BRIEFLY, GREAT 4096 03:00:44,016 --> 03:00:46,085 THING, RANU. WE ARE THINKING 4097 03:00:46,085 --> 03:00:48,454 BETA CENTER WOULD BE MORE OF 4098 03:00:48,454 --> 03:00:49,588 ADMINISTRATIVE HOME FOR THIS AS 4099 03:00:49,588 --> 03:00:53,459 WE GET STARTED SO SOME OF THE 4100 03:00:53,459 --> 03:00:55,294 SUPPORT WE COULD PROVIDE, 4101 03:00:55,294 --> 03:00:57,830 STORAGE AREAS COULD BE 4102 03:00:57,830 --> 03:01:02,201 SUPPORTIVE TO PHANTOM LIBRARY. 4103 03:01:02,201 --> 03:01:06,272 >> THANK YOU FOR THE 4104 03:01:06,272 --> 03:01:11,343 CLARIFICATION, BOTH OF YOU. 4105 03:01:11,343 --> 03:01:16,982 4106 03:01:16,982 --> 03:01:18,717 >> DOCTOR, YOUR HAND IS UP. 4107 03:01:18,717 --> 03:01:20,853 >> YES, I APPLAUD YOU FOR 4108 03:01:20,853 --> 03:01:23,756 THIS EFFORT. DEVELOPING PHANTOMS 4109 03:01:23,756 --> 03:01:29,461 AND STANDARDIZING IS JUST 4110 03:01:29,461 --> 03:01:31,630 CRITICAL. WE WORKED IN THE SPACE 4111 03:01:31,630 --> 03:01:35,567 QUITE A BIT. I THINK ONE OF THIS 4112 03:01:35,567 --> 03:01:38,637 THINGS THAT MIGHT BE WORTH 4113 03:01:38,637 --> 03:01:41,173 VETTING, ONE OF THE CHALLENGES 4114 03:01:41,173 --> 03:01:42,474 IS CALIBRATION. PARTICULARLY 4115 03:01:42,474 --> 03:01:45,110 WITH THE IDEA OF OUTSOURCING, 4116 03:01:45,110 --> 03:01:47,279 PUTTING OUT PROTOCOLS FOR 4117 03:01:47,279 --> 03:01:47,980 DEVELOPING PHANTOMS WHEN PEOPLE 4118 03:01:47,980 --> 03:01:49,415 ARE DEVELOPING, THEY WANT TO 4119 03:01:49,415 --> 03:01:51,317 BUILD THE PHANTOM AND MIGHT PUT 4120 03:01:51,317 --> 03:01:57,723 A STUDENT ON IT OR SOMETHING. 4121 03:01:57,723 --> 03:01:59,358 THEY DON'T BE HAVE THE ABILITY 4122 03:01:59,358 --> 03:02:00,392 TO CALIBRATE AND CONFIDENCE THEY 4123 03:02:00,392 --> 03:02:02,027 HAVE DONE IT CORRECTLY. I DON'T 4124 03:02:02,027 --> 03:02:04,029 KNOW IF THERE IS A RULE OR MIGHT 4125 03:02:04,029 --> 03:02:05,464 BE WORTH DOING THINKING ABOUT 4126 03:02:05,464 --> 03:02:10,970 HOW TO PROVIDING CALIBRATION SO 4127 03:02:10,970 --> 03:02:15,374 THAT IF YOU OUTSOURCE THE 4128 03:02:15,374 --> 03:02:17,776 PHANTOMS OR RECIPES, SOMEONE 4129 03:02:17,776 --> 03:02:18,978 COULD SEND, HAVE KAL BAITED AND 4130 03:02:18,978 --> 03:02:21,480 COME BACK. A LOT DON'T HAVE THAT 4131 03:02:21,480 --> 03:02:22,247 CALIBRATION TOOL THEMSELVES. 4132 03:02:22,247 --> 03:02:24,717 THEY ARE COMING UP WITH A NEW 4133 03:02:24,717 --> 03:02:25,818 INNOVATED WAY TO DO THAT. 4134 03:02:25,818 --> 03:02:27,453 >> THANK YOU. THAT IS AN 4135 03:02:27,453 --> 03:02:30,622 IMPORTANT POINT. THAT IS WHERE 4136 03:02:30,622 --> 03:02:39,865 WE ARE HOPING PARTNERS BECAUSE 4137 03:02:39,865 --> 03:02:43,402 THEY HAVE METHODS FOR 4138 03:02:43,402 --> 03:02:46,105 CALIBRATION FOR LEVEL OF 4139 03:02:46,105 --> 03:02:48,374 MATERIAL AND AS A WHOLE PHANTOM 4140 03:02:48,374 --> 03:02:52,144 AND ALL DETAIL. FOR EXAMPLE IF 4141 03:02:52,144 --> 03:02:53,512 YOU DON'T HAVE ONE, CAN AFFECT 4142 03:02:53,512 --> 03:02:55,247 THE WAY YOUR PHANTOM IS BEING 4143 03:02:55,247 --> 03:03:03,789 MADE. WE ARE HOPING THAT IS WHAT 4144 03:03:03,789 --> 03:03:06,692 THEY ARE DOING, CALIBRATE. 4145 03:03:06,692 --> 03:03:13,232 PHANTOMS COME IN, CALIBRATE 4146 03:03:13,232 --> 03:03:13,932 AGAIN G 4147 03:03:13,932 --> 03:03:14,933 AGAIN AND AGAIN DEPENDING ON USE 4148 03:03:14,933 --> 03:03:17,369 CASE AND SAY THIS HAS BEEN 4149 03:03:17,369 --> 03:03:18,871 CALIBRATED. THIS IS OUR HOPE, 4150 03:03:18,871 --> 03:03:21,073 HAVE THE PARTNERSHIP OF NEST TO 4151 03:03:21,073 --> 03:03:22,641 HELP WITH CALIBRATION OF SOME OF 4152 03:03:22,641 --> 03:03:26,378 THESE AS WE MOVE FORWARD. GREAT 4153 03:03:26,378 --> 03:03:27,046 POINT, THANK YOU. 4154 03:03:27,046 --> 03:03:33,218 4155 03:03:33,218 --> 03:03:36,355 >> THANK YOU VERY MUCH, 4156 03:03:36,355 --> 03:03:39,992 BRUCE, FOR THAT. I'M LIKE HERE 4157 03:03:39,992 --> 03:03:43,228 MAYBE HE IS CLEARER THAN ME. IS 4158 03:03:43,228 --> 03:03:47,099 NIBIB GOING TO FUND THIS? WHAT 4159 03:03:47,099 --> 03:03:52,471 ARE WE-WORKING ON AS 4160 03:03:52,471 --> 03:03:52,838 COUNCILMEMBERS? 4161 03:03:52,838 --> 03:03:54,473 >> THIS IS JUST A CONCEPT. WE 4162 03:03:54,473 --> 03:03:57,076 ARE NOT SAYING THAT -- LIKE SO 4163 03:03:57,076 --> 03:03:58,911 WE ARE ALREADY HAVING THE BETA 4164 03:03:58,911 --> 03:04:00,612 CENTER SO WE ARE USING OUR 4165 03:04:00,612 --> 03:04:03,782 EXISTING CENTER AS RESOURCE TO 4166 03:04:03,782 --> 03:04:07,186 SHARE SOME OF THESE PHANTOMS. 4167 03:04:07,186 --> 03:04:09,021 FOR SOME OF CONCEPTS WE HAVE 4168 03:04:09,021 --> 03:04:12,925 THREE APPROACHES. AGAIN WE ARE 4169 03:04:12,925 --> 03:04:15,027 TRYING TO CLEAR THE CONCEPT, 4170 03:04:15,027 --> 03:04:17,796 HAPPY WITH CONCEPT OF THING 4171 03:04:17,796 --> 03:04:19,098 NEEDED FOR THE COMMUNITY. WHAT 4172 03:04:19,098 --> 03:04:28,874 ELSE CAN WE DO TO MAKE IT 4173 03:04:28,874 --> 03:04:32,177 BETTER. THE HOPE IS EXISTING 4174 03:04:32,177 --> 03:04:33,612 PHANTOM OR DEVELOPING THE 4175 03:04:33,612 --> 03:04:35,314 PHANTOM THEN WE HAVE TO THINK 4176 03:04:35,314 --> 03:04:36,715 ABOUT IF CONFERENCE GETS CLEARED 4177 03:04:36,715 --> 03:04:38,183 WE HAVE TO THINK ABOUT THE 4178 03:04:38,183 --> 03:04:41,487 BUDGET AND ALL DETAILS. AT THIS 4179 03:04:41,487 --> 03:04:43,422 POINT THEY ARE JUST PRESENTING 4180 03:04:43,422 --> 03:04:46,291 CONCEPT TO GET YOUR INPUT TOWARD 4181 03:04:46,291 --> 03:04:50,329 IF THIS IS A GOOD IDEA, SHOULD 4182 03:04:50,329 --> 03:04:51,563 MOVE FORWARD AND WHAT ARE 4183 03:04:51,563 --> 03:04:53,265 THOUGHTS AND DETAILS. STILL HAVE 4184 03:04:53,265 --> 03:04:54,666 TO SIT DOWN AND THINK ABOUT SOME 4185 03:04:54,666 --> 03:05:01,306 OF DETAILS OF THE PARTNERSHIP 4186 03:05:01,306 --> 03:05:02,708 AND BUDGET WE CURRENTLY DO NOT 4187 03:05:02,708 --> 03:05:03,575 HAVE IN HAND. 4188 03:05:03,575 --> 03:05:06,612 >> THIS IS AN EXCELLENT IDEA, 4189 03:05:06,612 --> 03:05:07,079 THANK YOU. 4190 03:05:07,079 --> 03:05:08,981 >> I THINK WE CAN SEE THE 4191 03:05:08,981 --> 03:05:10,749 VIDEO CAME ON. IF YOU HAVE 4192 03:05:10,749 --> 03:05:11,116 INPUT. 4193 03:05:11,116 --> 03:05:14,786 >> YAH, JUST WANTED TO FOLLOW 4194 03:05:14,786 --> 03:05:25,297 UP ON WHAT IS AFROUZ SAID. A 4195 03:05:27,266 --> 03:05:28,333 LIBRARY, FREE OF CHARGE TO 4196 03:05:28,333 --> 03:05:30,936 COMMUNITY TO GET TO LIBRARY? AND 4197 03:05:30,936 --> 03:05:33,639 NIBIB BETA CENTER, WHICH IS, YOU 4198 03:05:33,639 --> 03:05:42,114 KNOW, SUBSET OF THIS UPON FAP 4199 03:05:42,114 --> 03:05:46,251 TOM 4200 03:05:46,251 --> 03:05:50,088 TOM -- PHANTOM LIBRARY. BUT THE 4201 03:05:50,088 --> 03:05:52,191 REASON IS TO SHARE. BUT AT THE 4202 03:05:52,191 --> 03:05:53,692 NIBIB WE PROPOSE TO SUPPORT 4203 03:05:53,692 --> 03:05:56,728 PHANTOM DEVELOPMENTS AND PHANTOM 4204 03:05:56,728 --> 03:05:58,096 CALIBRATION, VALIDATION, 4205 03:05:58,096 --> 03:06:00,532 VERIFICATION AND SUPPORT OF THE 4206 03:06:00,532 --> 03:06:06,972 COMMUNITY TO ACTUALLY WITH OUR 4207 03:06:06,972 --> 03:06:07,673 PART 4208 03:06:07,673 --> 03:06:10,442 PARTNERS, FDA AND NSF, ET 4209 03:06:10,442 --> 03:06:11,677 CETERA, TO DO WHATEVER IS 4210 03:06:11,677 --> 03:06:15,347 NECESSARY. SOMETIMES IN SOME 4211 03:06:15,347 --> 03:06:21,720 CASES LEVERAGE EXISTING PHANTOMS 4212 03:06:21,720 --> 03:06:24,456 ALREADY SCATTERED IN LABORATORY. 4213 03:06:24,456 --> 03:06:27,092 SEVERAL NIH-FUNDED 4214 03:06:27,092 --> 03:06:28,026 INVESTIGATORS. WE NEED A LITTLE 4215 03:06:28,026 --> 03:06:31,330 SUPPORT TO CARRY THAT EXTRA 4216 03:06:31,330 --> 03:06:33,999 MILES TO BE ABLE TO HAVE IT 4217 03:06:33,999 --> 03:06:40,806 CALIBRATED AND VERIFIED SO 4218 03:06:40,806 --> 03:06:44,309 LIBRARY CAN TAKE AND THIS CAN 4219 03:06:44,309 --> 03:06:48,614 BECOME A RESOURCE TO LEND TO THE 4220 03:06:48,614 --> 03:06:51,049 COMMUNITY TO HELP THEM DO BETTER 4221 03:06:51,049 --> 03:06:52,985 WITH QUANTITATIVE IMAGING. TO 4222 03:06:52,985 --> 03:06:57,022 ANSWER YOUR QUESTION, RANU AND 4223 03:06:57,022 --> 03:07:00,959 SAM. YES, PROPOSING BOTH AS 4224 03:07:00,959 --> 03:07:05,097 RESOURCE SHARING BUT ALSO TO 4225 03:07:05,097 --> 03:07:08,934 EXPAND EXISTING LIBRARY FUNDING 4226 03:07:08,934 --> 03:07:14,473 WHEN NEEDED. 4227 03:07:14,473 --> 03:07:17,009 >> RHONDA, YOU SHOULD GO 4228 03:07:17,009 --> 03:07:18,543 AHEAD. I'M GOING TO HAVE LAST 4229 03:07:18,543 --> 03:07:20,078 WORDS, SUMMARY COMMENTS SO YOU 4230 03:07:20,078 --> 03:07:22,114 SHOULD GO AHEAD. 4231 03:07:22,114 --> 03:07:23,615 >> THANK YOU. SO I'M COMING 4232 03:07:23,615 --> 03:07:25,617 FROM LITTLE OUTSIDE THE FIELD 4233 03:07:25,617 --> 03:07:28,920 BUT TRYING TO LOOK THIS BECOMES 4234 03:07:28,920 --> 03:07:29,521 SUCCESSFUL. CLEARLY WE NEED 4235 03:07:29,521 --> 03:07:32,591 STANDARDIZED PHANTOMS THAT COULD 4236 03:07:32,591 --> 03:07:34,293 BE REALLY HELPFUL. THINK IT 4237 03:07:34,293 --> 03:07:37,596 MIGHT HELP A LOT, AT LEAST FOR 4238 03:07:37,596 --> 03:07:40,732 ME, MIGHT HELP TO UNDERSTAND 4239 03:07:40,732 --> 03:07:44,202 WHAT MAY BE INSPIRATIONAL 4240 03:07:44,202 --> 03:07:46,271 PROGRAMS LIKE THE MODEL THAT 4241 03:07:46,271 --> 03:07:49,941 BUILD NEW PHANTOMS OR COMMUNITY 4242 03:07:49,941 --> 03:07:51,777 ET CETERA, WHAT IMMEDIATE ACTION 4243 03:07:51,777 --> 03:07:53,412 APPROACHES WHERE YOU HAVE 4244 03:07:53,412 --> 03:07:55,447 EXISTING THAT JUST NEED 4245 03:07:55,447 --> 03:07:57,049 CALIBRATION AND MAYBE NIBIB 4246 03:07:57,049 --> 03:07:59,685 WOULD FUND THAT PART. THEN A 4247 03:07:59,685 --> 03:08:02,321 MODEL FOR DISTRIBUTION OF WHAT 4248 03:08:02,321 --> 03:08:03,588 WOULD BE MODEL FOR DISTRIBUTION 4249 03:08:03,588 --> 03:08:05,857 OF THESE PHANTOMS. ALSO LOOKING 4250 03:08:05,857 --> 03:08:08,060 INTO IT, SOMEBODY BORROWS THAT 4251 03:08:08,060 --> 03:08:11,697 PHANTOM, BREAK THAT PHANTOM. YOU 4252 03:08:11,697 --> 03:08:13,632 HAVE THIS SPECIALIZED PHANTOM. 4253 03:08:13,632 --> 03:08:17,069 WHAT WOULD BE PROCEDURES YOU 4254 03:08:17,069 --> 03:08:18,403 MIGHT USE. THOSE ARE DETAILS TO 4255 03:08:18,403 --> 03:08:21,206 BE WORKED OUT. FOR ME AS I'M 4256 03:08:21,206 --> 03:08:23,041 LOOKING AT WHOLE CONCEPT SAYING 4257 03:08:23,041 --> 03:08:25,844 OKAY, GREAT RESOURCE, DON'T KNOW 4258 03:08:25,844 --> 03:08:27,245 EXACTLY WHO IS GOING TO BUILD 4259 03:08:27,245 --> 03:08:29,581 THESE, HOW WE GOING TO MAKE SURE 4260 03:08:29,581 --> 03:08:31,316 FUTURE HAPPEN, MAKE ACCESS TO 4261 03:08:31,316 --> 03:08:33,118 THESE PHANTOMS. SO FEW MORE 4262 03:08:33,118 --> 03:08:34,886 DETAILS LIKE THAT, AS YOU ALL 4263 03:08:34,886 --> 03:08:36,455 ARE THINKING THROUGH THIS 4264 03:08:36,455 --> 03:08:38,390 CONCEPT. MAYBE TAKING SMALLER 4265 03:08:38,390 --> 03:08:42,294 CHUNK AND BREAKING IT DOWN IN A 4266 03:08:42,294 --> 03:08:43,595 PIECE. THAT MIGHT HELP THAT. IS 4267 03:08:43,595 --> 03:08:44,963 MY OVERALL SYSTEMS THINKING. 4268 03:08:44,963 --> 03:08:47,032 >> THANK YOU, RANU. YOU WANT 4269 03:08:47,032 --> 03:08:47,899 TO GO AHEAD? 4270 03:08:47,899 --> 03:08:51,002 >> YOU GO AHEAD. 4271 03:08:51,002 --> 03:08:52,337 >> SO I JUST WANT TO MAKE 4272 03:08:52,337 --> 03:08:56,241 SURE THAT YES, WE ARE DOING BOTH 4273 03:08:56,241 --> 03:08:59,845 APPROACHES YOU MENTIONED. WE ARE 4274 03:08:59,845 --> 03:09:01,913 TRYING TO SUPPORT THE COMMUNITY 4275 03:09:01,913 --> 03:09:03,715 TO BUILD NOVEL PHANTOM THAT CAN 4276 03:09:03,715 --> 03:09:05,650 BE SHARED THROUGH SHARED 4277 03:09:05,650 --> 03:09:07,986 RESOURCE. THEN ALL OF THESE WILL 4278 03:09:07,986 --> 03:09:12,391 GO THROUGH THE CAPTURIZATION AND 4279 03:09:12,391 --> 03:09:16,328 CALIBRATION. LET'S SAY EXISTING 4280 03:09:16,328 --> 03:09:17,229 CALIBRATION. WE NEED THIS. THAT 4281 03:09:17,229 --> 03:09:19,765 IS WHY THEY ARE WORKING WITH 4282 03:09:19,765 --> 03:09:23,335 NEST AND FDA TOWARD CURE 4283 03:09:23,335 --> 03:09:27,472 RADIATION, MA CURE ASIAN SHGS / 4284 03:09:27,472 --> 03:09:28,473 /* CURATION. THESE PHANTOMS THAT 4285 03:09:28,473 --> 03:09:33,278 ARE AVAILABLE THAT HAVE BEEN 4286 03:09:33,278 --> 03:09:34,780 CURATED, STANDARDIZED BY THE 4287 03:09:34,780 --> 03:09:38,383 NEST AND SENT OUT TO THE 4288 03:09:38,383 --> 03:09:39,818 COMMUNITY. EXPANDING THE SAME 4289 03:09:39,818 --> 03:09:42,687 MODEL. SO ONE OF THE APPROACHES 4290 03:09:42,687 --> 03:09:45,123 WAS WHAT YOU MENTIONED. EXISTING 4291 03:09:45,123 --> 03:09:46,691 PHANTOM HELPING THEM GET 4292 03:09:46,691 --> 03:09:49,327 THROUGH, CURATED, MAKE SENSE AND 4293 03:09:49,327 --> 03:09:59,571 DISSEMINA 4294 03:10:00,839 --> 03:10:04,276 DISSEMINATED.C THEN A LARGER 4295 03:10:04,276 --> 03:10:05,844 SCALE APPROACH. AT THE END OF 4296 03:10:05,844 --> 03:10:08,246 THE DAY THERE WILL BE A 4297 03:10:08,246 --> 03:10:09,648 CHARACTERIZATION AND CALIBRATION 4298 03:10:09,648 --> 03:10:13,318 WITHIN EACH OF THESE. WE JUST 4299 03:10:13,318 --> 03:10:16,421 DON'T WANT TO SEND A RANDOM 4300 03:10:16,421 --> 03:10:18,290 PHANTOM THAT MIGHT NOT WORK. WE 4301 03:10:18,290 --> 03:10:20,759 TRYING TO ACTUALLY MAKE THE 4302 03:10:20,759 --> 03:10:22,494 STANDARDS THAT ARE -- SO POINT 4303 03:10:22,494 --> 03:10:24,496 WELL TAKEN. YES, THIS WAS THE 4304 03:10:24,496 --> 03:10:26,164 CONCEPT. WE ARE DEFT WORKING ON 4305 03:10:26,164 --> 03:10:30,969 DETAILS TO MAKE IT BETTER AND 4306 03:10:30,969 --> 03:10:31,837 DEFINITELY APPRECIATE YOUR 4307 03:10:31,837 --> 03:10:35,707 INPUT, THANK YOU. 4308 03:10:35,707 --> 03:10:36,908 >> BRUCE. 4309 03:10:36,908 --> 03:10:39,377 >> BRUCE TROMBERG: OKAY. THANK 4310 03:10:39,377 --> 03:10:42,948 YOU, AFROUZ AND EVERYONE. I WANT 4311 03:10:42,948 --> 03:10:46,184 TO WRAP UP A LITTLE OF THIS IN 4312 03:10:46,184 --> 03:10:48,019 SORT OF WHAT IS THE ULTIMATE 4313 03:10:48,019 --> 03:10:49,688 THING. TOUGH LESSON, ALL OF US 4314 03:10:49,688 --> 03:10:52,190 WHO DEVELOP DEVICES HAVE LEARNED 4315 03:10:52,190 --> 03:11:02,167 THE FDA IS THE ULTIMATE ARGUED 4316 03:11:02,167 --> 03:11:03,502 ARBITOR OF PERFORMANCE. IF 4317 03:11:03,502 --> 03:11:04,936 ANYTHING WILL GET DISSEMINATED 4318 03:11:04,936 --> 03:11:07,272 IT WILL GO THROUGH THE FDA. THIS 4319 03:11:07,272 --> 03:11:11,343 IS BASED ON ALL OF US DWOOP 4320 03:11:11,343 --> 03:11:12,310 DEVELOPING AND SENSING DEVICE, 4321 03:11:12,310 --> 03:11:14,312 OUR COMMUNITY DEVELOPS THEIR 4322 03:11:14,312 --> 03:11:16,348 OWN. IF YOU ARE DOING THEIR 4323 03:11:16,348 --> 03:11:17,916 COMMERCIALIZATION YOU GO TO THE 4324 03:11:17,916 --> 03:11:19,885 FDA WITH OUR OWN. THANK GOODNESS 4325 03:11:19,885 --> 03:11:22,287 WE HAVE OSUL AT THE FDA, 4326 03:11:22,287 --> 03:11:23,488 BUILDING THESE TECHNOLOGIES. 4327 03:11:23,488 --> 03:11:25,423 THEY ARE MAKING PHANTOMS. SO 4328 03:11:25,423 --> 03:11:27,626 THEY HAVE KIND OF LIKE AN 4329 03:11:27,626 --> 03:11:29,461 APPROXIMATELY WAY BUT OSUL IS 4330 03:11:29,461 --> 03:11:33,098 THE SCIENCE PEOPLE, NOT THE 4331 03:11:33,098 --> 03:11:37,435 REGULATORY PEOPLE. WE WOULD -- 4332 03:11:37,435 --> 03:11:39,504 OUR COMMUNITY NEEDS TO HAVE -- 4333 03:11:39,504 --> 03:11:40,839 THE REGULATORY PEOPLE HAVE 4334 03:11:40,839 --> 03:11:42,908 CONFIDENCE THAT ME, FROM MY LAB 4335 03:11:42,908 --> 03:11:46,278 WITH MY PHANTOM, I SAW THIS IS 4336 03:11:46,278 --> 03:11:49,447 THE PERFORMANCE REALLY IS 4337 03:11:49,447 --> 03:11:51,316 PERFORMANCE THEY CAN UNDERSTAND 4338 03:11:51,316 --> 03:11:54,352 AND EXTRAPOLATE AND COMPARE TO 4339 03:11:54,352 --> 03:11:57,355 OTHER PLATFORMS. SO WHAT THIS 4340 03:11:57,355 --> 03:11:59,357 WOULD DO IS IT WOULD TAKE ALL 4341 03:11:59,357 --> 03:12:03,528 THAT EXPERTISE OF OSUL WHO MAKE 4342 03:12:03,528 --> 03:12:05,497 PHANTOMS, LIKE AMAZING ONES. 4343 03:12:05,497 --> 03:12:06,798 THEY CAN'T REALLY SEND THOSE 4344 03:12:06,798 --> 03:12:08,199 BACK TO THE MANUFACTURER WHO 4345 03:12:08,199 --> 03:12:10,135 SAYS I HAVE A NEW TECHNOLOGY AND 4346 03:12:10,135 --> 03:12:13,505 THEY SAY JUST MEASURE IT ON 4347 03:12:13,505 --> 03:12:17,976 THIS. BUT WE CAN THROUGH NIBIB. 4348 03:12:17,976 --> 03:12:21,146 IF WE CAN ADOPT THOSE AND GET 4349 03:12:21,146 --> 03:12:27,118 MYSELF TO AGR-- GET MIS TO AGRE 4350 03:12:27,118 --> 03:12:29,187 WE HAVE A GOLD STANDARD AND 4351 03:12:29,187 --> 03:12:32,090 ALLOWS THE CREATIVITY OF OPEN 4352 03:12:32,090 --> 03:12:33,124 SOURCE AND ENTIRE COMMUNITY. 4353 03:12:33,124 --> 03:12:33,892 EVERYBODY WILL HAVE SOMETHING TO 4354 03:12:33,892 --> 03:12:37,963 COMPARE TO. HOW CAN WE STIMULATE 4355 03:12:37,963 --> 03:12:42,033 VIBRANT ACTIVITY? LIKE THIS IS 4356 03:12:42,033 --> 03:12:44,502 IS AN AREA OF REGULATORY SCIENCE 4357 03:12:44,502 --> 03:12:45,904 PEOPLE SKIP OVER BUT THE 4358 03:12:45,904 --> 03:12:47,472 ULTIMATE BOTTLENECK TO GETTING 4359 03:12:47,472 --> 03:12:48,673 THINGS CLEARED AND AUTHORIZED. 4360 03:12:48,673 --> 03:12:50,408 SO THE WAY WE CAN DO THAT IS A 4361 03:12:50,408 --> 03:12:55,847 WAY WE DISCUSSED IN 2019 WITH 4362 03:12:55,847 --> 03:13:00,218 ZANE AND HIS BOSS, THERE IS THIS 4363 03:13:00,218 --> 03:13:04,155 WONDERFUL IUCRC MECHANISM THAT 4364 03:13:04,155 --> 03:13:07,826 NSF HAS. GETTING BACK TO RONU'S 4365 03:13:07,826 --> 03:13:10,061 COMMENT, WOULD WE PUT MONEY? IN 4366 03:13:10,061 --> 03:13:17,102 DEPENDS ON THE BUDGET. BUT COST 4367 03:13:17,102 --> 03:13:20,939 MODEL IS EFFECTIVE. SAYS TO THE 4368 03:13:20,939 --> 03:13:21,673 COMMUNITY PARTNERSHIPS, THE 4369 03:13:21,673 --> 03:13:23,375 GOVERNMENT WILL PROVIDE SOME 4370 03:13:23,375 --> 03:13:27,379 RESOURCES AND IN-KIND SUPPORT 4371 03:13:27,379 --> 03:13:31,683 BUT WITH NIBIB AND FDA AND 4372 03:13:31,683 --> 03:13:32,684 INDUSTRY KIND OF COMING TOGETHER 4373 03:13:32,684 --> 03:13:35,920 WE THINK IT WOULD BENEFIT 4374 03:13:35,920 --> 03:13:37,756 EVERYONE IN ACCELERATING 4375 03:13:37,756 --> 03:13:39,824 AUTHORIZATION PATHWAYS AND 4376 03:13:39,824 --> 03:13:43,161 GIVING PEOPLE REALLY CONCRETE 4377 03:13:43,161 --> 03:13:44,763 FOUNDATIONS FOR NEW 4378 03:13:44,763 --> 03:13:47,532 TECHNOLOGIES. IT VERY AMBITIOUS, 4379 03:13:47,532 --> 03:13:50,969 I KNOW. THE CENTER COMES IN 4380 03:13:50,969 --> 03:13:54,372 BECAUSE THE FDA IS NOT GOING TO 4381 03:13:54,372 --> 03:13:56,608 DISTRIBUTE THESE. NIST, WE 4382 03:13:56,608 --> 03:13:57,809 PROBABLY ALL WORK WITH NIST. 4383 03:13:57,809 --> 03:14:01,212 THEY ARE AMAZING AT 4384 03:14:01,212 --> 03:14:03,314 CHARACTERIZATIONING AND 4385 03:14:03,314 --> 03:14:06,151 VALIDATING MATERIALS BUT NOT 4386 03:14:06,151 --> 03:14:07,986 DEEPLY INTO SORT OF MEDICAL 4387 03:14:07,986 --> 03:14:10,055 APPLICATION AND LANGUAGE. SO 4388 03:14:10,055 --> 03:14:11,356 CULTURALLY IT IS OUR COMMUNITY 4389 03:14:11,356 --> 03:14:14,359 THAT NEEDS TO TAKE ON 4390 03:14:14,359 --> 03:14:15,193 RESPONSIBILITY OF BEING THAT 4391 03:14:15,193 --> 03:14:18,997 INTERFACE. I THINK IT IS AN 4392 03:14:18,997 --> 03:14:19,831 ENORMOUS OPPORTUNITY FOR GROWTH 4393 03:14:19,831 --> 03:14:22,000 AND MANY AREAS. WE LOOK FORWARD 4394 03:14:22,000 --> 03:14:24,769 TO MORE COMMENTS FROM ALL OF YOU 4395 03:14:24,769 --> 03:14:26,504 AND PARTICIPATION. ALL OF YOU 4396 03:14:26,504 --> 03:14:28,473 DEVELOPING TECHNOLOGIES IN THIS. 4397 03:14:28,473 --> 03:14:36,314 WE HOPE IT GETS OFF THE GROUND. 4398 03:14:36,314 --> 03:14:39,317 4399 03:14:39,317 --> 03:14:41,553 >> WE STILL HAVE MORE 4400 03:14:41,553 --> 03:14:41,953 COMMENTS. 4401 03:14:41,953 --> 03:14:45,657 >> THIS IS GREAT. THANK YOU, 4402 03:14:45,657 --> 03:14:49,627 BRUCE, FOR CLARIFYING. I THINK 4403 03:14:49,627 --> 03:14:52,530 IT IS WONDERFUL. I COMPLETELY 4404 03:14:52,530 --> 03:14:54,866 AGREE NEED FOR STANDARDIZATION 4405 03:14:54,866 --> 03:14:57,368 FOR PHANTOMS. I HAVE TWO KIND OF 4406 03:14:57,368 --> 03:14:59,471 QUESTIONS. ONE, HOW WILL DATA BE 4407 03:14:59,471 --> 03:15:01,906 SHARED? I GUESS ANOTHER PART IS 4408 03:15:01,906 --> 03:15:03,508 I GUESS INTELLECTUAL PROPERTY. 4409 03:15:03,508 --> 03:15:05,477 IS THIS CONSIDERED PRETTY 4410 03:15:05,477 --> 03:15:06,177 COMPETITIVE? HOW IS THAT GOING 4411 03:15:06,177 --> 03:15:09,380 TO BE DEALT WITH IF YOU ARE 4412 03:15:09,380 --> 03:15:18,389 DOING A NOVEL, YOU KNOW, PHANTOM 4413 03:15:18,389 --> 03:15:19,724 OR A NOVEL INSTRUMENT? I 4414 03:15:19,724 --> 03:15:20,558 UNDERSTAND HOW THE PHANTOM 4415 03:15:20,558 --> 03:15:21,826 ITSELF WILL BE SHARED. I THINK 4416 03:15:21,826 --> 03:15:23,628 THAT IS GREAT. THE OTHER 4417 03:15:23,628 --> 03:15:25,530 QUESTION IS THE KIND OF META -- 4418 03:15:25,530 --> 03:15:28,767 ALL THE OTHER DATA ON TOP. HOW 4419 03:15:28,767 --> 03:15:34,939 IS THAT GOING TO BE DISTRIBUTED 4420 03:15:34,939 --> 03:15:40,011 OR CURATED? I'M CURIOUS THE DATA 4421 03:15:40,011 --> 03:15:41,946 AND INTELLECTUAL PROPERTY PART. 4422 03:15:41,946 --> 03:15:44,149 >> SURE. I CAN ANSWER TO DATA 4423 03:15:44,149 --> 03:15:47,719 THAN IP. THIS IS SOMETHING 4424 03:15:47,719 --> 03:15:54,192 WORKED ON WITH OUR OFFICES 4425 03:15:54,192 --> 03:15:55,059 INTERNALLY. DEFINITELY SOMETHING 4426 03:15:55,059 --> 03:15:59,130 WE ARE WORKING ON BECAUSE THIS 4427 03:15:59,130 --> 03:15:59,998 IS A IMPORTANT QUESTION. IN 4428 03:15:59,998 --> 03:16:03,434 TERMS OF DATA, WE DON'T JUST 4429 03:16:03,434 --> 03:16:05,637 ACCEPT THE PHYSICAL PHANTOM. HAS 4430 03:16:05,637 --> 03:16:07,305 TO COME WITH COMPREHENSIVE 4431 03:16:07,305 --> 03:16:09,707 DOCUMENTATION IN TERMS OF LIKE 4432 03:16:09,707 --> 03:16:13,278 HOW MANY MILLIGRAM OF SUPPOSED 4433 03:16:13,278 --> 03:16:17,615 MATERIAL THEY ARE USING. 4434 03:16:17,615 --> 03:16:19,751 PROCEDURE EXACT, THINKING OF 4435 03:16:19,751 --> 03:16:20,819 INCORPORATING VIDEO YES OF HOW 4436 03:16:20,819 --> 03:16:22,821 THESE ARE BEING MADE. INCLUSION 4437 03:16:22,821 --> 03:16:24,956 OF THE MOLD THESE PHANTOMS ARE 4438 03:16:24,956 --> 03:16:27,192 MADE OF. NOT JUST THE PHANTOM. 4439 03:16:27,192 --> 03:16:28,226 IF YOU ARE MAKING WITH A 4440 03:16:28,226 --> 03:16:30,929 SPECIFIC SHAPE AND IF THAT HAS 4441 03:16:30,929 --> 03:16:33,164 BEEN PD PRINTED. SHARE THE MOLD 4442 03:16:33,164 --> 03:16:37,235 WITH THE PHANTOM AS THOUGH THE 4443 03:16:37,235 --> 03:16:39,838 3D DATA USED BY THE GRANTEE OR 4444 03:16:39,838 --> 03:16:41,105 COMMUNITY TO REPLICATE THAT 4445 03:16:41,105 --> 03:16:51,549 PHANTOM, IF NEEDED. ALSO 4446 03:16:53,117 --> 03:16:54,652 COMPREHENSIVE MATERIAL OF WHERE 4447 03:16:54,652 --> 03:16:57,255 THE MATERIALS ARE PURCHASED. WE 4448 03:16:57,255 --> 03:16:59,123 THINK ONE THING IS LACKING AND 4449 03:16:59,123 --> 03:17:01,292 WANT TO MAKE SURE IT WILL BE 4450 03:17:01,292 --> 03:17:02,493 INCORPORATED WITH THE DATA, IF 4451 03:17:02,493 --> 03:17:06,431 THE ISSUE, IF YOU ARE USING A 4452 03:17:06,431 --> 03:17:09,400 SPECIFIC TUMOR, YOU HAVE TO BE 4453 03:17:09,400 --> 03:17:12,437 SPECIFIC ABOUT THE DIAMETER OF 4454 03:17:12,437 --> 03:17:14,505 THAT. ANY OTHER DATA IN TERMS OF 4455 03:17:14,505 --> 03:17:18,643 LIKE HOW YOU PRODUCE OR CREATED 4456 03:17:18,643 --> 03:17:20,411 THAT PHANTOM SHOULD BE INVOLVED. 4457 03:17:20,411 --> 03:17:22,947 SO I THINK THAT IS DATA PART. IN 4458 03:17:22,947 --> 03:17:24,449 TERMS OF THE IPS, THIS IS 4459 03:17:24,449 --> 03:17:27,318 SOMETHING WE NEED TO THINK 4460 03:17:27,318 --> 03:17:29,754 ABOUT. DEPENDING ON COMPLEXITY 4461 03:17:29,754 --> 03:17:31,322 OF PHANTOM WILL IMPACT THE ISSUE 4462 03:17:31,322 --> 03:17:35,326 BUT SOMETHING WE WILL WORK WITH 4463 03:17:35,326 --> 03:17:37,295 OUR TRANSFER OFFICE TO FURTHER 4464 03:17:37,295 --> 03:17:41,366 FIGURE OUT DETAILS OF IT. BUT SO 4465 03:17:41,366 --> 03:17:45,003 FAR BASED ON SERVICE WITH NIS 4466 03:17:45,003 --> 03:17:49,474 AND IP, PHANTOM LIBRARIES WE 4467 03:17:49,474 --> 03:17:51,342 DIDN'T HAVE A LOT OF ISSUE BUT 4468 03:17:51,342 --> 03:17:52,877 POINT IS WE NEED TO THINK ABOUT. 4469 03:17:52,877 --> 03:17:54,178 SO I APPRECIATE YOU BRINGING 4470 03:17:54,178 --> 03:17:55,246 THIS UP. TESTIFY %BACK 4471 03:17:55,246 --> 03:17:56,547 >> THANK YOU. I THINK WHAT YOU 4472 03:17:56,547 --> 03:17:58,549 SAID IS SO IMPORTANT. THE 4473 03:17:58,549 --> 03:17:59,417 TRANSFER OF KNOWLEDGE OF THE 4474 03:17:59,417 --> 03:18:01,185 PHANATOM MAKING. I WAS ALSO 4475 03:18:01,185 --> 03:18:05,023 THINKING ABOUT THE DATA YOU 4476 03:18:05,023 --> 03:18:07,025 ACTUALLY ACQUIRE FROM USING THE 4477 03:18:07,025 --> 03:18:08,426 PHANTOM. LIKE HOW IS THAT GOING 4478 03:18:08,426 --> 03:18:10,228 TO BE DISSEMINATE ED?ENTER DO 4479 03:18:10,228 --> 03:18:13,197 YOU THEN PUT A SPECIAL MARKER SO 4480 03:18:13,197 --> 03:18:15,300 PEOPLE CAN FIND IT SO YOU ARE 4481 03:18:15,300 --> 03:18:16,467 BASICALLY TRYING TO CHANGE THE 4482 03:18:16,467 --> 03:18:19,237 CULTURE AND SAY WE ARE TRYING TO 4483 03:18:19,237 --> 03:18:21,539 STANDARDIZE. I WAS CURIOUS. I 4484 03:18:21,539 --> 03:18:24,976 REALIZE IT IS A BIG PROJECT BUT 4485 03:18:24,976 --> 03:18:27,111 YOU HAVE THE OPPORTUNITY TO NAME 4486 03:18:27,111 --> 03:18:30,281 THEM A SPECIAL WAY SO THEN 4487 03:18:30,281 --> 03:18:31,382 BECOMES RECOGNIZED TO BE EASY TO 4488 03:18:31,382 --> 03:18:33,818 FIND THAT WAY. LIKE 4489 03:18:33,818 --> 03:18:35,653 DISSEMINATING THAT PART OF THE 4490 03:18:35,653 --> 03:18:36,421 DATA TO. 4491 03:18:36,421 --> 03:18:38,189 >> THAT IS A VERY VALID 4492 03:18:38,189 --> 03:18:41,793 POINT. LET'S SAY YOU HAVE 4493 03:18:41,793 --> 03:18:43,594 OPTICAL. SIMPLE CW YOU ARE 4494 03:18:43,594 --> 03:18:45,863 WORKING ON. IF YOU HAVE USED 4495 03:18:45,863 --> 03:18:48,766 YOUR DEVICE, LET'S SAY EXACT 4496 03:18:48,766 --> 03:18:51,169 WHAT IS IN ANOTHER LAB, YOU CAN 4497 03:18:51,169 --> 03:18:52,870 REPRODUCE THE DATA AND SHOW WHAT 4498 03:18:52,870 --> 03:18:55,039 ARE LEVEL OF INTENSITY YOU ARE 4499 03:18:55,039 --> 03:18:56,374 GETTING BASED ON THE SPECIFIC 4500 03:18:56,374 --> 03:19:02,513 USE PHANTOM, HOW MUCH IT HAS 4501 03:19:02,513 --> 03:19:04,983 IMPACTED CHANGES IN SCATTERED 4502 03:19:04,983 --> 03:19:06,351 AND INCLUDE THOSE. IF ANOTHER IS 4503 03:19:06,351 --> 03:19:10,021 USING IT FOR THE SAME DEVICE, AS 4504 03:19:10,021 --> 03:19:13,958 I MENTIONED LOOK AT BETWEEN AND 4505 03:19:13,958 --> 03:19:15,760 IN DEVICE VARIABILITY SO THEY 4506 03:19:15,760 --> 03:19:16,995 CAN SAY I PUT MY DEVICE THERE 4507 03:19:16,995 --> 03:19:20,798 UNDER SIMILAR CONDITIONS, SO THE 4508 03:19:20,798 --> 03:19:21,866 CONDITION HAS TO BE VARIABLE 4509 03:19:21,866 --> 03:19:25,069 WITHIN THE DOCUMENTATION. THESE 4510 03:19:25,069 --> 03:19:27,472 ARE THE VALUES -- THESE ARE IN 4511 03:19:27,472 --> 03:19:29,741 TERM OF THE PRIME. WHAT IF OTHER 4512 03:19:29,741 --> 03:19:31,976 LAB IS GETTING OR VALUES ARE 4513 03:19:31,976 --> 03:19:35,346 CLOSED. THAT WOULD BE ALSO 4514 03:19:35,346 --> 03:19:36,914 BUILDING BACKGROUND TWICE 4515 03:19:36,914 --> 03:19:38,416 INFORMATION RELATED TO PHANTOM 4516 03:19:38,416 --> 03:19:39,884 TESTED ON. I THINK THAT BECOMES 4517 03:19:39,884 --> 03:19:41,019 VERY IMPORTANT. YOU CAN HAVE 4518 03:19:41,019 --> 03:19:42,854 THIS SORT OF REFERENCE DATA. NOT 4519 03:19:42,854 --> 03:19:46,224 JUST FOR THE PHANTOM BUT ALSO 4520 03:19:46,224 --> 03:19:47,091 FOR THE DEVICE THAT SPECIFIC 4521 03:19:47,091 --> 03:19:51,462 DEVICE YOU ARE USING AND ALLOWS 4522 03:19:51,462 --> 03:19:55,733 ONCE ARE ES STAP DIED YOU CAN 4523 03:19:55,733 --> 03:19:59,370 VALIDATE DIFFERENT DEVICES TO BE 4524 03:19:59,370 --> 03:20:02,273 ABLE TO COMPARE THEM. 4525 03:20:02,273 --> 03:20:04,442 >> THAT IS FANTASTIC. CAN I 4526 03:20:04,442 --> 03:20:06,077 ADD ONE MORE THING, THAT IS 4527 03:20:06,077 --> 03:20:09,814 GREAT. I REALIZE IT IS OUT OF 4528 03:20:09,814 --> 03:20:12,183 SCOPE. BUT WHAT WOULD BE GREAT 4529 03:20:12,183 --> 03:20:13,751 IF IT IS FAN PHANATOM COMPARED 4530 03:20:13,751 --> 03:20:15,219 TO ACTUALLY TISSUE. LIBRARIES OR 4531 03:20:15,219 --> 03:20:17,989 DISEASE TISSUE. I KNOW IT IS OUT 4532 03:20:17,989 --> 03:20:19,857 OF SCOPE BUT I'M CURIOUS BECAUSE 4533 03:20:19,857 --> 03:20:22,293 OBVIOUSLY AT THE END OF THE DAY 4534 03:20:22,293 --> 03:20:24,395 IT HAS TO MIMIC THE CLINICAL. SO 4535 03:20:24,395 --> 03:20:25,863 I'M CURIOUS IF YOU ARE THINKING 4536 03:20:25,863 --> 03:20:28,466 ABOUT THAT. I KNOW IT IS A LOT. 4537 03:20:28,466 --> 03:20:31,602 >> NO, THAT IS OUR ULTIMATE 4538 03:20:31,602 --> 03:20:33,704 GOAL. MAKING THIS TISSUE 4539 03:20:33,704 --> 03:20:35,973 MIMICKING PHANATOM. EVERY TIME 4540 03:20:35,973 --> 03:20:37,942 YOU SAY THIS, IT HAS TO MIMIC 4541 03:20:37,942 --> 03:20:39,277 THAT. I THINK ALONG THE WAY 4542 03:20:39,277 --> 03:20:42,947 THERE HAS TO BE A LOT OF WORK 4543 03:20:42,947 --> 03:20:44,615 FOR PHANTOM IN TERMS OF MAKING 4544 03:20:44,615 --> 03:20:46,884 SURE THE MODEL IS MATCHING. BUT 4545 03:20:46,884 --> 03:20:49,620 ALSO TESTING SOME OF THESE EARLY 4546 03:20:49,620 --> 03:20:53,391 ON WITH LET'S SAY ANIMAL TISSUE 4547 03:20:53,391 --> 03:20:56,394 OR IN HUMAN MODEL TO MAKE SURE 4548 03:20:56,394 --> 03:21:00,331 VALUE S ARE WITHIN RANGE. OUR 4549 03:21:00,331 --> 03:21:02,900 HOPE IS AT END OF DAY THESE 4550 03:21:02,900 --> 03:21:05,503 STANDARDIZE AND COMPARE, REDUCE 4551 03:21:05,503 --> 03:21:07,572 NEED FOR USING HUMAN ANIMAL 4552 03:21:07,572 --> 03:21:11,876 MODEL AT EARLY STAGE TO ALLOW 4553 03:21:11,876 --> 03:21:16,047 THESE TO THEN MOVE TO HUMAN. 4554 03:21:16,047 --> 03:21:19,884 YES, INCLUDE DATA. GREAT POINT. 4555 03:21:19,884 --> 03:21:23,154 IT IS AMBITIOUS BUT THAT IS OUR 4556 03:21:23,154 --> 03:21:24,689 GOAL. WE TRYING TO INCLUDE AS 4557 03:21:24,689 --> 03:21:28,559 MUCH DATA AS POSSIBLE. ONCE TALK 4558 03:21:28,559 --> 03:21:34,665 ABOUT THIS, IT TAKES A WHOLE 4559 03:21:34,665 --> 03:21:35,967 VILLAGE TO PUT THAT TOGETHER. 4560 03:21:35,967 --> 03:21:37,468 APPRECIATE YOUR INPUT. 4561 03:21:37,468 --> 03:21:38,603 >> GREAT, IT IS VERY 4562 03:21:38,603 --> 03:21:39,837 EXCITING, THANK YOU. 4563 03:21:39,837 --> 03:21:41,973 >> IF I CAN JUST COMMENT ON 4564 03:21:41,973 --> 03:21:44,075 JOYCE'S -- SHE POSED AN 4565 03:21:44,075 --> 03:21:46,043 INTERESTING DILEMMA WITH RESPECT 4566 03:21:46,043 --> 03:21:49,013 TO INTELLECTUAL PROPERTY. OUR 4567 03:21:49,013 --> 03:21:51,249 STANDARD MODEL RIGHT NOW IS 4568 03:21:51,249 --> 03:21:52,250 THERE IS SOME COMMERCIALIZATION 4569 03:21:52,250 --> 03:21:54,385 THAT TAKES PLACE, TAKES CARE OF 4570 03:21:54,385 --> 03:21:57,522 DISSEMINATION SO A COMPANY WILL 4571 03:21:57,522 --> 03:22:01,592 DO THE JOB AND EVERYBODY WILL 4572 03:22:01,592 --> 03:22:05,596 BUY A PHANTOM BUT THAT IS NOT 4573 03:22:05,596 --> 03:22:11,068 WORKING WELL. SO COULD MOVE IN 4574 03:22:11,068 --> 03:22:14,172 THAT DIRECTION. LET'S SAY 4575 03:22:14,172 --> 03:22:16,874 EMERGING FROM THE IRCs WHICH 4576 03:22:16,874 --> 03:22:19,877 MOVE FORWARD WITH NON-EXCLUSIVE 4577 03:22:19,877 --> 03:22:22,280 ROYALTY-FREE LICENSES THAT SORT 4578 03:22:22,280 --> 03:22:24,448 OF COME OUT OF THEIR SYSTEM SO 4579 03:22:24,448 --> 03:22:26,117 CLASSICALLY COMPETITIVE OR COULD 4580 03:22:26,117 --> 03:22:30,388 JUST OPEN UP THE ENTIRE UNIVERSE 4581 03:22:30,388 --> 03:22:32,023 IF THE FDA GETS ON BOARD. AS 4582 03:22:32,023 --> 03:22:34,425 LONG AS YOU HAVE A COMMON 4583 03:22:34,425 --> 03:22:38,396 DENOMINATOR OR GOLD STANDARD 4584 03:22:38,396 --> 03:22:42,366 THAT IS BLESSED BY NIS AND FDA 4585 03:22:42,366 --> 03:22:44,936 SAYING WE WILL MAKE REGULATORY 4586 03:22:44,936 --> 03:22:46,337 DIVISIONS ON HOW YOUR DEVICE 4587 03:22:46,337 --> 03:22:47,371 MEASURE ED WITH YOUR OWN 4588 03:22:47,371 --> 03:22:52,743 PHANATOM PERFORMS WITH RESPECT 4589 03:22:52,743 --> 03:22:55,046 TO OUR PHANATOM AND FIVE 4590 03:22:55,046 --> 03:22:56,247 ATTRIBUTES, THEN THE FDA WILL 4591 03:22:56,247 --> 03:22:59,951 SET THE CRITERIA FOR 4592 03:22:59,951 --> 03:23:01,852 ACCEPTABI 4593 03:23:01,852 --> 03:23:02,553 ACCEPTABILITY. WE HAVE DONE THIS 4594 03:23:02,553 --> 03:23:06,657 IN RADAX WITH DEVELOPMENT OF 4595 03:23:06,657 --> 03:23:08,926 RAPID ANTIGEN TESTS MORE QUICKLY 4596 03:23:08,926 --> 03:23:10,127 THAN COMPARING TO EXISTING 4597 03:23:10,127 --> 03:23:11,762 BOOKEND TESTS THAT ARE 4598 03:23:11,762 --> 03:23:16,000 VALIDATED, BY LOOKING AT THEIR 4599 03:23:16,000 --> 03:23:17,568 PERFORMANCE. SO IT IS GETTING 4600 03:23:17,568 --> 03:23:19,003 REGULATORY TO NOT LOOK AT EVERY 4601 03:23:19,003 --> 03:23:21,772 THING AS IF IT IS A TOTALLY NEW 4602 03:23:21,772 --> 03:23:23,374 THING BUT TO COMPARE TO 4603 03:23:23,374 --> 03:23:27,078 VALIDATED ESTABLISHED BOOKENDS 4604 03:23:27,078 --> 03:23:31,482 OF PERFORMANCE AND 4605 03:23:31,482 --> 03:23:33,851 DIMENSIONALITY WILL DEPEND ON 4606 03:23:33,851 --> 03:23:36,320 CLAIMS SO MAY BE LIMITED IN 4607 03:23:36,320 --> 03:23:44,161 TERMS OF DIMENSION, MAY BE QUITE 4608 03:23:44,161 --> 03:23:47,365 COMPLEX. SO THIS WILL BE A 4609 03:23:47,365 --> 03:23:49,133 COMMUNITY EFFORT. WE ARE REALLY 4610 03:23:49,133 --> 03:23:50,268 GOING TO NEED OUR EXPERTS TO 4611 03:23:50,268 --> 03:23:51,469 WEIGH IN. 4612 03:23:51,469 --> 03:23:54,839 >> TO ADD TO WHAT BRUCE SAID, 4613 03:23:54,839 --> 03:23:56,274 REGULATORY IS ACTUALLY SIMPLE. 4614 03:23:56,274 --> 03:23:58,409 YOU TELL ME YOU CAN DO 4615 03:23:58,409 --> 03:23:59,443 SOMETHING, PROVE IT. THESE 4616 03:23:59,443 --> 03:24:01,612 PHANATOMS ARE THE WAY TO PROVE 4617 03:24:01,612 --> 03:24:05,016 IT. YOU HAVE TO DEMONSTRATE THE 4618 03:24:05,016 --> 03:24:06,817 PHANATOMS WORK. THAT THEY ARE 4619 03:24:06,817 --> 03:24:08,552 REPLICATING WHAT YOU SAY YOU ARE 4620 03:24:08,552 --> 03:24:11,122 TRYING TO MEASURE. YOU KNOW, IN 4621 03:24:11,122 --> 03:24:15,493 SOME INSTANCES THERE MAY NOT BE 4622 03:24:15,493 --> 03:24:17,828 A TISSUE EQUIVALENT. IF YOU TELL 4623 03:24:17,828 --> 03:24:21,532 ME YOU CAN MEASURE AT 80 MICRONS 4624 03:24:21,532 --> 03:24:23,100 AND SBO2 ON CANCER, HOW DO YOU 4625 03:24:23,100 --> 03:24:26,037 CUT IT OUT AND SHOW ME YOU CAN 4626 03:24:26,037 --> 03:24:32,276 DO THAT? AT 200 OR 400 MICRONS 4627 03:24:32,276 --> 03:24:33,744 OR 10 MILLIMETERS. YOU GET INTO 4628 03:24:33,744 --> 03:24:34,845 A BIND OF PROVING THAT WHAT YOU 4629 03:24:34,845 --> 03:24:37,181 ARE SAYING YOU CAN DO IS 4630 03:24:37,181 --> 03:24:40,284 ACTUALLY WHAT YOUR DEVICE DOES. 4631 03:24:40,284 --> 03:24:43,821 THAT IS WHERE THE PHANTOMS COME 4632 03:24:43,821 --> 03:24:45,723 IN. THEY CAN AGENDAMENT OR HELP. 4633 03:24:45,723 --> 03:24:47,358 YOU HAVE TO DEMONSTRATE THEY 4634 03:24:47,358 --> 03:24:48,826 WILL MY MAKE WHAT THEY SAY. 4635 03:24:48,826 --> 03:24:52,163 THERE HAS TO BE CLARIFICATION OF 4636 03:24:52,163 --> 03:24:57,068 THAT. WE ARE EASY, JUST PROVE 4637 03:24:57,068 --> 03:24:57,601 IT. 4638 03:24:57,601 --> 03:25:02,473 4639 03:25:02,473 --> 03:25:04,542 >> VERY GOOD. BRUCE, OKAY 4640 03:25:04,542 --> 03:25:07,878 WITH ALL THE INPUT? VERY GOOD. 4641 03:25:07,878 --> 03:25:11,048 THANK YOU SO MUCH, EVERYONE. I'M 4642 03:25:11,048 --> 03:25:13,184 HEARING VERY STRONG SUPPORT FOR 4643 03:25:13,184 --> 03:25:14,819 CONCEPT. LOT OF FANTASTIC INPUT 4644 03:25:14,819 --> 03:25:17,555 ON THE IMPLEMENTATION TO HELP US 4645 03:25:17,555 --> 03:25:18,989 ACHIEVE SUCCESS, SO THANK YOU 4646 03:25:18,989 --> 03:25:22,360 VERY MUCH. SO COUNCILMEMBER, WE 4647 03:25:22,360 --> 03:25:24,762 HAVE ONE MORE CONCEPT CLEARANCE. 4648 03:25:24,762 --> 03:25:27,832 YOU ARE AWARE OF WHAT WE HAVE 4649 03:25:27,832 --> 03:25:28,866 FOR CLOSED SESSION. WE HAVE 4650 03:25:28,866 --> 03:25:30,935 AMPLE TIME SO WE WILL BE ABLE TO 4651 03:25:30,935 --> 03:25:33,537 TAKE A 10, 15 MINUTE BREAK AND 4652 03:25:33,537 --> 03:25:34,805 COMPLETE BY 4:00 TODAY, SHOULD 4653 03:25:34,805 --> 03:25:37,341 BE NO PROBLEM, SO THANK YOU. SO 4654 03:25:37,341 --> 03:25:40,077 WITH THAT, IT IS A TIMLINESS 4655 03:25:40,077 --> 03:25:42,580 UPDATE I WILL TURN THE NEXT 4656 03:25:42,580 --> 03:25:45,082 CONCEPT CLEARANCE OVER TO DR. 4657 03:25:45,082 --> 03:25:55,025 TUBA FEHR FOR HER PRESENTATION. 4658 03:25:55,025 --> 03:25:56,293 >> ALL HEAR ME OKAY? 4659 03:25:56,293 --> 03:25:59,497 >> YES, VERY WELL. 4660 03:25:59,497 --> 03:26:01,832 >> GREAT. 4661 03:26:01,832 --> 03:26:04,001 >> THANK YOU, DAVID. MY NAME 4662 03:26:04,001 --> 03:26:07,104 IS TUBA FEHR, PROGRAM DIRECTOR 4663 03:26:07,104 --> 03:26:10,808 AND WITH DEPARTMENT OF TECH 4664 03:26:10,808 --> 03:26:12,543 TECHNOLOGY INAUGURALS AT NIB. 4665 03:26:12,543 --> 03:26:16,414 I'M EXCITED TO PRESENT A CONCEPT 4666 03:26:16,414 --> 03:26:21,318 CLEARANCE FOR BIOMEDICAL FOR 4667 03:26:21,318 --> 03:26:28,726 NEXTGEN TECHNOLOGIES BIOTECH. 4668 03:26:28,726 --> 03:26:31,362 SORRY, TRYING TO -- THE PURPOSE 4669 03:26:31,362 --> 03:26:36,333 OF THE INITIATIVE IS TO TURN 4670 03:26:36,333 --> 03:26:37,401 INNOVATIVE DISCOVE RIS INTO 4671 03:26:37,401 --> 03:26:39,403 HUMAN HEALTH THROUGH IMPROVED 4672 03:26:39,403 --> 03:26:41,772 COLLABORATION BY ADAPTING 4673 03:26:41,772 --> 03:26:44,141 EXISTING NIH FUNDING MECHANISMS. 4674 03:26:44,141 --> 03:26:45,843 NIH ALREADY HAS EXISTING 4675 03:26:45,843 --> 03:26:47,244 COLLABORATIONS WITH OUTSIDE 4676 03:26:47,244 --> 03:26:51,715 PARTNERS INCLUDING OTHER FEDERAL 4677 03:26:51,715 --> 03:26:54,318 AGENCIES. HOWEVER THESE -- THERE 4678 03:26:54,318 --> 03:26:57,488 ARE LIMITATIONS. NIH IS 4679 03:26:57,488 --> 03:26:58,689 PRIMARILY BIOMEDICAL RESEARCH 4680 03:26:58,689 --> 03:27:00,257 AGENCY. THOSE PARTNERS THAT 4681 03:27:00,257 --> 03:27:01,759 SUPPORT MORE FOUNDATIONAL SIGNS 4682 03:27:01,759 --> 03:27:06,197 TEND TO FALL ON OPPOSITE END OF 4683 03:27:06,197 --> 03:27:07,431 RESEARCH SPECTRUM. 4684 03:27:07,431 --> 03:27:09,467 IF DISTANCE BETWEEN TWO PARTNERS 4685 03:27:09,467 --> 03:27:12,937 RESEARCH DOMAINS IS TOO FAR THIS 4686 03:27:12,937 --> 03:27:14,305 INADVERTENTLY LEADS TO LIMITED 4687 03:27:14,305 --> 03:27:18,976 SPACE THAT FAVORS OVERLAPPING 4688 03:27:18,976 --> 03:27:20,077 INTERESTS, NAMELY MIDDLE OF 4689 03:27:20,077 --> 03:27:21,779 SPECTRUM WHERE PROJECT COULD BE 4690 03:27:21,779 --> 03:27:24,415 GOOD FIT FOR EITHER AGENCY'S 4691 03:27:24,415 --> 03:27:30,654 MISSION AND INTEREST. AS A 4692 03:27:30,654 --> 03:27:32,056 RESULT GRARNTEES ON FOUNDATIONA 4693 03:27:32,056 --> 03:27:34,358 SCIENCE ARE NOT NECESSARILY 4694 03:27:34,358 --> 03:27:35,826 TRANSITIONED TO NIH FUNDING . 4695 03:27:35,826 --> 03:27:37,027 THE U FURTHER ON THE SPECTRUM 4696 03:27:37,027 --> 03:27:39,864 THE LARGER THE EFFORT TO MAKE 4697 03:27:39,864 --> 03:27:41,432 THE JOURNEY TOWARD THE NIH. 4698 03:27:41,432 --> 03:27:43,334 THEREFORE THE BIGGEST LIMITATION 4699 03:27:43,334 --> 03:27:44,468 OF CURRENT COLLABORATIVE 4700 03:27:44,468 --> 03:27:47,204 APPROACH IS IT IS SUBOPTIMAL FOR 4701 03:27:47,204 --> 03:27:51,008 TRANSITIONING DISCOVERIES AT THE 4702 03:27:51,008 --> 03:27:52,643 FURTHER END OF THE RESEARCH 4703 03:27:52,643 --> 03:27:54,879 SPECTRUM TO APPLICATIONS 4704 03:27:54,879 --> 03:27:56,480 RELEVANT TO THE NIH MISSION. TO 4705 03:27:56,480 --> 03:27:59,717 TURN THESE DISCOVERIES INTO 4706 03:27:59,717 --> 03:28:01,452 BIOMEDICAL TECHNOLOGIES REQUIRES 4707 03:28:01,452 --> 03:28:03,320 ADDITIONAL APPLICATIONS, WHICH 4708 03:28:03,320 --> 03:28:04,755 RESULTS IN LOST TIME AND EFFORT. 4709 03:28:04,755 --> 03:28:07,057 TRANSITION OF FOUNDATIONAL 4710 03:28:07,057 --> 03:28:09,026 KNOWLEDGE TO BIOMEDICAL 4711 03:28:09,026 --> 03:28:12,062 TECHNOLOGYIES CAN BE INEFFICIENT 4712 03:28:12,062 --> 03:28:14,064 FOR THAT REASON. TRANSITION 4713 03:28:14,064 --> 03:28:15,165 HAPPENS OVER LONG TIME FRAME IF 4714 03:28:15,165 --> 03:28:19,036 AT ALL. FOUNDATIONAL KNOWLEDGE 4715 03:28:19,036 --> 03:28:22,006 CAN STAY SILOED. HERE WE PRESENT 4716 03:28:22,006 --> 03:28:26,210 PROPOSAL SOLUTION TO OVERCOME 4717 03:28:26,210 --> 03:28:30,314 LIMITATIONS. THE GOAL IS 4718 03:28:30,314 --> 03:28:32,082 ACCELERATE TRANSITION OF NOVEL 4719 03:28:32,082 --> 03:28:34,118 DISCOVERIES. THAT IS TWO EARLY 4720 03:28:34,118 --> 03:28:36,387 STAGE. TWO BIOMEDICAL 4721 03:28:36,387 --> 03:28:37,621 TECHNOLOGIES AT NIH THROUGH 4722 03:28:37,621 --> 03:28:39,156 INTERAGENCY COLLABORATION. WE 4723 03:28:39,156 --> 03:28:40,925 ARE PROPOSING TO ACCOMPLISH THIS 4724 03:28:40,925 --> 03:28:43,694 GOAL BY TAKING A FUNDING 4725 03:28:43,694 --> 03:28:45,796 MECHANISM WE USE INTERNALLY AT 4726 03:28:45,796 --> 03:28:48,632 THE NIH, THE AWARDING PROCESS 4727 03:28:48,632 --> 03:28:50,301 AND ADAPTING TO CAT LIES 4728 03:28:50,301 --> 03:28:52,336 EXTERNAL COLLABORATION WITH 4729 03:28:52,336 --> 03:28:54,872 PARTNERS. THIS APPROACH IS 4730 03:28:54,872 --> 03:28:58,375 MODELLED AFTER THE R21, R33 4731 03:28:58,375 --> 03:29:00,411 MECHANISM WHERE PROJECT IS 4732 03:29:00,411 --> 03:29:04,615 DIVIDED INTO TWO DISTINCT 4733 03:29:04,615 --> 03:29:06,383 PHASES. UP WITH INVOLVES 4734 03:29:06,383 --> 03:29:08,252 EXPLORATORY AND FEASIBILITY. 4735 03:29:08,252 --> 03:29:10,821 PHASE II FOCUSES ON EXPANDED 4736 03:29:10,821 --> 03:29:12,690 DEVELOPMENT OF PHASE 1 4737 03:29:12,690 --> 03:29:13,724 ACTIVITIES. TRANSITION TO PHASE 4738 03:29:13,724 --> 03:29:15,759 2 FOR ANY PROJECT IS NOT 4739 03:29:15,759 --> 03:29:17,995 GUARANTEED AS THERE IS A 4740 03:29:17,995 --> 03:29:20,598 MILESTONE-DRIVEN GO/NO GO POINT 4741 03:29:20,598 --> 03:29:23,067 IN BETWEEN THE TWO PHASES. THIS 4742 03:29:23,067 --> 03:29:25,336 IS NOT NEW TO NIH. WE ARE ONLY 4743 03:29:25,336 --> 03:29:27,638 TAKING OLD TOOL THAT EXISTS AND 4744 03:29:27,638 --> 03:29:32,376 TEACHING IT NEW TRICKS. THE 4745 03:29:32,376 --> 03:29:34,078 PROPOSED AWARDING PROCESS IS 4746 03:29:34,078 --> 03:29:38,716 MEANT TO EXPAND EXISTING 4747 03:29:38,716 --> 03:29:40,217 COLLABORATION WITH PARTNER 4748 03:29:40,217 --> 03:29:42,052 TOWARD FURTHER ENDS OF THE 4749 03:29:42,052 --> 03:29:44,254 SPECTRUM. UNDER THE MECHANISM A 4750 03:29:44,254 --> 03:29:49,893 SINGLE APPLICATION WITH IN 4751 03:29:49,893 --> 03:29:52,896 INTEGRATED PROJECT WILL ALLOW 4752 03:29:52,896 --> 03:29:54,665 DISCOVERIES DURING THE DOMAIN 4753 03:29:54,665 --> 03:29:57,067 INTO PHASE I INTO BIOMEDICAL 4754 03:29:57,067 --> 03:29:58,736 TECHNOLOGIES RELATIVE TO NIH 4755 03:29:58,736 --> 03:30:03,374 MISSION DURING PHASE TWO. 4756 03:30:03,374 --> 03:30:07,978 THAT SAID WE WANT TO ENSURE 4757 03:30:07,978 --> 03:30:10,147 SUCCESS THROUGH OVERSIGHT. 4758 03:30:10,147 --> 03:30:11,448 INCLUDING QUANTITATIVE 4759 03:30:11,448 --> 03:30:13,951 MILESTONES, METRICS OF SUCCESS, 4760 03:30:13,951 --> 03:30:16,053 WHERE ONLY THOSE PROJECTS THAT 4761 03:30:16,053 --> 03:30:17,688 DEMONSTRATE PROOF OF CONCEPT, 4762 03:30:17,688 --> 03:30:19,590 THEIR DISCOVERIES CAN BE 4763 03:30:19,590 --> 03:30:21,158 DEVELOPED INTO BIOMEDICAL 4764 03:30:21,158 --> 03:30:23,360 TECHNOLOGY WILL BE ALLOWED TO 4765 03:30:23,360 --> 03:30:25,095 TRANSITION TO PHASE 2 AT NIH. 4766 03:30:25,095 --> 03:30:26,997 THERE WILL BE A MIDPOINT REVIEW 4767 03:30:26,997 --> 03:30:30,868 BE PROGRAM STAFF TO ASSESS 4768 03:30:30,868 --> 03:30:34,972 REDNESS TO PHASE 2 AND GO 4769 03:30:34,972 --> 03:30:36,874 DECISION AT END OF PHASE 1. 4770 03:30:36,874 --> 03:30:39,309 WHILE PLAN PROPOSED BY 4771 03:30:39,309 --> 03:30:42,746 INVESTIGATORS FOR PHASES 1 AND 2 4772 03:30:42,746 --> 03:30:43,547 PROVIDES COLLECTIVE ROAD MAP FOR 4773 03:30:43,547 --> 03:30:46,383 LONG JOURNEY FROM PARTNER AGENCY 4774 03:30:46,383 --> 03:30:48,986 TO NIH, MILESTONES WILL PROVIDE 4775 03:30:48,986 --> 03:30:50,754 GOAL POSTS ALONG THIS JOURNEY 4776 03:30:50,754 --> 03:30:52,523 AND PROGRAMMATIC OVERSIGHT WILL 4777 03:30:52,523 --> 03:30:54,525 ENSURE PROJECT DOES NOT GET LOST 4778 03:30:54,525 --> 03:31:00,964 IN THIS UNCHARTED TERRITORY. WE 4779 03:31:00,964 --> 03:31:02,332 ENVISION MANY FIELDS COULD 4780 03:31:02,332 --> 03:31:04,835 BENEFIT FROM THE CONCEPT, WHERE 4781 03:31:04,835 --> 03:31:06,837 DISCOVERIES ARE TOO EARLY STAGE 4782 03:31:06,837 --> 03:31:09,306 FOR NIH TO BE PICKED UP BUT CAN 4783 03:31:09,306 --> 03:31:11,408 BE BROUGHT IN. FOR EXAMPLE 4784 03:31:11,408 --> 03:31:13,077 FOUNDATIONAL COST IN SYNTHETIC 4785 03:31:13,077 --> 03:31:15,312 BIOLOGY CAN BE TURNED INTO TOOLS 4786 03:31:15,312 --> 03:31:17,181 AND TECHNOLOGIES TO MODIFY CELL 4787 03:31:17,181 --> 03:31:20,384 AND TISSUE FUNCTION. QUANTUM 4788 03:31:20,384 --> 03:31:22,286 TECHNOLOGIES AND SENSES IN 4789 03:31:22,286 --> 03:31:24,121 PARTICULAR COULD BE TO NEW 4790 03:31:24,121 --> 03:31:26,356 TECHNOLOGIES TO AFFECT HEALTH 4791 03:31:26,356 --> 03:31:29,827 OUTCOMES. DISCOVERIES IN 4792 03:31:29,827 --> 03:31:31,929 CHEMICAL MATERIALS COULD BE 4793 03:31:31,929 --> 03:31:34,498 TURNED TO SCAFFOLDS TO MODIFY OR 4794 03:31:34,498 --> 03:31:36,066 ENHANCE TISSUE FUNCTION AND 4795 03:31:36,066 --> 03:31:36,734 MATERIALS WITH PROPERTYIES CAN 4796 03:31:36,734 --> 03:31:42,439 BE USED TO IMPROVE BIOMEDICAL 4797 03:31:42,439 --> 03:31:45,476 IMAGING. IN SUMMARY I HOPE I WAS 4798 03:31:45,476 --> 03:31:48,645 ABLE TO CONVINCE YOU THIS UNIQUE 4799 03:31:48,645 --> 03:31:50,214 APPROACH TO COLLABORATION WILL 4800 03:31:50,214 --> 03:31:53,016 USHER IN A NEW PHASE WHERE WE 4801 03:31:53,016 --> 03:31:54,384 ARE ABLE TO TAKE FOUNDATIONAL 4802 03:31:54,384 --> 03:31:56,353 KNOWLEDGE OUT OF ITS SILO AND 4803 03:31:56,353 --> 03:31:58,322 BRING TOWARDS APPLY 2 4804 03:31:58,322 --> 03:32:00,791 DEVELOPMENT FOR DIAGNOSIS, 4805 03:32:00,791 --> 03:32:02,726 THERAPY AND PREVENTION OF 4806 03:32:02,726 --> 03:32:04,194 DISEASE. THANK YOU, I'M HAPPY TO 4807 03:32:04,194 --> 03:32:11,368 ANSWER ANY QUESTIONS. 4808 03:32:11,368 --> 03:32:19,409 4809 03:32:19,409 --> 03:32:29,486 4810 03:32:36,059 --> 03:32:37,594 >> WOULD YOU LIKE TO CALL ON 4811 03:32:37,594 --> 03:32:37,828 HANDS? 4812 03:32:37,828 --> 03:32:41,198 >> YES, KATHY. 4813 03:32:41,198 --> 03:32:43,400 4814 03:32:43,400 --> 03:32:45,803 >> YES. I THINK THIS IS A 4815 03:32:45,803 --> 03:32:50,541 TERRIFIC IDEA TO LEVERAGE THIS 4816 03:32:50,541 --> 03:32:53,944 SUCCESSFUL TOOL TO FACILITATE 4817 03:32:53,944 --> 03:32:55,312 BRIDGING THIS GAP. I LOVE THIS 4818 03:32:55,312 --> 03:32:57,014 IDEA. I HAD A QUESTION ABOUT 4819 03:32:57,014 --> 03:33:00,317 KIND OF REVIEWS FOR THE PHASE 1 4820 03:33:00,317 --> 03:33:03,787 AND PHASE 2, SINCE IT WILL BE 4821 03:33:03,787 --> 03:33:04,955 INTERAGENCY. WOULD DIVISION BE 4822 03:33:04,955 --> 03:33:07,991 -- LET'S SAY PARTNER WITH NSF. 4823 03:33:07,991 --> 03:33:12,296 NIH AND NSF STAFF WOULD BOTH 4824 03:33:12,296 --> 03:33:15,933 REVIEW THE PROPOSALS FOR PHASE 1 4825 03:33:15,933 --> 03:33:17,134 AND 2 OR CLEAR TRANSITION 4826 03:33:17,134 --> 03:33:18,869 BETWEEN WHO IS MAKING THOSE 4827 03:33:18,869 --> 03:33:20,370 CALLS, WHICH AGENCY. HOW WOULD 4828 03:33:20,370 --> 03:33:21,438 THAT BE NAVIGATED? 4829 03:33:21,438 --> 03:33:23,574 >> THAN BES FOR THE QUESTION, 4830 03:33:23,574 --> 03:33:27,311 YES. SO THERE WILL BE ONE 4831 03:33:27,311 --> 03:33:30,914 REVIEW. IT WILL BE A JOINT 4832 03:33:30,914 --> 03:33:32,783 REVIEW. SAY NSF WE ARE 4833 03:33:32,783 --> 03:33:36,053 COLLABORATING WITH. THEY WOULD 4834 03:33:36,053 --> 03:33:38,589 COME TOGETHER AND DO REVIEW AND 4835 03:33:38,589 --> 03:33:40,390 DECIDE ON WHICH APPLICATIONS 4836 03:33:40,390 --> 03:33:44,261 WOULD BE FUNDED AT BOTH AGENCIES 4837 03:33:44,261 --> 03:33:46,129 BECAUSE PARTNER AGENCY WOULD 4838 03:33:46,129 --> 03:33:50,000 NEED TO AGREE TO PHASE 1 OF 4839 03:33:50,000 --> 03:33:53,804 PROJECT. N NIH WITH PHASE II. 4840 03:33:53,804 --> 03:33:56,840 WOULD BE SINGLE PACKAGE REVIEWED 4841 03:33:56,840 --> 03:33:58,408 IN JOINT COLLABORATION SO WE CAN 4842 03:33:58,408 --> 03:34:02,045 BOTH AGREE ON WHAT WE WANT TO 4843 03:34:02,045 --> 03:34:02,846 FUND JOINTLY. 4844 03:34:02,846 --> 03:34:03,647 >> THANK YOU. 4845 03:34:03,647 --> 03:34:05,249 >> CERTAINLY. 4846 03:34:05,249 --> 03:34:05,649 >> JENNIFER. 4847 03:34:05,649 --> 03:34:07,651 >> THANK YOU, I AGREE. THIS 4848 03:34:07,651 --> 03:34:09,653 IS A MARVELOUS IDEA. DOES SOLVE 4849 03:34:09,653 --> 03:34:12,389 A LONG-STANDING PROBLEM I SEE A 4850 03:34:12,389 --> 03:34:14,258 LOT. WHERE I SAID PEOPLE OVER IN 4851 03:34:14,258 --> 03:34:16,360 OUR BASIC SCIENCES OR PHYSICAL 4852 03:34:16,360 --> 03:34:18,228 SCIENCES WHO HAVE IDEAS WOULD 4853 03:34:18,228 --> 03:34:20,364 LOVE TO GET ENGAGED WITH NIH, 4854 03:34:20,364 --> 03:34:22,332 HAVE NO IDEA, NO TRACK RECORD, 4855 03:34:22,332 --> 03:34:24,601 ET CETERA, WE CAN TRY TO 4856 03:34:24,601 --> 03:34:26,169 COLLABORATION. THAT MAY HAVE 4857 03:34:26,169 --> 03:34:28,939 MIXED RESULTS. SO I UNDERSTAND 4858 03:34:28,939 --> 03:34:30,440 THIS IS A CONCEPT CLEARANCE. 4859 03:34:30,440 --> 03:34:31,808 PRETTY HIGH LEVEL BUT DO YOU 4860 03:34:31,808 --> 03:34:33,844 HAVE IDEA WHO PARTNERS WOULD BE 4861 03:34:33,844 --> 03:34:36,513 AND WOULD YOU EXPECT TO HAVE 4862 03:34:36,513 --> 03:34:38,181 CALLS FOR VERY SPECIFIC TYPES OF 4863 03:34:38,181 --> 03:34:39,549 TECHNOLOGIES YOU WANT THE FOCUS 4864 03:34:39,549 --> 03:34:40,817 ON TRANSLATE ING?ENTER 4865 03:34:40,817 --> 03:34:41,885 >> THANK YOU FOR THE 4866 03:34:41,885 --> 03:34:43,687 QUESTION, YES. SO AGAIN, THIS IS 4867 03:34:43,687 --> 03:34:46,223 A HIGH-LEVEL CONCEPT. WE CAN 4868 03:34:46,223 --> 03:34:49,092 ENVISION ANY FEDERAL AGENCY WHO 4869 03:34:49,092 --> 03:34:50,861 FOCUSES ON MORE BASIC SCIENCE 4870 03:34:50,861 --> 03:34:53,363 COULD BE A GOOD PARTNER FOR 4871 03:34:53,363 --> 03:34:55,265 THIS. KATHY BROUGHT UP NSF, THAT 4872 03:34:55,265 --> 03:34:58,769 WOULD BE A GOOD PARTNER, DOD, 4873 03:34:58,769 --> 03:35:01,371 DOE, ANY AGENCY THAT HAS 4874 03:35:01,371 --> 03:35:02,039 FOUNDATIONAL RESEARCH WOULD BE 4875 03:35:02,039 --> 03:35:06,009 GOOD PARTNER. THAT SAID THIS 4876 03:35:06,009 --> 03:35:08,011 EFFORT REQUIRES SOME LEGAL 4877 03:35:08,011 --> 03:35:10,147 FRAMEWORK SUCH AS PRESENCE OF 4878 03:35:10,147 --> 03:35:14,151 MOUs. WE DO HAVE ONE WITH NSF 4879 03:35:14,151 --> 03:35:17,788 CURRENTLY. AS LONG AS WE HAVE AN 4880 03:35:17,788 --> 03:35:20,691 EXISTING MOU WITH PARTNER 4881 03:35:20,691 --> 03:35:25,796 AGENCY, WE ARE -- WE CAN 4882 03:35:25,796 --> 03:35:28,165 IMPLEMENT IN JOINT 4883 03:35:28,165 --> 03:35:29,366 COLLABORATIONSN. TERMS OF 4884 03:35:29,366 --> 03:35:31,101 ANNOUNCEMENTS IT WOULD FOCUS ON 4885 03:35:31,101 --> 03:35:33,870 SPECIFIC ANNOUNCEMENTS. THE IDEA 4886 03:35:33,870 --> 03:35:37,407 OF THE BIPHASIC WOULD BE SAME 4887 03:35:37,407 --> 03:35:39,076 BUT CAN TAKE AND REPURPOSE FOR 4888 03:35:39,076 --> 03:35:41,478 -- TO FOCUS ON ANY SORT OF 4889 03:35:41,478 --> 03:35:43,113 EMERGING TECHNOLOGY OR ANY 4890 03:35:43,113 --> 03:35:46,950 SUBTOPIC UNDER EMERGING 4891 03:35:46,950 --> 03:35:50,053 TECHNOLOGY SO IT IS VERY 4892 03:35:50,053 --> 03:35:53,123 FLEXIBLE. THINK OF IT AS A 4893 03:35:53,123 --> 03:35:54,891 PARENT PARENT ANNOUNCEMENT. YOU 4894 03:35:54,891 --> 03:35:58,996 CAN REPURPOSE IT FOR ANY TOPIC, 4895 03:35:58,996 --> 03:36:03,767 IF YOU LIKE. I GUESS JUST SORT 4896 03:36:03,767 --> 03:36:06,203 OF GOING ALONG LINES OF THAT, 4897 03:36:06,203 --> 03:36:08,138 ONE OF THE THINGS I OFTEN SEE 4898 03:36:08,138 --> 03:36:10,407 THERE ARE FOUNDATIONAL 4899 03:36:10,407 --> 03:36:13,377 TECHNOLOGIES. BUT THOSE 4900 03:36:13,377 --> 03:36:14,311 INVESTIGATORS DON'T REALLY KNOW 4901 03:36:14,311 --> 03:36:17,314 WHERE THEY CAN BE APPLIED SO 4902 03:36:17,314 --> 03:36:18,281 SORT OF DEVELOPING TECHNOLOGY 4903 03:36:18,281 --> 03:36:21,718 WITHOUT AN APPLICATION. SO LIKE 4904 03:36:21,718 --> 03:36:25,389 I GUESS I WONDER WILL THERE BE 4905 03:36:25,389 --> 03:36:29,726 SOME WAY TO ALMOST -- MATCH OR 4906 03:36:29,726 --> 03:36:32,229 MARY TO HELP THEM FACILITATE 4907 03:36:32,229 --> 03:36:34,931 THAT APPLICATION SPACE WITHIN 4908 03:36:34,931 --> 03:36:37,034 THE NIH OR MAYBE IT WILL BE 4909 03:36:37,034 --> 03:36:39,703 BUILT INTO THE PROPOSALS. BUT IT 4910 03:36:39,703 --> 03:36:42,639 IS SOMETHING THAT I EVEN AS -- 4911 03:36:42,639 --> 03:36:44,074 NAVIGATING AS ME TRYING TO 4912 03:36:44,074 --> 03:36:48,879 ALIGN, HEY THS, THIS COULD BE 4913 03:36:48,879 --> 03:36:49,579 APPLIED TO.ENTERTHIS SOMETHING I 4914 03:36:49,579 --> 03:36:51,782 SPENT A LOT OF TIME ON. 4915 03:36:51,782 --> 03:36:54,584 >> ABSOLUTELY, VALID POINT . 4916 03:36:54,584 --> 03:36:56,219 THE BURDEN FOR THIS IS ON THE 4917 03:36:56,219 --> 03:36:57,120 INVESTIGATOR BECAUSE THEY WILL 4918 03:36:57,120 --> 03:36:59,189 NEED TO PUT TOGETHER APPLICATION 4919 03:36:59,189 --> 03:37:02,859 FOR BOTH PHASE I AND PHASE II SO 4920 03:37:02,859 --> 03:37:04,361 REALLY NEED TO HAVE THOUGHT 4921 03:37:04,361 --> 03:37:05,896 ABOUT WHAT TECHNOLOGY DURING 4922 03:37:05,896 --> 03:37:07,330 PHASE I AND WHAT ARE SOME OF 4923 03:37:07,330 --> 03:37:08,698 POTENTIAL APPLICATIONS THEY 4924 03:37:08,698 --> 03:37:12,169 COULD PURSUE AT THE NIH. THAT 4925 03:37:12,169 --> 03:37:15,439 SAID AS YOU MENTIONED IT IS HARD 4926 03:37:15,439 --> 03:37:16,840 TO THINK THAT FAR AHEAD IN 4927 03:37:16,840 --> 03:37:20,043 FUTURE SO WE ENVISION WE WILL BE 4928 03:37:20,043 --> 03:37:23,346 HOLDING -- IF WE DECIDE TO GO 4929 03:37:23,346 --> 03:37:25,615 PURSUIT A SPECIFIC ANNOUNCEMENT 4930 03:37:25,615 --> 03:37:27,317 IN THIS MECHANISM IN FUTURE WE 4931 03:37:27,317 --> 03:37:30,454 WILL BE HOLDING WEBINARS AND 4932 03:37:30,454 --> 03:37:32,022 STOCKILY ENCOURAGE INVESTIGATORS 4933 03:37:32,022 --> 03:37:37,360 TO GET IN TOUCH WITH PARTNER 4934 03:37:37,360 --> 03:37:38,662 AGENCY STAFF AND NIH STAFF 4935 03:37:38,662 --> 03:37:40,697 BECAUSE IT IS HARD TO THINK IN 4936 03:37:40,697 --> 03:37:43,166 TERMS AND THAT LONG-TERM OF TIME 4937 03:37:43,166 --> 03:37:45,135 FRAME. WE WILL PROVIDE THE 4938 03:37:45,135 --> 03:37:46,770 NECESSARY GUIDANCE AND RESOURCES 4939 03:37:46,770 --> 03:37:49,806 FOR THEM TO MAKE THAT GAP. 4940 03:37:49,806 --> 03:37:52,542 AGAIN, THE PHASE 1 AND PHASE 2, 4941 03:37:52,542 --> 03:37:54,411 THEY WILL NEED TO CONCEIVE AS 4942 03:37:54,411 --> 03:37:56,480 WELL AS TRANSITION MILESTONE SO 4943 03:37:56,480 --> 03:37:58,648 SET UP THEIR OWN SUCCESS METRICS 4944 03:37:58,648 --> 03:38:01,351 TO TRANSITION TO PHASE 2 AS WELL 4945 03:38:01,351 --> 03:38:02,752 AS THINKING THAT FAR AHEAD 4946 03:38:02,752 --> 03:38:05,255 TOWARDS THE NIH FOR THOSE 4947 03:38:05,255 --> 03:38:06,389 INVESTIGATORS ESPECIALLY WHO 4948 03:38:06,389 --> 03:38:09,226 FALL UNDER THE BASIC SCIENCE 4949 03:38:09,226 --> 03:38:09,893 FOUNDATIONAL SCIENCE DOMAIN AT 4950 03:38:09,893 --> 03:38:11,495 THE AGENCY. I HOPE THAT ANSWERS 4951 03:38:11,495 --> 03:38:12,429 YOUR QUESTION. 4952 03:38:12,429 --> 03:38:16,867 >> YAH, THANKS. 4953 03:38:16,867 --> 03:38:17,033 4954 03:38:17,033 --> 03:38:17,467 >> DAN? 4955 03:38:17,467 --> 03:38:20,337 >> JUST TO FOLLOW UP ON WHAT 4956 03:38:20,337 --> 03:38:24,441 YOU WERE JUST DISCUSSING, I 4957 03:38:24,441 --> 03:38:25,942 WONDER WHETHER IT WOULD BE SORT 4958 03:38:25,942 --> 03:38:28,778 OF A NEAT ADDITION TO THIS 4959 03:38:28,778 --> 03:38:30,914 PROGRAM TO START COMPILING LISTS 4960 03:38:30,914 --> 03:38:33,950 OF PEOPLE WHO ARE ON THE MORE 4961 03:38:33,950 --> 03:38:35,652 TRANSLATIONAL SIDE OF SOME OF 4962 03:38:35,652 --> 03:38:38,255 THE EVERY YAS. YOU SAID YOU WERE 4963 03:38:38,255 --> 03:38:39,689 FOCUSSING ON SPECIFIC 4964 03:38:39,689 --> 03:38:41,324 ANNOUNCEMENTS SO WHY NOT GATHER 4965 03:38:41,324 --> 03:38:43,326 A LIST OF PEOPLE WHO HAVE SORT 4966 03:38:43,326 --> 03:38:46,129 OF A -- MORE OF A TRANSLATIONAL 4967 03:38:46,129 --> 03:38:47,831 HISTORY SO IF PEOPLE CALL YOU UP 4968 03:38:47,831 --> 03:38:49,900 AND SAY HEY, LISTEN, I HAVE THIS 4969 03:38:49,900 --> 03:38:51,902 GREAT IDEA BUT I'M NOT EXACTLY 4970 03:38:51,902 --> 03:38:53,637 SURE THE BEST PERSON TO WORK 4971 03:38:53,637 --> 03:38:57,507 WITH. YOU'VE GOT THAT CAPACITY. 4972 03:38:57,507 --> 03:39:01,077 I'M JUST PARROTING THE IDEA BUT 4973 03:39:01,077 --> 03:39:04,147 IT SEEMS TO ME SORT OF NEAT 4974 03:39:04,147 --> 03:39:04,481 OPPORTUNITY. 4975 03:39:04,481 --> 03:39:05,582 >> THANK YOU FOR THE 4976 03:39:05,582 --> 03:39:07,918 SUGGESTION, ABSOLUTELY. 4977 03:39:07,918 --> 03:39:09,819 >> I THINK ALSO ANOTHER NEAT 4978 03:39:09,819 --> 03:39:11,521 OPPORTUNITY FOR STORY TELLING 4979 03:39:11,521 --> 03:39:13,156 FOR SUCCESSES IN THIS PROGRAM, I 4980 03:39:13,156 --> 03:39:15,258 KNOW YOU HAVE TO ESTABLISH 4981 03:39:15,258 --> 03:39:18,562 BEFORE YOU HAVE SUCCESS T BUT 4982 03:39:18,562 --> 03:39:19,963 MAKES FOR A WONDERFUL STORY, 4983 03:39:19,963 --> 03:39:23,600 THIS HAND-OFF FACILITATED BY 4984 03:39:23,600 --> 03:39:28,238 MULTIPLE, YOU KNOW, MULTIPLE 4985 03:39:28,238 --> 03:39:30,106 INSTITUTES. AND PRESUMABLY 4986 03:39:30,106 --> 03:39:34,144 CULMINATING IN SOME DELIVERABLE 4987 03:39:34,144 --> 03:39:38,782 TECHNOLOGY. SO I THINK NIBIB -- 4988 03:39:38,782 --> 03:39:42,152 IF IT PLAYS ROLE NOT AS FINAL 4989 03:39:42,152 --> 03:39:43,787 RECIPIENT BUT AS FACILITATOR 4990 03:39:43,787 --> 03:39:46,790 THAT IS A NICE PART OF THE STORY 4991 03:39:46,790 --> 03:39:48,959 FOR NIBIB. 4992 03:39:48,959 --> 03:39:51,695 >> YES, THANK YOU. 4993 03:39:51,695 --> 03:39:52,529 4994 03:39:52,529 --> 03:39:56,766 >> THANKS, BRUCE. 4995 03:39:56,766 --> 03:39:59,936 >> SO MAYBE IF ANYBODY HAS 4996 03:39:59,936 --> 03:40:01,571 ANY MORE COMMENTS, MAYBE YOU 4997 03:40:01,571 --> 03:40:03,707 SHOULD SPEAK. I JUST WAS GOING 4998 03:40:03,707 --> 03:40:07,143 TO WRAP SOME STUFF UP WITH A 4999 03:40:07,143 --> 03:40:11,481 PERSONAL PERSPECTIVE -- 5000 03:40:11,481 --> 03:40:13,750 >> IF I MAY PICK YOU UP ON 5001 03:40:13,750 --> 03:40:16,353 YOUR HONOR, ON BE HALF OF NIBIB 5002 03:40:16,353 --> 03:40:18,054 THAT HAS BEEN QUITE THE GROUP 5003 03:40:18,054 --> 03:40:19,956 EFFORT TO ESTABLISH A UNIQUE 5004 03:40:19,956 --> 03:40:20,957 PATHWAY. IT INVOLVED US OF 5005 03:40:20,957 --> 03:40:24,628 COURSE HAVING TO DO A LOT OF 5006 03:40:24,628 --> 03:40:25,528 ADMINISTRATIVE RESEARCH AT NIH 5007 03:40:25,528 --> 03:40:28,465 TO FIGURE OUT IF IT IS ALLOWED, 5008 03:40:28,465 --> 03:40:32,302 CHIEF OF GRANTS MANAGEMENT AND 5009 03:40:32,302 --> 03:40:33,937 ONCALI WAS INVOLVED AND INVOLVED 5010 03:40:33,937 --> 03:40:35,272 THE NIH OFFICE DIRECTOR. WE 5011 03:40:35,272 --> 03:40:36,640 COULD REACH OUT TO COLLEAGUES 5012 03:40:36,640 --> 03:40:38,475 AND NEED TO FIGURE OUT IF IT IS 5013 03:40:38,475 --> 03:40:40,143 EVEN LEGAL. IT IS, OF COURSE. 5014 03:40:40,143 --> 03:40:41,811 THANK YOU SO MUCH. I JUST WANTED 5015 03:40:41,811 --> 03:40:43,747 TO MENTION THAT BRUCE, GIVE CUE 5016 03:40:43,747 --> 03:40:47,350 DOES TO THE WHOLE TEAM WORKING 5017 03:40:47,350 --> 03:40:49,753 ON THIS. YAH, NO. THIS IS 5018 03:40:49,753 --> 03:40:54,124 AMAZING. HOPEFULLY GAME 5019 03:40:54,124 --> 03:40:57,727 CHANGING. WHEN I WAS AN 5020 03:40:57,727 --> 03:41:00,063 INVESTIGATOR, LIKE ALL YOU, I 5021 03:41:00,063 --> 03:41:03,800 WOULD WRITE GRANTS TO NHS, DOD, 5022 03:41:03,800 --> 03:41:08,872 DOE AND I REALLY WISHED FOR SOME 5023 03:41:08,872 --> 03:41:10,907 INTEGRATION. I WOULDN'T HAVE TO 5024 03:41:10,907 --> 03:41:12,475 COMPARTMENT MENTAL IZE. MAYBE IT 5025 03:41:12,475 --> 03:41:16,346 IS GOOD TO HAVE THOSE 5026 03:41:16,346 --> 03:41:20,483 COMPARTMENTS SOMETIME BUT SO 5027 03:41:20,483 --> 03:41:22,485 MUCH SYNERGY ESPECIALLY THOSE 5028 03:41:22,485 --> 03:41:23,820 DEVELOPING FUNDAMENTAL 5029 03:41:23,820 --> 03:41:24,888 TECHNOLOGIES. IT WOULD BE NICE 5030 03:41:24,888 --> 03:41:27,123 TO SORT OF HAVE THAT ENTIRE 5031 03:41:27,123 --> 03:41:28,958 FUNDAMENTAL TO APPLIED SUPPORTED 5032 03:41:28,958 --> 03:41:39,936 IN A KNOWI INTEGRATED WEATAY AN 5033 03:41:39,936 --> 03:41:41,838 DIVIDING U US AND WE HAVE TO 5034 03:41:41,838 --> 03:41:43,473 SPEND THE TIME TO WRITE 5035 03:41:43,473 --> 03:41:45,208 PROPOSALS TO THE ALL THE 5036 03:41:45,208 --> 03:41:47,077 DIFFERENT AGENCIES. IF THIS CAN 5037 03:41:47,077 --> 03:41:48,244 GET GOING IT WOULD BE WONDERFUL. 5038 03:41:48,244 --> 03:41:52,048 I THINK IN THE BIOMATERIALS 5039 03:41:52,048 --> 03:41:54,784 SPACE AND OUR -- AS WE POINTED 5040 03:41:54,784 --> 03:41:57,654 OUT, AFFILIATED DEVICES RELATED 5041 03:41:57,654 --> 03:42:00,023 TO THOSE BIOMATERIALS THAT NEED 5042 03:42:00,023 --> 03:42:03,827 TO BE STANDARDIZED AND WIDELY 5043 03:42:03,827 --> 03:42:05,161 DISSEMINATED TO DRIVE DISCOVERY, 5044 03:42:05,161 --> 03:42:07,330 THIS COULD BE SO IMPACTFUL SO WE 5045 03:42:07,330 --> 03:42:08,865 ARE EAGERLY LOOKING FORWARD TO 5046 03:42:08,865 --> 03:42:10,834 SEEING HOW YOU NAVIGATE THIS, 5047 03:42:10,834 --> 03:42:11,134 THANK YOU. 5048 03:42:11,134 --> 03:42:12,235 >> THANK YOU, BRUCE. 5049 03:42:12,235 --> 03:42:15,472 >> THANK YOU, EVERYONE. 5050 03:42:15,472 --> 03:42:18,708 5051 03:42:18,708 --> 03:42:20,877 >> GREAT THANK YOU SO MUCH, 5052 03:42:20,877 --> 03:42:24,547 EVER. THANK YOU VERY MUCH, TUBA. 5053 03:42:24,547 --> 03:42:29,152 SO THAT CONCLUDES OUR OPEN 5054 03:42:29,152 --> 03:42:31,388 SESSION. BRUCE, BEFORE I 5055 03:42:31,388 --> 03:42:32,622 OFFICIALLY CLOSE OPEN SESSION 5056 03:42:32,622 --> 03:42:33,990 DID YOU HAVE ANY FINAL REMARKS 5057 03:42:33,990 --> 03:42:37,761 YOU MIGHT WANT TO MAKE? 5058 03:42:37,761 --> 03:42:38,428 5059 03:42:38,428 --> 03:42:39,696 >> BRUCE TROMBERG: SURE THANKS, 5060 03:42:39,696 --> 03:42:41,898 DAVE. AGAIN, I WOULD LIKE TO 5061 03:42:41,898 --> 03:42:43,433 THANK COUNCIL AND ALL OUR 5062 03:42:43,433 --> 03:42:44,901 SUPPORTERS FOR HANGING ON THE 5063 03:42:44,901 --> 03:42:48,238 LINE ON THE VIDEO CAST. I THINK 5064 03:42:48,238 --> 03:42:50,407 THIS WAS A REASONABLY GOOD 5065 03:42:50,407 --> 03:42:52,242 SNAPSHOT FOR YOU, WITH NOT TOO 5066 03:42:52,242 --> 03:42:54,677 MUCH INFORMATION CONTENT AND 5067 03:42:54,677 --> 03:42:57,947 SOME COHERENT THEMES EMERGING. I 5068 03:42:57,947 --> 03:42:59,849 LOOK FORWARD TO JOINING EVERYONE 5069 03:42:59,849 --> 03:43:04,587 LIVE, IN-PERSON IN MAY. EVEN IF 5070 03:43:04,587 --> 03:43:06,956 YOU ARE ROTATING OFF COUNCIL AND 5071 03:43:06,956 --> 03:43:08,358 WE HAVE SOME COUNCILMEMBERS WHO 5072 03:43:08,358 --> 03:43:12,695 ARE, WE ENCOURAGE YOU TO COME 5073 03:43:12,695 --> 03:43:14,998 VISIT. MY AMBITION AT SOME POINT 5074 03:43:14,998 --> 03:43:18,101 IS HAVE A COUNCIL REUNION. DAVE, 5075 03:43:18,101 --> 03:43:21,538 YOU WILL LET ME KNOW IF WE CAN 5076 03:43:21,538 --> 03:43:24,574 PUT THAT TOGETHER AND DO IT ON A 5077 03:43:24,574 --> 03:43:26,776 PERIODIC BASIC. WE HAVE SPECIFIC 5078 03:43:26,776 --> 03:43:28,578 MEETINGS BUT WE ARE INTERESTED 5079 03:43:28,578 --> 03:43:30,146 IN YOUR SUGGESTION FOR WAYS TO 5080 03:43:30,146 --> 03:43:32,449 CONVENE OUR COMMUNITY. AS WE 5081 03:43:32,449 --> 03:43:34,484 OPEN BACK UP MORE FOR IN-PERSON 5082 03:43:34,484 --> 03:43:36,085 MEETINGS. AGAIN, THANKS TO ALL 5083 03:43:36,085 --> 03:43:37,454 OF YOU AND EVERYBODY ON THE 5084 03:43:37,454 --> 03:43:40,089 CALL. THANKS TO OUR AMAZING 5085 03:43:40,089 --> 03:43:43,026 NIBIB TEAM FOR ALL OF THE WORK 5086 03:43:43,026 --> 03:43:46,396 YOU HAVE DONE IN PREPARATION FOR 5087 03:43:46,396 --> 03:43:47,931 COUNCIL. ALL RIGHT. 5088 03:43:47,931 --> 03:43:49,065 >> THANK YOU SO MUCH, BRUCE. 5089 03:43:49,065 --> 03:43:51,034 BEFORE WE -- THANK YOU SO MUCH. 5090 03:43:51,034 --> 03:43:52,268 BEFORE WE OFFICIALLY ADJOURN I 5091 03:43:52,268 --> 03:43:54,204 WOULD LIKE TO REMIND THE 5092 03:43:54,204 --> 03:43:55,572 COUNCILMEMBERS AND MY COLLEAGUES 5093 03:43:55,572 --> 03:43:57,307 ON THE NIBIB STAFF WHO ATTEND 5094 03:43:57,307 --> 03:43:58,875 THE CLOSED SESSION, IT IS A 5095 03:43:58,875 --> 03:44:00,210 SEPARATE MEETING REQUEST FROM 5096 03:44:00,210 --> 03:44:02,712 PAM WITH A SEPARATE LINK. SO WE 5097 03:44:02,712 --> 03:44:06,049 WILL BEGIN -- LET'S TAKE A 5098 03:44:06,049 --> 03:44:07,750 15-MINUTE BREAK. LET'S BEGIN 5099 03:44:07,750 --> 03:44:09,819 CLOSED SESSION AT 3:00 P.M. 5100 03:44:09,819 --> 03:44:11,788 EASTERN TIME, PLEASE. SO NOW 5101 03:44:11,788 --> 03:44:13,957 I'LL OFFICIALLY ADJOURN THE OPEN 5102 03:44:13,957 --> 03:44:17,327 SESSION. I'D LIKE TO THANK ALL 5103 03:44:17,327 --> 03:44:19,896 OF VISITORS TO ATTEND THE VIDEO 5104 03:44:19,896 --> 03:44:21,397 CAST, HOPEFULLY WE CAN SEE YOU 5105 03:44:21,397 --> 03:44:23,066 AT THE NEXT MEETING. THE THIS 5106 03:44:23,066 --> 03:44:25,134 OPEN MEETING OF THE 64TH MEETING 5107 03:44:25,134 --> 03:44:27,871 OF THE NIBIB NATIONAL ADVISORY 5108 03:44:27,871 --> 03:44:29,205 COUNCIL IS HEREBY ADJOURNED. 5109 03:44:29,205 --> 03:44:29,672 THANK YOU, EVERYONE. 5110 03:44:29,672 --> 03:44:29,772 5111 03:45:13,049 --> 03:45:23,760 [MEETING ADJOURNED AT 1:45 CS]